0001628908-18-000083.txt : 20181108 0001628908-18-000083.hdr.sgml : 20181108 20181108161839 ACCESSION NUMBER: 0001628908-18-000083 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 99 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181108 DATE AS OF CHANGE: 20181108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evolent Health, Inc. CENTRAL INDEX KEY: 0001628908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 320454912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37415 FILM NUMBER: 181169927 BUSINESS ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-389-6000 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 10-Q 1 evh09301810-q.htm 10-Q Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________
FORM 10-Q
_________________________
  
(Mark One)
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
For the quarterly period ended September 30, 2018
OR
 
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
For the transition period from              to               
 
Commission File Number:  001-37415
_________________________
 Evolent Health, Inc.
(Exact name of registrant as specified in its charter)
_________________________
Delaware
32-0454912
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
 
 
800 N. Glebe Road, Suite 500, Arlington, Virginia
22203
(Address of principal executive offices)
(Zip Code)
  
(571) 389-6000
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name, former address and former fiscal year, if changed since last report.)
_________________________
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐
Smaller reporting company ☐ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No  ☒
 
As of November 5, 2018, there were 78,341,481 shares of the registrant’s Class A common stock outstanding and 3,885,947 shares of the registrant’s Class B common stock outstanding.



Evolent Health, Inc.
Table of Contents






Explanatory Note

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, “Evolent,” the “Company,” “we,” “our” and “us” refer to Evolent Health, Inc. and its consolidated subsidiaries. Evolent Health LLC, a subsidiary of Evolent Health, Inc. through which we conduct our operations, has owned all of our operating assets and substantially all of our business since inception. Evolent Health, Inc. is a holding company and its principal asset is all of the Class A common units of Evolent Health LLC.

FORWARD-LOOKING STATEMENTS - CAUTIONARY LANGUAGE
 
Certain statements made in this report and in other written or oral statements made by us or on our behalf are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”).  A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like:  “believe,” “anticipate,” “expect,” “estimate,” “aim,” “predict,” “potential,” “continue,” “plan,” “project,” “will,” “should,” “shall,” “may,” “might” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance.  In particular, these include statements relating to future actions, trends in our businesses, prospective services, future performance or financial results and the outcome of contingencies, such as legal proceedings.  We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.
 
These statements are only predictions based on our current expectations and projections about future events. Forward-looking statements involve risks and uncertainties that may cause actual results, level of activity, performance or achievements to differ materially from the results contained in the forward-looking statements.  Risks and uncertainties that may cause actual results to vary materially, some of which are described within the forward-looking statements, include, among others: 

the structural change in the market for health care in the United States;
uncertainty in the health care regulatory framework;
uncertainty in the public exchange market;
the uncertain impact of CMS waivers to Medicaid rules;
the uncertain impact of the results of the 2018 congressional, state and local elections, as well as subsequent elections, may have on health care laws and regulations;
our ability to effectively manage our growth;
the significant portion of revenue we derive from our largest partners, and the potential loss, termination or renegotiation of customer contracts;
our ability to offer new and innovative products and services;
risks related to completed and future acquisitions, investments and alliances, including the acquisition of assets from New Mexico Health Connections (“NMHC”) and the acquisitions of Valence Health Inc., excluding Cicerone Health Solutions, Inc. (“Valence Health”), Aldera Holdings, Inc. (“Aldera”) and NCIS Holdings, Inc. (“New Century Health”), which may be difficult to integrate, divert management resources, result in unanticipated costs or dilute our stockholders;
certain risks and uncertainties associated with the acquisition of assets from NMHC and the acquisitions of Valence Health, Aldera and New Century Health, including future revenues may be less than expected, the timing and extent of new lives expected to come onto the platform may not occur as expected and the expected results of Evolent may not be impacted as anticipated;
risks relating to our ability to maintain profitability for our and New Century Health’s performance-based contracts and products;
the growth and success of our partners, which is difficult to predict and is subject to factors outside of our control, including premium pricing reductions, selection bias in at-risk membership and the ability to control and, if necessary, reduce health care costs, particularly in New Mexico;
our ability to attract new partners;
the increasing number of risk-sharing arrangements we enter into with our partners;
our ability to recover the significant upfront costs in our partner relationships;
our ability to estimate the size of our target market;
our ability to maintain and enhance our reputation and brand recognition;
consolidation in the health care industry;
competition which could limit our ability to maintain or expand market share within our industry;
risks related to governmental payor audits and actions, including whistleblower claims;
our ability to partner with providers due to exclusivity provisions in our contracts;
restrictions and penalties as a result of privacy and data protection laws;
adequate protection of our intellectual property, including trademarks;
any alleged infringement, misappropriation or violation of third-party proprietary rights;
our use of “open source” software;
our ability to protect the confidentiality of our trade secrets, know-how and other proprietary information;
our reliance on third parties and licensed technologies;
our ability to use, disclose, de-identify or license data and to integrate third-party technologies;
data loss or corruption due to failures or errors in our systems and service disruptions at our data centers;

1


online security risks and breaches or failures of our security measures;
our reliance on Internet infrastructure, bandwidth providers, data center providers, other third parties and our own systems for providing services to our users;
our reliance on third-party vendors to host and maintain our technology platform;
our ability to contain health care costs, implement increases in premium rates on a timely basis, maintain adequate reserves for policy benefits or maintain cost effective provider agreements;
risks related to our offshore operations;
the risk of a significant reduction in the enrollment in our health plan;
our dependency on our key personnel, and our ability to attract, hire, integrate and retain key personnel;
the risk of potential future goodwill impairment on our results of operations;
our indebtedness and our ability to obtain additional financing;
our ability to achieve profitability in the future;
the requirements of being a public company;
our adjusted results may not be representative of our future performance;
the risk of potential future litigation;
our holding company structure and dependence on distributions from Evolent Health LLC;
our obligations to make payments to certain of our pre-IPO investors for certain tax benefits we may claim in the future;
our ability to utilize benefits under the tax receivables agreement described herein;
our ability to realize all or a portion of the tax benefits that we currently expect to result from past and future exchanges of Class B common units of Evolent Health LLC for our Class A common stock, and to utilize certain tax attributes of Evolent Health Holdings and an affiliate of TPG;
distributions that Evolent Health LLC will be required to make to us and to the other members of Evolent Health LLC;
our obligations to make payments under the tax receivables agreement that may be accelerated or may exceed the tax benefits we realize;
different interests among our pre-IPO investors, or between us and our pre-IPO investors;
the terms of agreements between us and certain of our pre-IPO investors;
the potential volatility of our Class A common stock price;
the potential decline of our Class A common stock price if a substantial number of shares are sold or become available for sale or if a large number of Class B common units are exchanged for shares of Class A common stock;
provisions in our second amended and restated certificate of incorporation and second amended and restated by-laws and provisions of Delaware law that discourage or prevent strategic transactions, including a takeover of us;
the ability of certain of our investors to compete with us without restrictions;
provisions in our second amended and restated certificate of incorporation which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees;
our intention not to pay cash dividends on our Class A common stock;
our ability to maintain effective internal control over financial reporting;
our expectations regarding the additional management attention and costs that will be required as we have transitioned from an “emerging growth company” to a “large accelerated filer”; and
our lack of public company operating experience.

The risks included here are not exhaustive.  Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Our Annual Report on Form 10-K for the year ended December 31, 2017 (the “2017 Form 10-K”), this Form 10-Q and other documents filed with the SEC include additional factors that could affect our businesses and financial performance.  Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.
 
Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.  Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results.  In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this report.

2


PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
EVOLENT HEALTH, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except share data)

 
 
As of
 
 
As of
 
 
September 30,
December 31,
  
 
2018
 
 
2017
 
ASSETS
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
221,837

 
 
$
238,433

 
Restricted cash and restricted investments
 
42,328

 
 
62,398

 
Accounts receivable, net (amounts related to affiliates: 2018 - $7,774; 2017 - $3,358)
 
60,054

 
 
48,947

 
Prepaid expenses and other current assets (amounts related to affiliates: 2018 - $48; 2017 - $25)
 
14,667

 
 
8,404

 
Notes receivable
 
6,000

 
 
20,000

 
Contract assets
 
3,705

 
 

 
Total current assets
 
348,591

 
 
378,182

 
Restricted cash and restricted investments
 
3,394

 
 
3,287

 
Investments in and advances to equity method investees
 
5,672

 
 
1,531

 
Property and equipment, net
 
68,692

 
 
50,922

 
Prepaid expenses and other noncurrent assets (amounts related to affiliates: 2018 - $2,500; 2017 - $0)
 
15,181

 
 
9,328

 
Contract assets
 
1,000

 
 

 
Contract cost assets
 
14,252

 
 

 
Intangible assets, net
 
230,806

 
 
241,261

 
Goodwill
 
635,088

 
 
628,186

 
Total assets
 
$
1,322,676

 
 
$
1,312,697

 
 
 
 
 
 
 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
Accounts payable (amounts related to affiliates: 2018 - $1,425; 2017 - $10,284)
 
$
30,535

 
 
$
42,930

 
Accrued liabilities (amounts related to affiliates: 2018 - $4,812; 2017 - $719)
 
47,189

 
 
29,572

 
Accrued compensation and employee benefits
 
28,989

 
 
35,390

 
Deferred revenue
 
22,360

 
 
24,807

 
Claims reserves
 
10,338

 
 

 
Total current liabilities
 
139,411

 
 
132,699

 
Long-term debt, net of discount
 
122,082

 
 
121,394

 
Other long-term liabilities
 
10,885

 
 
9,861

 
Deferred tax liabilities, net
 
1,725

 
 
2,437

 
Total liabilities
 
274,103

 
 
266,391

 
 
 
 
 
 
 
 
Commitments and Contingencies (See Note 9)
 

 
 

 
 
 
 
 
 
 
 
Shareholders' Equity (Deficit)
 
 
 
 
 
 
Class A common stock - $0.01 par value; 750,000,000 shares authorized; 78,392,052 and 74,723,597
 
 
 
 
 
 
shares issued and outstanding as of September 30, 2018, and December 31, 2017, respectively
 
784

 
 
747

 
Class B common stock - $0.01 par value; 100,000,000 shares authorized; 765,646 and 2,653,544
 
 
 
 
 
 
shares issued and outstanding as of September 30, 2018, and December 31, 2017, respectively
 
8

 
 
27

 
Additional paid-in capital
 
971,341

 
 
924,153

 
Accumulated other comprehensive income (loss)
 
(264
)
 
 

 
Retained earnings (accumulated deficit)
 
66,696

 
 
85,952

 
Total shareholders' equity (deficit) attributable to Evolent Health, Inc.
 
1,038,565

 
 
1,010,879

 
Non-controlling interests
 
10,008

 
 
35,427

 
Total shareholders' equity (deficit)
 
1,048,573

 
 
1,046,306

 
Total liabilities and shareholders' equity (deficit)
 
$
1,322,676

 
 
$
1,312,697

 

See accompanying Notes to Consolidated Financial Statements
3


EVOLENT HEALTH, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(unaudited, in thousands, except per share data)

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018

2017
 
2018
 
2017
Revenue
 
 
 
 
 
 
 
Transformation services (1)
$
9,230

 
$
8,204

 
$
23,950

 
$
23,799

Platform and operations services (1)
118,094

 
99,708

 
341,258

 
297,422

Premiums
22,623

 

 
68,751

 

Total revenue
149,947

 
107,912

 
433,959

 
321,221

 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
expenses presented separately below) (1)
73,967

 
68,281

 
214,945

 
203,804

Claims expenses
16,992

 

 
52,169

 

Selling, general and administrative expenses (1)
59,566

 
45,834

 
172,495

 
150,474

Depreciation and amortization expenses
10,352

 
7,717

 
29,882

 
21,236

Change in fair value of contingent consideration and indemnification asset
100

 
100

 
(1,404
)
 
300

Total operating expenses
160,977

 
121,932

 
468,087

 
375,814

Operating income (loss)
(11,030
)
 
(14,020
)
 
(34,128
)
 
(54,593
)
Interest income
968

 
411

 
2,918

 
813

Interest expense
(853
)
 
(880
)
 
(2,561
)
 
(2,781
)
Income (loss) from equity method investees
(1,381
)
 
(369
)
 
(2,787
)
 
(1,446
)
Other income (expense), net
(124
)
 
15

 
(64
)
 
21

Income (loss) before income taxes and non-controlling interests
(12,420
)
 
(14,843
)
 
(36,622
)
 
(57,986
)
Provision (benefit) for income taxes
135

 
(1,714
)
 
29

 
(2,009
)
Net income (loss)
(12,555
)
 
(13,129
)
 
(36,651
)
 
(55,977
)
Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Net income (loss) attributable to Evolent Health, Inc.
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
 
 
 
 
 
 
 
 
Earnings (Loss) Available for Common Shareholders
 
 
 
 
 
 
 
Basic
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
Diluted
(12,429
)
 
(12,588
)
 
(35,971
)
 
(47,506
)
 
 
 
 
 
 
 
 
Earnings (Loss) per Common Share
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.18
)
 
$
(0.47
)
 
$
(0.78
)
Diluted
(0.16
)
 
(0.18
)
 
(0.47
)
 
(0.78
)
 
 
 
 
 
 
 
 
Weighted-Average Common Shares Outstanding
 
 
 
 
 
 
 
Basic
77,999

 
70,328

 
76,871

 
60,867

Diluted
77,999

 
70,328

 
76,871

 
60,867

 
 
 
 
 
 
 
 
Comprehensive income (loss)
 
 
 
 
 
 
 
Net income (loss)
$
(12,555
)
 
$
(13,129
)
 
$
(36,651
)
 
(55,977
)
Other comprehensive income (loss), net of taxes, related to:
 
 
 
 
 
 
 
Foreign currency translation adjustment
(116
)
 

 
(264
)
 

Total comprehensive income (loss)
(12,671
)
 
(13,129
)
 
(36,915
)
 
(55,977
)
Total comprehensive income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Total comprehensive income (loss) attributable to Evolent Health, Inc.
$
(12,545
)
 
$
(12,588
)
 
$
(36,235
)
 
$
(47,506
)

(1) See Note 16 for amounts related to affiliates included in these line items.



See accompanying Notes to Consolidated Financial Statements
4



EVOLENT HEALTH, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands)

 
For the Nine
 
Months Ended
 
September 30,
  
2018
 
2017
Cash Flows from Operating Activities
 
 
 
Net income (loss)
$
(36,651
)
 
$
(55,977
)
Adjustments to reconcile net income (loss) to net cash and restricted cash
 
 
 
provided by (used in) operating activities:
 
 
 
(Income) loss from equity method investees
2,787

 
1,446

Change in fair value of contingent consideration and indemnification asset
(1,404
)
 
300

Depreciation and amortization expenses
29,882

 
21,236

Amortization of deferred financing costs
688

 
685

Stock-based compensation expense
12,560

 
16,172

Deferred tax provision (benefit)
34

 
(2,668
)
Amortization of contract cost assets
1,900

 

Other
(111
)
 
88

Changes in assets and liabilities, net of acquisitions:
 
 
 
Accounts receivables, net
(11,241
)
 
(5,075
)
Prepaid expenses and other current and noncurrent assets
(15,393
)
 
(5,125
)
Contract assets
240

 

Contract cost assets
(4,568
)
 

Accounts payable
6,451

 
10,591

Accrued liabilities
13,946

 
(11,075
)
Accrued compensation and employee benefits
(7,059
)
 
(7,707
)
Deferred revenue
828

 
4,835

Claims reserves
10,338

 

Other long-term liabilities
1,090

 
(1,719
)
Net cash and restricted cash provided by (used in) operating activities
4,317

 
(33,993
)
 
 
 
 
Cash Flows from Investing Activities
 
 
 
Cash paid for asset acquisitions or business combinations
(11,552
)
 
(3,694
)
Principal repayment for implementation funding loan
14,000

 

Amount received from escrow in asset acquisition
500

 

Maturities and sales of investments

 
44,210

Investments in and advances to equity method investees
(6,807
)
 

Purchases of property and equipment
(29,117
)
 
(21,349
)
Purchases and maturities of restricted investments
8,043

 
(3,200
)
Net cash and restricted cash provided by (used in) investing activities
(24,933
)
 
15,967

 
 
 
 
Cash Flows from Financing Activities
 
 
 
Change in restricted cash held on behalf of partners for claims processing
(17,344
)
 
(25,648
)
Proceeds from issuance of common stock, net of stock issuance costs

 
166,947

Proceeds from stock option exercises
10,588

 
3,802

Taxes withheld and paid for vesting of restricted stock units
(1,179
)
 
(1,179
)
Net cash and restricted cash provided by (used in) financing activities
(7,935
)
 
143,922

Effect of exchange rate on cash and cash equivalents and restricted cash
35

 

Net increase (decrease) in cash and cash equivalents and restricted cash
(28,516
)
 
125,896

Cash and cash equivalents and restricted cash as of beginning-of-period
295,363

 
170,029

Cash and cash equivalents and restricted cash as of end-of-period
$
266,847

 
$
295,925


See accompanying Notes to Consolidated Financial Statements
5




EVOLENT HEALTH, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)
(unaudited, in thousands)

 
 
 
 
 
 
 
 
 
 
 
 
Accum-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ulated
 
 
Retained
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other
 
 
Earnings
 
 
 
 
 
Class A
 
Class B
 
Additional
 
Comprehensive
 
(Accum-
 
Non-
 
Total
 
Common Stock
 
Common Stock
 
Paid-in
 
 
Income
 
 
ulated
 
Controlling
 
Equity
 
Shares
 
Amount
 
Shares
 
Amount
 
Capital
 
 
(Loss)
 
 
Deficit)
 
Interests
 
(Deficit)
Balance as of December 31, 2016
52,587

 
$
506

 
15,347

 
$
153

 
$
555,250

 
 
$

 
 
$
146,617

 
$
209,588

 
$
912,114

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock-based compensation expense

 

 

 

 
20,437

 
 

 
 

 

 
20,437

Exercise of stock options
788

 
28

 

 

 
4,054

 
 

 
 

 

 
4,082

Restricted stock units vested, net of shares withheld for taxes
149

 
2

 

 

 
(1,274
)
 
 

 
 

 

 
(1,272
)
Shares released from Valence Health escrow
(310
)
 
(3
)
 

 

 
911

 
 

 
 

 

 
908

Exchange of Class B common stock
12,693

 
126

 
(12,693
)
 
(126
)
 
168,883

 
 

 
 

 
(168,883
)
 

Tax impact of 2017 Securities Offerings

 

 

 

 
12,857

 
 

 
 

 

 
12,857

Issuance of Class A common stock during August 2017 Primary
8,816

 
88

 

 

 
166,859

 
 

 
 

 

 
166,947

Reclassification of non-controlling interests

 

 

 

 
(3,824
)
 
 

 
 

 
3,824

 

Net income (loss)

 

 

 

 

 
 

 
 
(60,665
)
 
(9,102
)
 
(69,767
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2017
74,723

 
747

 
2,654

 
27

 
924,153

 
 

 
 
85,952

 
35,427

 
1,046,306

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cumulative-effect adjustment from adoption of ASC 606

 

 

 

 

 
 

 
 
16,715

 
594

 
17,309

Stock-based compensation expense

 

 

 

 
12,560

 
 

 
 

 

 
12,560

Exercise of stock options
1,574

 
16

 

 

 
10,572

 
 

 
 

 

 
10,588

Restricted stock units vested, net of shares withheld for taxes
207

 
2

 

 

 
(1,181
)
 
 

 
 

 

 
(1,179
)
Exchange of Class B common stock
1,888

 
19

 
(1,888
)
 
(19
)
 
25,334

 
 

 
 

 
(25,334
)
 

Tax impact of Class B Exchanges

 

 

 

 
908

 
 

 
 

 

 
908

Settlement of indemnification asset

 

 

 

 
(1,004
)
 
 

 
 

 

 
(1,004
)
Foreign Currency Translation Adjustment

 

 

 

 

 
 
(264
)
 
 

 

 
(264
)
Reclassification of non-controlling interests

 

 

 

 
(1
)
 
 

 
 

 
1

 

Net income (loss)

 

 

 

 

 
 

 
 
(35,971
)
 
(680
)
 
(36,651
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of September 30, 2018
78,392

 
$
784

 
766

 
$
8

 
$
971,341

 
 
$
(264
)
 
 
$
66,696

 
$
10,008

 
$
1,048,573


See accompanying Notes to Consolidated Financial Statements
6


EVOLENT HEALTH, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


1. Organization

Evolent Health, Inc. was incorporated in December 2014 in the state of Delaware, and is a managed services firm that supports leading health systems and physician organizations in their migration toward value-based care and population health management. The Company operates through two segments. The Company’s services segment (“Services”) provides our customers, who we refer to as partners, with a population management platform, integrated data and analytics capabilities, claims processing services, including pharmacy benefit management, and comprehensive health plan administration services. Together these services enable health systems to manage patient health in a more cost-effective manner. The Company’s contracts are structured as a combination of advisory fees, monthly member service fees, percentage of plan premiums and shared medical savings arrangements. The Company’s wholly-owned subsidiary, True Health New Mexico, Inc. (“True Health”) operates as a separate segment and is a commercial health plan we operate in New Mexico that focuses on small and large businesses. The Company’s headquarters is located in Arlington, Virginia.

Our predecessor, Evolent Health Holdings, Inc. (“Evolent Health Holdings”), merged with and into Evolent Health, Inc. in connection with the offering reorganization which occurred on June 4, 2015 (the “Offering Reorganization”), as discussed in our 2017 Form 10-K.

Prior to our initial public offering (“IPO”) in June 2015 and the Offering Reorganization we undertook in connection therewith, Evolent Health Holdings did not control Evolent Health LLC, our operating subsidiary company due to certain participating rights granted to our investor, TPG Global, LLC and certain of its affiliates (“TPG”). However, Evolent Health Holdings was able to exert significant influence on Evolent Health LLC and, accordingly, accounted for its investment in Evolent Health LLC using the equity method of accounting through June 3, 2015. Subsequent to the Offering Reorganization, the financial results of Evolent Health LLC have been consolidated in the financial statements of Evolent Health, Inc. Following the Offering Reorganization, the IPO, various securities offerings and sales (as described in Note 4) and acquisitions (as described in Note 4), as of September 30, 2018, Evolent Health, Inc. owned 99.0% of Evolent Health LLC, holds 100% of the voting rights, is the sole managing member and, therefore, controls its operations.

Since its inception, the Company has incurred losses from operations. As of September 30, 2018, the Company had cash and cash equivalents of $221.8 million. The Company believes it has sufficient liquidity for the next 12 months as of the date the financial statements were available to be issued.

2. Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles

Basis of Presentation

In our opinion, the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to fairly state our financial position, results of operations, and cash flows. The Consolidated Balance Sheet at December 31, 2017, has been derived from audited financial statements as of that date. The interim consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain footnote disclosures normally included in financial statements prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) have been omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (“SEC”). The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our 2017 Form 10-K.

Summary of Significant Accounting Policies
 
Certain GAAP policies that significantly affect the determination of our financial position, results of operations and cash flows, are summarized below. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2017 Form 10-K for a complete summary of our significant accounting policies.

Accounting Estimates and Assumptions

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue

7


recognition including variable consideration, discounts and credits, estimated selling prices for performance obligations in contracts with multiple performance obligations, claims reserves, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.

Principles of Consolidation
 
The consolidated financial statements include the accounts of Evolent Health, Inc. and its subsidiaries. All inter-company accounts and transactions are eliminated in consolidation.

Operating Segments

Operating segments are defined as components of a business that earn revenue and incur expenses for which discrete financial information is available that is evaluated, on a regular basis, by the chief operating decision maker (“CODM”) to decide how to allocate resources and assess performance. The Company operates through two segments: (1) Services, and (2) True Health. Our Services segment consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services. Our True Health segment consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses. See Note 17 for a discussion of our operating results by segment.

Revenue Recognition

Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. See “Changes in Accounting Principles” below for our updated revenue recognition policy as a result of our adoption of Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers.

Our True Health segment derives revenue from premiums that are earned over the terms of the related insurance policies. The portion of premiums that will be earned in the future or are received prior to the effectiveness of the policy are deferred and reported as premiums received in advance. These amounts are generally classified as short-term deferred revenue on our Consolidated Balance Sheets.

8


Restricted Cash and Restricted Investments

Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:

 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Collateral for letters of credit
 
 
 
 
 
 
for facility leases (1)
 
$
3,710

 
 
$
3,812

 
Collateral with financial institutions (2)
 
22,028

 
 
24,725

 
Claims processing services (3)
 
8,942

 
 
26,286

 
Collateral for reinsurance agreement (4)
 
10,000

 
 
10,000

 
Other
 
1,042

 
 
862

 
Total restricted cash
 
 
 
 
 
 
and restricted investments
 
45,722

 
 
65,685

 
 
 
 
 
 
 
 
Current restricted investments
 

 
 
8,150

 
Current restricted cash
 
42,328

 
 
54,248

 
Total current restricted cash
 
 
 
 
 
 
and restricted investments
 
42,328

 
 
62,398

 
 
 
 
 
 
 
 
Noncurrent restricted investments
 
712

 
 
605

 
Noncurrent restricted cash
 
2,682

 
 
2,682

 
Total noncurrent restricted cash
 
 
 
 
 
 
and restricted investments
 
$
3,394

 
 
$
3,287

 

(1) Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note 9 for further discussion of our lease commitments.
(2) Represents collateral held with financial institutions for risk-sharing arrangements. As of September 30, 2018, and December 31, 2017, approximately $22.0 million and $16.6 million of the collateral amount was in a trust account and invested in a money market fund. The amounts invested in money market funds are considered restricted cash and are carried at fair value, which approximates cost. See Note 15 for further discussion of our fair value measurement. As of December 31, 2017, approximately $8.2 million of the collateral amount was invested in restricted certificates of deposit with remaining maturities of less than 12 months. The restricted investments are classified as held-to-maturity and stated at amortized cost. Fair value of the certificates of deposit is determined using Level 2 inputs and approximates amortized cost as of December 31, 2017. See Note 9 for further discussion of our risk-sharing arrangements.
(3) Represents cash held by Evolent on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.
(4) Represents restricted cash required as part of our capital only reinsurance agreement to provide balance sheet support to NMHC. There is no transfer of underwriting risk to Evolent and we are not at risk for any cash payments on behalf of NMHC as part of the agreement. The reinsurance agreement is further discussed in Note 9. As of September 30, 2018, the full $10.0 million amount was invested in a money market fund. The amount invested in the money market fund is considered restricted cash and is carried at fair value, which approximates cost. As of December 31, 2017, the full $10.0 million amount was held in a FDIC participating bank account.


9


The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statements of cash flows.

 
As of September 30,
 
As of December 31,
 
2018
 
2017
 
2017
 
2016
Cash and cash equivalents
$
221,837

 
$
287,143

 
$
238,433

 
$
134,563

Restricted cash and restricted investments
45,722

 
16,932

 
65,685

 
40,416

Restricted investments included in
 
 
 
 
 
 
 
restricted cash and restricted investments
(712
)
 
(8,150
)
 
(8,755
)
 
(4,950
)
Total cash and cash equivalents and restricted cash
 
 
 
 
 
 
 
shown in the consolidated statements of cash flows
$
266,847

 
$
295,925

 
$
295,363

 
$
170,029


Notes Receivable

Notes receivable are carried at the face amount of each note plus respective accrued interest receivable, less received payments. The Company does not typically carry notes receivable in the course of its regular business, but contributed $20.0 million in the form of an implementation funding loan (the “Implementation Loan”) under an agreement with a current customer entered during the year ended December 31, 2017. The Implementation Loan is expected to support implementation services to assist the customer in expanding its Medicaid membership. The Implementation Loan carries a fixed interest rate of 2.5% per annum and the terms of the agreement governing the Implementation Loan require it to be repaid in ten equal monthly installments of $2.0 million, plus accrued interest, during 2018. As of September 30, 2018, the outstanding principal balance of the Implementation Loan was $6.0 million, excluding approximately $0.1 million of accrued interest. As of December 31, 2017, the outstanding principal balance of the Implementation Loan was $20.0 million, excluding approximately $0.1 million of accrued interest.

Intangible Assets, Net

Identified intangible assets are recorded at their estimated fair values at the date of acquisition and are amortized over their respective estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are used. The Company acquired additional intangible assets in conjunction with a strategic acquisition made during 2018. Information regarding the determination and allocation of the fair value of the acquired assets and liabilities is further described within Note 4.

The following summarizes the estimated useful lives by asset classification:

Corporate trade name
20 years
Customer relationships
15-25 years
Technology
5 years
Provider network contracts
5 years

Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the asset’s carrying value. The Company evaluates recoverability by determining whether the undiscounted cash flows expected to result from the use and eventual disposition of that asset or group exceed the carrying value at the evaluation date. If the undiscounted cash flows are not sufficient to cover the carrying value, the Company measures an impairment loss as the excess of the carrying amount of the long-lived asset or group over its fair value. See Note 7 for additional discussion regarding our intangible assets.

Goodwill

We recognize the excess of the purchase price, plus the fair value of any non-controlling interests in the acquiree, over the fair value of identifiable net assets acquired as goodwill. Goodwill is not amortized, but is reviewed at least annually for indications of impairment, with consideration given to financial performance and other relevant factors. We perform impairment tests of goodwill at a reporting unit level, which is consistent with the way management evaluates our business. Goodwill is assigned to the reporting unit that benefits from the synergies arising from each business combination.


10


Foreign Currency

The Company established an international subsidiary during the first quarter of 2018. The functional currency of our international subsidiary is the Indian Rupee. We translate the financial statements of this subsidiary to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenue, costs, and expenses. Translation gains and losses are recorded in accumulated other comprehensive income (loss) as a component of shareholders' equity. We recorded a foreign currency translation loss of $0.1 million and $0.3 million on our Consolidated Statements of Operations for the three and nine months ended September 30, 2018, which resulted in an “Accumulated other comprehensive loss” of $0.3 million on our Consolidated Balance Sheet as of September 30, 2018.

Changes in Accounting Principles

Adoption of ASU 2014-09, Revenue from Contracts with Customers

As discussed in Note 3, the Company adopted ASU 2014-09, Revenue from Contracts with Customers, effective January 1, 2018. The following is our updated accounting policy with respect to revenue recognition for our Services segment.

Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. Revenue is recognized when control of the services is transferred to our customers. We use the following 5-Step model, outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), to determine revenue recognition on our contracts with customers:

Identify the contract(s) with a customer
Identify the performance obligations in the contract
Determine the transaction price
Allocate the transaction price to performance obligations
Recognize revenue when (or as) the entity satisfies a performance obligation

Transformation Services Revenue

Transformation services consist of strategic assessments, or Blueprint contracts, and implementation services whereby we assist the customer in launching its population health or health plan strategy. In certain cases, transformation services can also include revenue associated with our support of certain one-time wind-down activities for clients who are exiting a line of business or population. The transformation services are usually completed within 12 months. We generally receive a fixed fee for transformation services and recognize revenue over time using an input method based on hours incurred compared to the total estimated hours required to satisfy our performance obligation.

Platform and Operations Services Revenue

Platform and operations services generally include multi-year arrangements with customers to provide various population health, health plan operations and claims processing services on an ongoing basis, as well as transition or run-out services to customers receiving primarily third-party administration (“TPA”) services. Our performance obligation in these arrangements is to provide an integrated suite of services, including access to our platform that is customized to meet the specialized needs of our customers. Generally we will apply the series guidance to the performance obligation as we have determined that each time increment is distinct. We primarily utilize a variable fee structure for these services that typically include a monthly payment that is calculated based on a specified per member per month rate, multiplied by the number of members that our partners are managing under a value-based care arrangement or a percentage of plan premiums. Our arrangements may also include other variable fees related to service level agreements, shared medical savings arrangements and other performance measures. Variable consideration is estimated using the most likely amount based on our historical experience and best judgment at the time. Due to the nature of our arrangements certain estimates may be constrained if it is probable that a significant reversal of revenue will occur when the uncertainty is resolved. We recognize revenue for platform and operations services over time using the time elapsed output method. Fixed consideration is recognized ratably over the contract term. In accordance with the series guidance, we allocate variable consideration to the period to which the fees relate.

Contracts with Multiple Performance Obligations

Our contracts with customers may contain multiple performance obligations, primarily when the customer has requested both transformation services and platform and operations services as these services are distinct from one another. When a contract has multiple performance obligations, we allocate the transaction price to each performance obligation based on the relative standalone selling price using the expected cost margin approach. This approach requires estimates regarding both the level of effort it will take to

11


satisfy the performance obligation as well as fees that will be received under the variable pricing model. We also take into consideration customer demographics, current market conditions, the scope of services and our overall pricing strategy and objectives when determining the standalone selling price.

Principal vs Agent

We occasionally use third parties to assist in satisfying our performance obligations. In order to determine whether we are the principal or agent in the arrangement, we review each third-party relationship on a contract by contract basis. We are an agent when our role is to arrange for another entity to provide the services to the customer. In these instances, we do not control the service before it is provided and recognize revenue on a net basis. We are the principal when we control the good or service prior to transferring control to the customer. We recognize revenue on a gross basis when we are the principal in the arrangement.

In accordance with the requirements under ASU 2014-09, the impact of adoption to our consolidated financial statements was as follows. See Note 5 for additional disclosures regarding Evolent's contracts with customers.

Condensed Consolidated Statements of Operations
 
 
 
 
 
 
 
 
 
(unaudited, in thousands)
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended September 30, 2018
 
 
 
 
 
Amounts without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Revenue
 
 
 
 
 
 
 
 
 
Transformation services
 
$
9,230

 
 
$
9,556

 
 
$
(326
)
 
Platform and operations services
 
118,094

 
 
117,942

 
 
152

 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
 
 
presented separately below)
 
73,967

 
 
77,409

 
 
(3,442
)
 
Selling, general and administrative expenses
 
59,566

 
 
59,676

 
 
(110
)
 
Income (loss) before income taxes and non-controlling interests
 
(12,420
)
 
 
(15,798
)
 
 
3,378

 
 
 
 
 
 
 
 
 
 
 
 
For the Nine Months Ended September 30, 2018
 
 
 
 
 
Amounts without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Revenue
 
 
 
 
 
 
 
 
 
Transformation services
 
$
23,950

 
 
$
25,272

 
 
$
(1,322
)
 
Platform and operations services
 
341,258

 
 
339,485

 
 
1,773

 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
 
 
presented separately below)
 
214,945

 
 
218,786

 
 
(3,841
)
 
Selling, general and administrative expenses
 
172,495

 
 
173,644

 
 
(1,149
)
 
Income (loss) before income taxes and non-controlling interests
 
(36,622
)
 
 
(42,063
)
 
 
5,441

 


12


Condensed Consolidated Balance Sheets
 
 
 
 
 
 
 
 
 
(unaudited, in thousands)
 
 
 
 
 
 
 
 
 
 
As of September 30, 2018
 
 
 
 
 
Balances without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Assets
 
 
 
 
 
 
 
 
 
Accounts receivable, net
 
$
60,054

 
 
$
57,848

 
 
$
2,206

 
Contract assets (current)
 
3,705

 
 

 
 
3,705

 
Contract assets (noncurrent)
 
1,000

 
 

 
 
1,000

 
Contract cost assets
 
14,252

 
 

 
 
14,252

 
 
 
 
 
 
 
 
 
 
 
Liabilities and Shareholders' Equity (Deficit)
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
Deferred revenue
 
$
22,360

 
 
$
24,100

 
 
$
(1,740
)
 
Other long-term liabilities
 
10,885

 
 
10,746

 
 
139

 
 
 
 
 
 
 
 
 
 
 
Shareholders' Equity (Deficit)
 
 
 
 
 
 
 
 
 
Retained earnings (accumulated deficit)
 
66,696

 
 
44,580

 
 
22,116

 
Non-controlling interests
 
10,008

 
 
9,361

 
 
647

 


Adoption of ASU 2016-18, Statement of Cash Flows: Restricted Cash

The Company adopted ASU 2016-18, Statement of Cash Flows: Restricted Cash, effective December 31, 2017, using the retroactive transition method, which resulted in the recast of our statement of cash flows for each period presented. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2017 Form 10-K for further information about the adoption.

The amendments in the ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.

A significant portion of the Company’s restricted cash consists of cash held on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed. Under the previous standard, there was no net impact to the statement of cash flows related to these amounts as the changes in accounts payable and accounts receivable were offset by the change in restricted cash. Upon adoption of ASU 2016-18, the change in restricted cash held on behalf of partners for claims processing would no longer net to zero, thereby potentially having a significant impact on cash flows from operations period over period. Given the pass-through nature of these claim payments, the change in restricted cash held on behalf of partners for claims processing is presented within cash flows from financing activities on our statements of changes in cash flows.


13


The following table summarizes the impact of the change in accounting principle to the Company’s Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 (in thousands):

 
For the Nine Months Ended September 30, 2017
 
As Reported
Adjustments
As Adjusted
Cash Flows from Investing Activities
 
 
 
 
 
 
 
 
Purchases and maturities of restricted investments
 
$

 
 
$
(3,200
)
 
 
$
(3,200
)
Change in restricted cash and restricted investments
 
(2,164
)
 
 
2,164

 
 

Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) investing activities
 
17,003

 
 
(1,036
)
 
 
15,967

 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities
 
 
 
 
 
 
 
 
Change in restricted cash held on behalf of
 
 
 
 
 
 
 
 
partners for claims processing
 

 
 
(25,648
)
 
 
(25,648
)
Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) financing activities
 
169,570

 
 
(25,648
)
 
 
143,922

 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash
 
 
 
 
 
 
 
 
equivalents and restricted cash
 
152,580

 
 
(26,684
)
 
 
125,896

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of beginning-of-period
 
134,563

 
 
35,466

 
 
170,029

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of end-of-period
 
$
287,143

 
 
$
8,782

 
 
$
295,925


3. Recently Issued Accounting Standards

Adoption of New Accounting Standards

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting. The update expands the scope of ASC Topic 718, Compensation - Stock Compensation (“ASC 718”), to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU specifies that ASC 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments in the update also clarify that ASC 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606. The update is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity’s adoption date of ASC 606. We adopted the requirements of this standard effective July 1, 2018, and there was no impact to our financial condition and results of operations for the three and nine months ended September 30, 2018. Going forward, we do not expect the adoption to have a material impact on our financial condition or results of operations.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, in order to clarify the principles of recognizing revenue. This standard establishes the core principle of recognizing revenue to depict the transfer of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB defines a five-step process that systematically identifies the various components of the revenue recognition process, culminating with the recognition of revenue upon satisfaction of an entity’s performance obligations. By completing all five steps of the process, the core principles of revenue recognition will be achieved. The new revenue standard (including updates) is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. The guidance permits two methods of adoption: i) the full retrospective method applying the standard to each prior reporting period presented, or ii) the modified retrospective method with a cumulative effect of initially applying the guidance recognized at the date of initial application. The standard also allows entities to apply certain practical expedients at their discretion. The Company adopted the standard effective January 1, 2018, using the modified retrospective method for only contracts that were not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC Topic 605, Revenue Recognition (“ASC 605”). The adoption of this standard resulted in changes related to revenue recognition for contracts that contain certain features, such as variable consideration. These changes generally accelerate revenue recognition. In addition, certain customer setup costs, which have historically been expensed as incurred, will now

14


be capitalized. Evolent recognized the cumulative effect of applying the new revenue standard as a $17.3 million adjustment to the opening balance of retained earnings, including non-controlling interests, in the first quarter of 2018, primarily as a result of capitalization of expenses related to contract acquisition and fulfillment costs and acceleration of revenue due to variable consideration estimation. See Note 5 for additional disclosures regarding Evolent's contracts with customers. See Note 2 for updated revenue recognition accounting policy and the impact of adopting the new revenue recognition standard on Evolent’s financial statements.

Future Adoption of New Accounting Standards

In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal Use Software: Customers Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Services Contract. The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The amendments in this update should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We are currently evaluating the impact of adoption on our financial condition and results of operations.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. With respect to assets measured at amortized cost, such as held-to-maturity assets, the update requires presentation of the amortized cost net of a credit loss allowance. The update eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses as opposed to the previous standard, when an entity only considered past events and current conditions. With respect to available for sale debt securities, the update requires that credit losses be presented as an allowance rather than as a write-down. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We intend to adopt the requirements of this standard effective January 1, 2020, and are currently evaluating the impact of the adoption on our financial condition and results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight‑line basis over the term of the lease, respectively. A lessee is also required to record a right‑of‑use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU 2016-02 (ASC Topic 842) supersedes the previous leases standard, ASC 840, Leases. The ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available.

The Company has formulated an implementation team that is currently engaged in the evaluation process. We intend to adopt the requirements of this standard effective January 1, 2019, using a modified retrospective approach. We expect to take advantage of the package of practical expedients permitted within the new standard. In July 2018, the FASB issued ASU 2018-11, which is intended to make targeted improvements to ASU 2016-02. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The requirements of ASU 2018-11 are effective on the same date as the requirements of ASU 2016-02. Pursuant to ASU 2018-11, the Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements and recognize a cumulative-effect adjustment to the opening balance of retaining earnings. We anticipate that this standard will result in a material increase in the assets and liabilities on our consolidated balance sheets; however, we do not believe adoption will have a material impact on our results of operations.


15


4. Transactions

Business Combinations

New Mexico Health Connections

On January 2, 2018, the Company, through its wholly-owned subsidiary, True Health, completed its previously announced acquisition of assets related to NMHC’s commercial, small and large group business. The assets include a health plan management services organization with a leadership team and employee base with experience working locally with providers to run NMHC’s suite of preventive, disease and care management programs. The consideration paid by the Company in connection with the acquisition consisted of $10.3 million in cash (subject to certain adjustments), of which $0.3 million was deposited in an escrow account. This acquisition is expected to allow the Company to leverage its platform to support a value-based, provider-centric model of care in New Mexico.

The Company commenced operations of the commercial health plan and began reporting the results of True Health as a new reportable segment during the first quarter of 2018. See Note 17 for further information about the Company’s segment reporting. At the time of the acquisition, the Company also entered into a managed services agreement (“MSA”) with NMHC to support its ongoing business. During the fourth quarter of 2017, the Company also entered into a reinsurance agreement with NMHC to provide balance sheet support. See Note 9 for further discussion of the reinsurance agreement. The MSA and reinsurance agreement were considered separate transactions and accounted for outside of the business combination. Therefore, there is no allocation of purchase price to these agreements at fair value.

The Company incurred approximately $1.2 million in transaction costs related to the NHMC transaction, materially all of which were recorded within “Selling, general and administrative expenses” on our Consolidated Statements of Operations for the year ended December 31, 2017. The transaction was accounted for as a business combination using purchase accounting.

The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of January 2, 2018, as follows (in thousands):

Purchase consideration
 
Cash paid to NMHC
$
10,000

Cash paid to escrow agent
252

Total consideration
$
10,252

 
 
Identifiable intangible assets acquired and liabilities assumed
 
Customer relationships
$
2,700

Provider network contracts
2,300

Above market lease
(100
)
Accrued compensation and employee benefits
(474
)
 
 
Goodwill
5,826

Net assets acquired
$
10,252


Identifiable intangible assets associated with customer relationships and provider network contracts will be amortized on a straight-line basis over their estimated useful lives of 15 and 5 years, respectively. The customer relationships represent existing contracts in place to provide health plan services to a number of large and small group customers throughout the state of New Mexico. The provider network contracts represent a network of hospitals and physicians to service the health plan customers. The fair value of the customer relationship intangible asset was primarily determined using the income approach. The income approach estimates fair value for an asset based on the present value of cash flows projected to be generated by the asset. Projected cash flows are discounted at a required rate of return that reflects the relative risk of achieving the cash flows and the time value of money. The fair value of the provider network intangible asset was primarily determined using the cost approach. The cost approach estimates the fair value for an asset based on the amount it would cost to replace the asset. Goodwill is calculated as the difference between the acquisition date fair value of the total consideration and the fair value of the net assets acquired, and represents the future economic benefits that we expect to achieve as a result of the acquisition. Goodwill associated with the acquisition of True Health is allocated entirely to the True Health segment. The goodwill is attributable primarily to the acquired workforce and expected cost synergies, none of which qualify for recognition as a separate intangible asset. Goodwill is considered an indefinite-lived asset. The transaction is an asset acquisition for tax purposes, and as such the tax-basis in the acquired assets is equal to the book-basis fair value calculated and is recorded at the True Health legal entity. Therefore, no opening balance sheet deferred tax liability was recorded.

16



The amounts above reflect management’s preliminary estimate of the fair value of the tangible and intangible assets acquired and liabilities assumed based on a valuation performed using currently available information. Any remaining adjustments are expected to be finalized within one year of the acquisition date.

True Health is a separate segment, and its results of operations are provided in Note 17 - Segment Reporting.

Pro Forma Financial Information (Unaudited)

The unaudited pro forma Consolidated Statements of Operations presented below gives effect to the NMHC transaction as if it took place on January 1, 2017. The following pro forma information includes adjustments to:

reclassify transaction costs related to the NMHC transaction to the period beginning January 1, 2017;
record revenue and expenses related to the MSA beginning January 1, 2017; and
record amortization expenses related to intangible assets beginning January 1, 2017, for intangible assets acquired as part of the NMHC transaction.

This pro forma data is presented for informational purposes only and does not purport to be indicative of the results of future operations or of the results that would have occurred had the transactions described above occurred in the specified prior periods. The pro forma adjustments are based on available information and assumptions that the Company believes are reasonable to reflect the impact of these transactions on the Company’s historical financial information on a pro forma basis (in thousands, except per share data).
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Revenue
$
149,947

 
$
129,820

 
$
433,959

 
$
378,801

Net income (loss)
(12,555
)
 
(11,320
)
 
(36,651
)
 
(65,113
)
Net income (loss) attributable to non-controlling interests
(126
)
 
(413
)
 
(680
)
 
(8,414
)
Net income (loss) attributable to Evolent Health, Inc.
(12,429
)
 
(10,907
)
 
(35,971
)
 
(56,699
)
 
 
 
 
 
 
 
 
Net income (loss) per Common Share available to common shareholders
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.16
)
 
$
(0.47
)
 
$
(0.93
)
Diluted
(0.16
)
 
(0.16
)
 
(0.47
)
 
(0.93
)

Securities Offerings and Sales

Under an exchange agreement we entered into at the time of our IPO, we granted TPG, The Advisory Board Company (“The Advisory Board”) and Ptolemy Capital, LLC (“Ptolemy Capital”) (together, the “Investor Stockholders”) an exchange right that allows receipt of newly-issued shares of the Company’s Class A common stock in exchange (a “Class B Exchange”) for an equal number of shares of the Company’s Class B common stock (which are subsequently canceled) and an equal number of Evolent Health LLC’s Class B common units (“Class B units”). Class B units received by the Company from relevant Investor Stockholders are simultaneously exchanged for an equivalent number of Class A units of Evolent Health LLC, and Evolent Health LLC cancels the Class B units it receives in the Class B Exchange. The cancellation of the Class B units results in an increase in the Company’s economic interest in Evolent Health LLC.

March and June 2018 Private Sales

In March 2018, The Advisory Board sold 3.0 million shares of the Company’s Class A common Stock in a private sale (the “March 2018 Private Sale”). The shares sold in the March 2018 Private Sale consisted of 1.2 million existing shares of the Company’s Class A common stock owned by The Advisory Board and 1.8 million newly-issued shares of the Company’s Class A common stock received by The Advisory Board pursuant to a Class B Exchange for all of its outstanding shares of the Company’s Class B common stock and Class B units. The Company did not receive any proceeds from the March 2018 Private Sale. Subsequent to this Class B Exchange, in June 2018, The Advisory Board sold all of their remaining shares of the Company’s Class A common stock and no longer owns any shares of our Class A common stock.

As a result of this Class B Exchange and Evolent Health LLC’s cancellation of the Class B units during the March 2018 Private Sale, the Company’s economic interest in Evolent Health LLC increased from 96.6% to 98.9% immediately following the March 2018

17


Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

August 2017 Primary Offering

In August 2017, the Company completed a primary offering of 8.8 million shares of its Class A common stock at a price to the public of $19.85 per share and a corresponding price to the underwriters of $19.01 per share (the “August 2017 Primary”). This offering resulted in net cash proceeds to the Company of approximately $166.9 million (gross proceeds of $175.0 million, net of $8.1 million in underwriting discounts and stock issuance costs). For each share of Class A common stock issued by Evolent Health, Inc., the Company received a corresponding Class A common unit from Evolent Health LLC in exchange for contributing the issuance proceeds to Evolent Health LLC. As a result of the Class A common stock and Class A common units issued during the August 2017 Primary, the Company’s economic interest in Evolent Health LLC increased from 96.1% to 96.6% immediately following the August 2017 Primary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

Secondary Offerings

The Investor Stockholders initiated several Class B Exchanges as part of various secondary offerings during 2017, thus increasing the Company’s economic interest in Evolent Health LLC, as discussed below. The Company did not receive any proceeds from the secondary offerings described below.

June 2017 Secondary Offering

In June 2017, the Company completed a secondary offering of 4.5 million shares of its Class A common stock at a price to the underwriters of $25.87 per share (the “June 2017 Secondary”).

The shares sold in the June 2017 Secondary consisted of 0.7 million existing shares of the Company’s Class A common stock owned and held by certain Investor Stockholders and 3.8 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.

As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the June 2017 Secondary, the Company’s economic interest in Evolent Health LLC increased from 90.5% to 96.1% immediately following the June 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

May 2017 Secondary Offering

In May 2017, the Company completed a secondary offering of 7.0 million shares of its Class A common stock at a price to the underwriters of $24.30 per share (the “May 2017 Secondary”). The shares were sold by the Investor Stockholders and certain management selling stockholders (together with the Investor Stockholders, the “Selling Stockholders”).

The shares sold in the May 2017 Secondary consisted of 3.1 million existing shares of the Company’s Class A common stock owned and held by the Selling Stockholders, 3.8 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges and 0.1 million shares issued upon the exercise of options by certain management selling stockholders.

As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the May 2017 Secondary, the Company’s economic interest in Evolent Health LLC increased from 84.9% to 90.5% immediately following the May 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

March 2017 Secondary Offering

In March 2017, the Company completed a secondary offering of 7.5 million shares of its Class A common stock at a price to the underwriters of $19.53 per share (the “March 2017 Secondary”).

The shares sold in the March 2017 Secondary consisted of 3.1 million existing shares of the Company’s Class A common stock owned and held by the Investor Stockholders and 4.4 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.


18


As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the March 2017 Secondary, the Company’s economic interest in Evolent Health LLC increased from 77.4% to 83.9% immediately following the March 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

In connection with the March 2017 Secondary, the underwriters exercised, in full, their option to purchase an additional 1.1 million shares of Class A common stock (the “March 2017 Option to Purchase Additional Shares”) from the Investor Stockholders at a price of $19.53 per share. The March 2017 Option to Purchase Additional Shares closed in May 2017.

The shares sold in the March 2017 Option to Purchase Additional Shares consisted of 0.5 million existing shares of the Company’s Class A common stock owned and held by certain Investor Stockholders. It also included 0.6 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.

As a result of the Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the March 2017 Option to Purchase Additional Shares, the Company’s economic interest in Evolent Health LLC increased from 83.9% to 84.9% immediately following the March 2017 Option to Purchase Additional Shares, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

The June 2017 Secondary, May 2017 Secondary, March 2017 Secondary and March 2017 Option to Purchase Additional Shares are collectively referred to as the “2017 Secondary Offerings.”

The Company’s economic interest in Evolent Health LLC will increase if further Class B Exchanges occur.

Asset Acquisitions

Accordion Health, Inc.

On June 8, 2017, the Company entered into an agreement to acquire Accordion Health, Inc. (“Accordion”) for $3.2 million (the “Accordion Purchase Agreement”). Accordion provides technology that the Company believes enhances its risk-adjustment factor services to its partners. In addition to technology assets, the software development team from Accordion joined Evolent as full-time employees. Under the terms of the Accordion Purchase Agreement, members of the software development team will be eligible for an additional $0.8 million earn-out, contingent upon the completion of specified software development targets.

We accounted for the transaction as an asset acquisition as substantially all of the fair value of the gross assets acquired was concentrated in a single identified asset, thus satisfying the requirements of the screen test introduced in ASU 2017-01. The assets acquired in the transaction were measured based on the amount of cash paid to Accordion, including transaction costs, as the fair value of the assets given was more readily determinable than the fair value of the assets received. We classified and designated the identifiable assets acquired as a $3.3 million technology intangible asset, inclusive of approximately $0.1 million of capitalized transaction costs. We also assessed and determined the useful life of the acquired intangible assets to be five years, subject to amortization. The Company will account for the contingent earn-out as a post-acquisition expense as the specified software development targets are achieved. The transaction was a taxable stock acquisition and the Company recognized deferred tax liability of $2.0 million related to the book-tax basis difference in the acquired asset, which resulted in a $2.0 million increase in the value of the intangible asset. The additional deferred tax liability represents a future source of taxable income that enables the Company to release some of its previously established valuation allowance, the reduction of which is accounted for outside of acquisition accounting, resulting in income tax benefit.


19


5. Revenue Recognition

As discussed in Note 3, we adopted ASU 2014-09, effective January 1, 2018, which introduces ASC 606. See Note 2 for the updated revenue recognition policy and the impact of adopting the new revenue recognition standard on the Company’s financial statements. The following are other relevant disclosures as required by the adoption of ASU 2014-09. Provisions within ASC 606 are only applicable to revenues derived from our Services segment.

Disaggregation of Revenue

The following table represents Evolent’s Services segment revenue disaggregated by revenue type for the three and nine months ended September 30, 2018 (in thousands), excluding revenues from our True Health segment and from our downside risk sharing arrangements through our insurance subsidiary, which are accounted for under ASC 944, Financial Services-Insurance.

  
For the Three
For the Nine
 
Months Ended
Months Ended
  
September 30,
September 30,
 
 
2018
 
 
2018
 
Services Revenue
 
 
 
 
 
 
Transformation services
 
$
9,230

 
 
$
23,950

 
Platform and operations services
 
116,226

 
 
335,509

 

Transaction Price Allocated to the Remaining Performance Obligations

For contracts with a term that is greater than one year, we have allocated approximately $125.0 million of transaction price to performance obligations that are unsatisfied or partially unsatisfied as of September 30, 2018. We do not include variable consideration that is allocated entirely to a wholly unsatisfied performance obligation accounted for under the series guidance in the calculation. As a result, the balance represents the value of the fixed consideration in our long-term contracts that will be recognized as revenue in a future period and excludes the majority of our platform and operations revenue, which is primarily derived based on variable consideration as discussed in Note 2. We expect to recognize revenue on approximately 60% and 84% of these remaining performance obligations by December 31, 2019, and December 31, 2020, respectively, with the remaining balance to be recognized thereafter. However, because our existing contracts may be canceled or renegotiated including for reasons outside our control, the amount of this revenue that we actually receive may be less than this estimate.

Contract Balances

Contract balances consist of accounts receivable, contract assets and deferred revenue. Contract assets are recorded when the right to consideration for services is conditional on something other than the passage of time. Contract assets relating to unbilled receivables are transferred to accounts receivable when the right to consideration becomes unconditional. We classify contract assets as current or noncurrent based on the timing of our rights to the unconditional payments. Our contract assets are generally classified as current and recorded within “Contract assets” on our consolidated balance sheets. Our current accounts receivable are classified within “Accounts receivable, net” on our consolidated balance sheets and our noncurrent accounts receivable are classified within “Prepaid expenses and other noncurrent assets” on our consolidated balance sheets.

Deferred revenue includes advance customer payments and billings in excess of revenue recognized. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue. Our current deferred revenue is recorded within “Deferred revenue” on our consolidated balance sheets, and noncurrent deferred revenue is recorded within “Other long-term liabilities” on our consolidated balance sheets.


20


The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):

 
 
As of
 
 
As of
 
 
September 30,
January 1,
 
 
2018
 
2018
Short-term receivables (1)
 
$
58,190

 
 
$
47,131

 
Long-term receivables (1)
 
6,550

 
 

 
Short-term contract assets
 
3,705

 
 
3,710

 
Long-term contract assets
 
1,000

 
 
1,791

 
Short-term deferred revenue
 
22,360

 
 
26,147

 
Long-term deferred revenue
 
1,000

 
 
493

 
(1) Excludes pharmacy claims receivable and premiums receivable

During the nine months ended September 30, 2018, our contract asset balance decreased by $0.8 million, primarily as the right to the consideration became unconditional and the associated balance is reclassified to accounts receivable. During the nine months ended September 30, 2018, our deferred revenue decreased by $3.3 million, primarily as a result of the recognition of variable consideration estimate.

The amount of revenue recognized during the three and nine months ended September 30, 2018, from amounts included in deferred revenue at the beginning of the period was $3.7 million and $17.0 million, respectively. The amount of revenue recognized during the three and nine months ended September 30, 2018 from performance obligations satisfied (or partially satisfied) in previous periods, due primarily to net gain share as well as other estimates, was $9.4 million and $11.5 million, respectively.

Contract Costs

Certain bonuses and commissions earned by our sales team are considered incremental costs of obtaining a contract with a customer that we expect to be recoverable. The capitalized contract acquisition costs are classified as noncurrent assets and recorded within “Contract cost assets” on our consolidated balance sheets. Amortization expense is recorded within “Selling, general and administrative expenses” on the accompanying consolidated statements of operations. As of September 30, 2018, the Company had $2.0 million of contract acquisition cost assets, net of accumulated amortization, and amortization expense of $0.1 million and $0.2 million for the three and nine months ended September 30, 2018, respectively.

In our platforms and operations arrangements, we incur certain costs related to the implementation of our platform before we begin to satisfy our performance obligation to the customer. The costs, which we expect to recover, are considered costs to fulfill a contract. Our contract fulfillment costs primarily include our employee labor costs and third-party vendor costs. The capitalized contract fulfillment costs are classified as noncurrent and recorded within “Contract cost assets” on our consolidated balance sheets. Amortization expense is recorded within “Cost of revenue” on the accompanying consolidated statements of operations. As of September 30, 2018, the Company had $12.3 million of contract fulfillment cost assets, net of accumulated amortization, and amortization expense of $0.6 million and $1.7 million for the three and nine months ended September 30, 2018, respectively.

The majority of the contract cost balance was recorded as part of the transition adjustment that was recorded upon implementation of ASC 606. These costs are deferred and then amortized on a straight-line basis over a period of benefit that we have determined to be five years. The period of benefit was based on our technology, the nature of our customer arrangements and other factors.


21


6. Property and Equipment, Net

The following summarizes our property and equipment (in thousands):
 
 
 
As of
 
 
As of
 
  
September 30,
December 31,
  
 
2018
 
 
2017
 
Computer hardware
 
$
8,602

 
 
$
5,667

 
Furniture and equipment
 
3,038

 
 
2,448

 
Internal-use software development costs
 
73,679

 
 
48,557

 
Leasehold improvements
 
9,638

 
 
8,708

 
Total property and equipment
 
94,957

 
 
65,380

 
Accumulated depreciation and amortization
 
(26,265
)
 
 
(14,458
)
 
Total property and equipment, net
 
$
68,692

 
 
$
50,922

 

The Company capitalized $7.0 million and $25.1 million of internal-use software development costs for the three and nine months ended September 30, 2018, respectively, and $8.4 million and $20.4 million for the three and nine months ended September 30, 2017, respectively. The net book value of capitalized internal-use software development costs was $58.7 million and $42.1 million as of September 30, 2018, and December 31, 2017, respectively.

Depreciation expense related to property and equipment was $4.3 million and $11.8 million for the three and nine months ended September 30, 2018, respectively, of which amortization expense related to capitalized internal-use software development costs was $3.1 million and $8.5 million, respectively. Depreciation expense related to property and equipment was $2.3 million and $6.0 million for the three and nine months ended September 30, 2017, respectively, of which amortization expense related to capitalized internal-use software development costs was $1.2 million and $2.8 million, respectively.

7. Goodwill and Intangible Assets, Net

Goodwill

Goodwill has an estimated indefinite life and is not amortized; rather, it is reviewed for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.

The Company has two reporting units: Services and True Health. Our annual goodwill impairment review occurs during the fourth quarter of each fiscal year. In interim periods between annual goodwill reviews, we also evaluate qualitative factors that could cause us to believe the estimated fair value of each of our reporting units may be lower than the carrying value and trigger a quantitative assessment, including, but not limited to (i) macroeconomic conditions, (ii) industry and market considerations, (iii) our overall financial performance, including an analysis of our current and projected cash flows, revenues and earnings, (iv) a sustained decrease in share price and (v) other relevant entity-specific events including changes in strategy, partners, or litigation.

We did not identify any qualitative factors that would trigger a quantitative goodwill impairment test during the nine months ended September 30, 2018. We will perform our annual impairment test as of October 31, 2018.

The following tables summarize the changes in the carrying amount of goodwill, by reportable segment, for the periods presented (in thousands):

 
 
For the Nine Months Ended September 30, 2018
 
 
 
Services
 
 
True Health
 
Consolidated
Balance as of beginning-of-period (1)
 
$
628,186

 
 
$

 
 
$
628,186

 
Goodwill Acquired (2)
 
1,234

 
 
5,826

 
 
7,060

 
Measurement period adjustments (2)
 
4

 
 

 
 
4

 
Foreign currency translation (2)
 
(162
)
 
 

 
 
(162
)
 
Balance as of end-of-period
 
$
629,262

 
 
$
5,826

 
 
$
635,088

 

(1) Net of cumulative inception to date impairment of $160.6 million.
(2) Goodwill acquired, measurement period adjustments and foreign currency translation are all related to transactions completed during the first quarter of 2018.

22


 
 
For the Year
 
 
 
Ended
 
 
 
December 31,
 
 
2017 (1)
 
Balance as of beginning-of-period (2)
 
$
626,569

 
Measurement period adjustments (3)
 
1,617

 
Balance as of end-of-period
 
$
628,186

 

(1) All of the goodwill was allocated to the Services segment as of December 31, 2017, as the True Health segment was not established until the first quarter of 2018.
(2) Net of cumulative inception to date impairment of $160.6 million.
(3) Represents measurement period adjustments related to Valence Health and Aldera. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” in our 2017 Form 10-K for further information regarding the Valence Health and Aldera transactions.

Intangible Assets, Net

Details of our intangible assets (in thousands) are presented below:

 
 
As of September 30, 2018
 
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
  
Useful Life
Amount
Amortization
Value
Corporate trade name
 
16.7
 
$
19,000

 
$
3,166

 
$
15,834

Customer relationships (1)
 
19.5
 
208,719

 
25,550

 
183,169

Technology
 
2.4
 
55,933

 
27,264

 
28,669

Below market lease, net
 
4.3
 
4,097

 
2,918

 
1,179

Provider network contracts
 
4.3
 
2,300

 
345

 
1,955

Total
 
 
 
$
290,049

 
$
59,243

 
$
230,806


(1) The increase in the gross carrying amount of the customer relationships intangible is attributable to $2.7 million of acquired customer relationships from the NMHC transaction and $2.5 million related the Vestica Healthcare LLC (“Vestica”) transaction. The Company acquired certain assets from Vestica in March 2016. The transaction included additional consideration of up to $4.0 million, which was being held in escrow and was recorded within “Prepaid expenses and other noncurrent assets” on our Consolidated Balance Sheets. In February 2018, the Company and Vestica reached an agreement to settle $3.5 million of the $4.0 million in escrow. Based on the terms of the settlement agreement, the Company reclassified the unamortized portion of the additional consideration from “Prepaid expenses and other noncurrent assets” into “Customer relationships” as of the settlement date. See Note 4 for further information about the NMHC transaction and see “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” of our 2017 Form 10-K for further information about the Vestica transaction.

 
 
As of December 31, 2017
  
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
 
Useful Life
Amount
Amortization
Value
Corporate trade name
 
17.4
 
$
19,000

 
$
2,454

 
$
16,546

Customer relationships
 
20.5
 
203,500

 
18,312

 
185,188

Technology
 
3.1
 
55,802

 
17,810

 
37,992

Below market lease, net
 
4.8
 
4,197

 
2,662

 
1,535

Total
 
 
 
$
282,499

 
$
41,238

 
$
241,261


Amortization expense related to intangible assets was $6.1 million and $18.0 million for the three and nine months ended September 30, 2018, respectively, and $5.3 million and $15.0 million for the three and nine months ended September 30, 2017, respectively.


23


Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the assets’ carrying value. We did not identify any circumstances during nine months ended September 30, 2018, that would require an impairment test for our intangible assets.

8. Long-term Debt

In December 2016, the Company issued $125.0 million aggregate principal amount of its 2.00% Convertible Senior Notes due 2021 (the “2021 Notes”) in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2021 Notes were issued at par for net proceeds of $120.4 million. We incurred $4.6 million of debt issuance costs in connection with the 2021 Notes, which we are amortizing to non-cash interest expense using the straight line method over the contractual term of the 2021 Notes, since this method was not materially different from the effective interest method. The closing of the private placement of the 2021 Notes occurred on December 5, 2016.

Holders of the 2021 Notes are entitled to cash interest payments, which are payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2017, at a rate equal to 2.00% per annum. The 2021 Notes will mature on December 1, 2021, unless earlier repurchased or converted in accordance with their terms prior to such date. In addition, holders of the 2021 Notes may require the Company to repurchase their 2021 Notes upon the occurrence of a fundamental change at a price equal to 100.00% of the principal amount of the 2021 Notes being repurchased, plus any accrued and unpaid interest. Upon maturity, and at the option of the holders of the 2021 Notes, the principal amount of the notes may be settled via shares of the Company’s Class A common stock. For the three and nine months ended September 30, 2018 and 2017, the Company recorded approximately $0.6 million and $1.9 million, respectively, in interest expense and $0.2 million and $0.7 million, respectively, in non-cash interest expense related to the amortization of deferred financing costs.

The 2021 Notes are convertible into shares of the Company’s Class A common stock, based on an initial conversion rate of 41.6082 shares of Class A common stock per $1,000 principal amount of the 2021 Notes, which is equivalent to an initial conversion price of approximately $24.03 per share of the Company’s Class A common stock. In the aggregate, the 2021 Notes are initially convertible into 5.2 million shares of the Company’s Class A common stock (excluding any shares issuable by the Company upon a conversion in connection with a make-whole provision upon a fundamental change under the indenture between Evolent Health, Inc. and U.S. Bank National Association, as trustee, related to the 2.00% convertible senior notes due 2021, dated as of December 5, 2016).

The 2021 Notes are convertible, in multiples of $1,000 principal amount, at the option of the holders at any time prior to the close of business on the business day immediately preceding the maturity date. Upon conversion, we will deliver for each $1,000 principal amount of notes converted a number of shares of our Class A common stock equal to the applicable conversion rate (together with a cash payment in lieu of delivering any fractional share) on the third business day following the relevant conversion date.

Convertible Senior Notes Carrying Value

While the 2021 Notes are recorded on our accompanying unaudited interim consolidated balance sheets at their net carrying value of $122.1 million as of September 30, 2018, the 2021 Notes are privately traded by qualified institutional buyers (within the meaning of Rule 144A under the Securities Act of 1933, as amended) and their fair value was $169.1 million, based on a traded price on September 28, 2018, a Level 2 input. The fair value as of December 31, 2017, was $120.4 million, based on a traded price on December 29, 2017, a Level 2 input. The 2021 Notes also have embedded conversion options and contingent interest provisions, which have not been recorded as separate financial instruments.

The following table summarizes the carrying value of the long-term debt (in thousands):

 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Carrying value
 
$
122,082

 
 
$
121,394

 
Unamortized discount
 
2,918

 
 
3,606

 
Principal amount
 
$
125,000

 
 
$
125,000

 
Remaining amortization period (years)
 
3.2

 
 
3.9

 


24


9. Commitments and Contingencies

Contingencies

Tax Receivables Agreement

In connection with the Offering Reorganization, the Company entered into the Tax Receivables Agreement (the “TRA”) with certain of its investors, which provides for the payment by the Company to these investors of 85% of the amount of the tax benefits, if any, that the Company is deemed to realize as a result of increases in our tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. These payment obligations are obligations of the Company. For purposes of the TRA, the benefit deemed realized by the Company will be computed by comparing its actual income tax liability to the amount of such taxes that the Company would have been required to pay had there been no increase to the tax basis of the assets of the Company as a result of the exchanges or had the Company had no NOL carryforward balance. The actual amount and timing of any payments under the TRA will vary depending upon a number of factors, including:
 
the timing of the exchanges and the price of the Class A shares at the time of the transaction, triggering a tax basis increase in the Company’s asset and a corresponding benefit to be realized under the TRA; and
the amount and timing of our taxable income - the Company will be required to pay 85% of the tax savings as and when realized, if any. If the Company does not have taxable income, it will not be required to make payments under the TRA for that taxable year because no tax savings were actually realized.

Due to the items noted above, and the fact that the Company is in a full valuation allowance position such that the deferred tax assets related to the Company’s historical pre-IPO losses and tax basis increase benefit from exchanges have not been realized, the Company has not recorded a liability pursuant to the TRA.

Litigation Matters

We are engaged from time to time in certain legal disputes arising in the ordinary course of business, including employment claims. When the likelihood of a loss contingency becomes probable and the amount of the loss can be reasonably estimated, we accrue a liability for the loss contingency. We continue to review accruals and adjust them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained, and our views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in our accrued liabilities would be recorded in the period in which such determination is made. The Company is not aware of any legal proceedings or claims as of September 30, 2018, that the Company believes will have, individually or in the aggregate, a material adverse effect on the Company’s financial position or result of operations.

Commitments

Commitments to Equity-Method Investees

The Company has contractual arrangements with its equity-method investees that will require the Company to provide operating capital support in the form of equity financing of up to $2.6 million as of September 30, 2018, in accordance with the Company’s contribution agreements with its equity-method investees. These obligations are outside of Company’s control and payment could be requested during 2018. The Company did not have any contingent commitments to equity-method investees as of December 31, 2017.

Letter of Credit

During the first quarter of 2017, the Company entered into an agreement to provide a letter of credit, for up to $5.0 million, to assist a customer in demonstrating adequate reserves to the customer’s state regulatory authorities. The letter of credit is effective from September 30, 2017 through June 30, 2019, and carries a quarterly facility rental fee of 0.80% per annum on the amount of the outstanding balance. The letter of credit will terminate after June 30, 2019. The letter of credit is presented at the face amount plus accrued facility rental fee, less received payments. There was no outstanding balance related to this letter of credit as of September 30, 2018, or December 31, 2017.

25



Lease Commitments

The Company has entered into lease agreements for its primary office locations in Arlington, Virginia, Lisle, Illinois, Chicago, Illinois, Albuquerque, New Mexico and Pune, India. Certain leases acquired as part of the Valence Health transaction included existing sublease agreements for office locations in Chicago, Illinois. The Company also has several smaller leases in various locations within Texas and California. Total rental expense, net of sublease income, on operating leases was $3.3 million and $10.1 million for the three and nine months ended September 30, 2018, respectively, and $3.0 million and $8.0 million for the three and nine months ended September 30, 2017, respectively.

In connection with various lease agreements, the Company is required to maintain $3.7 million in letters of credit and, as such, held $3.7 million in restricted cash and restricted investments as collateral for the letters of credit as of September 30, 2018.

Indemnifications

The Company’s customer agreements generally include a provision by which the Company agrees to defend its partners against third-party claims (a) for death, bodily injury, or damage to personal property caused by Company negligence or willful misconduct, (b) by former or current Company employees arising from such managed service agreements, (c) for intellectual property infringement under specified conditions and (d) for Company violation of applicable laws, and to indemnify them against any damages and costs awarded in connection with such claims. To date, the Company has not incurred any material costs as a result of such indemnities and has not accrued any liabilities related to such obligations in the accompanying consolidated financial statements.

Registration Rights Agreement

We entered into a registration rights agreement with The Advisory Board, the University of Pittsburgh Medical Center (“UPMC”), TPG and another investor to register for sale under the Securities Act of 1933, as amended, shares of our Class A common stock, including those delivered in exchange for Class B common stock and Class B common units. Subject to certain conditions and limitations, this agreement provides these investors with certain demand, piggyback and shelf registration rights. The registration rights granted under the registration rights agreement will terminate upon the date the holders of shares that are a party thereto no longer hold any such shares that are entitled to registration rights. Pursuant to our contractual obligations under this agreement, we filed a registration statement on Form S-3 with the SEC on July 28, 2016, which was declared effective on August 12, 2016.

Pursuant to certain terms of the registration rights agreement, certain Investor Stockholders sold 19.7 million shares of the Company’s Class A common stock during the 2017 Secondary Offerings, as discussed in Note 4. The Company incurred $0.3 million and $1.5 million in expenses related to the 2017 Secondary Offerings for the three and nine months ended September 30, 2017, pursuant to the terms of the registration rights agreement. The expenses were recorded within “Selling, general and administrative expenses” on our Consolidated Statements of Operations. We did not incur any expenses related to secondary offerings or other sales of shares by our Investor Stockholders for the three and nine months ended September 30, 2018.

We will continue to pay all expenses relating to any demand, piggyback or shelf registration, other than underwriting discounts and commissions and any transfer taxes, subject to specified conditions and limitations. The registration rights agreement includes customary indemnification provisions, including indemnification of the participating holders of shares of Class A common stock and their directors, officers and employees by us for any losses, claims, damages or liabilities in respect thereof and expenses to which such holders may become subject under the Securities Act of 1933, as amended, state law or otherwise.
 
Guarantees
 
As part of our strategy to support certain of our partners in the Next Generation Accountable Care Program, we entered into upside and downside risk sharing arrangements. Our downside risk-sharing arrangements are limited to our fees and are executed through our wholly-owned captive insurance company. To satisfy the capital requirements of our insurance entity as well as state insurance regulators, Evolent entered into letters of credit of $22.0 million as of September 30, 2018, to secure potential losses related to insurance services. This amount is in excess of our actuarial assessment of loss.

Reinsurance Agreement
 
During the fourth quarter of 2017, the Company entered into a 15-month, $10.0 million capital-only reinsurance agreement with NMHC, expiring on December 31, 2018. The purpose of the capital-only reinsurance is to provide balance sheet support to NMHC. There is no uncertainty to the outcome of the agreement as there is no transfer of underwriting risk to Evolent or True Health, and neither Evolent nor True Health is at risk for any cash payments on behalf of NMHC. As a result, this agreement does not qualify for reinsurance accounting. The Company will record a quarterly fee of approximately $0.2 million as non-operating income on its

26


consolidated statements of operations and will maintain $10.0 million in restricted cash and restricted investments on its consolidated balance sheets for the duration of the reinsurance agreement.

UPMC Reseller Agreement

The Company and UPMC are parties to a reseller, services and non-competition agreement, dated August 31, 2011, which was amended and restated by the parties on June 27, 2013 (as amended through the date hereof, the “UPMC Reseller Agreement”). Under the terms of the UPMC Reseller Agreement, UPMC has appointed the Company as a non-exclusive reseller of certain services, subject to certain conditions and limitations specified in the UPMC Reseller Agreement. In consideration for the Company’s obligations under the UPMC Reseller Agreement and subject to certain conditions described therein, UPMC has agreed not to sell certain products and services directly to a defined list of 20 of the Company’s customers.
 
Credit and Concentration Risk

The Company is subject to significant concentrations of credit risk related to cash and cash equivalents and accounts receivable. As of September 30, 2018, approximately 72.3% of our $266.8 million of cash and cash equivalents (including restricted cash) were held in bank deposits with FDIC participating banks, approximately 27.4% were held in money market funds and less than 1.0% were held in international banks. While the Company maintains its cash and cash equivalents with financial institutions with high credit ratings, it often maintains these deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any realized losses on cash and cash equivalents to date.

The Company is also subject to significant concentration of accounts receivable risk as a substantial portion of our trade accounts receivable is derived from a small number of our partners. The following table summarizes those partners who represented at least 10.0% of our trade accounts receivable for the periods presented:
 
 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Customer B
 
*

 
 
11.8
%
 
Customer C
 
16.2
%
 
 
32.1
%
 
Customer D
 
*

 
 
16.5
%
 
 
* Represents less than 10.0% of the respective balance

In addition, the Company is subject to significant concentration of revenue risk as a substantial portion of our revenue is derived from a small number of contractual relationships with our operating partners.
 
The following table summarizes those partners who represented at least 10.0% of our revenue for the periods presented:
 
 
 
For the Three
 
For the Nine
 
 
Months Ended
 
Months Ended
 
 
September 30,
 
September 30,
 
 
2018
 
2017
 
2018
 
2017
Customer A
 
18.8
%
 
19.0
%
 
18.9
%
 
18.5
%
Customer B
 
*

 
*

 
*

 
10.0
%
 
* Represents less than 10.0% of the respective balance

27


10. Earnings (Loss) Per Common Share
 
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Net income (loss)
$
(12,555
)
 
$
(13,129
)
 
$
(36,651
)
 
$
(55,977
)
Less:
 
 
 
 
 
 
 
Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Net income (loss) available for common shareholders (1) (2)
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding (2) (3)
77,999

 
70,328

 
76,871

 
60,867

 
 
 
 
 
 
 
 
Earnings (Loss) per Common Share
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.18
)
 
$
(0.47
)
 
$
(0.78
)
Diluted
(0.16
)
 
(0.18
)
 
(0.47
)
 
(0.78
)

(1) 
For periods of net loss, net income (loss) available for common shareholders is the same for both basic and diluted purposes.
(2) 
Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for one share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.
(3) 
For periods of net loss, shares used in the earnings (loss) per common share calculation represent basic shares as using diluted shares would be anti-dilutive.

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Exchangeable Class B common stock
766

 
2,654

 
1,251

 
8,846

Restricted stock units ("RSUs")
1,197

 
577

 
923

 
557

Stock options and performance-based stock options
2,698

 
2,976

 
2,486

 
3,031

Convertible senior notes
5,201

 
5,201

 
5,201

 
5,201

Total
9,862

 
11,408

 
9,861

 
17,635



28


11. Stock-based Compensation

Total compensation expense by award type and line item in our consolidated financial statements was as follows (in thousands):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
  
September 30,
 
September 30,
  
2018
 
2017
 
2018
 
2017
Award Type
 
 
 
 
 
 
 
Stock options
$
2,139

 
$
4,291

 
$
7,009

 
$
12,452

Performance-based stock options
113

 
113

 
334

 
335

RSUs
1,795

 
1,304

 
5,217

 
3,385

Total
$
4,047

 
$
5,708

 
$
12,560

 
$
16,172

 
 
 
 
 
 
 
 
Line Item
 
 
 
 
 
 
 
Cost of revenue
$
376

 
$
401

 
$
1,130

 
$
1,143

Selling, general and
 
 
 
 
 
 
 
administrative expenses
3,671

 
5,307

 
11,430

 
15,029

Total
$
4,047

 
$
5,708

 
$
12,560

 
$
16,172


No stock-based compensation in the totals above was capitalized as software development costs for the three and nine months ended September 30, 2018 and 2017, respectively.

Stock-based awards were granted as follows (in thousands):
 
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Stock options
3

 
84

 
1,054

 
961

RSUs
18

 
37

 
857

 
461


12. Income Taxes

For interim periods, we recognize an income tax provision (benefit) based on our estimated annual effective tax rate expected for the full year.

The Company recorded $0.1 million and less than $0.1 million in income tax expense for the three and nine months ended September 30, 2018, respectively, which resulted in effective tax rates of (0.9)% and (0.1)%, respectively. The Company recorded $1.7 million and $2.0 million in income tax benefit for the three and nine months ended September 30, 2017, respectively, which resulted in effective tax rates of 11.6% and 3.5%, respectively. The income tax benefit recorded during the three and nine months ended September 30, 2018, primarily relates to the change in indefinite-lived components and components expected to reverse outside of the net operating loss carryover period as part of the outside basis difference in our partnership interest in Evolent Health LLC. With the exception of these components, the Company continues to record a valuation allowance against the net deferred tax assets. As a result of the Tax Cuts and Jobs Act (the “Tax Act”) enacted on December 22, 2017, and subsequent state jurisdictions conforming to certain provisions of the Tax Act with respect to the indefinite carryforward period and 80% taxable income limitation on NOLs arising after December 31, 2017, these components of the deferred tax liabilities are comprised of the entire nonconforming state indefinite-lived components and those outside of the NOL carryforward period and a portion of our federal and conforming states components that could not be used as a source of income. As of December 31, 2017, the Company had recorded a provisional estimate of the financial statement impact of the Tax Act in accordance with SEC Staff Accounting Bulletin No. 118. During the three and nine months ended September 30, 2018, the change in the initial provisional estimates is immaterial. The Company will continue to evaluate any further adjustments necessary through 2018.

As a result of the increase in our ownership of Evolent Health LLC following the March 2018 Private Sale discussed in Note 4 above, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by approximately $0.9 million for the nine months ended September 30, 2018. The effect of this change in the deferred tax liability was recorded as additional paid-in capital.

29


As a result of the increase in our ownership of Evolent Health LLC following the August 2017 Primary and 2017 Secondary Offerings discussed in Note 4 above, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by $13.1 million for the nine months ended September 30, 2017. The effect of this change in the deferred tax liability was recorded as $12.8 million of additional paid-in capital and $0.3 million of income tax benefit.

As of December 31, 2017, the Company had unrecognized tax benefits of $0.8 million that, if recognized, would not affect the effective tax rate. As of September 30, 2018, the Company has released all unrecognized tax benefits due to the filing of a federal income tax automatic accounting method change application. The Company is not currently subject to income tax audits in any U.S., state, or foreign jurisdictions for any tax year.

Tax Receivables Agreement

In connection with the Offering Reorganization, the Company entered into the TRA with certain of its investors, which provides for the payment by the Company to these investors of 85% of the amount of the tax benefits, if any, that the Company is deemed to realize as a result of increases in our tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. See Note 9 above and “Part II - Item 8. Financial Statements and Supplementary Data - Note 12” in our 2017 Form 10-K for discussion of our TRA.

13. Investments In and Advances to Equity Method Investees

The Company has entered into joint venture agreements with various entities. As of September 30, 2018, the Company’s economic and voting interests in these entities ranged between 4% and 40%. As of December 31, 2017, the Company’s economic interests in these entities ranged between 26% and 40% and voting interests ranged between 27% and 40%. The Company determined that it has significant influence over these entities but that it does not have control over any of the entities. Accordingly, the investments are accounted for under the equity method of accounting and the Company is allocated its proportional share of the entities’ earnings and losses for each reporting period. The Company’s proportional share of the losses from these investments was approximately $1.4 million and $2.8 million for the three and nine months ended September 30, 2018, respectively, and $0.4 million and $1.4 million for the three and nine months ended September 30, 2017, respectively.

The Company signed services agreements with certain of the aforementioned entities to provide certain management, operational and support services to help manage elements of their service offerings. Revenues related to these services agreements was $5.1 million and $5.9 million for the three and nine months ended September 30, 2018, respectively, and less than $0.1 million and $0.4 million for the three and nine months ended September 30, 2017, respectively.

14. Non-controlling Interests

Immediately following the Offering Reorganization and IPO (as described in our 2017 Form 10-K), the Company owned 70.3% of Evolent Health LLC. The Company’s ownership percentage changes with the issuance of Class A common stock and Class B Exchanges.

The Company completed the 2017 Secondary Offerings during 2017. The shares sold in the 2017 Secondary Offerings consisted of 20.1 million shares of the Company’s Class A common stock, consisting of 7.4 million existing shares of the Company’s Class A common stock owned and held by certain Selling Stockholders, 12.6 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges and 0.1 million shares issued upon the exercise of options by certain management selling stockholders. As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of its Class B common units during the 2017 Secondary Offerings, the Company’s economic interest in Evolent Health LLC increased from 77.4% to 96.1% immediately following the June 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

In addition, the Company issued 8.8 million shares of its Class A Common Stock during the August 2017 Primary for net proceeds of $166.9 million. For each share of Class A common stock issued by Evolent Health, Inc., the Company received a corresponding Class A common unit from Evolent Health LLC in exchange for contributing the issuance proceeds to Evolent Health LLC. As a result of the Class A common stock and Class A common units issued in conjunction with the August 2017 Primary, the Company’s economic interest in Evolent Health LLC increased from 96.1% to 96.6% immediately following the August 2017 Primary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

The Company completed the March 2018 Private Sale during March 2018. The shares sold in the March 2018 Private Sale consisted of 1.2 million existing shares of the Company’s Class A common stock owned and held by The Advisory Board and 1.8 million newly-issued shares of the Company’s Class A common stock received by The Advisory Board pursuant to a Class B Exchange.

30



As a result of this Class B Exchange and Evolent Health LLC’s cancellation of the Class B units during the March 2018 Private Sale, the Company’s economic interest in Evolent Health LLC increased from 96.6% to 98.9% immediately following the March 2018 Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

As of September 30, 2018, and December 31, 2017, we owned 99.0% and 96.6% of the economic interests in Evolent Health LLC, respectively. See Note 4 for further discussion of the March 2018 Private Sale, August 2017 Primary and 2017 Secondary Offerings.

Changes in non-controlling interests (in thousands) for the periods presented were as follows:

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Non-controlling interests as of beginning-of-period
$
10,148

 
$
34,680

 
$
35,427

 
$
209,588

Cumulative-effect adjustment from adoption of new accounting principle

 

 
594

 

Decrease in non-controlling interests as a result of Class B Exchanges

 

 
(25,334
)
 
(168,883
)
Reclassification of non-controlling interests
(14
)
 
1,793

 
1

 
3,698

Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Non-controlling interests as of end-of-period
$
10,008

 
$
35,932

 
$
10,008

 
$
35,932


15. Fair Value Measurement
 
GAAP defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) assuming an orderly transaction in the most advantageous market at the measurement date. GAAP also establishes a hierarchical disclosure framework which prioritizes and ranks the level of observability of inputs used in measuring fair value. These tiers include:

Level 1 - inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date;
Level 2 - inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date and the fair value can be determined through the use of models or other valuation methodologies; and
Level 3 - inputs to the valuation methodology are unobservable inputs in situations where there is little or no market activity for the asset or liability.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the particular asset or liability being measured.


31


Recurring Fair Value Measurements
 
In accordance with GAAP, certain assets and liabilities are required to be recorded at fair value on a recurring basis. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands):

 
As of September 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
41,186

 
$

 
$

 
$
41,186

Restricted cash and restricted investments (1)
32,028

 

 

 
32,028

Total
$
73,214

 
$

 
$

 
$
73,214

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,300

 
8,300


 
As of December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
60,535

 
$

 
$

 
$
60,535

Restricted cash and restricted investments (1)
16,575

 

 

 
16,575

Total
$
77,110

 
$

 
$

 
$
77,110

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,700

 
8,700

(1) Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of September 30, 2018, and December 31, 2017, as presented in the tables above.
(2) Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (“Passport”) acquisition as described below.
The Company recognizes any transfers between levels within the hierarchy as of the beginning of the reporting period. There were no transfers between fair value levels for the three and nine month periods ended September 30, 2018 and 2017, respectively.
In the absence of observable market prices, the fair value is based on the best information available and involves a significant degree of judgment, taking into consideration a combination of internal and external factors, including the appropriate risk adjustments for non-performance and liquidity risks.

The strategic alliance with Passport includes a provision for additional equity consideration contingent upon the Company obtaining new third-party Medicaid business in future periods. The contingent consideration of $8.3 million and $8.7 million is a mark-to-market liability recorded within “Other long-term liabilities” on our Consolidated Balance Sheets as of September 30, 2018, and December 31, 2017. We recorded a re-measurement loss of approximately $0.1 million for the three months ended September 30, 2018, and a re-measurement gain of approximately $0.4 million for the nine months ended September 30, 2018, and re-measurement losses of approximately $0.1 million and $0.3 million for the three and nine months ended September 30, 2017, respectively, based on changes in the underlying assumptions of the fair value calculation. The fair value of the contingent equity consideration was estimated based on the real options approach, a form of the income approach, which estimated the probability of the Company achieving future revenues under the agreement. The significant unobservable inputs used in the fair value measurement of the Passport contingent consideration are the five-year risk-adjusted recurring revenue compound annual growth rate (“CAGR”) and the applicable discount rate. A significant increase in the assumed five-year risk-adjusted recurring revenue CAGR projection or decrease in discount rate in isolation would result in a significantly higher fair value of the contingent consideration.


32


The changes in our contingent consideration, measured at fair value, for which the Company uses Level 3 inputs to determine fair value are as follows (in thousands):
                                                                  
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Balance as of beginning-of-period
$
8,200

 
$
8,500

 
$
8,700

 
$
8,300

Realized and unrealized (gains) losses, net
100

 
100

 
(400
)
 
300

Balance as of end-of-period
$
8,300

 
$
8,600

 
$
8,300

 
$
8,600


The following table summarizes the fair value (in thousands), valuation techniques and significant unobservable inputs of our Level 3 fair value measurements as of the periods presented:

 
As of September 30, 2018
 
 
Fair
 
Valuation
 
Significant
 
Assumption or
 
 
Value
 
Technique
 
Unobservable Inputs
 
Input Ranges
 
Contingent consideration (1)
$
8,300

 
Real options approach
 
Risk-adjusted recurring revenue CAGR
 
112.7
%
(2) 
 
 
 
 
 
Discount rate/time value
 
3.8% - 4.5%

 
(1) Related to additional Passport earn-out consideration as described above.
(2) The risk-adjusted recurring revenue CAGR is calculated over the five-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of $1.0 million, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is 78.6%.

 
As of December 31, 2017
 
 
Fair
 
Valuation
 
Significant
 
Assumption or
 
 
Value
 
Technique
 
Unobservable Inputs
 
Input Ranges
 
Contingent consideration (1)
$
8,700

 
Real options approach
 
Risk-adjusted recurring revenue CAGR
 
92.5
%
(2) 
 
 
 
 
 
Discount rate/time value
 
2.7% - 4.0%

 

(1) Related to additional Passport earn-out consideration as described above.
(2) The risk-adjusted recurring revenue CAGR is calculated over the five-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of $1.0 million, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is 19.2%.

Nonrecurring Fair Value Measurements

In addition to the assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets and liabilities at fair value on a nonrecurring basis as required by GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. This includes goodwill, intangible assets, property, plant and equipment, held-to-maturity investments and equity method investments. While not carried at fair value on a recurring basis, these items are continually monitored for indicators of impairment that would indicate current carrying value is greater than fair value. In those situations, the assets are considered impaired and written down to current fair value. See Notes 4, 5, 6, 7 and 13 for further discussion of assets measured at fair value on a nonrecurring basis.

Other Fair Value Disclosures

The carrying amounts of cash and cash equivalents (those not held in a money market fund), restricted cash, receivables, prepaid expenses, accounts payable, accrued liabilities and accrued compensation approximate their fair values because of the relatively short-term maturities of these items and financial instruments.

See Note 8 for information regarding the fair value of the 2021 Notes.


33


16. Related Parties

The entities described below are considered related parties and the balances and/or transactions with them are reported in our consolidated financial statements.

As discussed in Note 13, the Company has economic interests in several entities that are accounted for under the equity method of accounting. The Company has allocated its proportional share of the investees’ earnings and losses each reporting period. In addition, Evolent has entered into services agreements with certain of the entities to provide certain management, operational and support services to help the entities manage elements of their service offerings. Revenues related to these services agreements was $5.1 million and $5.9 million for the three and nine months ended September 30, 2018, respectively, and less than $0.1 million and $0.4 million for the three and nine months ended September 30, 2017, respectively.

The Company also works closely with UPMC, one of its founding investors. The Company’s relationship with UPMC is a subcontractor relationship where UPMC has agreed to execute certain tasks (primarily TPA services) relating to certain customer commitments. We also conduct business with a company in which UPMC holds a significant equity interest.

Additionally, prior to the Offering Reorganization, we issued shares of our stock to certain of our partners while concurrently entering into revenue contracts with those partners. Those partners are considered related parties and the balances and/or transactions with them were reported on our consolidated financial statements for the periods in which they held a significant equity interest in Evolent Health, Inc.

The following table presents revenues and expenses attributable to our related parties (in thousands):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Revenue
 
 
 
 
 
 
 
Transformation services
$
5,332

 
$
352

 
$
6,112

 
$
597

Platform and operations services
12,180

 
9,411

 
27,072

 
24,764

Expenses
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization expenses)
2,390

 
5,299

 
6,842

 
17,382

Selling, general and administrative expenses
241

 
514

 
620

 
1,038


17. Segment Reporting

We define our reportable segments based on the way the chief operating decision maker (“CODM”), currently the Chief Executive Officer, manages the operations for purposes of allocating resources and assessing performance. We classify our operations into two reportable segments as follows:

Services, which consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services; and
True Health, which consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses.

In the ordinary course of business, our reportable segments enter into transactions with one another. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues and expenses recognized by the segment that is the counterparty to the transaction are eliminated in consolidation and do not affect consolidated results.

The CODM uses Adjusted Revenue and Adjusted EBITDA as the relevant segment performance measures to evaluate the performance of the segments and allocate resources.

Adjusted Revenue and Adjusted EBITDA are segment performance financial measures that offer a useful view of the overall operation of our businesses and may be different than similarly-titled segment performance financial measures used by other companies. Adjusted Revenue is defined as the sum of Adjusted Services Revenue and True Health premiums revenue less intersegment eliminations. Adjusted Services Revenue is defined as Services revenue adjusted to exclude the impact of purchase accounting adjustments. Adjusted Services Revenue consists of Adjusted Transformation Services Revenue and Adjusted Platform

34


and Operations Services Revenue, which are defined as transformation services revenue and platform and operations services revenue, respectively, before the effect of intersegment eliminations and adjusted to exclude the impact of purchase accounting adjustments. The company’s Adjusted Services Revenue for the nine months ended September 30, 2018, includes a $4.5 million adjustment related to revenue that was contracted for prior to 2018 and that was properly excluded from revenue in our 2017 results under the revenue recognition rules then in effect under ASC 605. On January 1, 2018, we adopted the new revenue recognition rules under ASC 606 using the modified retrospective method, which required us to include this $4.5 million as part of the cumulative transition adjustment to beginning retained earnings as of January 1, 2018. Under ASC 605, and based on proportionate performance revenue recognition, we would have recognized an additional $4.5 million in revenue during 2018, primarily within our Adjusted Transformation Services Revenue. The Company has therefore included this revenue, and related profit, in its adjusted results for the nine months ended September 30, 2018, as they had not been previously reported prior to 2018 and the contracts are expected to be completed within 2018. This is a one-time adjustment and it will not reoccur in future periods.

Adjusted EBITDA is the sum of Services Adjusted EBITDA and True Health Adjusted EBITDA and is defined as EBITDA (net income (loss) attributable to Evolent Health, Inc. before interest income, interest expense, (provision) benefit for income taxes, depreciation and amortization expenses), adjusted to exclude changes in fair value of contingent consideration and indemnification assets, income (loss) from equity method investees, other income (expense), net, net (income) loss attributable to non-controlling interests, purchase accounting adjustments, stock-based compensation expenses, severance costs, amortization of contract cost assets recorded as a result of a one-time ASC 606 transition adjustment, transaction costs related to acquisitions and business combinations and other one-time adjustments (which for the nine months ended September 30, 2018, includes the ASC 606 transition adjustment described above). When Adjusted EBITDA is discussed in this report, the most directly comparable GAAP financial measure is net income (loss) attributable to Evolent Health, Inc.

Management considers Adjusted Revenue and Adjusted EBITDA to be the appropriate metrics to evaluate and compare the ongoing operating performance of our segments on a consistent basis across reporting periods as they eliminate the effect of items which are not indicative of each segment's core operating performance.

35



The following tables present our segment information (in thousands):

 
 
 
 
 
 
 
Intersegment
 
 
 
 
 
Services
 
True Health (1)
Eliminations
Consolidated
Adjusted Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
9,230

 
 
$

 
 
$

 
 
$
9,230

 
Adjusted Platform and Operations Services
 
121,845

 
 

 
 
(3,537
)
 
 
118,308

 
Adjusted Services Revenue
 
131,075

 
 

 
 
(3,537
)
 
 
127,538

 
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 

 
 
22,829

 
 
(206
)
 
 
22,623

 
Adjusted Revenue
 
131,075

 
 
22,829

 
 
(3,743
)
 
 
150,161

 
Purchase accounting adjustments (2)
 
(214
)
 
 

 
 

 
 
(214
)
 
Total revenue
 
$
130,861

 
 
$
22,829

 
 
$
(3,743
)
 
 
$
149,947

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
8,204

 
 
$

 
 
$

 
 
$
8,204

 
Adjusted Platform and Operations Services
 
100,157

 
 

 
 

 
 
100,157

 
Adjusted Services Revenue
 
108,361

 
 

 
 

 
 
108,361

 
Adjusted Revenue
 
108,361

 
 

 
 

 
 
108,361

 
Purchase accounting adjustments (2)
 
(449
)
 
 

 
 

 
 
(449
)
 
Total revenue
 
$
107,912

 
 
$

 
 
$

 
 
$
107,912

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segments
 
 
 
 
 
 
Services
 
True Health (1)
Total
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
4,065

 
 
$
732

 
 
$
4,797

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
2,648

 
 
$

 
 
$
2,648

 
 
 
 

(1) 
The True Health segment was created in January 2018.
(2) 
Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were no purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.


36


 
 
 
 
 
 
 
Intersegment
 
 
 
 
 
Services
 
True Health (1)
Eliminations
Consolidated
Adjusted Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
27,605

 
 
$

 
 
$

 
 
$
27,605

 
Adjusted Platform and Operations Services
 
353,697

 
 

 
 
(10,949
)
 
 
342,748

 
Adjusted Services Revenue
 
381,302

 
 

 
 
(10,949
)
 
 
370,353

 
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 

 
 
69,353

 
 
(602
)
 
 
68,751

 
Adjusted Revenue
 
381,302

 
 
69,353

 
 
(11,551
)
 
 
439,104

 
ASC 606 transition adjustment (2)
 
(4,498
)
 
 

 
 

 
 
(4,498
)
 
Purchase accounting adjustments (3)
 
(647
)
 
 

 
 

 
 
(647
)
 
Total revenue
 
$
376,157

 
 
$
69,353

 
 
$
(11,551
)
 
 
$
433,959

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
23,799

 
 
$

 
 
$

 
 
$
23,799

 
Adjusted Platform and Operations Services
 
298,646

 
 

 
 

 
 
298,646

 
Adjusted Services Revenue
 
322,445

 
 

 
 

 
 
322,445

 
Adjusted Revenue
 
322,445

 
 

 
 

 
 
322,445

 
Purchase accounting adjustments (3)
 
(1,224
)
 
 

 
 

 
 
(1,224
)
 
Total revenue
 
$
321,221

 
 
$

 
 
$

 
 
$
321,221

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segments
 
 
 
 
 
 
Services
 
True Health (1)
Total
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
16,674

 
 
$
921

 
 
$
17,595

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
(5,689
)
 
 
$

 
 
$
(5,689
)
 
 
 
 

(1) 
The True Health segment was created in January 2018.
(2) 
Adjustment to Adjusted Transformation Services Revenue was approximately $3.7 million and the adjustment to Adjusted Platform and Operations Services Revenue was approximately $0.8 million.
(3) 
Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were no purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.


37


The following table presents our reconciliation of segments total Adjusted EBITDA to net income (loss) attributable to Evolent Health, Inc. (in thousands):

 
 
For the Three
 
For the Nine
 
 
Months Ended
 
Months Ended
 
 
September 30,
 
September 30,
 
 
2018
 
2017
 
2018
 
2017
Net Income (Loss) Attributable to
 
 
 
 
 
 
 
 
Evolent Health, Inc.
 
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
Less:
 
 
 
 
 
 
 
 
Interest income
 
968

 
411

 
2,918

 
813

Interest expense
 
(853
)
 
(880
)
 
(2,561
)
 
(2,781
)
(Provision) benefit for income taxes
 
(135
)
 
1,714

 
(29
)
 
2,009

Depreciation and amortization expenses
 
(10,352
)
 
(7,717
)
 
(29,882
)
 
(21,236
)
Income (loss) from equity method investees
 
(1,381
)
 
(369
)
 
(2,787
)
 
(1,446
)
Change in fair value of contingent
 
 
 
 
 
 
 
 
consideration and indemnification asset
 
(100
)
 
(100
)
 
1,404

 
(300
)
Other income (expense), net
 
(124
)
 
15

 
(64
)
 
21

Net (income) loss attributable to
 
 
 
 
 
 
 
 
non-controlling interests
 
126

 
541

 
680

 
8,471

ASC 606 transition adjustments
 

 

 
(4,498
)
 

Purchase accounting adjustments
 
(214
)
 
(449
)
 
(647
)
 
(1,224
)
Stock-based compensation expense
 
(4,047
)
 
(5,708
)
 
(12,560
)
 
(16,172
)
Severance costs
 

 

 
(1,489
)
 

Amortization of contract cost assets
 
(658
)
 

 
(1,797
)
 

Transaction costs
 
(456
)
 
(2,694
)
 
(2,254
)
 
(9,972
)
Adjusted EBITDA
 
$
4,797

 
$
2,648

 
$
17,595

 
$
(5,689
)

Asset information by segment is not a key measure of performance used by the CODM. Accordingly, we have not disclosed asset information by segment.

18. True Health Claims Reserves

Claims reserves for the True Health segment reflect estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process), and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.

The Company uses actuarial principles and assumptions that are consistently applied each reporting period and recognizes the actuarial best estimate of the ultimate liability along with a margin for adverse deviation. This approach is consistent with actuarial standards of practice that the liabilities be adequate under moderately adverse conditions.

This liability predominately consists of incurred but not reported amounts and reported claims in process including expected development on reported claims. The liability is primarily calculated using "completion factors" developed by comparing the claim incurred date to the date claims were paid. Completion factors are impacted by several key items including changes in: 1) electronic (auto-adjudication) versus manual claim processing, 2) provider claims submission rates, 3) membership and 4) the mix of products.

The Company’s policy is to use historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. The Company estimates the liability for claims incurred in each month by applying the current estimates of completion factors to the current paid claims data. This approach implicitly assumes that historical completion rates will be a useful indicator for the current period notwithstanding that we did not own NMHC’s commercial business prior to January 2, 2018.

For more recent months, the Company expects to rely more heavily on medical cost trend analysis that reflects expected claim payment patterns and other relevant operational considerations. Medical cost trend is primarily impacted by medical service utilization and unit costs that are affected by changes in the level and mix of medical benefits offered, including inpatient, outpatient and

38


pharmacy, the impact of copays and deductibles, changes in provider practices and changes in consumer demographics and consumption behavior.

For each reporting period, the Company compares key assumptions used to establish the claims reserves to actual experience. When actual experience differs from these assumptions, claims reserves are adjusted through current period shareholders' net income. Additionally, the Company evaluates expected future developments and emerging trends that may impact key assumptions. The process used to determine this liability requires the Company to make critical accounting estimates that involve considerable judgment, reflecting the variability inherent in forecasting future claim payments. These estimates are highly sensitive to changes in the Company's key assumptions, specifically completion factors and medical cost trends.

Activity in claims reserves was as follows (in thousands):

 
For the Nine
 
Months Ended
 
September 30,
 
 
2018
 
Incurred costs related to current period
 
$
52,169

 
Paid costs related to current period
 
41,831

 
Change during the period
 
10,338

 
Beginning balance
 

 
Ending balance
 
$
10,338

 

19. Supplemental Cash Flow Information

The following represents supplemental disclosure of non-cash investing and financing information (in thousands):

 
For the Nine
 
Months Ended
 
September 30,
 
2018
 
2017
Accrued property and equipment purchases
$
501

 
$
83

Increase to goodwill from measurement period adjustments
 
 
 
related to business combinations
4

 
1,766

Decrease in accrued financing costs related to 2021 Notes

 
196

Consideration for asset acquisitions or business combinations
500

 

Settlement of escrow related to asset acquisition
2,519

 

Settlement of indemnification asset
1,004

 

Tax benefit related to Accordion intangible technology

 
2,042

 
 
 
 
Effects of Class B Exchanges
 
 
 
Decrease in non-controlling interests as a result of Class B Exchanges
25,334

 
168,883

Decrease in deferred tax liability as a result of securities offerings
908

 
12,992


20. Subsequent Events

Acquisition of New Century Health

On October 1, 2018, the Company completed its previously announced acquisition of New Century Health. The closing merger consideration, net of cash on hand and certain closing adjustments, was $221.6 million, based on the closing price of Evolent’s Class A common stock on the New York Stock Exchange on October 1, 2018, and consisted of 3.1 million shares of Evolent Class B common stock, an equal number of Evolent Health LLC Class B units and $117.2 million in cash. The shares issued at closing represent 3.8% of the Company’s issued and outstanding Class A common stock and Class B common stock after the transaction. The purchase price of $221.6 million includes an earn-out potential of up to $20.0 million, payable in cash and Evolent Class B common stock, subject to the satisfaction of certain conditions related to the operating results of New Century Health in 2019. Shares to be issued in relation to the earn-out are limited to 1.0 million shares of Evolent’s Class B common stock, with full payment expected to be made during the

39


first quarter of 2020. The shares at closing were, and the shares for the earn-out, if any, will be issued in transactions exempt from registration under the Securities Act of 1933, as amended.

Convertible debt issuance

In October 2018, the Company issued $172.5 million aggregate principal amount of its 1.50% Convertible Senior Notes due 2025 (the “2025 Notes”) in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2025 Notes were issued at par for net proceeds, excluding expenses, of $167.3 million. We incurred $5.2 million of debt issuance costs in connection with the 2025 Notes, which will be amortized to non-cash interest expense over the contractual term of the 2025 Notes. The closing of the private placement of $150.0 million aggregate principal amount of the 2025 Notes occurred on October 22, 2018, and the initial purchasers completed the exercise in full of their option to purchase an additional $22.5 million aggregate principal amount of the 2025 Notes on October 24, 2018. The Company loaned the net proceeds to Evolent Health LLC, which intends to use the net proceeds for working capital and other general corporate purposes.

Holders of the 2025 Notes are entitled to cash interest payments, which are payable semiannually in arrears on April 15 and October 15 of each year, beginning on April 15, 2019, at a rate equal to 1.50% per annum. The 2025 Notes will mature on October 15, 2025, unless earlier repurchased, redeemed or converted in accordance with their terms prior to such date.

Prior to the close of business on the business day immediately preceding April 15, 2025, the 2025 Notes will be convertible at the option of the holders only upon the satisfaction of certain conditions, as described in the indenture, dated as of October 22, 2018 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. On or after April 15, 2025, until the close of business on the business day immediately preceding the maturity date, holders may convert, at their option, all or any portion of their notes at the conversion rate at any time irrespective of any conditions.

The 2025 Notes will be convertible at an initial conversion rate of 29.9135 shares of Class A common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $33.43 per share of the Company’s Class A common stock. In the aggregate, the 2025 Notes are initially convertible into 5.2 million shares of the Company’s Class A common stock (excluding any shares issuable by the Company upon a conversion in connection with a make-whole fundamental change or a notice of redemption as described in the Indenture). The conversion rate may be adjusted under certain circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s Class A common stock or a combination of cash and shares of the Company’s Class A common stock, at the Company’s election.

Holders of the 2025 Notes may require the Company to repurchase all or part of their notes upon the occurrence of a fundamental change at a price equal to 100.0% of the principal amount of the notes being repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Company may not redeem the 2025 Notes prior to October 20, 2022. The Company may redeem for cash all or any portion of the 2025 Notes, at its option, on or after October 20, 2022, if the last reported sale price of the Company’s Class A common stock has been at least 130.0% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100.0% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.


40


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the Company’s financial condition and results of operations. The MD&A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes to consolidated financial statements (“Notes”) presented in “Part I - Item 1. Financial Statements” of this Form 10-Q; our 2017 Form 10-K, including the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; and our current reports on Form 8-K filed in 2018.

INTRODUCTION
 
Background and Recent Events

Evolent Health, Inc. is a holding company whose principal asset is all of the Class A common units it holds in Evolent Health LLC, and its only business is to act as sole managing member of Evolent Health LLC. Substantially all of our operations are conducted through Evolent Health LLC and its consolidated subsidiaries. The financial results of Evolent Health LLC are consolidated in the financial statements of Evolent Health, Inc.

Transactions

Convertible debt issuance

In October 2018, the Company issued the 2025 Notes in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2025 Notes were issued at par for net proceeds, excluding expenses, of $167.3 million. We incurred $5.2 million of debt issuance costs in connection with the 2025 Notes, which will be amortized to non-cash interest expense over the contractual term of the 2025 Notes. The closing of the private placement of $150.0 million aggregate principal amount of the 2025 Notes occurred on October 22, 2018, and the initial purchasers completed the exercise in full of their option to purchase an additional $22.5 million aggregate principal amount of the 2025 Notes on October 24, 2018. The Company loaned the net proceeds to Evolent Health LLC, which intends to use the net proceeds for working capital and other general corporate purposes.

Acquisition of New Century Health

On October 1, 2018, the Company completed its previously announced acquisition of New Century Health. The closing merger consideration, net of cash on hand and certain closing adjustments, was $221.6 million, based on the closing price of Evolent’s Class A common stock on the New York Stock Exchange on October 1, 2018, and consisted of 3.1 million shares of Evolent Class B common stock, an equal number of Evolent Health LLC Class B units and $117.2 million in cash. The shares issued at closing represent 3.8% of the Company’s issued and outstanding Class A common stock and Class B common stock after the transaction. The purchase price of $221.6 million includes an earn-out potential of up to $20.0 million, payable in cash and Evolent Class B common stock, subject to the satisfaction of certain conditions related to the operating results of New Century Health in 2019. Shares to be issued in relation to the earn-out are limited to 1.0 million shares of Evolent’s Class B common stock, with full payment expected to be made during the first quarter of 2020. The shares at closing were and the shares for the earn-out, if any, will be issued in transactions exempt from registration under the Securities Act of 1933, as amended.

Acquisition of certain assets from New Mexico Health Connections

On January 2, 2018, the Company, through its wholly-owned subsidiary, True Health, completed its previously announced acquisition of assets related to NMHC’s commercial business. The assets include a health plan management services organization with a leadership team and employee base with experience working locally with providers to run NMHC’s suite of preventive, disease and care management programs. The consideration paid by the Company in connection with the acquisition consisted of $10.3 million in cash (subject to certain adjustments), of which $0.3 million was deposited in an escrow account. This acquisition is expected to allow the Company to leverage its platform to support a value-based, provider-centric model of care in New Mexico. Refer to “Part I - Item 1. Financial Statements - Note 4” in this Form 10-Q for details of the accounting for this transaction.

Following the acquisition of NMHC’s assets, we now operate through two segments, the Services segment and the True Health segment.

41



March and June 2018 Private Sales

Under an exchange agreement we entered into at the time of our IPO, we granted the Investor Stockholders an exchange right that allows receipt of newly-issued shares of the Company’s Class A common stock in exchange for an equal number of shares of the Company’s Class B common stock (which are subsequently canceled) and an equal number of Evolent Health LLC’s Class B units. Class B units received by the Company from relevant Investor Stockholders are simultaneously exchanged for an equivalent number of Class A units of Evolent Health LLC, and Evolent Health LLC cancels the Class B units it receives in the Class B Exchange. The cancellation of the Class B units results in an increase in the Company’s economic interest in Evolent Health LLC.

In the March 2018 Private Sale, The Advisory Board sold 3.0 million shares of the Company’s Class A common Stock. The shares sold in the March 2018 Private Sale consisted of 1.2 million existing shares of the Company’s Class A common stock owned by The Advisory Board and 1.8 million newly-issued shares of the Company’s Class A common stock received by The Advisory Board pursuant to a Class B Exchange for all of its remaining shares of the Company’s Class B common stock and Class B units. The Company did not receive any proceeds from the March 2018 Private Sale. Subsequent to this Class B Exchange, in June 2018, The Advisory Board sold all of their remaining shares of the Company’s Class A common stock and no longer owns any shares of our Class A common stock.

As a result of this Class B Exchange and Evolent Health LLC’s cancellation of the Class B units during the March 2018 Private Sale, the Company’s economic interest in Evolent Health LLC increased from 96.6% to 98.9% immediately following the March 2018 Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

Business Overview
 
We are a market leader and a pioneer in the new era of health care delivery and payment, in which leading providers are taking on increasing clinical and financial responsibility for the populations they serve. Our purpose-built platform, powered by our technology, proprietary processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (“FFS”) reimbursement to value-based payment models. By partnering with providers to accelerate their path to value-based care, we enable our provider partners to expand their market opportunity, diversify their revenue streams, grow market share and improve the quality of the care they provide.

We consider value-based care to be the necessary convergence of health care payment and delivery. We believe the pace of this convergence is accelerating, driven by price pressure in traditional FFS health care, a market environment that is incentivizing value-based care models and innovation in data and technology. We believe providers are positioned to lead this transition to value-based care because of their control over large portions of health care delivery costs, their primary position with consumers and their strong local brand.

In our Services business, we market and sell our services primarily to major providers throughout the United States. We typically work with our partners in two phases. In the transformation phase, we initially work with our partners to develop a strategic plan for their transition to a value-based care model which includes sizing the market opportunity for our partner and creating a blueprint for executing that opportunity. During the second portion of the transformation phase, which typically lasts twelve to fifteen months, we generally work with our partner to implement the blueprint by establishing the resources necessary to launch its strategy and capitalize on the opportunity. During the transformation phase, we seek opportunities to enter into long-term service agreements, which we call the platform and operations phase. In the platform and operations phase, we deliver a wide range of services that support our partner in the execution of its new strategy. Certain contracts in the platform and operations phase can range from three to ten years in length, while others are shorter in duration, depending on the nature of the services. In the platform and operations phase, we also establish a local market presence and embed our resources alongside our partners. Revenue from these long-term contracts is not guaranteed because certain of these contracts are terminable for convenience or other reasons by our partners after a notice period has passed, though certain partners would be required to pay us a termination fee in certain circumstances. In addition, at times our contracts may be renegotiated or amended to change the nature and price of the services and/or the time period over which they are provided.

As of September 30, 2018, our Services business had over 30 operating partners, and a significant portion of our revenue is concentrated with several partners. Our largest partner, Passport, comprised 18.9% of our revenue for the nine months ended September 30, 2018.

In addition, our Truth Health business is a commercial health plan we operate in New Mexico that focuses on small and large businesses. We expect to be able to leverage our platform to support a value-based provider-centric model of care in the state.


42


We have incurred operating losses since our inception, as we have invested heavily in resources to support our growth. We intend to continue to invest aggressively in the success of our partners, expand our geographic footprint and further develop our capabilities. We may continue to incur operating losses for the foreseeable future and may need to raise additional capital through equity and debt financings in order to fund our operations. Additional funds may not be available on terms favorable to us or at all. If we are unable to achieve our revenue growth and cost management objectives, we may not be able to achieve profitability. As of the date the financial statements were available to be issued, we believe we have sufficient liquidity for the next twelve months.

We manage our operations and allocate resources through two reportable segments, Services and True Health.

Critical Accounting Policies and Estimates
 
The MD&A included in our 2017 Form 10-K contains a detailed discussion of our critical accounting policies and estimates. There have been no material changes to our critical accounting policies and estimates since our 2017 Form 10-K, except as discussed below. See “Item 1. Financial Statements - Note 2” in this Form 10-Q for a summary of our significant accounting policies and see “Item 1. Financial Statements - Note 3” in this Form 10-Q for information regarding the Company’s adoption of new accounting standards.

Revenue from contracts with customers

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, in order to clarify the principles of recognizing revenue. The Company adopted the standard effective January 1, 2018, using the modified retrospective method for only contracts that were not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC 605. Evolent recognized the cumulative effect of applying the new revenue standard as a $17.3 million adjustment to the opening balance of retained earnings in the first quarter of 2018. See “Part I - Item 1. Financial Statements - Note 2” in this Form 10-Q for our updated revenue recognition policy and the impact of adopting the new revenue recognition standard on Evolent’s financial statements. See “Part I - Item 1. Financial Statements - Note 5” in this Form 10-Q for additional disclosures regarding Evolent's contracts with customers.

Operating Segments

Operating segments are defined as components of a business that earn revenue and incur expenses for which discrete financial information is available that is evaluated, on a regular basis, by the CODM to decide how to allocate resources and assess performance. The Company operates through two segments: (1) Services, and (2) True Health. Our Services segment consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services. Our True Health segment consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses.

43



Adoption of ASU 2016-18

The Company adopted ASU 2016-18, Statement of Cash Flows: Restricted Cash, effective December 31, 2017, using the retroactive transition method, which resulted in the recast of our statement of cash flows for each period presented. See “Part I - Item 1. Financial Statements - Note 2” in this Form 10-Q and “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2017 Form 10-K for further information about the adoption.

The following table summarizes the impact of the change in accounting principle to the Company’s Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 (in thousands):

 
For the Nine Months Ended September 30, 2017
 
As Reported
Adjustments
As Adjusted
Cash Flows from Investing Activities
 
 
 
 
 
 
 
 
Purchases and maturities of restricted investments
 
$

 
 
$
(3,200
)
 
 
$
(3,200
)
Change in restricted cash and restricted investments
 
(2,164
)
 
 
2,164

 
 

Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) investing activities
 
17,003

 
 
(1,036
)
 
 
15,967

 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities
 
 
 
 
 
 
 
 
Change in restricted cash held on behalf of
 
 
 
 
 
 
 
 
partners for claims processing
 

 
 
(25,648
)
 
 
(25,648
)
Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) financing activities
 
169,570

 
 
(25,648
)
 
 
143,922

 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash
 
 
 
 
 
 
 
 
equivalents and restricted cash
 
152,580

 
 
(26,684
)
 
 
125,896

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of beginning-of-period
 
134,563

 
 
35,466

 
 
170,029

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of end-of-period
 
$
287,143

 
 
$
8,782

 
 
$
295,925

 


44


RESULTS OF OPERATIONS

Evolent Health, Inc. is a holding company and its principal asset is all of the Class A common units in Evolent Health LLC, which has owned all of our operating assets and substantially all of our business since inception. The financial results of Evolent Health LLC are consolidated in the financial statements of Evolent Health, Inc.

Key Components of our Results of Operations

Revenue

Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. We collect a fixed fee from our partners during the transformation phase and revenue is recognized over time using an input method based on hours incurred compared to the total estimated house required to satisfy our performance obligation. In the case of implementation revenues tied to certain health plan services activities, such revenue is deferred and amortized over the life of the contract. Transformation revenue can fluctuate based on both the timing of when contracts are executed with partners, the scope of the delivery and the timing of work being performed.

During the platform and operations phase, our revenue structure shifts to a primarily variable fee structure which typically includes a monthly payment that is calculated based on a specified rate, or per member per month, multiplied by the number of members that our partners are managing under a value-based care arrangement or a percentage of plan premiums. We recognize revenue for platforms and operations services over time using the time elapsed output method. Fixed consideration is recognized ratably over the contract term. In accordance with the series guidance, we allocate variable consideration to the period to which the fees relate. The platform and operations agreements often include other variable fees including service level agreements, shared medical savings arrangements and other performance measures. Variable consideration is estimated using the most likely amount, however we do not estimate variable consideration at contract inception if the variable fees will be allocated entirely to the platform and operations services performance obligation. In some cases we are required to estimate revenue using the most likely amount that we believe we are entitled to receive. All estimates are based on historical experience and the Company's best judgment at the time to the extent it is probable that a significant reversal of revenue recognized will not occur. Due to the nature of our arrangements certain estimates may be constrained until the uncertainty is further resolved.

Our platform and operations revenue may vary based on the nature of the population, the timing of new populations transitioning to our platform and the type of services being utilized by our partners. After a specified period, certain of our platform and operations contracts are terminable for convenience by our partners after a notice period has passed and the partner has paid a termination fee. We also have arrangements with multiple performance obligations (including both transformation and platform and operations components) and we allocate the transaction price to each performance obligation based on each unit’s relative selling price.

Our True Health segment derives revenue from premiums that are earned over the terms of the related insurance policies. The portion of premiums that will be earned in the future or are received prior to the effectiveness of the policy are deferred and reported as premiums received in advance.

In the ordinary course of business, our reportable segments enter into transactions with one another. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues and expenses recognized by the segment that is the counterparty to the transaction are eliminated in consolidation and do not affect consolidated results.

Cost of revenue (exclusive of depreciation and amortization)

Our cost of revenue includes direct expenses and shared resources that perform services in direct support of clients. Costs consist primarily of employee-related expenses (including compensation, benefits and stock-based compensation), expenses for TPA support and other services, as well as other professional fees. Our cost of revenue also includes expenses related to patient claims and costs resulting from changes in our claims reserves.

Claims expenses

Our claims expenses include the cost of medical and pharmacy claims that have been incurred during the quarter but not reported, including expected development on reported claims, and those that have been reported but not yet paid (reported claims in process), as well as other medical care expenses and services costs. Claims expenses incurred pertain to our True Health segment.



45


Selling, general and administrative expenses

Our selling, general and administrative expenses consist of employee-related expenses (including compensation, benefits and stock-based compensation) for selling and marketing, corporate development, finance, legal, human resources, corporate information technology, professional fees and other corporate expenses associated with these functional areas. Selling, general and administrative expenses also include costs associated with our centralized infrastructure and research and development activities to support our network development capabilities, claims processing services, technology infrastructure, clinical program development and data analytics.

Depreciation and amortization expense

Depreciation and amortization expenses consist of the amortization of intangible assets associated with the step up in fair value of Evolent Health LLC’s assets and liabilities for the Offering Reorganization, amortization of intangible assets recorded as part of our various business combinations and asset acquisitions and depreciation of property and equipment, including the amortization of capitalized software.

Evolent Health, Inc. Consolidated Results

 
For the Three
 
 
 
For the Nine
 
 
 
 
 
Months Ended
 
Change Over
 
Months Ended
 
Change Over
 
September 30,
 
Prior Period
 
September 30,
 
Prior Period
(in thousands)
2018
 
2017
 
$
 
%
 
2018
 
2017
 
$
 
%
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transformation services
$
9,230

 
$
8,204

 
$
1,026

 
12.5%
 
$
23,950

 
$
23,799

 
$
151

 
0.6%
Platform and operations services
118,094

 
99,708

 
18,386

 
18.4%
 
341,258

 
297,422

 
43,836

 
14.7%
Total Services
127,324

 
107,912

 
19,412

 
18.0%
 
365,208

 
321,221

 
43,987

 
13.7%
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
22,623

 

 
22,623

 
—%
 
68,751

 

 
68,751

 
—%
Total revenue
149,947

 
107,912

 
42,035

 
39.0%
 
433,959

 
321,221

 
112,738

 
35.1%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
expenses presented separately below)
73,967

 
68,281

 
5,686

 
8.3%
 
214,945

 
203,804

 
11,141

 
5.5%
Claims expenses
16,992

 

 
16,992

 
—%
 
52,169

 

 
52,169

 
—%
Selling, general and
 
 
 
 


 

 
 
 
 
 
 
 
 
administrative expenses
59,566

 
45,834

 
13,732

 
30.0%
 
172,495

 
150,474

 
22,021

 
14.6%
Depreciation and amortization expenses
10,352

 
7,717

 
2,635

 
34.1%
 
29,882

 
21,236

 
8,646

 
40.7%
Change in fair value of contingent
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
consideration and indemnification asset
100

 
100

 

 
—%
 
(1,404
)
 
300

 
(1,704
)
 
N/A
Total operating expenses
160,977
 
121,932

 
39,045

 
32.0%
 
468,087

 
375,814

 
92,273

 
24.6%
Operating income (loss)
$
(11,030
)
 
$
(14,020
)
 
$
2,990

 
21.3%
 
$
(34,128
)
 
$
(54,593
)
 
$
20,465

 
37.5%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transformation services revenue as
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a % of total revenue
6.2
%
 
7.6
%
 
 
 
 
 
5.5
%
 
7.4
%
 
 
 
 
Platform and operations services
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
revenue as a % of total revenue
78.8
%
 
92.4
%
 
 
 
 
 
78.6
%
 
92.6
%
 
 
 
 
Premiums as a
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% of total revenue
15.1
%
 
%
 
 
 
 
 
15.8
%
 
%
 
 
 
 
Cost of revenue as a %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of total revenue
49.3
%
 
63.3
%
 
 
 
 
 
49.5
%
 
63.4
%
 
 
 
 
Claims expenses as a
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% of premiums
75.1
%
 
%
 
 
 
 
 
75.9
%
 
%
 
 
 
 
Selling, general and administrative
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
expenses as a % of total revenue
39.7
%
 
42.5
%
 
 
 
 
 
39.7
%
 
46.8
%
 
 
 
 

46



Comparison of the Operating Results for the Three Months Ended September 30, 2018 to 2017

Revenue

Total revenue increased by $42.0 million, or 39.0%, to $149.9 million for the three months ended September 30, 2018, as compared to the same period in 2017.

Transformation services revenue increased by $1.0 million, or 12.5%, to $9.2 million for the three months ended September 30, 2018, as compared to the same period in 2017, due primarily to implementation efforts associated with new Medicaid managed care contracts. Overall, our offering has become more product-oriented, thereby resulting in lower average transformation services revenue per newly added partner. As a result, we expect future transformation services revenue to decrease as a percentage of total revenue. Transformation services revenue accounted for 6.2% and 7.6% of our total revenue for the three months ended September 30, 2018, and 2017, respectively.

Platform and operations services revenue accounted for 78.8% and 92.4% of our total revenue for the three months ended September 30, 2018 and 2017, respectively. Platform and operations services revenue increased by $18.4 million, or 18.4%, to $118.1 million for the three months ended September 30, 2018, as compared to the same period in 2017, primarily as a result of an increase in our average PMPM fee, an aggregate enrollment growth of 16.4% in lives on platform and net gain share. We ended the quarter with over 30 operating partners compared to over 25 as of September 30, 2017.

Premiums accounted for $22.6 million, or 15.1% of our total revenue for the three months ended September 30, 2018. Total revenue for the three months ended September 30, 2017, did not include any revenue from premiums as we did not own a health plan prior to January 2, 2018.

Cost of Revenue

Cost of revenue increased by $5.7 million, or 8.3%, to $74.0 million for the three months ended September 30, 2018, as compared to the same period in 2017. Cost of revenue increased period over period as a result of business combinations completed during the first quarter of 2018. We incurred additional personnel costs of $1.4 million to support our growing customer base and service offerings. Our professional fees decreased by $1.3 million, due to the nature and timing of our projects. Additionally, our technology services, TPA fees and other costs increased by $5.6 million period over period. The increase is attributable to costs to support our growth. Approximately $0.4 million of total personnel costs were attributable to stock-based compensation expense for the three months ended September 30, 2018 and 2017. Cost of revenue represented 49.3% and 63.3% of total revenue for the three months ended September 30, 2018 and 2017, respectively. Our cost of revenue decreased as a percentage of our total revenue and we expect this trend to continue going forward.

Claims Expenses

Claims expenses attributable to our True Health segment were $17.0 million for the three months ended September 30, 2018, as compared to zero for the same period of the prior year, and consisted of claims paid during the period and the change in reserve for incurred but unreported claims. Claims expenses represented 75.1% of premiums for the three months ended September 30, 2018.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $13.7 million, or 30.0%, to $59.6 million for the three months ended September 30, 2018, as compared to the same period in 2017. Approximately $1.1 million of the increase in selling, general and administrative expenses was attributable to premium tax and other assessments. These expenses were incurred during the three months ended September 30, 2018, but were not incurred during the same period in 2017. During the three months ended September 30, 2018, we also incurred additional selling, general and administrative expenses due partially to growth in our business resulting from business combinations completed during the first quarter of 2018. Technology costs, personnel costs, legal fees, professional fees, lease costs and other costs related to our growth increased by $2.6 million, $4.1 million, $0.7 million, $4.1 million, $0.3 million and $0.9 million, respectively, period over period, as a result of the growing customer base and service offerings. Approximately $3.7 million and $5.3 million of total personnel costs were attributable to stock-based compensation expense for the three months ended September 30, 2018 and 2017, respectively. One-time transaction, transition and severance costs accounted for approximately $0.5 million of total selling, general and administrative expenses for the three months ended September 30, 2018 and 2017. Selling, general and administrative expenses represented 39.7% and 42.5% of total revenue for the three months ended September 30, 2018 and 2017, respectively. While our selling, general and administrative expenses are expected to grow as our business grows, we expect them to continue to decrease as a percentage of our total revenue over the long term.


47


Depreciation and Amortization Expenses

Depreciation and amortization expenses increased $2.6 million, or 34.1%, to $10.4 million for the three months ended September 30, 2018, as compared to the same period in 2017. The increase was due primarily to additional depreciation and amortization expenses related to assets acquired through business combinations and asset acquisitions subsequent to the third quarter of 2017 and the increase in amortization expense for internal-use software. We expect depreciation and amortization expenses to increase in future periods as we continue to capitalize internal-use software and amortize intangible assets resulting from asset acquisitions and business combinations (including possible future transactions).

Change in fair value of contingent consideration and indemnification asset

We recorded a loss from change in fair value of contingent consideration and indemnification asset of $0.1 million for the three months ended September 30, 2018, as compared to a loss of $0.1 million for the same period in 2017. This variance is the result of a change in the fair value of a mark-to-market contingent liability, which were acquired as a result of business combinations during 2016. The indemnification asset was settled during the second quarter of 2018. See “Part I - Item 1. Financial Statements - Note 15” in this Form 10-Q for further details regarding the fair value of our mark-to-market contingent liability.

Comparison of the Operating Results for the Nine Months Ended September 30, 2018 to 2017

Revenue

Total revenue increased by $112.7 million, or 35.1%, to $434.0 million for the nine months ended September 30, 2018, as compared to the same period in 2017.

Transformation services revenue increased by $0.2 million, or 0.6%, to $24.0 million for the nine months ended September 30, 2018, as compared to the same period in 2017, due primarily to the fact that our offering has become more product-oriented, thereby resulting in lower average transformation services revenue per newly added partner. As a result, we expect transformation services revenue to continue to decrease as a percentage of total revenue. Transformation services revenue accounted for 5.5% and 7.4% of our total revenue for the nine months ended September 30, 2018, and 2017, respectively.

Platform and operations services revenue accounted for 78.6% and 92.6% of our total revenue for the nine months ended September 30, 2018 and 2017, respectively. Platform and operations services revenue increased by $43.8 million, or 14.7%, to $341.3 million for the nine months ended September 30, 2018, as compared to the same period in 2017, primarily as a result of an increase in our average PMPM fee, an aggregate enrollment growth of 16.4% in lives on platform and net gain share. We ended the quarter with over 30 operating partners compared to over 25 as of September 30, 2017.

Premiums accounted for $68.8 million, or 15.8% of our total revenue for the nine months ended September 30, 2018. Total revenue for the nine months ended September 30, 2017, did not include any revenue from premiums as we did not own a health plan prior to January 2, 2018.

Cost of Revenue

Cost of revenue increased by $11.1 million, or 5.5%, to $214.9 million for the nine months ended September 30, 2018, as compared to the same period in 2017. Cost of revenue increased period over period as a result of business combinations completed during the first quarter of 2018. We incurred additional personnel costs of $13.7 million to support our growing customer base and service offerings. Our professional fees decreased by $8.3 million, due to the nature and timing of our projects. Additionally, our technology services, TPA fees and other costs increased by $5.8 million period over period. The increase is attributable to costs to support our growth. Approximately $1.1 million of total personnel costs were attributable to stock-based compensation expense for the nine months ended September 30, 2018 and 2017. Cost of revenue represented 49.5% and 63.4% of total revenue for the nine months ended September 30, 2018 and 2017, respectively. Our cost of revenue decreased as a percentage of our total revenue and we expect this trend to continue going forward.

Claims Expenses

Claims expenses attributable to our True Health segment were $52.2 million for the nine months ended September 30, 2018, as compared to zero for the same period of the prior year, and consisted of claims paid during the period and the change in reserve for incurred but unreported claims. Claims expenses represented 75.9% of premiums for the nine months ended September 30, 2018.


48


Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $22.0 million, or 14.6%, to $172.5 million for the nine months ended September 30, 2018, as compared to the same period in 2017. Approximately $3.8 million of the increase in selling, general and administrative expenses was attributable to premium tax and other assessments. These expenses were incurred during the nine months ended September 30, 2018, but were not incurred during the same period in 2017. During the nine months ended September 30, 2018, we also incurred additional selling, general and administrative expenses due partially to growth in our business resulting from business combinations completed during the first quarter of 2018. Technology costs, personnel costs, professional fees, lease costs and other costs related to our growth increased by $5.4 million, $5.7 million, $3.6 million, $1.8 million and $2.7 million, respectively, period over period, as a result of the growing customer base and service offerings. These amounts were offset by a decrease in legal fees of $1.0 million, period over period. Approximately $11.4 million and $15.0 million of total personnel costs were attributable to stock-based compensation expense for the nine months ended September 30, 2018 and 2017, respectively. One-time transaction, transition and severance costs accounted for approximately $3.2 million and $5.6 million of total selling, general and administrative expenses for the nine months ended September 30, 2018 and 2017, respectively. Selling, general and administrative expenses represented 39.7% and 46.8% of total revenue for the nine months ended September 30, 2018 and 2017, respectively. While our selling, general and administrative expenses are expected to grow as our business grows, we expect them to continue to decrease as a percentage of our total revenue over the long term.

Depreciation and Amortization Expenses

Depreciation and amortization expenses increased $8.6 million, or 40.7%, to $29.9 million for the nine months ended September 30, 2018, as compared to the same period in 2017. The increase was due primarily to additional depreciation and amortization expenses related to assets acquired through business combinations and asset acquisitions during 2017 and 2018 and the increase in amortization expense for internal-use software. We expect depreciation and amortization expenses to increase in future periods as we continue to capitalize internal-use software and amortize intangible assets resulting from asset acquisitions and business combinations (including possible future transactions).

Change in fair value of contingent consideration and indemnification asset

We recorded a gain from change in fair value of contingent consideration and indemnification asset of $1.4 million for the nine months ended September 30, 2018, as compared to a loss of $0.3 million for the same period in 2017. This variance is the result of changes in the fair values of a mark-to-market contingent liability and a mark-to-market indemnification asset, both of which were acquired as a result of business combinations during 2016. The indemnification asset was settled during the second quarter of 2018. See “Part I - Item 1. Financial Statements - Note 15” in this Form 10-Q for further details regarding the fair value of our mark-to-market contingent liability.

Discussion of Non-Operating Results

Interest income

Interest income consists of interest from investing cash in money market funds, interest from both our short-term and long-term investments, interest earned on the capital-only reinsurance agreement with NMHC and interest from the Implementation Loan. We recorded interest income of $1.0 million and $2.9 million for the three and nine months ended September 30, 2018, respectively, and $0.4 million and $0.8 million for the three and nine months ended September 30, 2017, respectively. Interest income increased for the three and nine month periods ended September 30, 2018, as compared to the same periods in 2017 as a result of additional interest income generated from cash received from the August 2017 Primary Offering, the Implementation Loan and the capital-only reinsurance agreement with NMHC.

Interest expense

Our interest expense is primarily attributable to the 2021 Notes, which the Company issued in December 2016. Holders of the 2021 Notes are entitled to cash interest payments, which are payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2017, at a rate equal to 2.00% per annum. In addition, we incurred $4.6 million of debt issuance costs in connection with the 2021 Notes, which we are amortizing to non-cash interest expense using the straight line method over the contractual term of the 2021 Notes. We recorded interest expense (including amortization of deferred financing costs) of approximately $0.9 million and $2.6 million related to our 2021 Notes for the three and nine months ended September 30, 2018 and 2017, respectively. See “Part I - Item 1. Financial Statements - Note 8” in this Form 10-Q for further details of our convertible debt offering.


49


Income (loss) from equity method investees

The Company has acquired economic interests in several entities that are accounted for under the equity method of accounting. The Company is allocated its proportional share of the investees’ earnings and losses each reporting period. The Company’s proportional share of the losses from these investments was approximately $1.4 million and $2.8 million for the three and nine months ended September 30, 2018, respectively, and $0.4 million and $1.4 million for the three and nine months ended September 30, 2017, respectively. The equity method investments are further discussed at “Part I - Item 1. Financial Statements - Note 13” in this Form 10-Q.

Provision (benefit) for income taxes

The Company recorded $0.1 million and less than $0.1 million in income tax expense for the three and nine months ended September 30, 2018, which resulted in effective tax rates of (0.9)% and (0.1)%, respectively. The Company recorded $1.7 million and $2.0 million in income tax benefit for the three and nine months ended September 30, 2017, which resulted in effective tax rates of 11.6% and 3.5%, respectively. The difference between our effective tax rate and our statutory rate is due primarily to the fact that we have certain permanent items which include, but are not limited to, income attributable to the non-controlling interest, the impact of certain tax deduction limits related to meals and entertainment and other permanent nondeductible expenses. In addition, the Company maintains a full valuation allowance recorded against its net deferred tax assets, with the exception of certain indefinite-lived components and components expected to reverse outside of the net operating loss carryover period as part of the outside basis difference in our partnership interest in Evolent Health LLC.

As discussed in “Part I - Item 1. Financial Statements - Note 4” in this Form 10-Q, pursuant to the March 2018 Private Sale, the Company increased its ownership in Evolent Health LLC from 96.6% to 98.9% immediately following the March 2018 Private Sale. As a result, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by $0.9 million for the nine months ended September 30, 2018. The effect of this change in the deferred tax liability was recorded as additional paid-in capital.

During the three and nine months ended September 30, 2018, management examined all sources of taxable income that may be available for the realization of its net deferred tax assets. Given the Company’s cumulative loss position, management concluded that there are no current sources of taxable income and we are currently reflecting a full valuation allowance in our financial statements recorded against our net deferred tax assets, with the exception of the full nonconforming states and a portion of the federal and conforming states indefinite-lived components and those expected to reverse outside of the net operating loss carryover period as part of the outside basis difference in our partnership interest in Evolent Health LLC. As of September 30, 2018, the Company had $1.7 million of deferred tax liability that would not provide a source of income to recognize the deferred tax assets.

Net income (loss) attributable to non-controlling interests

We consolidate the results of Evolent Health LLC as we have 100% of the voting rights of the entity; however, as of September 30, 2018, we owned 99.0% of the economic rights of the results of operations of Evolent Health LLC and, therefore, eliminate the non-controlling interest from our results of operations. For the three and nine months ended September 30, 2018, our results reflect net losses of $0.1 million and $0.7 million, respectively, attributable to non-controlling interests, which represents 1.1% and 2.0% of the operating losses of Evolent Health LLC. For the three and nine months ended September 30, 2017, our results reflect net losses of $0.5 million and $8.5 million, respectively, attributable to non-controlling interests, which represents 3.9% and 15.5% of the operating losses of Evolent Health LLC. The Company’s economic interest in Evolent Health LLC increased as compared to the prior period as a result of the Class B Exchanges in connection with the March 2018 Private Sale and the issuance of shares of Class A common stock in conjunction with option exercises and RSU vests since the prior period.


50


REVIEW OF CONSOLIDATED FINANCIAL CONDITION

Liquidity and Capital Resources
 
Since its inception, the Company has incurred operating losses and net cash outflows from operations. The Company incurred operating losses of $34.1 million and $54.6 million for the nine months ended September 30, 2018 and 2017, respectively. Net cash and restricted cash provided by operating activities was $4.3 million for the nine months ended September 30, 2018 and net cash and restricted cash used in operating activities was $34.0 million for the nine months ended September 30, 2017. As of September 30, 2018, the Company had $221.8 million of cash and cash equivalents and $45.7 million in restricted cash and restricted investments.

We believe our current cash, cash equivalents and other sources of liquidity will be sufficient to meet our working capital and capital expenditure requirements for at least the next twelve months as of the date the financial statements were available to be issued. Our future capital requirements will depend on many factors, including our rate of revenue growth, the expansion of our sales and marketing activities and the timing and extent of our spending to support our acquisition and investment efforts and expansion into other markets. We may also seek to invest in, or acquire complementary businesses, applications or technologies.

Cash Flows

The following summary of cash flows (in thousands) has been derived from our financial statements included in “Item 1. Financial Statements”:

 
For the Nine
 
Months Ended
 
September 30,
  
2018
 
2017
Net cash and restricted cash provided by (used in) operating activities
$
4,317

 
$
(33,993
)
Net cash and restricted cash provided by (used in) investing activities
(24,933
)
 
15,967

Net cash and restricted cash provided by (used in) financing activities
(7,935
)
 
143,922

 
Operating Activities
 
Cash flows provided by operating activities of $4.3 million for the nine months ended September 30, 2018, were due primarily to our net loss of $36.7 million, partially offset by non-cash items, including depreciation and amortization expenses of $29.9 million, stock-based compensation expense of $12.6 million and loss from equity-method investees of $2.8 million. Our operating cash outflows were affected by the timing of our customer and vendor payments. A decrease in accrued compensation and employee benefits, combined with increases in accounts receivable, prepaid expenses and contract cost assets, contributed approximately $38.3 million to our cash outflows. Those cash outflows were offset by increases in accrued liabilities, accounts payable, claims reserves and other long-term liabilities of approximately $31.8 million.
 
Cash flows used in operating activities of $34.0 million for the nine months ended September 30, 2017, were due primarily to our net loss of $56.0 million, partially offset by non-cash items, including depreciation and amortization expenses of $21.2 million and stock-based compensation expense of $16.2 million. Our operating cash outflows were affected by the timing of our customer and vendor payments. Decreases in accrued liabilities, accrued compensation and employee benefits and other long-term liabilities, combined with an increase in accounts receivable and prepaid expenses and other current and noncurrent assets, contributed approximately $30.7 million to our cash outflows. Those cash outflows were partially offset by increases in accounts payable and deferred revenue of approximately $15.4 million.
 
Investing Activities
 
Cash flows used in investing activities of $24.9 million for the nine months ended September 30, 2018, were primarily attributable to purchases of property and equipment of $29.1 million and cash paid for asset acquisitions, business combinations and equity method investments of $18.4 million. These cash outflows were partially offset by maturities of restricted investments of $8.0 million and a $14.0 million principal repayment of the Implementation Loan.
 
Cash flows provided by investing activities of $16.0 million for the nine months ended September 30, 2017, were due primarily to maturities of investments of $44.2 million, offset by purchases of property and equipment of $21.3 million, cash paid for an asset acquisition of $3.7 million and cash paid to purchase restricted investments of $3.2 million.


51


Financing Activities
 
Cash flows used in financing activities of approximately $7.9 million for the nine months ended September 30, 2018, were primarily related to a decrease of $17.3 million in the amount of restricted cash held on behalf of our partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed. This decrease was offset by approximately $9.4 million as a result of proceeds from stock options exercises, net of taxes withheld and paid for vests of restricted stock units.

Cash flows provided by financing activities of approximately $143.9 million for the nine months ended September 30, 2017, were primarily related to net proceeds of $166.9 million from the August 2017 Primary. In addition, we had inflows of $2.6 million related to stock option exercises, net of taxes withheld and paid for vests of restricted stock units. These amounts were partially offset by a decrease of $25.6 million in the amount of restricted cash held on behalf of our partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.

Contractual Obligations

Our contractual obligations (in thousands) as of September 30, 2018, were as follows:

 
Less
 
 
 
 
 
More
 
 
 
Than
 
1 to 3
 
3 to 5
 
Than
 
 
 
1 Year
 
Years
 
Years
 
5 Years
 
Total
Operating leases for facilities
$
8,044

 
$
12,679

 
$
7,443

 
$
11,420

 
$
39,586

Contingent equity commitments
2,553

 

 

 

 
2,553

Purchase obligations
6,981

 
2,297

 
105

 

 
9,383

2021 Notes interest payments
2,496

 
4,992

 
1,278

 

 
8,766

2021 Notes principal repayment

 

 
125,000

 

 
125,000

Total
$
20,074

 
$
19,968

 
$
133,826

 
$
11,420

 
$
185,288


During the nine months ended September 30, 2018, there were no material changes outside the ordinary course of business to our contractual obligations set forth above.

Restricted Cash and Restricted Investments

Restricted cash and restricted investments of $45.7 million is carried at cost and includes cash held on behalf of other entities for pharmacy and claims management services of $8.9 million, collateral for letters of credit required as security deposits for facility leases of $3.7 million, amounts held with financial institutions for risk-sharing arrangements of $22.0 million, amounts held as supplemental capital for a reinsurance agreement of $10.0 million and other restricted balances as of September 30, 2018. Restricted investments are stated at amortized cost. See “Part I - Item 1. Financial Statements - Note 2” in this Form 10-Q for further details of the Company’s restricted cash and restricted investments balances.
 
Uses of Capital

Our principal uses of cash are in the operation and expansion of our business and the pursuit of strategic acquisitions. The Company does not anticipate paying a cash dividend on our Class A common stock in the foreseeable future.

OTHER MATTERS

Off-balance Sheet Arrangements

Through September 30, 2018, the Company had not entered into any off-balance sheet arrangements, other than the operating leases noted above, and did not have any holdings in variable interest entities.

Related Party Transactions

In the ordinary course of business, we enter into transactions with related parties, including our partners and our pre-IPO investors, TPG and UPMC. Information regarding transactions and amounts with related parties is discussed in Note 16 in our notes to consolidated financial statements included in “Part I - Item 1. Financial Statements” in this Form 10-Q as well as under the heading “Certain Relationships and Related Party Transactions” in our proxy statement on Schedule 14A filed with the SEC on April 27, 2018.


52


Other Factors Affecting Our Business

In general, our business is subject to a changing social, economic, legal, legislative and regulatory environment. Although the eventual effect on us of the changing environment in which we operate remains uncertain, these factors and others could have a material effect on our results of operations, liquidity and capital resources. Factors that could cause actual results to differ materially from those set forth in this section are described in “Part I - Item 1A. Risk Factors” in our 2017 Form 10-K and “Part II - Item 1A Risk Factors” and “Forward-Looking Statements – Cautionary Language” in this Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates.

Interest Rate Risk

As of September 30, 2018, cash and cash equivalents and restricted cash and restricted investments was $267.6 million, which consisted primarily of bank deposits with FDIC participating banks of $192.9 million, bank deposits in international banks of $0.8 million and cash equivalents deposited in a money-market fund of $73.2 million. Changes in interest rates affect the interest earned on our cash and cash equivalents.

We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure.

As of September 30, 2018, we had $122.1 million, net of deferred offering costs, of aggregate principal amount of convertible notes outstanding, which are fixed rate instruments. Therefore, our results of operations are not subject to fluctuations in interest rates relating to our convertible notes.

Foreign Currency Exchange Risk

We have foreign currency risks related to our revenue and operating expenses denominated in currencies other than the U.S. dollar, primarily the Indian Rupee. In general, we are a net payor of currencies other than the U.S. dollar. Accordingly, changes in exchange rates, and in particular a strengthening of the U.S. dollar, may, in the future, negatively affect our operating results as expressed in U.S. dollars.

At this time, we have not entered into, but in the future we may enter into, derivatives or other financial instruments in an attempt to hedge our foreign currency exchange risk. It is difficult to predict the effect hedging activities would have on our results of operations. We recognized foreign currency translation losses of $0.1 million and $0.3 million for the three and nine months ended September 30, 2018.

Inflation Risk

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.


53


Item 4. Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our principal executive officer and principal financial officer have concluded that, as of September 30, 2018, our disclosure controls and procedures were effective.

Remediation of Previously Identified Material Weakness

As discussed in our 2017 Form 10-K, prior to the remediation of our material weakness, we did not maintain a sufficient complement of resources with an appropriate level of accounting knowledge, experience and training to address accounting for complex, non-routine transactions. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness resulted in the revision of the Company’s consolidated financial statements for the quarter ended June 30, 2017.

Management has been actively engaged in the implementation of remediation efforts to address the underlying causes of the previously identified material weakness. Management’s remediation activities included the following:

hired additional full-time accounting resources and financial planning and analysis resources with experience to address complex, non-routine transactions:
from December 31, 2014, to March 31, 2018, we hired several key senior and mid-level personnel as our finance and accounting headcount increased from 9 to over 40. The expansion of our finance and accounting team included the following key hires:
during 2015 we hired a senior director of revenue, a director of financial reporting, a manager of revenue and a senior revenue accountant;
during 2016 we hired an associate director of revenue;
during 2017 we hired an associate director of accounting and a senior director of tax; and
during the first quarter of 2018, we hired a senior director of technical accounting.
expanded finance and accounting staff, including additional senior resources, to allow for the reallocation of responsibilities across our accounting department based on potential risk and complexity of transactions and/or tasks to be reviewed;
strengthened our review procedures and controls and formalized documentation of the reviews surrounding complex, non-routine transactions;
implemented additional monitoring programs, which included the formation of a disclosure committee comprised of members of our executive committee and finance and accounting leadership;
implemented training programs for various processes to train employees in respect of our established processes and controls, especially with regard to complex, non-routine transactions;
engaged our actuarial department to assist in the review of significant estimates in various areas, including incurred but not reported liabilities;
implemented a new contract management process to facilitate the documentation and review of complex contracts by appropriate accounting personnel and relevant company stakeholders;
engaged external technical accounting experts to aid with accounting for complex, non-routine transactions, where necessary; and
engaged external tax accounting experts to aid with complex tax matters.

The process of implementing and maintaining an effective team and process over complex, non-routine transactions is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments. During 2017 and first quarter of 2018, we completed the hiring of further senior, technical personnel identified as part of our remediation plan. Responsibilities for these key personnel include the accounting for complex and non-routine transactions. We have also previously finalized and concluded the design effectiveness of controls surrounding the complex and non-routine transactions that gave rise to the material weakness. Management has tested the operating effectiveness of such designed controls based on the guidelines established in the Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and have found them to be effective. As such, management has concluded that the previously identified and disclosed material weakness has been remediated as of June 30, 2018.


54


Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter.

Inherent Limitations of Internal Controls

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

55


PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Information regarding reportable legal proceedings is contained within Note 9 in “Part I – Item 1. Financial Statements” of this Form 10-Q.

Item 1A. Risk Factors

Part I, Item 1A. “Risk Factors” in our 2017 Form 10-K, and other documents filed with the SEC include discussions of our risk factors. The information presented below updates, and should be read in conjunction with, the risk factors and information disclosed in our 2017 Form 10-K. Except as presented below, there have been no material changes from the risk factors described in our 2017 Form 10-K for the quarterly period ended September 30, 2018.

Risks relating to our business and industry

The market for health care in the United States is in the early stages of structural change and is rapidly evolving, which makes it difficult to forecast demand for our products and services.

The market for health care in the United States is in the early stages of structural change and is rapidly evolving. Our future financial performance will depend in part on growth in this market and on our ability to adapt to emerging demands of this market. It is difficult to predict with any precision the future growth rate and size of our target market.

The rapidly evolving nature of the market in which we operate, as well as other factors that are beyond our control, reduce our ability to accurately evaluate our long-term outlook and forecast annual performance. We believe that demand for our products and services has been driven in large part by price pressure in traditional FFS health care, a regulatory environment that is incentivizing value-based care models, a rapid expansion of retail insurance, broader use of the Internet and advances in technology. Widespread acceptance of the value-based care model is critical to our future growth and success. A reduction in demand for our products and services caused by lack of acceptance, technological challenges, competing offerings or other factors would result in a lower revenue growth rate or decreased revenue, either of which could negatively impact our business and results of operations. For example, a large portion of New Century Health’s revenue is derived from customers in the managed care industry, including risk bearing providers and national and regional managed care companies. Changes in this industry’s business practices could negatively impact us and New Century Health. For example, if New Century Health’s managed care customers seek to provide services directly to their subscribers instead of contracting with New Century Health for such services, we and New Century Health could be adversely affected. In addition, our business, financial condition and results of operations may be adversely affected if health care reform is not implemented in accordance with our expectations or if it is amended in a way that impacts our business and results in our failure to execute our growth strategies.

We have made and may make acquisitions, investments and alliances, including the completed acquisitions of Valence Health, Aldera, New Century Health and assets from NMHC, which may be difficult to integrate, divert management resources, result in unanticipated costs or dilute our stockholders.

Part of our business strategy is to acquire or invest in companies, businesses, products or technologies that complement our current products and services, enhance our market coverage or technical capabilities or offer growth opportunities. This may include acquiring or investing in companies, businesses, products or technologies that are tangential to our current business and in which we have limited or no prior operating experience, which was the case in our recent acquisition of assets from NMHC. That and other acquisitions, investments or alliances, including the recent acquisition of New Century Health, could result in new, material risks to our results of operations, financial condition, business and prospects. These new risks could include increased variability in revenues and prospects associated with various risk sharing arrangements. Consistent with our business strategy, we continuously evaluate, and are currently in the process of evaluating, potential acquisition targets and investments. However, there can be no assurance that any of these potential acquisitions or investments will be consummated. As an example, in December 2017, we announced the termination of a previously announced agreement whereby we had agreed to purchase Premier Health Plan, subject to certain closing conditions.

In February 2016, we entered into a strategic alliance with a leading nonprofit community-based and provider-sponsored health plan administering Kentucky Medicaid and federal Medicare Advantage benefits. More recently, on October 3, 2016, we completed the acquisition of Valence Health, on November 1, 2016, we completed the acquisition of Aldera, on January 2, 2018, we completed the acquisition of assets from NMHC and on October 1, 2018, we completed the acquisition of New Century Health. The recently completed acquisitions of Valence Health, Aldera, New Century Health and assets from NMHC, as well as other

56


acquisitions, investments and alliances, could pose numerous risks to our business which could negatively impact our financial condition and results of operations, including:

difficulty integrating the purchased operations, products or technologies;
substantial unanticipated integration costs, delays and challenges that may arise in integration;
assimilation of the acquired businesses, which may divert significant management attention and financial resources from our other operations and could disrupt our ongoing business;
the loss of key customers who are in turn subject to risks and financial dislocation in their businesses;
the loss of key employees, particularly those of the acquired operations;
difficulty retaining or developing the acquired business’ customers;
adverse effects on our existing business relationships with customers, suppliers, other partners, standing with regulators;
challenges related to the integration and operation of businesses that operate in new geographic areas and new markets or lines of business;
unanticipated financial losses in the acquired business, including the risk of higher than expected health care costs;
failure to realize the potential cost savings or other financial benefits or the strategic benefits of the acquisitions, including failure to consummate any proposed or contemplated transaction; and
liabilities, including acquired litigation, and expenses from the acquired businesses for contractual disputes with customers and other third parties, infringement of intellectual property rights, data privacy violations or other claims and failure to obtain indemnification for such liabilities or claims, and distraction of our personnel in connection with any related proceedings.

We may be unable to integrate the operations, products, technologies or personnel gained through the Valence Health, Aldera, New Century Health or NMHC acquisitions, or integrate or complete any other such transaction without a material adverse effect on our business, financial condition and results of operations. Transaction agreements may impose limitations on our ability, or the ability of the business to be acquired, to conduct business. Events outside our control, including operating changes or regulatory changes, could also adversely affect our ability to realize anticipated revenues, synergies, benefits and cost savings. In addition, revenues of acquired businesses or companies, prior to and after consummation of a transaction, may be less than expected. Counterparties in transactions may have contracts with customers and other business partners which may require consents from these parties in connection with a transaction. If these consents cannot be obtained, the Company may suffer a loss of potential future revenue and may lose rights that are material to its business and the business of any combined company. Any such disruptions could limit our ability to achieve the anticipated benefits of the transaction. Any integration may be unpredictable, or subject to delays or changed circumstances, and we and any targets may not perform in accordance with our expectations.

We have also entered into a number of joint ventures. Conflicts or disagreements between us and any joint venture partner may negatively impact the benefits expected to be achieved by the joint venture or may ultimately threaten the ability of such joint venture to continue. We are also subject to additional risks and uncertainties because we may be dependent upon and subject to the liability, losses or reputational damage relating to joint venture partners that are not entirely under our control.

In connection with these acquisitions, investments or alliances, we could incur significant costs, debt, amortization expenses related to intangible assets or large and immediate write-offs or other impairments or charges, assume liabilities or issue stock that would dilute our current stockholders’ ownership. For example, as part of the closing consideration for the Valence Health acquisition, we issued 6.8 million shares of our Class A common stock. In addition, in connection with the acquisition of New Century Health, we issued 3,120,301 shares of Class B common stock which is convertible into Class A common stock, and New Century Health’s management’s team may be eligible to receive an additional $20,000,000 as Earnout Consideration, subject to the satisfaction of certain conditions related to the operating results of New Century Health in 2019. The Earnout Consideration may be settled, among other options, in the form of Class B common stock, which could have an adverse effect on the market price of our Class A common stock. In addition, the market price for our Class A common stock could be affected, following the consummation of any other transaction, by factors that have not historically affected the market price for our Class A common stock.

Failure to accurately underwrite performance-based contracts or to avoid reductions in performance-based contract rates could result in a reduction in profitability for New Century Health or us.

New Century Health, which we recently acquired, derives its revenue primarily from arrangements under which New Century Health assumes responsibility for a portion of the total cost of treatments (for oncology and cardiology patients) in exchange for a fixed fee. These are typically referred to as “performance-based contracts”. As a result of the recent acquisition of New Century Health and our own continued growth and expansion into performance-based contracts and products, if the Company is unable to accurately underwrite the health care cost risk for New Century Health and other performance-based contracts and products and control associated costs, the Company’s profitability could decline. The profitability of New Century Health’s performance-based

57


contracts could also be reduced if New Century Health is unable to maintain its historical margins. The competitive environment for New Century Health’s performance-based products could result in pricing pressures which could cause New Century Health to reduce its rates. In addition, customer demands or expectations as to margin levels could cause New Century Health to reduce its rates. A reduction in performance-based contract rates which are not accompanied by a reduction in covered services or expected underlying care trend could result in a decrease of New Century Health’s operating margins.

Our offshore support and professional services may prove difficult to manage or may not allow us to realize our cost reduction goals.
 
We use certain offshore resources to provide certain support and professional services, which requires technical and logistical coordination. If we are unable to maintain acceptable standards of quality in support and professional services, our attempts to reduce costs and drive growth through margin improvements in technical support and professional services may be negatively impacted, which would adversely affect our results of operations. Our offshore resources, and their ability to provide support and professional services to our domestic operations, are subject to domestic regulation at the federal, state and local levels. In certain cases, those regulations restrict or prohibit us from using our offshore resources. As a result, we may not be able to reduce costs for our domestic operations or fully realize our margin improvement goals.

Risks relating to our structure
 
The conditional conversion feature of the notes, if triggered, may adversely affect our financial condition and operating results.
 
In the event the conditional conversion feature of the notes is triggered, holders of notes will be entitled to convert the notes at any time during specified periods at their option. See “Description of notes-Conversion rights.” If one or more holders elect to convert their notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our Class A common stock (other than paying cash in lieu of delivering any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.
 
The accounting method for convertible debt securities that may be settled in cash, such as the notes, could have a material effect on our reported financial results.
 
Under ASC 470-20, Debt with Conversion and Other Options, which we refer to as ASC 470-20, an entity must separately account for the liability and equity components of the convertible debt instruments (such as the notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the notes is that the equity component is required to be included in the additional paid-in capital section of stockholders’ equity on our consolidated balance sheet, and the value of the equity component would be treated as original issue discount for purposes of accounting for the debt component of the notes. As a result, we may be required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the notes to their face amount over the term of the notes. We may report lower net income in our financial results because ASC 470-20 will require interest to include both the current period’s amortization of the debt discount and the instrument’s coupon interest, which could adversely affect our reported or future financial results, the trading price of our Class A common stock and the trading price of the notes.
 
In addition, under certain circumstances, convertible debt instruments (such as the notes) that may be settled entirely or partly in cash are currently accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the notes are not included in the calculation of diluted earnings per share except to the extent that the conversion value of the notes exceeds their principal amount. Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. We cannot be sure that the accounting standards in the future will continue to permit the use of the treasury stock method. If we are unable to use the treasury stock method in accounting for the shares issuable upon conversion of the notes, then our diluted earnings per share would be adversely affected.

Risks relating to our Class A Common Stock
 
We previously identified a material weakness in our internal control over financial reporting in both fiscal years 2016 and 2017. Although we believe this material weakness has since been remediated, our independent registered public accounting firm may disagree when it assesses our internal control over financial reporting in connection with its audit of our annual financial statements for the year ended December 31, 2018. If our conclusion that our previously reported material weakness

58


has been remediated subsequently proves to be incorrect or if we identify additional material weaknesses in the future, we and our auditor may conclude that our internal control over financial reporting is not effective and we may be unable to produce timely and accurate financial statements, any of which could adversely impact our investors’ confidence and our stock price.
 
Prior to the completion of our IPO, we were a private company and had limited accounting personnel to fully execute our accounting processes and address our internal control over financial reporting. Upon becoming a publicly-traded company, we became required to comply with the SEC’s rules implementing Sections 302 and 404 of the Sarbanes-Oxley Act, which require management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of controls over financial reporting.
 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. During the course of preparing for our IPO, we determined that we had a material weakness in the design and operating effectiveness of our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness that we identified was that we did not maintain a sufficient complement of resources with an appropriate level of accounting knowledge, experience and training to address accounting for complex, non-routine transactions. This material weakness resulted in the revision of the Company’s consolidated financial statements for the quarter ended June 30, 2017. As a result of this material weakness, our management concluded as of December 31, 2016 and as of December 31, 2017 that our internal control over financial reporting was not effective, and also that our disclosure controls and procedures were not effective. In addition, our independent registered public accounting firm, which audits our annual financial statements, issued an adverse opinion on the effectiveness of internal control over financial reporting as of December 31, 2017.

We believe we have remediated the previously identified material weakness as of June 30, 2018. Our remediation efforts included hiring additional, and reallocating existing, accounting and finance personnel with technical accounting and financial reporting experience, enhancing our training programs within our accounting and finance department, enhancing our internal review procedures during the financial statement close process and refining our existing internal control documentation. However, our independent registered accounting firm will not assess our internal control over financial reporting again until it completes its audit of our annual financial statements for fiscal year 2018 and we cannot assure you that our independent registered public accounting firm will agree with our assessment that our material weakness has been remediated or what our auditor’s conclusion will be about the effectiveness of our internal control over financial reporting when it completes its next audit in early 2019. In addition, we cannot assure you that the remediation measures we have taken to design and implement an effective control environment to date will be sufficient to identify or prevent future material weaknesses or significant deficiencies from occurring. Any newly identified material weakness could result in a misstatement of our financial statements or disclosures that would result in a material misstatement of our annual or interim consolidated financial statements that would not be prevented or detected.

A control system, no matter how well designed and operated, can provide only reasonable assurance that the control system’s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and all instances of fraud will be detected. If we identify future material weaknesses in our internal control over financial reporting or if we are unable to comply with the demands that are placed upon us as a public company, including the requirements of Section 404 of the Sarbanes-Oxley Act, in a timely manner, we may be unable to accurately report our financial results, or report them within the timeframes required by the SEC. In addition, if we are unable to assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our Class A common stock could be negatively affected. We also could become subject to investigations by the NYSE, the SEC or other regulatory authorities.


59


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits

EVOLENT HEALTH, INC.
Exhibit Index for the Report on Form 10-Q
For the Quarter Ended September 30, 2018

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
*
 
The Company agrees to furnish supplementally to the SEC a copy of any omitted schedule or exhibit upon the
 
 
request of the SEC in accordance with Item 601(b)(2) of Regulation S-K


60


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

EVOLENT HEALTH, INC.
 
Registrant
 
 
 
 
By:
/s/ Nicholas McGrane
Name:
Nicholas McGrane
Title:
Chief Financial Officer
 
 
 
By:
/s/ Lydia Stone
Name:
Lydia Stone
Title:
Chief Accounting Officer and Controller

Dated: November 8, 2018




61
EX-31.1 2 a093018exhibit311.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1
 
Certification Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002

I, Frank Williams, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Evolent Health, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:
November 8, 2018
/s/ Frank Williams
 
 
 
Name: Frank Williams
 
 
 
Title: Chief Executive Officer
 


EX-31.2 3 a093018exhibit312.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2
 
Certification Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002

I, Nicholas McGrane, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Evolent Health, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:
November 8, 2018
/s/ Nicholas McGrane
 
 
 
Name: Nicholas McGrane
 
 
 
Title: Chief Financial Officer
 


EX-32.1 4 a093018exhibit321.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1
 
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906
Of the Sarbanes-Oxley Act of 2002

I, Frank Williams, Chief Executive Officer of Evolent Health, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

1.
The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2018 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:
November 8, 2018
/s/ Frank Williams
 
 
 
Name: Frank Williams
 
 
 
Title: Chief Executive Officer
 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


EX-32.2 5 a093018exhibit322.htm EXHIBIT 32.2 Exhibit

Exhibit 32.2
 
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906
Of the Sarbanes-Oxley Act of 2002

I, Nicholas McGrane, Chief Financial Officer of Evolent Health, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

1.
The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2018 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:
November 8, 2018
/s/ Nicholas McGrane
 
 
 
Name: Nicholas McGrane
 
 
 
Title: Chief Financial Officer
 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


EX-101.INS 6 evh-20180930.xml XBRL INSTANCE DOCUMENT 0001628908 2018-01-01 2018-09-30 0001628908 us-gaap:CommonClassBMember 2018-11-05 0001628908 us-gaap:CommonClassAMember 2018-11-05 0001628908 2017-12-31 0001628908 us-gaap:CommonClassBMember 2018-09-30 0001628908 2018-09-30 0001628908 us-gaap:CommonClassAMember 2018-09-30 0001628908 us-gaap:CommonClassAMember 2017-12-31 0001628908 us-gaap:CommonClassBMember 2017-12-31 0001628908 2018-07-01 2018-09-30 0001628908 2017-01-01 2017-09-30 0001628908 2017-07-01 2017-09-30 0001628908 evh:TransformationServicesMember 2017-01-01 2017-09-30 0001628908 evh:TransformationServicesMember 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember 2017-07-01 2017-09-30 0001628908 evh:PremiumsRevenueMember 2018-07-01 2018-09-30 0001628908 evh:PremiumsRevenueMember 2017-07-01 2017-09-30 0001628908 evh:PremiumsRevenueMember 2017-01-01 2017-09-30 0001628908 evh:TransformationServicesMember 2017-07-01 2017-09-30 0001628908 evh:PremiumsRevenueMember 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember 2018-07-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember 2017-01-01 2017-09-30 0001628908 evh:TransformationServicesMember 2018-07-01 2018-09-30 0001628908 2016-12-31 0001628908 2017-09-30 0001628908 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001628908 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001628908 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2017-12-31 0001628908 us-gaap:RetainedEarningsMember 2018-09-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-12-31 0001628908 2017-01-01 2017-12-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001628908 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001628908 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-09-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-09-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-12-31 0001628908 us-gaap:RetainedEarningsMember 2017-12-31 0001628908 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2016-12-31 0001628908 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001628908 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2018-09-30 0001628908 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2017-12-31 0001628908 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001628908 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2016-12-31 0001628908 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2016-12-31 0001628908 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0001628908 us-gaap:RetainedEarningsMember 2016-12-31 0001628908 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-12-31 0001628908 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001628908 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001628908 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2018-09-30 0001628908 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001628908 evh:EvolentHealthLLCMember 2018-09-30 0001628908 evh:PreOrganizationMembersMember evh:EvolentHealthLLCMember 2018-09-30 0001628908 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201618Member 2017-01-01 2017-09-30 0001628908 us-gaap:AccountingStandardsUpdate201618Member 2017-01-01 2017-09-30 0001628908 srt:ScenarioPreviouslyReportedMember us-gaap:AccountingStandardsUpdate201618Member 2016-12-31 0001628908 srt:ScenarioPreviouslyReportedMember us-gaap:AccountingStandardsUpdate201618Member 2017-01-01 2017-09-30 0001628908 us-gaap:AccountingStandardsUpdate201618Member 2016-12-31 0001628908 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201618Member 2016-12-31 0001628908 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201618Member 2017-09-30 0001628908 us-gaap:AccountingStandardsUpdate201618Member 2017-09-30 0001628908 srt:ScenarioPreviouslyReportedMember us-gaap:AccountingStandardsUpdate201618Member 2017-09-30 0001628908 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0001628908 evh:TransformationServicesMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0001628908 evh:TransformationServicesMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0001628908 evh:TransformationServicesMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0001628908 evh:TransformationServicesMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2018-09-30 0001628908 evh:RestrictedCashforLettersofCreditforFacilityLeasesMember 2018-09-30 0001628908 evh:RestrictedCashforBenefitManagementServicesMember 2017-12-31 0001628908 evh:RestrictedCashforBenefitManagementServicesMember 2018-09-30 0001628908 evh:CollateralwithFinancialInstitutionsMember 2017-12-31 0001628908 evh:RestrictedCashforLettersofCreditforFacilityLeasesMember 2017-12-31 0001628908 evh:RestrictedCashforOtherContractualCommitmentsMember 2017-12-31 0001628908 evh:RestrictedCashForReinsuranceAgreementMember 2018-09-30 0001628908 evh:RestrictedCashForReinsuranceAgreementMember 2017-12-31 0001628908 evh:RestrictedCashforOtherContractualCommitmentsMember 2018-09-30 0001628908 evh:CollateralwithFinancialInstitutionsMember 2018-09-30 0001628908 us-gaap:ContractBasedIntangibleAssetsMember 2018-01-01 2018-09-30 0001628908 us-gaap:DevelopedTechnologyRightsMember 2018-01-01 2018-09-30 0001628908 us-gaap:TradeNamesMember 2018-01-01 2018-09-30 0001628908 evh:CurrentCustomerMember evh:ImplementationFundLoanMember us-gaap:LoansPayableMember 2017-12-31 0001628908 us-gaap:MoneyMarketFundsMember 2018-09-30 0001628908 evh:CurrentCustomerMember evh:ImplementationFundLoanMember us-gaap:LoansPayableMember 2017-01-01 2017-12-31 0001628908 evh:CurrentCustomerMember evh:ImplementationFundLoanMember us-gaap:LoansPayableMember 2018-09-30 0001628908 us-gaap:BankTimeDepositsMember 2017-12-31 0001628908 evh:CollateralWithFinancialInstitutionsMoneyMarketFundMember 2017-12-31 0001628908 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-09-30 0001628908 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-30 0001628908 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2018-01-01 2018-09-30 0001628908 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2018-01-01 2018-09-30 0001628908 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-03-31 0001628908 evh:NewMexicoHealthConnectionsMember us-gaap:CustomerRelationshipsMember 2018-01-02 0001628908 evh:NewMexicoHealthConnectionsMember 2018-01-02 0001628908 evh:NewMexicoHealthConnectionsMember us-gaap:AboveMarketLeasesMember 2018-01-02 0001628908 evh:NewMexicoHealthConnectionsMember 2018-01-02 2018-01-02 0001628908 evh:NewMexicoHealthConnectionsMember us-gaap:ContractBasedIntangibleAssetsMember 2018-01-02 0001628908 evh:EvolentHealthLLCMember 2018-03-31 0001628908 evh:EvolentHealthSellingStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2017-03-01 2017-03-31 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-06-30 0001628908 us-gaap:CommonClassAMember 2017-08-01 2017-08-31 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-05-01 2017-05-31 0001628908 evh:UnderwritersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-08-31 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-03-01 2018-03-31 0001628908 evh:EvolentHealthLLCMember us-gaap:OverAllotmentOptionMember 2017-03-31 0001628908 evh:ManagementSellingStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-05-01 2017-05-31 0001628908 evh:EvolentHealthLLCMember 2017-04-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-05-01 2017-05-31 0001628908 evh:AccordionHealthInc.Member evh:TechnologyAssetsMember 2017-06-08 0001628908 evh:EvolentHealthLLCMember 2017-05-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-08-01 2017-08-31 0001628908 evh:EvolentHealthLLCMember 2017-08-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-03-31 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-03-01 2017-03-31 0001628908 evh:NewMexicoHealthConnectionsMember us-gaap:ContractBasedIntangibleAssetsMember 2018-01-02 2018-01-02 0001628908 evh:EvolentHealthSellingStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-06-01 2017-06-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-08-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-03-01 2018-03-31 0001628908 evh:EvolentHealthSellingStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-05-01 2017-05-31 0001628908 evh:AccordionHealthInc.Member evh:TechnologyAssetsMember 2017-06-08 2017-06-08 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2017-03-01 2017-03-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-05-31 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-06-01 2017-06-30 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2017-03-01 2017-03-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2017-03-31 0001628908 evh:EvolentHealthLLCMember us-gaap:OverAllotmentOptionMember 2017-02-28 0001628908 evh:NewMexicoHealthConnectionsMember us-gaap:CustomerRelationshipsMember 2018-01-02 2018-01-02 0001628908 evh:EvolentHealthLLCMember 2017-06-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-06-01 2017-06-30 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-03-01 2017-03-31 0001628908 evh:AccordionHealthInc.Member 2017-06-08 0001628908 evh:EvolentHealthLLCMember 2017-03-31 0001628908 evh:EvolentHealthSellingStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-03-01 2018-03-31 0001628908 evh:EvolentHealthSellingStockholdersMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-03-01 2017-03-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-06-30 0001628908 evh:EvolentHealthLLCMember 2017-07-31 0001628908 evh:NewMexicoHealthConnectionsMember 2017-12-31 0001628908 evh:EvolentHealthLLCMember 2017-02-28 0001628908 evh:TransformationServicesMember evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 evh:TransformationServicesMember evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 evh:ContractFulfillmentCostsMember 2018-07-01 2018-09-30 0001628908 evh:BonusesAndCommissionsMember 2018-01-01 2018-09-30 0001628908 evh:ContractFulfillmentCostsMember 2018-09-30 0001628908 evh:BonusesAndCommissionsMember 2018-09-30 0001628908 evh:ContractFulfillmentCostsMember 2018-01-01 2018-09-30 0001628908 evh:BonusesAndCommissionsMember 2018-07-01 2018-09-30 0001628908 2018-01-01 0001628908 us-gaap:ComputerEquipmentMember 2017-12-31 0001628908 us-gaap:FurnitureAndFixturesMember 2018-09-30 0001628908 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-12-31 0001628908 us-gaap:ComputerEquipmentMember 2018-09-30 0001628908 us-gaap:LeaseholdImprovementsMember 2018-09-30 0001628908 us-gaap:FurnitureAndFixturesMember 2017-12-31 0001628908 us-gaap:LeaseholdImprovementsMember 2017-12-31 0001628908 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-09-30 0001628908 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-01-01 2017-09-30 0001628908 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-07-01 2017-09-30 0001628908 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-07-01 2018-09-30 0001628908 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-01-01 2018-09-30 0001628908 us-gaap:TradeNamesMember 2018-09-30 0001628908 us-gaap:CustomerRelationshipsMember 2018-09-30 0001628908 evh:BelowMarketLeasesNetMember 2018-01-01 2018-09-30 0001628908 us-gaap:DevelopedTechnologyRightsMember 2018-09-30 0001628908 evh:BelowMarketLeasesNetMember 2018-09-30 0001628908 us-gaap:CustomerRelationshipsMember 2018-01-01 2018-09-30 0001628908 us-gaap:ContractBasedIntangibleAssetsMember 2018-09-30 0001628908 evh:ServicesSegmentMember 2018-09-30 0001628908 evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 evh:TrueHealthSegmentMember 2017-12-31 0001628908 evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 evh:ServicesSegmentMember 2017-12-31 0001628908 evh:TrueHealthSegmentMember 2018-09-30 0001628908 us-gaap:DevelopedTechnologyRightsMember 2017-12-31 0001628908 evh:BelowMarketLeasesNetMember 2017-01-01 2017-12-31 0001628908 evh:BelowMarketLeasesNetMember 2017-12-31 0001628908 us-gaap:DevelopedTechnologyRightsMember 2017-01-01 2017-12-31 0001628908 us-gaap:TradeNamesMember 2017-12-31 0001628908 us-gaap:CustomerRelationshipsMember 2017-12-31 0001628908 us-gaap:CustomerRelationshipsMember 2017-01-01 2017-12-31 0001628908 us-gaap:TradeNamesMember 2017-01-01 2017-12-31 0001628908 evh:VesticaMember us-gaap:CustomerRelationshipsMember 2018-01-02 0001628908 evh:VesticaMember 2018-02-01 2018-02-28 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2018-07-01 2018-09-30 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2017-07-01 2017-09-30 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2018-09-30 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2016-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-12-01 2016-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:SeniorNotesMember 2017-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2016-12-01 2016-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:SeniorNotesMember 2018-06-27 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2017-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2017-01-01 2017-12-31 0001628908 evh:ConvertibleSeniorNotesdue2021Member us-gaap:SeniorNotesMember 2018-01-01 2018-09-30 0001628908 evh:CustomerCMember us-gaap:FinanceReceivablesMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0001628908 evh:CustomerCMember us-gaap:FinanceReceivablesMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-12-31 0001628908 evh:CustomerBMember us-gaap:FinanceReceivablesMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-12-31 0001628908 evh:CustomerDMember us-gaap:FinanceReceivablesMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-12-31 0001628908 us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2017-03-31 0001628908 evh:NewMexicoHealthConnectionsMember 2017-10-01 2017-12-31 0001628908 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-03-01 2017-08-31 0001628908 us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2017-01-01 2017-03-31 0001628908 evh:NewMexicoHealthConnectionsMember evh:RestrictedCashForReinsuranceAgreementMember 2017-12-31 0001628908 srt:MinimumMember 2018-09-30 0001628908 evh:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0001628908 evh:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-07-01 2017-09-30 0001628908 evh:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0001628908 evh:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001628908 evh:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-09-30 0001628908 us-gaap:StockOptionMember 2017-01-01 2017-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-09-30 0001628908 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-09-30 0001628908 us-gaap:StockOptionMember 2018-01-01 2018-09-30 0001628908 evh:ExchangeableClassBCommonStockMember 2018-07-01 2018-09-30 0001628908 evh:ExchangeableClassBCommonStockMember 2017-01-01 2017-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-30 0001628908 evh:ExchangeableClassBCommonStockMember 2017-07-01 2017-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0001628908 us-gaap:ConvertibleDebtSecuritiesMember 2018-07-01 2018-09-30 0001628908 us-gaap:StockOptionMember 2018-07-01 2018-09-30 0001628908 us-gaap:ConvertibleDebtSecuritiesMember 2017-01-01 2017-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001628908 us-gaap:StockOptionMember 2017-07-01 2017-09-30 0001628908 us-gaap:ConvertibleDebtSecuritiesMember 2017-07-01 2017-09-30 0001628908 evh:ExchangeableClassBCommonStockMember 2018-01-01 2018-09-30 0001628908 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0001628908 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-09-30 0001628908 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001628908 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001628908 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0001628908 us-gaap:PerformanceSharesMember 2018-01-01 2018-09-30 0001628908 us-gaap:PerformanceSharesMember 2018-07-01 2018-09-30 0001628908 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0001628908 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0001628908 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0001628908 us-gaap:PerformanceSharesMember 2017-07-01 2017-09-30 0001628908 us-gaap:CostOfSalesMember 2017-07-01 2017-09-30 0001628908 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0001628908 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0001628908 us-gaap:PerformanceSharesMember 2017-01-01 2017-09-30 0001628908 us-gaap:CostOfSalesMember 2017-01-01 2017-09-30 0001628908 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0001628908 evh:EvolentHealthLLCMember 2017-01-01 2017-09-30 0001628908 evh:EvolentHealthLLCMember evh:IncomeTaxExpenseBenefitMember 2017-01-01 2017-09-30 0001628908 evh:EvolentHealthLLCMember us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001628908 evh:EvolentHealthLLCMember us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-09-30 0001628908 evh:ServicesAgreementsMember us-gaap:EquityMethodInvesteeMember 2017-07-01 2017-09-30 0001628908 srt:MinimumMember 2017-12-31 0001628908 srt:MaximumMember 2018-09-30 0001628908 evh:ServicesAgreementsMember us-gaap:EquityMethodInvesteeMember 2018-07-01 2018-09-30 0001628908 srt:MaximumMember 2017-12-31 0001628908 evh:ServicesAgreementsMember us-gaap:EquityMethodInvesteeMember 2017-01-01 2017-09-30 0001628908 evh:ServicesAgreementsMember us-gaap:EquityMethodInvesteeMember 2018-01-01 2018-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2018-07-01 2018-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2017-06-30 0001628908 us-gaap:NoncontrollingInterestMember 2017-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2017-07-01 2017-09-30 0001628908 us-gaap:NoncontrollingInterestMember 2018-06-30 0001628908 evh:EvolentHealthSellingStockholdersMember us-gaap:CommonClassAMember 2017-01-01 2017-12-31 0001628908 evh:EvolentHealthLLCMember 2017-12-31 0001628908 us-gaap:CommonClassAMember 2017-01-01 2017-12-31 0001628908 evh:ManagementSellingStockholdersMember us-gaap:CommonClassAMember 2017-01-01 2017-12-31 0001628908 evh:EvolentHealthLLCMember 2015-06-05 0001628908 evh:InvestorStockholdersMember us-gaap:CommonClassAMember 2017-01-01 2017-12-31 0001628908 us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0001628908 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0001628908 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0001628908 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember evh:RealOptionsApproachValuationTechnique20172021Member 2018-09-30 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember evh:RealOptionsApproachValuationTechnique20172021Member 2017-01-01 2017-12-31 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember evh:RealOptionsApproachValuationTechnique20192021Member 2018-09-30 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember evh:RealOptionsApproachValuationTechnique20172021Member 2017-12-31 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember evh:RealOptionsApproachValuationTechnique20172021Member 2018-01-01 2018-09-30 0001628908 srt:MinimumMember us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember evh:RealOptionsApproachValuationTechnique20192021Member 2017-12-31 0001628908 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001628908 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001628908 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001628908 us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember evh:RealOptionsApproachValuationTechniqueMember 2017-12-31 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember evh:RealOptionsApproachValuationTechniqueMember 2017-12-31 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember evh:RealOptionsApproachValuationTechniqueMember 2018-09-30 0001628908 us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember evh:RealOptionsApproachValuationTechniqueMember 2018-09-30 0001628908 2018-06-30 0001628908 2017-06-30 0001628908 srt:MaximumMember us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputDiscountRateMember evh:RealOptionsApproachValuationTechniqueMember 2018-09-30 0001628908 srt:MinimumMember us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputDiscountRateMember evh:RealOptionsApproachValuationTechniqueMember 2018-09-30 0001628908 srt:MinimumMember us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputDiscountRateMember evh:RealOptionsApproachValuationTechniqueMember 2017-12-31 0001628908 srt:MaximumMember us-gaap:FairValueInputsLevel3Member evh:ContingentConsiderationLiabilityMember us-gaap:MeasurementInputDiscountRateMember evh:RealOptionsApproachValuationTechniqueMember 2017-12-31 0001628908 evh:PlatformsAndOperationsServicesMember srt:AffiliatedEntityMember 2017-07-01 2017-09-30 0001628908 evh:PlatformsAndOperationsServicesMember srt:AffiliatedEntityMember 2018-01-01 2018-09-30 0001628908 srt:AffiliatedEntityMember 2018-01-01 2018-09-30 0001628908 srt:AffiliatedEntityMember 2018-07-01 2018-09-30 0001628908 srt:AffiliatedEntityMember 2017-07-01 2017-09-30 0001628908 evh:TransformationServicesMember srt:AffiliatedEntityMember 2018-01-01 2018-09-30 0001628908 evh:PlatformsAndOperationsServicesMember srt:AffiliatedEntityMember 2017-01-01 2017-09-30 0001628908 evh:TransformationServicesMember srt:AffiliatedEntityMember 2017-01-01 2017-09-30 0001628908 srt:AffiliatedEntityMember 2017-01-01 2017-09-30 0001628908 evh:PlatformsAndOperationsServicesMember srt:AffiliatedEntityMember 2018-07-01 2018-09-30 0001628908 evh:TransformationServicesMember srt:AffiliatedEntityMember 2017-07-01 2017-09-30 0001628908 evh:TransformationServicesMember srt:AffiliatedEntityMember 2018-07-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:PlatformsAndOperationsServicesMember 2017-01-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:ServiceMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TrueHealthSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:TrueHealthSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:TrueHealthSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:TrueHealthSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:TrueHealthSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:ServiceMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:TransformationServicesMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:PlatformsAndOperationsServicesMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember 2017-01-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:ServiceMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:TrueHealthSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:ServiceMember 2018-01-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:TransformationServicesMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:TrueHealthSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-01-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:TrueHealthSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:ServiceMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:ServiceMember 2018-07-01 2018-09-30 0001628908 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TrueHealthSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:PlatformsAndOperationsServicesMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:TrueHealthSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember 2018-07-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:TrueHealthSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:TransformationServicesMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:TrueHealthSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:ServiceMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:ServiceMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:PlatformsAndOperationsServicesMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember evh:TransformationServicesMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:TrueHealthSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member evh:TrueHealthSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:IntersegmentEliminationMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PlatformsAndOperationsServicesMember evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 evh:PremiumsRevenueMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-07-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2018-01-01 2018-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:TransformationServicesMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2017-07-01 2017-09-30 0001628908 us-gaap:OperatingSegmentsMember evh:PremiumsRevenueMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member evh:ServicesSegmentMember 2017-01-01 2017-09-30 0001628908 evh:SeniorConvertibleNotesDue2025Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2018-10-31 0001628908 evh:SeniorConvertibleNotesDue2025Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2018-10-22 0001628908 evh:SeniorConvertibleNotesDue2025Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2018-10-01 2018-10-31 0001628908 evh:NewCenturyHealthMember us-gaap:SubsequentEventMember 2018-10-01 0001628908 evh:NewCenturyHealthMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2018-10-01 2018-10-01 0001628908 evh:NewCenturyHealthMember us-gaap:SubsequentEventMember 2018-10-01 2018-10-01 0001628908 evh:SeniorConvertibleNotesDue2025Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2018-10-24 0001628908 evh:NewCenturyHealthMember evh:CommonClassBUnitsMember us-gaap:SubsequentEventMember 2018-10-01 2018-10-01 0001628908 evh:SeniorConvertibleNotesDue2025Member us-gaap:SeniorNotesMember us-gaap:CommonClassAMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2018-10-01 2018-10-31 evh:segment xbrli:pure xbrli:shares evh:installment iso4217:USD evh:reporting_unit iso4217:USD xbrli:shares false --12-31 Q3 2018 2018-09-30 10-Q 0001628908 78341481 3885947 Yes false Large Accelerated Filer Evolent Health, Inc. false 3200000 100000 800000 2000000 3300000 2648000 2648000 2648000 0 -5689000 -5689000 -5689000 0 4797000 4797000 4065000 732000 17595000 17595000 16674000 921000 0 0 0 4498000 1004000 1004000 0 0 0 594000 2000000 -413000 -8414000 -126000 -680000 -11320000 -65113000 -12555000 -36651000 1000000.0 3100000 3100000 0.038 1000000 1000000 474000 0 0 658000 1797000 0.723 0.010 0.274 68281000 5299000 203804000 17382000 73967000 -3442000 77409000 2390000 214945000 -3841000 218786000 6842000 1000 1000 10 P30D 1.30 P20D 1 1 1 0.40 0.26 0.40 0.04 0 2600000 100000 400000 5100000 5900000 0 4568000 1 0.008 1766000 4000 0 168883000 0 25334000 25000 48000 0 2500000 166900000 449000 1224000 214000 647000 10000000 200000 P15M 16575000 0 0 16575000 32028000 0 0 32028000 0 0 0 0 100157000 0 8204000 0 108361000 0 108361000 0 100157000 8204000 108361000 108361000 0 0 0 0 298646000 0 23799000 0 322445000 0 322445000 0 298646000 23799000 322445000 322445000 -3537000 -206000 0 -3537000 -3743000 121845000 0 0 22829000 9230000 0 131075000 0 131075000 22829000 118308000 22623000 9230000 127538000 150161000 -10949000 -602000 0 -10949000 -11551000 353697000 0 0 69353000 27605000 0 381302000 0 381302000 69353000 342748000 68751000 27605000 370353000 439104000 0.60 0.84 P5Y P5Y 0 1004000 12992000 908000 908000 908000 12857000 12857000 2042000 0 0.85 2694000 9972000 456000 2254000 42930000 30535000 10284000 1425000 48947000 60054000 2206000 57848000 29572000 47189000 14458000 26265000 0 -264000 924153000 971341000 20437000 20437000 12560000 12560000 5708000 4291000 113000 1304000 401000 5307000 16172000 12452000 335000 3385000 1143000 15029000 4047000 2139000 113000 1795000 376000 3671000 12560000 7009000 334000 5217000 1130000 11430000 700000 685000 200000 688000 5300000 15000000 6100000 18000000 11408000 2654000 5201000 577000 2976000 17635000 8846000 5201000 557000 3031000 9862000 766000 5201000 1197000 2698000 9861000 1251000 5201000 923000 2486000 1312697000 1322676000 378182000 348591000 77110000 0 0 77110000 73214000 0 0 73214000 1200000 -0.16 -0.93 -0.16 -0.47 -0.16 -0.93 -0.16 -0.47 -10907000 -56699000 -12429000 -35971000 129820000 378801000 149947000 433959000 10252000 221600000 100000 300000 100000 -1404000 4000000 0 0 8700000 8700000 0 0 8300000 8300000 252000 300000 0.040 0.027 0.192 0.925 0.045 0.038 0.786 1.127 20000000.0 -100000 2300000 2700000 2500000 10252000 83000 501000 8400000 20400000 7000000 25100000 1200000 2800000 3100000 8500000 0 100000 600000 1900000 200000 1700000 P5Y 2000000 12300000 0 14252000 14252000 0 0 500000 134563000 287143000 238433000 221800000 221837000 60535000 0 0 60535000 41186000 0 0 41186000 266800000 170029000 35466000 134563000 170029000 295925000 8782000 287143000 295925000 295363000 266847000 125896000 -26684000 152580000 125896000 -28516000 0.01 0.01 0.01 0.01 750000000 100000000 750000000 100000000 74723597 2653544 78392052 765646 74723597 2653544 0 78392052 765646 747000 27000 784000 8000 -12588000 -47506000 -12545000 -36235000 -541000 -8471000 -126000 -680000 -13129000 -55977000 -12671000 -36915000 0.190 0.185 0.100 0.118 0.321 0.165 0.188 0.189 0.162 0 3705000 3705000 0 3710000 0 1000000 1000000 0 1791000 -800000 -3300000 24807000 22360000 -1740000 24100000 26147000 1000000 493000 3700000 17000000 9400000 11500000 168883000 25334000 121394000 122082000 1 17300000 24.03 33.43 0.0416082 0.0299135 5200000 5200000 P3Y10M25D P3Y2M24D 125000000.0 20000000.0 125000000 125000000 150000000.0 22500000.0 172500000.0 0.02 0.025 0.015 2000000.0 3606000 2918000 196000 0 4600000 5200000 -2668000 34000 2437000 1725000 2300000 6000000 4300000 11800000 7717000 21236000 10352000 29882000 21236000 29882000 3358000 7774000 719000 4812000 -0.18 -0.78 -0.16 -0.47 -0.18 -0.78 -0.16 -0.47 0 35000 0.116 0.035 -0.009 -0.001 35390000 28989000 0 0 0 0 0.40 0.27 0 2519000 -100000 -300000 -100000 400000 8300000 8500000 8600000 8700000 8700000 8700000 8200000 8300000 8300000 8300000 P5Y P5Y P15Y P25Y P15Y P5Y P5Y P20Y 41238000 2662000 18312000 17810000 2454000 59243000 2918000 345000 25550000 27264000 3166000 282499000 4197000 203500000 55802000 19000000 290049000 4097000 2300000 208719000 55933000 19000000 241261000 1535000 185188000 37992000 16546000 230806000 1179000 1955000 183169000 28669000 15834000 P4Y9M25D P20Y6M P3Y1M12D P17Y4M26D P4Y4M P4Y4M P19Y6M P2Y5M5D P16Y8M15D 626569000 628186000 628186000 0 635088000 629262000 5826000 5826000 7060000 1234000 5826000 -162000 -162000 0 160600000 160600000 1617000 4000 4000 0 -14843000 -57986000 -12420000 3378000 -15798000 -36622000 5441000 -42063000 -400000 -369000 -1446000 -1400000 -1400000 -1381000 -2787000 -2800000 -1700000 -1714000 -2009000 -2000000 135000 29000 10591000 6451000 5075000 11241000 -11075000 13946000 0 -240000 4835000 828000 -13100000 -300000 -12800000 -900000 -7707000 -7059000 0 10338000 -1719000 1090000 5125000 15393000 2164000 -2164000 0 3200000 -3200000 0 -3200000 -8043000 241261000 230806000 880000 2781000 853000 2561000 1900000 600000 100000 100000 411000 813000 968000 2918000 1531000 5672000 3700000 266391000 274103000 1312697000 1322676000 132699000 139411000 0 10338000 0 10338000 41831000 10338000 5000000.0 6550000 0 121394000 122082000 120400000 169100000 209588000 34680000 35932000 35427000 35427000 10148000 10008000 647000 9361000 10008000 0.839 0.849 0.961 0.966 0.989 0.990 0.703 0.774 0.839 0.849 0.905 0.961 0.966 143922000 -25648000 169570000 143922000 -7935000 15967000 -1036000 17003000 15967000 -24933000 -33993000 4317000 -12588000 -47506000 -12429000 -35971000 -541000 -541000 -8471000 -8471000 -126000 -680000 -680000 -12588000 -47506000 -12429000 -35971000 -12588000 -47506000 -12429000 -35971000 17309000 594000 16715000 0 500000 1793000 3698000 0 -3824000 3824000 -14000 0 -1000 1000 20000000 20000000 6000000 6000000 2 2 121932000 375814000 160977000 468087000 -14020000 -54593000 -11030000 -34128000 3000000 8000000 3300000 10100000 9328000 15181000 0 0 -116000 -264000 -264000 9861000 10885000 139000 10746000 -88000 111000 15000 21000 -124000 -64000 3500000 8100000 300000 1500000 1179000 1179000 10000000 117200000 3694000 11552000 0 6807000 21349000 29117000 8404000 14667000 0 14000000 175000000 166947000 0 120400000 167300000 -25648000 -25648000 0 -25648000 -17344000 44210000 0 3802000 10588000 -13129000 -55977000 -69767000 -9102000 -60665000 -12555000 -36651000 -680000 -35971000 65380000 5667000 2448000 8708000 48557000 94957000 8602000 3038000 9638000 73679000 50922000 42100000 68692000 58700000 58190000 47131000 40416000 16932000 65685000 10000000 16600000 24725000 10000000 26286000 3812000 862000 10000000 45722000 22028000 10000000 8942000 3700000 3710000 1042000 10000000 54248000 42328000 2682000 2682000 62398000 42328000 3287000 3394000 4950000 8150000 8755000 712000 8150000 0 605000 712000 85952000 66696000 22116000 44580000 107912000 0 0 0 0 -449000 0 107912000 0 99708000 9411000 0 8204000 352000 -449000 321221000 0 0 0 0 -1224000 0 321221000 0 297422000 24764000 0 23799000 597000 -1224000 149947000 -3743000 0 0 0 -214000 0 130861000 22829000 118094000 152000 117942000 12180000 116226000 22623000 9230000 -326000 9556000 5332000 9230000 -214000 433959000 -11551000 0 0 800000 0 3700000 -4498000 0 -647000 0 376157000 69353000 341258000 1773000 339485000 27072000 335509000 68751000 23950000 -1322000 25272000 6112000 23950000 -4498000 -647000 125000000 45834000 514000 150474000 1038000 59566000 -110000 59676000 241000 172495000 -1149000 173644000 620000 0 0 0 1489000 5708000 16172000 4047000 12560000 84249 37361 961313 461494 3444 18453 1053660 856501 19.53 19.53 25.87 24.30 19.01 19.85 52587000 15347000 74723000 2654000 78392000 766000 12693000 -12693000 1888000 -1888000 3100000 500000 4400000 600000 7500000 1100000 700000 3800000 4500000 3100000 3800000 100000 7000000 8800000 19700000 1200000 1800000 3000000 7400000 12600000 100000 20100000 8816000 149000 207000 788000 1574000 0 126000 -126000 168883000 -168883000 0 19000 -19000 25334000 -25334000 166947000 88000 166859000 -1272000 2000 -1274000 -1179000 2000 -1181000 4082000 28000 4054000 10588000 16000 10572000 310000 -908000 3000 -911000 1010879000 1038565000 912114000 506000 153000 555250000 0 209588000 146617000 1046306000 747000 27000 924153000 0 35427000 85952000 1048573000 784000 8000 971341000 -264000 10008000 66696000 0 0 16992000 52169000 800000 70328000 60867000 77999000 76871000 70328000 60867000 77999000 76871000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in non-controlling interests (in thousands) for the periods presented were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:703px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-controlling interests as of beginning-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,427</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">209,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative-effect adjustment from adoption of new accounting principle</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">594</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in non-controlling interests as a result of Class B Exchanges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(168,883</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification of non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,793</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(541</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(680</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,471</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-controlling interests as of end-of-period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our opinion, the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to fairly state our financial position, results of operations, and cash flows. The Consolidated Balance Sheet at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, has been derived from audited financial statements as of that date. The interim consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain footnote disclosures normally included in financial statements prepared in accordance with United States of America generally accepted accounting principles (&#8220;GAAP&#8221;) have been omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&#8220;SEC&#8221;). The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our opinion, the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to fairly state our financial position, results of operations, and cash flows. The Consolidated Balance Sheet at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, has been derived from audited financial statements as of that date. The interim consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain footnote disclosures normally included in financial statements prepared in accordance with United States of America generally accepted accounting principles (&#8220;GAAP&#8221;) have been omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&#8220;SEC&#8221;). The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain&#160;GAAP&#160;policies that significantly&#160;affect&#160;the&#160;determination&#160;of&#160;our financial&#160;position,&#160;results&#160;of&#160;operations&#160;and&#160;cash&#160;flows,&#160;are summarized below. See &#8220;Part II - Item 8. Financial Statements and Supplementary Data - Note 2&#8221; in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K for a complete summary of our significant accounting policies.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Estimates and Assumptions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including variable consideration, discounts and credits, estimated selling prices for performance obligations in contracts with multiple performance obligations, claims reserves, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of Evolent Health, Inc. and its subsidiaries. All inter-company accounts and transactions are eliminated in consolidation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Segments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating segments are defined as components of a business that earn revenue and incur expenses for which discrete financial information is available that is evaluated, on a regular basis, by the chief operating decision maker (&#8220;CODM&#8221;) to decide how to allocate resources and assess performance. The Company operates through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> segments: (1) Services, and (2) True Health. Our Services segment consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services. Our True Health segment consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses. See Note </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;"> for a discussion of our operating results by segment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. See &#8220;Changes in Accounting Principles&#8221; below for our updated revenue recognition policy as a result of our adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our True Health segment derives revenue from premiums that are earned over the terms of the related insurance policies. The portion of premiums that will be earned in the future or are received prior to the effectiveness of the policy are deferred and reported as premiums received in advance. These amounts are generally classified as short-term deferred revenue on our Consolidated Balance Sheets.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Cash and Restricted Investments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:</font></div><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collateral for letters of credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">for facility leases </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,812</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collateral with financial institutions </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims processing services </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,942</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,286</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collateral for reinsurance agreement </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,042</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">862</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,722</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,685</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,328</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and restricted investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,328</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,398</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent restricted investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">605</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total noncurrent restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,394</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,287</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of our lease commitments.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Represents collateral held with financial institutions for risk-sharing arrangements. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$22.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$16.6 million</font><font style="font-family:inherit;font-size:10pt;"> of the collateral amount was in a trust account and invested in a money market fund. The amounts invested in money market funds are considered restricted cash and are carried at fair value, which approximates cost. See Note </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of our fair value measurement. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$8.2 million</font><font style="font-family:inherit;font-size:10pt;"> of the collateral amount was invested in restricted certificates of deposit with remaining maturities of less than 12 months. The restricted investments are classified as held-to-maturity and stated at amortized cost. Fair value of the certificates of deposit is determined using Level 2 inputs and approximates amortized cost as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">See Note</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">9</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">for further discussion of our risk-sharing arrangements.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents cash held by Evolent on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents restricted cash required as part of our capital only reinsurance agreement to provide balance sheet support to NMHC. There is no transfer of underwriting risk to Evolent and we are not at risk for any cash payments on behalf of NMHC as part of the agreement. The reinsurance agreement is further discussed in Note </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the full </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> amount was invested in a money market fund. The amount invested in the money market fund is considered restricted cash and is carried at fair value, which approximates cost. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the full </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> amount was held in a FDIC participating bank account.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statements of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:675px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287,143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,722</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,932</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,416</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted investments included in</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restricted cash and restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(712</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,150</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,755</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,950</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash and cash equivalents and restricted cash</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">shown in the consolidated statements of cash flows</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295,925</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295,363</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170,029</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Notes Receivable</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">Notes receivable are carried at the face amount of each note plus respective accrued interest receivable, less received payments. The Company does not typically carry notes receivable in the course of its regular business, but contributed </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> in the form of an implementation funding loan (the &#8220;Implementation Loan&#8221;) under an agreement with a current customer entered during the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The Implementation Loan is expected to support implementation services to assist the customer in expanding its Medicaid membership. The Implementation Loan carries a fixed interest rate of&#160;</font><font style="font-family:inherit;font-size:10pt;">2.5%</font><font style="font-family:inherit;font-size:10pt;">&#160;per annum and the terms of the agreement governing the Implementation Loan require it to be repaid in&#160;</font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;">&#160;equal monthly installments of&#160;</font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, plus accrued interest, during 2018.</font><font style="font-family:inherit;font-size:11pt;color:#1f497d;"> </font><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the outstanding principal balance of the Implementation Loan was </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;">, excluding approximately </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of accrued interest. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the outstanding principal balance of the Implementation Loan was </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">, excluding approximately </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of accrued interest.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible Assets, Net</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identified intangible assets are recorded at their estimated fair values at the date of acquisition and are amortized over their respective estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are used. The Company acquired additional intangible assets in conjunction with a strategic acquisition made during 2018. Information regarding the determination and allocation of the fair value of the acquired assets and liabilities is further described within Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes the estimated useful lives by asset classification:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:466px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15-25 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the asset&#8217;s carrying value. The Company evaluates recoverability by determining whether the undiscounted cash flows expected to result from the use and eventual disposition of that asset or group exceed the carrying value at the evaluation date. If the undiscounted cash flows are not sufficient to cover the carrying value, the Company measures an impairment loss as the excess of the carrying amount of the long-lived asset or group over its fair value. See Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion regarding our intangible assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize the excess of the purchase price, plus the fair value of any non-controlling interests in the acquiree, over the fair value of identifiable net assets acquired as goodwill. Goodwill is not amortized, but is reviewed at least annually for indications of impairment, with consideration given to financial performance and other relevant factors. We perform impairment tests of goodwill at a reporting unit level, which is consistent with the way management evaluates our business. Goodwill is assigned to the reporting unit that benefits from the synergies arising from each business combination.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company established an international subsidiary during the first quarter of 2018. The functional currency of our international subsidiary is the Indian Rupee. We translate the financial statements of this subsidiary to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenue, costs, and expenses. Translation gains and losses are recorded in accumulated other comprehensive income (loss) as a component of shareholders' equity. We recorded a foreign currency translation loss of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> on our Consolidated Statements of Operations for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, which resulted in an &#8220;Accumulated other comprehensive loss&#8221; of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> on our Consolidated Balance Sheet as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes in Accounting Principles</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adoption of ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">, the Company adopted ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers,</font><font style="font-family:inherit;font-size:10pt;"> effective January 1, 2018. The following is our updated accounting policy with respect to revenue recognition for our Services segment. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. Revenue is recognized when control of the services is transferred to our customers. We use the following 5-Step model, outlined in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 606&#8221;), to determine revenue recognition on our contracts with customers:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Identify the contract(s) with a customer</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Identify the performance obligations in the contract</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Determine the transaction price</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Allocate the transaction price to performance obligations</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Recognize revenue when (or as) the entity satisfies a performance obligation</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Transformation Services Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services consist of strategic assessments, or Blueprint contracts, and implementation services whereby we assist the customer in launching its population health or health plan strategy. In certain cases, transformation services can also include revenue associated with our support of certain one-time wind-down activities for clients who are exiting a line of business or population. The transformation services are usually completed within 12 months. We generally receive a fixed fee for transformation services and recognize revenue over time using an input method based on hours incurred compared to the total estimated hours required to satisfy our performance obligation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Platform and Operations Services Revenue</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services generally include multi-year arrangements with customers to provide various population health, health plan operations and claims processing services on an ongoing basis, as well as transition or run-out services to customers receiving primarily third-party administration (&#8220;TPA&#8221;) services. Our performance obligation in these arrangements is to provide an integrated suite of services, including access to our platform that is customized to meet the specialized needs of our customers. Generally we will apply the series guidance to the performance obligation as we have determined that each time increment is distinct. We primarily utilize a variable fee structure for these services that typically include a monthly payment that is calculated based on a specified per member per month rate, multiplied by the number of members that our partners are managing under a value-based care arrangement or a percentage of plan premiums. Our arrangements may also include other variable fees related to service level agreements, shared medical savings arrangements and other performance measures. Variable consideration is estimated using the most likely amount based on our historical experience and best judgment at the time. Due to the nature of our arrangements certain estimates may be constrained if it is probable that a significant reversal of revenue will occur when the uncertainty is resolved. We recognize revenue for platform and operations services over time using the time elapsed output method. Fixed consideration is recognized ratably over the contract term. In accordance with the series guidance, we allocate variable consideration to the period to which the fees relate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts with Multiple Performance Obligations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our contracts with customers may contain multiple performance obligations, primarily when the customer has requested both transformation services and platform and operations services as these services are distinct from one another. When a contract has multiple performance obligations, we allocate the transaction price to each performance obligation based on the relative standalone selling price using the expected cost margin approach. This approach requires estimates regarding both the level of effort it will take to satisfy the performance obligation as well as fees that will be received under the variable pricing model. We also take into consideration customer demographics, current market conditions, the scope of services and our overall pricing strategy and objectives when determining the standalone selling price.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principal vs Agent</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We occasionally use third parties to assist in satisfying our performance obligations. In order to determine whether we are the principal or agent in the arrangement, we review each third-party relationship on a contract by contract basis. We are an agent when our role is to arrange for another entity to provide the services to the customer. In these instances, we do not control the service before it is provided and recognize revenue on a net basis. We are the principal when we control the good or service prior to transferring control to the customer. We recognize revenue on a gross basis when we are the principal in the arrangement.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the requirements under ASU 2014-09, the impact of adoption to our consolidated financial statements was as follows. See Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> for additional disclosures regarding Evolent's contracts with customers.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:716px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:12px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:14px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(unaudited, in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts without</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption of</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Higher/(Lower)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(326</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,094</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue (exclusive of depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">presented separately below)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,442</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,566</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,676</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(110</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes and non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,378</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts without</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption of</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Higher/(Lower)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,950</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,322</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339,485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,773</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue (exclusive of depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">presented separately below)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214,945</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218,786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,841</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172,495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,644</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,149</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes and non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,622</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42,063</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:715px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(unaudited, in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances without</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption of</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Higher/(Lower)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,054</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,848</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets (current)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets (noncurrent)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract cost assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and Shareholders' Equity (Deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,360</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,740</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,885</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,746</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shareholders' Equity (Deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings (accumulated deficit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,580</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,361</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adoption of ASU 2016-18, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows: Restricted Cash</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted ASU 2016-18, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows: Restricted Cash,</font><font style="font-family:inherit;font-size:10pt;"> effective December 31, 2017, using the retroactive transition method, which resulted in the recast of our statement of cash flows for each period presented. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">See &#8220;Part II - Item 8. Financial Statements and Supplementary Data - Note 2&#8221; in our</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Form 10-K for further information about the adoption.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amendments in the ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A significant portion of the Company&#8217;s restricted cash consists of cash held on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed. Under the previous standard, there was no net impact to the statement of cash flows related to these amounts as the changes in accounts payable and accounts receivable were offset by the change in restricted cash. Upon adoption of ASU 2016-18, the change in restricted cash held on behalf of partners for claims processing would no longer net to zero, thereby potentially having a significant impact on cash flows from operations period over period. Given the pass-through nature of these claim payments, the change in restricted cash held on behalf of partners for claims processing is presented within cash flows from financing activities on our statements of changes in cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the impact of the change in accounting principle to the Company&#8217;s Consolidated Statements of Cash Flows for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:586px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:293px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine Months Ended September 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flows from Investing Activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases and maturities of restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,200</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,200</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in restricted cash and restricted investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash and restricted cash provided by</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(used in) investing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flows from Financing Activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in restricted cash held on behalf of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">partners for claims processing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash and restricted cash provided by</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(used in) financing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,570</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net increase (decrease) in cash and cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,580</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,684</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents and</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restricted cash as of beginning-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,563</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,466</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170,029</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents and</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restricted cash as of end-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,782</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295,925</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The pro forma adjustments are based on available information and assumptions that the Company believes are reasonable to reflect the impact of these transactions on the Company&#8217;s historical financial information on a pro forma basis (in thousands, except per share data).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:703px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,555</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,320</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,651</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(65,113</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Evolent Health, Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,429</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,907</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,971</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56,699</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per Common Share available to common shareholders</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.93</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Transactions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">New Mexico Health Connections</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">January&#160;2, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company, through its wholly-owned subsidiary, True Health, completed its previously announced&#160;acquisition of assets related to NMHC&#8217;s commercial, small and large group business. The assets include a health plan management services organization with a leadership team and employee base with experience working locally with providers to run NMHC&#8217;s suite of preventive, disease and care management programs. The consideration paid by the Company in connection with the acquisition consisted of </font><font style="font-family:inherit;font-size:10pt;">$10.3 million</font><font style="font-family:inherit;font-size:10pt;"> in cash (subject to certain adjustments), of which </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> was deposited in an escrow account. This acquisition is expected to allow the Company to leverage its platform to support a value-based, provider-centric model of care in New Mexico. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company commenced operations of the commercial health plan and began reporting the results of True Health as a new reportable segment during the first quarter of 2018. See Note </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;"> for further information about the Company&#8217;s segment reporting. At the time of the acquisition, the Company also entered into a managed services agreement (&#8220;MSA&#8221;) with NMHC to support its ongoing business. During the fourth quarter of 2017, the Company also entered into a reinsurance agreement with NMHC to provide balance sheet support. See Note </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of the reinsurance agreement. The MSA and reinsurance agreement were considered separate transactions and accounted for outside of the business combination. Therefore, there is no allocation of purchase price to these agreements at fair value.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company incurred approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> in transaction costs related to the NHMC transaction, materially all of which were recorded within &#8220;Selling, general and administrative expenses&#8221; on our Consolidated Statements of Operations for the year ended December 31, 2017. The&#160;transaction&#160;was accounted for as a business combination using purchase accounting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of </font><font style="font-family:inherit;font-size:10pt;">January&#160;2, 2018</font><font style="font-family:inherit;font-size:10pt;">, as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:479px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid to NMHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid to escrow agent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Identifiable intangible assets acquired and liabilities assumed</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Above market lease</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and employee benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(474</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,826</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets associated with customer relationships and provider network contracts will be amortized on a straight-line basis over their estimated useful lives of&#160;</font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#160;years, respectively. The customer relationships represent existing contracts in place to provide health plan services to a number of large and small group customers throughout the state of New Mexico. The provider network contracts represent a network of hospitals and physicians to service the health plan customers. The fair value of the customer relationship intangible asset was primarily determined using the income approach. The income approach estimates fair value for an asset based on the present value of cash flows projected to be generated by the asset. Projected cash flows are discounted at a required rate of return that reflects the relative risk of achieving the cash flows and the time value of money. The fair value of the provider network intangible asset was primarily determined using the cost approach. The cost approach estimates the fair value for an asset based on the amount it would cost to replace the asset. Goodwill is calculated as the difference between the acquisition date fair value of the total consideration and the fair value of the net assets acquired, and represents the future economic benefits that we expect to achieve as a result of the acquisition. Goodwill associated with the acquisition of True Health is allocated entirely to the True Health segment. The goodwill is attributable primarily to the acquired workforce and expected cost synergies, none of which qualify for recognition as a separate intangible asset. Goodwill is considered an indefinite-lived asset. The transaction is an asset acquisition for tax purposes, and as such the tax-basis in the acquired assets is equal to the book-basis fair value calculated and is recorded at the True Health legal entity. Therefore, no opening balance sheet deferred tax liability was recorded.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts above reflect management&#8217;s preliminary estimate of the fair value of the tangible and intangible assets acquired and liabilities assumed based on a valuation performed using currently available information. Any remaining adjustments are expected to be finalized within one year of the acquisition date.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">True Health is a separate segment, and its results of operations are provided in Note </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;"> - Segment Reporting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Pro Forma Financial Information (Unaudited)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited pro forma Consolidated Statements of Operations presented below gives effect to the NMHC transaction as if it took place on January 1, 2017. The following pro forma information includes adjustments to:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reclassify transaction costs related to the NMHC transaction to the period beginning January 1, 2017;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">record revenue and expenses related to the MSA beginning January 1, 2017; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">record amortization expenses related to intangible assets beginning January 1, 2017, for intangible assets acquired as part of the NMHC transaction.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This pro forma data is presented for informational purposes only and does not purport to be indicative of the results of future operations or of the results that would have occurred had the transactions described above occurred in the specified prior periods. The pro forma adjustments are based on available information and assumptions that the Company believes are reasonable to reflect the impact of these transactions on the Company&#8217;s historical financial information on a pro forma basis (in thousands, except per share data).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:703px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,555</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,320</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,651</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(65,113</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Evolent Health, Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,429</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,907</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,971</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56,699</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per Common Share available to common shareholders</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.93</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities Offerings and Sales</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under an exchange agreement we entered into at the time of our IPO, we granted TPG, The Advisory Board Company (&#8220;The Advisory Board&#8221;) and Ptolemy Capital, LLC (&#8220;Ptolemy Capital&#8221;) (together, the &#8220;Investor Stockholders&#8221;) an exchange right that allows receipt of newly-issued shares of the Company&#8217;s Class A common stock in exchange (a &#8220;Class B Exchange&#8221;) for an equal number of shares of the Company&#8217;s Class B common stock (which are subsequently canceled) and an equal number of Evolent Health LLC&#8217;s Class B common units (&#8220;Class B units&#8221;). Class B units received by the Company from relevant Investor Stockholders are simultaneously exchanged for an equivalent number of Class A units of Evolent Health LLC, and Evolent Health LLC cancels the Class B units it receives in the Class B Exchange. The cancellation of the Class B units results in an increase in the Company&#8217;s economic interest in Evolent Health LLC.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">March and June 2018 Private Sales</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In March 2018, The Advisory Board sold </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">3.0 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> shares of the Company&#8217;s Class A common Stock in a private sale (the &#8220;March 2018 Private Sale&#8221;). The shares sold in the March 2018 Private Sale consisted of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">1.2 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> existing shares of the Company&#8217;s Class A common stock owned by The Advisory Board and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">1.8 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> newly-issued shares of the Company&#8217;s Class A common stock received by The Advisory Board pursuant to a Class B Exchange for all of its outstanding shares of the Company&#8217;s Class B common stock and Class B units. The Company did not receive any proceeds from the March 2018 Private Sale. Subsequent to this Class B Exchange, in June 2018, The Advisory Board sold all of their remaining shares of the Company&#8217;s Class A common stock and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">no</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> longer owns any shares of our Class A common stock.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of this Class B Exchange and Evolent Health LLC&#8217;s cancellation of the Class B units during the March 2018 Private Sale, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">96.6%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">98.9%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the March 2018 Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">August 2017 Primary Offering</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the Company completed a primary offering of </font><font style="font-family:inherit;font-size:10pt;">8.8 million</font><font style="font-family:inherit;font-size:10pt;"> shares of its Class A common stock at a price to the public of </font><font style="font-family:inherit;font-size:10pt;">$19.85</font><font style="font-family:inherit;font-size:10pt;"> per share and a corresponding price to the underwriters of </font><font style="font-family:inherit;font-size:10pt;">$19.01</font><font style="font-family:inherit;font-size:10pt;"> per share (the &#8220;August 2017 Primary&#8221;). This offering resulted in net cash proceeds to the Company of approximately </font><font style="font-family:inherit;font-size:10pt;">$166.9 million</font><font style="font-family:inherit;font-size:10pt;"> (gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$175.0 million</font><font style="font-family:inherit;font-size:10pt;">, net of </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;"> in underwriting discounts and stock issuance costs). For each share of Class A common stock issued by Evolent Health, Inc., the Company received a corresponding Class A common unit from Evolent Health LLC in exchange for contributing the issuance proceeds to Evolent Health LLC. As a result of the Class A common stock and Class A common units issued during the August 2017 Primary, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">96.1%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">96.6%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the August 2017 Primary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Secondary Offerings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Investor Stockholders initiated several Class B Exchanges as part of various secondary offerings during 2017, thus increasing the Company&#8217;s economic interest in Evolent Health LLC, as discussed below. The Company did not receive any proceeds from the secondary offerings described below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">June 2017 Secondary Offering</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2017, the Company completed a secondary offering of </font><font style="font-family:inherit;font-size:10pt;">4.5 million</font><font style="font-family:inherit;font-size:10pt;"> shares of its Class A common stock at a price to the underwriters of </font><font style="font-family:inherit;font-size:10pt;">$25.87</font><font style="font-family:inherit;font-size:10pt;"> per share (the &#8220;June 2017 Secondary&#8221;). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares sold in the June 2017 Secondary consisted of </font><font style="font-family:inherit;font-size:10pt;">0.7 million</font><font style="font-family:inherit;font-size:10pt;"> existing shares of the Company&#8217;s Class A common stock owned and held by certain Investor Stockholders and </font><font style="font-family:inherit;font-size:10pt;">3.8 million</font><font style="font-family:inherit;font-size:10pt;"> newly-issued shares of the Company&#8217;s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of these Class B Exchanges and Evolent Health LLC&#8217;s cancellation of the Class B units during the June 2017 Secondary, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">90.5%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">96.1%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the June 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">May 2017 Secondary Offering</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the Company completed a secondary offering of </font><font style="font-family:inherit;font-size:10pt;">7.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of its Class A common stock at a price to the underwriters of </font><font style="font-family:inherit;font-size:10pt;">$24.30</font><font style="font-family:inherit;font-size:10pt;"> per share (the &#8220;May 2017 Secondary&#8221;). The shares were sold by the Investor Stockholders and certain management selling stockholders (together with the Investor Stockholders, the &#8220;Selling Stockholders&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares sold in the May 2017 Secondary consisted of </font><font style="font-family:inherit;font-size:10pt;">3.1 million</font><font style="font-family:inherit;font-size:10pt;"> existing shares of the Company&#8217;s Class A common stock owned and held by the Selling Stockholders, </font><font style="font-family:inherit;font-size:10pt;">3.8 million</font><font style="font-family:inherit;font-size:10pt;"> newly-issued shares of the Company&#8217;s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges and </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares issued upon the exercise of options by certain management selling stockholders.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of these Class B Exchanges and Evolent Health LLC&#8217;s cancellation of the Class B units during the May 2017 Secondary, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">84.9%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">90.5%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the May 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">March 2017 Secondary Offering</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the Company completed a secondary offering of </font><font style="font-family:inherit;font-size:10pt;">7.5 million</font><font style="font-family:inherit;font-size:10pt;"> shares of its Class A common stock at a price to the underwriters of </font><font style="font-family:inherit;font-size:10pt;">$19.53</font><font style="font-family:inherit;font-size:10pt;"> per share (the &#8220;March 2017 Secondary&#8221;). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares sold in the March 2017 Secondary consisted of </font><font style="font-family:inherit;font-size:10pt;">3.1 million</font><font style="font-family:inherit;font-size:10pt;"> existing shares of the Company&#8217;s Class A common stock owned and held by the Investor Stockholders and </font><font style="font-family:inherit;font-size:10pt;">4.4 million</font><font style="font-family:inherit;font-size:10pt;"> newly-issued shares of the Company&#8217;s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of these Class B Exchanges and Evolent Health LLC&#8217;s cancellation of the Class B units during the March 2017 Secondary, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">77.4%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">83.9%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the March 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the March 2017 Secondary, the underwriters exercised, in full, their option to purchase an additional </font><font style="font-family:inherit;font-size:10pt;">1.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of Class A common stock (the &#8220;March 2017 Option to Purchase Additional Shares&#8221;) from the Investor Stockholders at a price of </font><font style="font-family:inherit;font-size:10pt;">$19.53</font><font style="font-family:inherit;font-size:10pt;"> per share. The March 2017 Option to Purchase Additional Shares closed in May 2017.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares sold in the March 2017 Option to Purchase Additional Shares consisted of </font><font style="font-family:inherit;font-size:10pt;">0.5 million</font><font style="font-family:inherit;font-size:10pt;"> existing shares of the Company&#8217;s Class A common stock owned and held by certain Investor Stockholders. It also included </font><font style="font-family:inherit;font-size:10pt;">0.6 million</font><font style="font-family:inherit;font-size:10pt;"> newly-issued shares of the Company&#8217;s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of the Class B Exchanges and Evolent Health LLC&#8217;s cancellation of the Class B units during the March 2017 Option to Purchase Additional Shares, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">83.9%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">84.9%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the March 2017 Option to Purchase Additional Shares, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The June 2017 Secondary, May 2017 Secondary, March 2017 Secondary and March 2017 Option to Purchase Additional Shares are collectively referred to as the &#8220;2017 Secondary Offerings.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s economic interest in Evolent Health LLC will increase if further Class B Exchanges occur.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Accordion Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">June&#160;8, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company entered into an agreement to acquire Accordion Health, Inc. (&#8220;Accordion&#8221;) for </font><font style="font-family:inherit;font-size:10pt;">$3.2 million</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Accordion Purchase Agreement&#8221;). Accordion provides technology that the Company believes enhances its risk-adjustment factor services to its partners. In addition to technology assets, the software development team from Accordion joined Evolent as full-time employees. Under the terms of the Accordion Purchase Agreement, members of the software development team will be eligible for an additional </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> earn-out, contingent upon the completion of specified software development targets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We accounted for the transaction as an asset acquisition as substantially all of the fair value of the gross assets acquired was concentrated in a single identified asset, thus satisfying the requirements of the screen test introduced in ASU 2017-01. The assets acquired in the transaction were measured based on the amount of cash paid to Accordion, including transaction costs, as the fair value of the assets given was more readily determinable than the fair value of the assets received. We classified and designated the identifiable assets acquired as a </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> technology intangible asset, inclusive of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of capitalized transaction costs. We also assessed and determined the useful life of the acquired intangible assets to be </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years, subject to amortization. The Company will account for the contingent earn-out as a post-acquisition expense as the specified software development targets are achieved. The transaction was a taxable stock acquisition and the Company recognized deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to the book-tax basis difference in the acquired asset, which resulted in a </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> increase in the value of the intangible asset. The additional deferred tax liability represents a future source of taxable income that enables the Company to release some of its previously established valuation allowance, the reduction of which is accounted for outside of acquisition accounting, resulting in income tax benefit.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Cash and Restricted Investments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Supplemental Cash Flow Information </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following represents supplemental disclosure of non-cash investing and financing information (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:572px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:426px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued property and equipment purchases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase to goodwill from measurement period adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">related to business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in accrued financing costs related to 2021 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration for asset acquisitions or business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of escrow related to asset acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,519</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of indemnification asset</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,004</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefit related to Accordion intangible technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,042</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Effects of Class B Exchanges</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in non-controlling interests as a result of Class B Exchanges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,883</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in deferred tax liability as a result of securities offerings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">908</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Tax Receivables Agreement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Offering Reorganization, the Company entered into the Tax Receivables Agreement (the &#8220;TRA&#8221;) with certain of its investors, which provides for the payment by the Company to these investors of </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the amount of the tax benefits, if any, that the Company is deemed to realize as a result of increases in our tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. These payment obligations are obligations of the Company. For purposes of the TRA, the benefit deemed realized by the Company will be computed by comparing its actual income tax liability to the amount of such taxes that the Company would have been required to pay had there been no increase to the tax basis of the assets of the Company as a result of the exchanges or had the Company had no NOL carryforward balance. The actual amount and timing of any payments under the TRA will vary depending upon a number of factors, including:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the timing of the exchanges and the price of the Class A shares at the time of the transaction, triggering a tax basis increase in the Company&#8217;s asset and a corresponding benefit to be realized under the TRA; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the amount and timing of our taxable income - the Company will be required to pay </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the tax savings as and when realized, if any. If the Company does not have taxable income, it will not be required to make payments under the TRA for that taxable year because no tax savings were actually realized.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to the items noted above, and the fact that the Company is in a full valuation allowance position such that the deferred tax assets related to the Company&#8217;s historical pre-IPO losses and tax basis increase benefit from exchanges have not been realized, the Company has not recorded a liability pursuant to the TRA.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Litigation Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are engaged from time to time in certain legal disputes arising in the ordinary course of business, including employment claims. When the likelihood of a loss contingency becomes probable and the amount of the loss can be reasonably estimated, we accrue a liability for the loss contingency. We continue to review accruals and adjust them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained, and our views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in our accrued liabilities would be recorded in the period in which such determination is made. The Company</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">is not aware of any legal proceedings or claims as</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, that the Company believes will have, individually or in the aggregate, a material adverse effect on the Company&#8217;s financial position or result of operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commitments to Equity-Method Investees</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has contractual arrangements with its equity-method investees that will require the Company to provide operating capital support in the form of equity financing of up to </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$2.6 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, in accordance with the Company&#8217;s contribution agreements with its equity-method investees. These obligations are outside of Company&#8217;s control and payment could be requested during 2018. The Company did </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">t have any contingent commitments to equity-method investees as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Letter of Credit</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company entered into an agreement to provide a letter of credit, for up to </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">, to assist a customer in demonstrating adequate reserves to the customer&#8217;s state regulatory authorities. The letter of credit is effective from September 30, 2017 through June 30, 2019, and carries a quarterly facility rental fee of </font><font style="font-family:inherit;font-size:10pt;">0.80%</font><font style="font-family:inherit;font-size:10pt;"> per annum on the amount of the outstanding balance. The letter of credit will terminate after June 30, 2019. The letter of credit is presented at the face amount plus accrued facility rental fee, less received payments. T</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">here was no outstanding balance related t</font><font style="font-family:inherit;font-size:10pt;">o this letter of credit as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lease Commitments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has entered into lease agreements for its primary office locations in Arlington, Virginia, Lisle, Illinois, Chicago, Illinois, Albuquerque, New Mexico and Pune, India. Certain leases acquired as part of the Valence Health transaction included existing sublease agreements for office locations in Chicago, Illinois. The Company also has several smaller leases in various locations within Texas and California. Total rental expense, net of sublease income, on operating leases was </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$10.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with various lease agreements, the Company is required to maintain </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> in letters of credit and, as such, held </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> in restricted cash and restricted investments as collateral for the letters of credit as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Indemnifications</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s customer agreements generally include a provision by which the Company agrees to defend its partners against third-party claims (a) for death, bodily injury, or damage to personal property caused by Company negligence or willful misconduct, (b) by former or current Company employees arising from such managed service agreements, (c) for intellectual property infringement under specified conditions and (d) for Company violation of applicable laws, and to indemnify them against any damages and costs awarded in connection with such claims. To date, the Company has not incurred any material costs as a result of such indemnities and has not accrued any liabilities related to such obligations in the accompanying consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Registration Rights Agreement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We entered into a registration rights agreement with The Advisory Board, the University of Pittsburgh Medical Center (&#8220;UPMC&#8221;), TPG and another investor to register for sale under the Securities Act of 1933, as amended, shares of our Class A common stock, including those delivered in exchange for Class B common stock and Class B common units. Subject to certain conditions and limitations, this agreement provides these investors with certain demand, piggyback and shelf registration rights. The registration rights granted under the registration rights agreement will terminate upon the date the holders of shares that are a party thereto no longer hold any such shares that are entitled to registration rights. Pursuant to our contractual obligations under this agreement, we filed a registration statement on Form S-3 with the SEC on July 28, 2016, which was declared effective on August 12, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Pursuant to certain terms of the registration rights agreement, certain Investor Stockholders sold</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">19.7 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">shares of the Company&#8217;s Class A common stock during the 2017 Secondary Offerings, as discussed in Note</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">4</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">. The Company incurred</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">in expenses related to the 2017 Secondary Offerings for the</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">three and nine</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">months ended</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, pursuant to the terms of the registration rights agreement. The expenses were recorded within &#8220;Selling, general and administrative expenses&#8221; on our Consolidated Statements of Operations. We did not incur any expenses related to secondary offerings or other sales of shares by our Investor Stockholders for the</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">months ended</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will continue to pay all expenses relating to any demand, piggyback or shelf registration, other than underwriting discounts and commissions and any transfer taxes, subject to specified conditions and limitations. The registration rights agreement includes customary indemnification provisions, including indemnification of the participating holders of shares of Class A common stock and their directors, officers and employees by us for any losses, claims, damages or liabilities in respect thereof and expenses to which such holders may become subject under the Securities Act of 1933, as amended, state law or otherwise.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Guarantees</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of our strategy to support certain of our partners in the Next Generation Accountable Care Program, we entered into upside&#160;and&#160;downside risk sharing arrangements. Our downside risk-sharing arrangements are limited to our&#160;fees&#160;and&#160;are executed through our wholly-owned captive insurance company. To satisfy the capital requirements of our insurance entity as well as&#160;state insurance regulators,&#160;Evolent entered into letters of credit of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$22.0 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, to secure potential losses related to insurance services. This amount is in excess of our actuarial assessment of loss.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reinsurance Agreement</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2017, the Company entered into a </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">-month, </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> capital-only reinsurance agreement with NMHC, expiring on December 31, 2018. The purpose of the capital-only reinsurance is to provide balance sheet support to NMHC. There is no uncertainty to the outcome of the agreement as there is no transfer of underwriting risk to Evolent or True Health, and neither Evolent nor True Health is at risk for any cash payments on behalf of NMHC. As a result, this agreement does not qualify for reinsurance accounting. The Company will record a quarterly fee of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> as non-operating income on its consolidated statements of operations and will maintain </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> in restricted cash and restricted investments on its consolidated balance sheets for the duration of the reinsurance agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">UPMC Reseller Agreement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and UPMC are parties to a reseller, services and non-competition agreement, dated August 31, 2011, which was amended and restated by the parties on June 27, 2013 (as amended through the date hereof, the &#8220;UPMC Reseller Agreement&#8221;). Under the terms of the UPMC Reseller Agreement, UPMC has appointed the Company as a non-exclusive reseller of certain services, subject to certain conditions and limitations specified in the UPMC Reseller Agreement. In consideration for the Company&#8217;s obligations under the UPMC Reseller Agreement and subject to certain conditions described therein, UPMC has agreed not to sell certain products and services directly to a defined list of 20 of the Company&#8217;s customers.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Credit and Concentration Risk</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to significant concentrations of credit risk related to cash and cash equivalents and accounts receivable. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">72.3%</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">of our</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$266.8 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">of cash and cash equivalents (including restricted cash) were held in bank deposits with FDIC participating banks, approximately</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">27.4%</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">were held in money market funds and less than</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">1.0%</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">were held in international banks.</font><font style="font-family:inherit;font-size:10pt;"> While the Company maintains its cash and cash equivalents with financial institutions with high credit ratings, it often maintains these deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any realized losses on cash and cash equivalents to date.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is also subject to significant concentration of accounts receivable risk as a substantial portion of our trade accounts receivable is derived from a small number of our partners. The following table summarizes those partners who represented at least </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> of our trade accounts receivable for the periods presented:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:7pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:346px;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer B</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer C</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer D</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">* Represents less than 10.0% of the respective balance </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company is subject to significant concentration of revenue risk as a substantial portion of our revenue is derived from a small number of contractual relationships with our operating partners.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes those partners who represented at least </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> of our revenue for the periods presented:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:474px;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">* Represents less than 10.0% of the respective balance</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of Evolent Health, Inc. and its subsidiaries. All inter-company accounts and transactions are eliminated in consolidation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">January 1,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term receivables </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,131</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term receivables </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term contract assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,710</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term contract assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term deferred revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">493</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Excludes pharmacy claims receivable and premiums receivable</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the carrying value of the long-term debt (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,606</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal amount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remaining amortization period (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-term Debt</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2016, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$125.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due </font><font style="font-family:inherit;font-size:10pt;">2021</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;2021 Notes&#8221;) in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2021 Notes were issued at par for net proceeds of </font><font style="font-family:inherit;font-size:10pt;">$120.4 million</font><font style="font-family:inherit;font-size:10pt;">. We incurred </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;"> of debt issuance costs in connection with the 2021 Notes, which we are amortizing to non-cash interest expense using the straight line method over the contractual term of the 2021 Notes, since this method was not materially different from the effective interest method. The closing of the private placement of the 2021 Notes occurred on </font><font style="font-family:inherit;font-size:10pt;">December&#160;5, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the 2021 Notes are entitled to cash interest payments, which are payable semiannually in arrears on </font><font style="font-family:inherit;font-size:10pt;">June 1</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 1</font><font style="font-family:inherit;font-size:10pt;"> of each year, beginning on </font><font style="font-family:inherit;font-size:10pt;">June&#160;1, 2017</font><font style="font-family:inherit;font-size:10pt;">, at a rate equal to </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> per annum. The 2021 Notes will mature on </font><font style="font-family:inherit;font-size:10pt;">December&#160;1, 2021</font><font style="font-family:inherit;font-size:10pt;">, unless earlier repurchased or converted in accordance with their terms prior to such date. In addition, holders of the 2021 Notes may require the Company to repurchase their 2021 Notes upon the occurrence of a fundamental change at a price equal to </font><font style="font-family:inherit;font-size:10pt;">100.00%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2021 Notes being repurchased, plus any accrued and unpaid interest. Upon maturity, and at the option of the holders of the 2021 Notes, the principal amount of the notes may be settled via shares of the Company&#8217;s Class A common stock. For the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded approximately </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in interest expense and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in non-cash interest expense related to the amortization of deferred financing costs.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2021 Notes are convertible into shares of the Company&#8217;s Class A common stock, based on an initial conversion rate of </font><font style="font-family:inherit;font-size:10pt;">41.6082</font><font style="font-family:inherit;font-size:10pt;"> shares of Class A common stock per </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of the 2021 Notes, which is equivalent to an initial conversion price of approximately </font><font style="font-family:inherit;font-size:10pt;">$24.03</font><font style="font-family:inherit;font-size:10pt;"> per share of the Company&#8217;s Class A common stock. In the aggregate, the 2021 Notes are initially convertible into </font><font style="font-family:inherit;font-size:10pt;">5.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s Class A common stock (excluding any shares issuable by the Company upon a conversion in connection with a make-whole provision upon a fundamental change under the indenture between Evolent Health, Inc. and U.S. Bank National Association, as trustee, related to the </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> convertible senior notes due 2021, dated as of December 5, 2016).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2021 Notes are convertible, in multiples of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount, at the option of the holders at any time prior to the close of business on the business day immediately preceding the maturity date. Upon conversion, we will deliver for each </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of notes converted a number of shares of our Class A common stock equal to the applicable conversion rate (together with a cash payment in lieu of delivering any fractional share) on the third business day following the relevant conversion date.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Senior Notes Carrying Value</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While the 2021 Notes are recorded on our accompanying unaudited interim consolidated balance sheets at their net carrying value of </font><font style="font-family:inherit;font-size:10pt;">$122.1 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the 2021 Notes are privately traded by qualified institutional buyers (within the meaning of Rule 144A under the Securities Act of 1933, as amended) and their fair value was </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$169.1 million</font><font style="font-family:inherit;font-size:10pt;">, based on a traded price on September 28</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, 2018,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">a Level 2 input. The fair value as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;">$120.4 million</font><font style="font-family:inherit;font-size:10pt;">, based on a traded price on </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">December 29, 2017, a Leve</font><font style="font-family:inherit;font-size:10pt;">l 2 input. The 2021 Notes also have embedded conversion options and contingent interest provisions, which have not been recorded as separate financial instruments.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the carrying value of the long-term debt (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,606</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal amount</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remaining amortization period (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents Evolent&#8217;s Services segment revenue disaggregated by revenue type for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> (in thousands), excluding revenues from our True Health segment and from our downside risk sharing arrangements through our insurance subsidiary, which are accounted for under ASC 944, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Services-Insurance</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,950</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335,509</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-based Compensation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total compensation expense by award type and line item in our consolidated financial statements was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Award Type</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,452</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Performance-based stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSUs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,795</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,304</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,385</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,047</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,708</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,560</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,172</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Line Item</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">376</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,130</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">administrative expenses</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,047</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,708</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,560</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,172</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">No</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> stock-based compensation in the totals above was capitalized as software development costs for the </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">three and nine</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> months ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based awards were granted as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">857</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">461</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total compensation expense by award type and line item in our consolidated financial statements was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Award Type</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,009</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,452</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Performance-based stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSUs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,795</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,304</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,385</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,047</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,708</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,560</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,172</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Line Item</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">376</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,130</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">administrative expenses</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,047</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,708</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,560</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,172</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (Loss) Per Common Share</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(55,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(541</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) available for common shareholders </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1) (2)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,429</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,588</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,971</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average common shares outstanding </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(2) (3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,328</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (Loss) per Common Share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.18</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.78</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For periods of net loss, net income (loss) available for common shareholders is the same for both basic and diluted purposes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For periods of net loss, shares used in the earnings (loss) per common share calculation represent basic shares as using diluted shares would be anti-dilutive.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchangeable Class B common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units ("RSUs")</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">577</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">923</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">557</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options and performance-based stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,698</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,976</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible senior notes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,862</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,408</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,861</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,635</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments In and Advances to Equity Method Investees</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has entered into joint venture agreements with various entities. As of&#160;</font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s economic and voting interests in these entities ranged between </font><font style="font-family:inherit;font-size:10pt;">4%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s economic interests in these entities ranged between </font><font style="font-family:inherit;font-size:10pt;">26%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> and voting interests ranged between </font><font style="font-family:inherit;font-size:10pt;">27%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;">. The Company determined that it has significant influence over these entities but that it does not have control over any of the entities. Accordingly, the investments are accounted for under the equity method of accounting and the Company is allocated its proportional share of the entities&#8217; earnings and losses for each reporting period. The Company&#8217;s proportional share of the losses from these investments was approximately </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company signed services agreements with certain of the aforementioned entities to provide certain management, operational and support services to help manage elements of their service offerings. Revenues related to these services agreements was </font><font style="font-family:inherit;font-size:10pt;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.9 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value (in thousands), valuation techniques and significant unobservable inputs of our Level 3 fair value measurements as of the periods presented:</font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:714px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:133px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:226px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:20px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assumption or</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unobservable Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Input Ranges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real options approach</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-adjusted recurring revenue CAGR</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate/time value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8% - 4.5%</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Related to additional Passport earn-out consideration</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">as described above.</font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> The risk-adjusted recurring revenue CAGR is calculated over the </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">five</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">78.6%</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:714px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:133px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:226px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:20px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assumption or</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unobservable Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Input Ranges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real options approach</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-adjusted recurring revenue CAGR</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate/time value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7% - 4.0%</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Related to additional Passport earn-out consideration as described above. </font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The risk-adjusted recurring revenue CAGR is calculated over the</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year period 2017-2021. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, resulting in a higher growth rate. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The risk-adjusted recurring revenue CAGR over the period 2019-2021 is</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">19.2%</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cash and cash equivalents </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restricted cash and restricted investments </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,028</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,028</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Contingent consideration </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cash and cash equivalents </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restricted cash and restricted investments </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,575</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Contingent consideration </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;"> Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as presented in the tables above.</font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (&#8220;Passport&#8221;) acquisition as described below.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurement</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) assuming an orderly transaction in the most advantageous market at the measurement date. GAAP also establishes a hierarchical disclosure framework which prioritizes and ranks the level of observability of inputs used in measuring fair value. These tiers include:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 - inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 - inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date and the fair value can be determined through the use of models or other valuation methodologies; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 - inputs to the valuation methodology are unobservable inputs in situations where there is little or no market activity for the asset or liability.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the particular asset or liability being measured. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recurring Fair Value Measurements</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with GAAP, certain assets and liabilities are required to be recorded at fair value on a recurring basis. The following table summarizes the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cash and cash equivalents </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restricted cash and restricted investments </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,028</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,028</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Contingent consideration </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cash and cash equivalents </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restricted cash and restricted investments </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,575</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Contingent consideration </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;"> Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as presented in the tables above.</font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (&#8220;Passport&#8221;) acquisition as described below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes any transfers between levels within the hierarchy as of the beginning of the reporting period. There were no transfers between fair value levels for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the absence of observable market prices, the fair value is based on the best information available and involves a significant degree of judgment, taking into consideration a combination of internal and external factors, including the appropriate risk adjustments for non-performance and liquidity risks.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The strategic alliance with Passport includes a provision for additional equity consideration contingent upon the Company obtaining new third-party Medicaid business in future periods. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The contingent consideration of</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">$8.3 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">is a mark-to-market liability recorded within &#8220;Other long-term liabilities&#8221; on our Consolidated Balance Sheets as of</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, and</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">. We recorded a re-measurement loss of approximately</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">for the</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">three</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">months ended</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, and a re-measurement gain of approximately</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and re-measurement losses of approximately</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, based on changes in the underlying assumptions of the fair value calculation. T</font><font style="font-family:inherit;font-size:10pt;">he fair value of the contingent equity consideration was estimated based on the real options approach, a form of the income approach, which estimated the probability of the Company achieving future revenues under the agreement. The significant unobservable inputs used in the fair value measurement of the Passport contingent consideration are the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year risk-adjusted recurring revenue compound annual growth rate (&#8220;CAGR&#8221;) and the applicable discount rate. A significant increase in the assumed </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year risk-adjusted recurring revenue CAGR projection or decrease in discount rate in isolation would result in a significantly higher fair value of the contingent consideration.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in our contingent consideration, measured at fair value, for which the Company uses Level 3 inputs to determine fair value are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of beginning-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Realized and unrealized (gains) losses, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of end-of-period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value (in thousands), valuation techniques and significant unobservable inputs of our Level 3 fair value measurements as of the periods presented:</font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:714px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:133px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:226px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:20px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assumption or</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unobservable Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Input Ranges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real options approach</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-adjusted recurring revenue CAGR</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate/time value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8% - 4.5%</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Related to additional Passport earn-out consideration</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;">as described above.</font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> The risk-adjusted recurring revenue CAGR is calculated over the </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">five</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">78.6%</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:714px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:133px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:226px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:82px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:20px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assumption or</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unobservable Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Input Ranges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real options approach</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-adjusted recurring revenue CAGR</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate/time value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7% - 4.0%</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Related to additional Passport earn-out consideration as described above. </font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The risk-adjusted recurring revenue CAGR is calculated over the</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year period 2017-2021. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, resulting in a higher growth rate. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The risk-adjusted recurring revenue CAGR over the period 2019-2021 is</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">19.2%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonrecurring Fair Value Measurements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets and liabilities at fair value on a nonrecurring basis as required by GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. This includes goodwill, intangible assets, property, plant and equipment, held-to-maturity investments and equity method investments. While not carried at fair value on a recurring basis, these items are continually monitored for indicators of impairment that would indicate current carrying value is greater than fair value. In those situations, the assets are considered impaired and written down to current fair value. See Notes </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of assets measured at fair value on a nonrecurring basis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Other Fair Value Disclosures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amounts of cash and cash equivalents (those not held in a money market fund), restricted cash, receivables, prepaid expenses, accounts payable, accrued liabilities and accrued compensation approximate their fair values because of the relatively short-term maturities of these items and financial instruments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;"> for information regarding the fair value of the 2021 Notes.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cash and cash equivalents </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restricted cash and restricted investments </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,028</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,028</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,214</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Contingent consideration </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cash and cash equivalents </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restricted cash and restricted investments </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,575</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Contingent consideration </font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;"> Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as presented in the tables above.</font></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (&#8220;Passport&#8221;) acquisition as described below.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in our contingent consideration, measured at fair value, for which the Company uses Level 3 inputs to determine fair value are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:543px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of beginning-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Realized and unrealized (gains) losses, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of end-of-period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonrecurring Fair Value Measurements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets and liabilities at fair value on a nonrecurring basis as required by GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. This includes goodwill, intangible assets, property, plant and equipment, held-to-maturity investments and equity method investments. While not carried at fair value on a recurring basis, these items are continually monitored for indicators of impairment that would indicate current carrying value is greater than fair value. In those situations, the assets are considered impaired and written down to current fair value. See Notes </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of assets measured at fair value on a nonrecurring basis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Other Fair Value Disclosures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amounts of cash and cash equivalents (those not held in a money market fund), restricted cash, receivables, prepaid expenses, accounts payable, accrued liabilities and accrued compensation approximate their fair values because of the relatively short-term maturities of these items and financial instruments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;"> for information regarding the fair value of the 2021 Notes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company established an international subsidiary during the first quarter of 2018. The functional currency of our international subsidiary is the Indian Rupee. We translate the financial statements of this subsidiary to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenue, costs, and expenses. Translation gains and losses are recorded in accumulated other comprehensive income (loss) as a component of shareholders' equity. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill and Intangible Assets, Net</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Goodwill</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill has an estimated indefinite life and is not amortized; rather, it is reviewed for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reporting units: Services and True Health. Our annual goodwill impairment review occurs during the fourth quarter of each fiscal year. In interim periods between annual goodwill reviews, we also evaluate qualitative factors that could cause us to believe the estimated fair value of each of our reporting units may be lower than the carrying value and trigger a quantitative assessment, including, but not limited to (i) macroeconomic conditions, (ii) industry and market considerations, (iii) our overall financial performance, including an analysis of our current and projected cash flows, revenues and earnings, (iv) a sustained decrease in share price and (v) other relevant entity-specific events including changes in strategy, partners, or litigation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We did not identify any qualitative factors that would trigger a quantitative goodwill impairment test during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. We will perform our annual impairment test as of October 31, </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the changes in the carrying amount of goodwill, by reportable segment, for the periods presented (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:540px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of beginning-of-period </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill Acquired </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,826</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,060</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Measurement period adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of end-of-period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">629,262</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,826</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">635,088</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Net of cumulative inception to date impairment of </font><font style="font-family:inherit;font-size:10pt;">$160.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Goodwill acquired, measurement period adjustments and foreign currency translation are all related to transactions completed during the first quarter of 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:340px;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of beginning-of-period </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">626,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Measurement period adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,617</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of end-of-period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> All of the goodwill was allocated to the Services segment as of December 31, 2017, as the True Health segment was not established until the first quarter of 2018.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Net of cumulative inception to date impairment of </font><font style="font-family:inherit;font-size:10pt;">$160.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents measurement period adjustments related to Valence Health and Aldera. See </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#8220;Part II - Item 8. Financial Statements and Supplementary Data - Note 4&#8221; in our</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Form 10-K for further information regarding the Valence Health and Aldera transactions.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible Assets, Net</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Details of our intangible assets (in thousands) are presented below:</font></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:551px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Life</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,834</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,719</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,169</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below market lease, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,179</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,955</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,049</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,243</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,806</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> The increase in the gross carrying amount of the customer relationships intangible is attributable to </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;"> of acquired customer relationships from the NMHC transaction and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> related the Vestica Healthcare LLC (&#8220;Vestica&#8221;) transaction. The Company acquired certain assets from Vestica in March 2016. The transaction included additional consideration of up to </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, which was being held in escrow and was recorded within &#8220;Prepaid expenses and other noncurrent assets&#8221; on our Consolidated Balance Sheets. In February 2018, the Company and Vestica reached an agreement to settle </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> in escrow. Based on the terms of the settlement agreement, the Company reclassified the unamortized portion of the additional consideration from &#8220;Prepaid expenses and other noncurrent assets&#8221; into &#8220;Customer relationships&#8221; as of the settlement date. See Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> for further information about the NMHC transaction and see &#8220;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Part II - Item 8. Financial Statements and Supplementary Data - Note 4</font><font style="font-family:inherit;font-size:10pt;">&#8221; of our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K for further information about the Vestica transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:551px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Life</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,312</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185,188</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,810</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below market lease, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,662</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,499</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,238</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense related to intangible assets was </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$5.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the assets&#8217; carrying value. We did not identify any circumstances during </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, that would require an impairment test for our intangible assets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize the excess of the purchase price, plus the fair value of any non-controlling interests in the acquiree, over the fair value of identifiable net assets acquired as goodwill. Goodwill is not amortized, but is reviewed at least annually for indications of impairment, with consideration given to financial performance and other relevant factors. We perform impairment tests of goodwill at a reporting unit level, which is consistent with the way management evaluates our business. Goodwill is assigned to the reporting unit that benefits from the synergies arising from each business combination.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible Assets, Net</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identified intangible assets are recorded at their estimated fair values at the date of acquisition and are amortized over their respective estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are used. The Company acquired additional intangible assets in conjunction with a strategic acquisition made during 2018. Information regarding the determination and allocation of the fair value of the acquired assets and liabilities is further described within Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes the estimated useful lives by asset classification:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:466px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15-25 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the asset&#8217;s carrying value. The Company evaluates recoverability by determining whether the undiscounted cash flows expected to result from the use and eventual disposition of that asset or group exceed the carrying value at the evaluation date. If the undiscounted cash flows are not sufficient to cover the carrying value, the Company measures an impairment loss as the excess of the carrying amount of the long-lived asset or group over its fair value. See Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion regarding our intangible assets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For interim periods, we recognize an income tax provision (benefit) based on our estimated annual effective tax rate expected for the full year.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> in income tax expense for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, which resulted in effective tax rates of </font><font style="font-family:inherit;font-size:10pt;">(0.9)%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">(0.1)%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The Company recorded </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> in income tax benefit for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, which resulted in effective tax rates of </font><font style="font-family:inherit;font-size:10pt;">11.6%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">3.5%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The income tax benefit recorded during the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, primarily relates to the change in indefinite-lived components and components expected to reverse outside of the net operating loss carryover period as part of the outside basis difference in our partnership interest in Evolent Health LLC. With the exception of these components, the Company continues to record a valuation allowance against the net deferred tax assets. As a result of the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;) enacted on </font><font style="font-family:inherit;font-size:10pt;">December&#160;22, 2017</font><font style="font-family:inherit;font-size:10pt;">, and subsequent state jurisdictions conforming to certain provisions of the Tax Act with respect to the indefinite carryforward period and </font><font style="font-family:inherit;font-size:10pt;">80%</font><font style="font-family:inherit;font-size:10pt;"> taxable income limitation on NOLs arising after December&#160;31, 2017, these components of the deferred tax liabilities are comprised of the entire nonconforming state indefinite-lived components and those outside of the NOL carryforward period and a portion of our federal and conforming states components that could not be used as a source of income. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had recorded a provisional estimate of the financial statement impact of the Tax Act in accordance with SEC Staff Accounting Bulletin No. 118. During the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the change in the initial provisional estimates</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">is immaterial. The C</font><font style="font-family:inherit;font-size:10pt;">ompany will continue to evaluate any further adjustments necessary through 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As a result of the increase in our ownership of Evolent Health LLC following the March 2018 Private Sale discussed in Note </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">4</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> above, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by approximately </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> for the </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">nine</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> months ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">. The effect of this change in the deferred tax liability was recorded as additional paid-in capital.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As a result of the increase in our ownership of Evolent Health LLC following the August 2017 Primary and 2017 Secondary Offerings discussed in Note</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">4</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">above, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">for the</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">nine</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">months ended</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">The effect of this change in the deferred tax liability was recorded as&#160;</font><font style="font-family:inherit;font-size:10pt;">$12.8 million</font><font style="font-family:inherit;font-size:10pt;">&#160;of additional paid-in capital and&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#160;of income tax benefit.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had unrecognized tax benefits of </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> that, if recognized, would not affect the effective tax rate. As of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has released all unrecognized tax benefits due to the filing of a federal income tax automatic accounting method change application. The Company is not currently subject to income tax audits in any U.S., state, or foreign jurisdictions for any tax year.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Tax Receivables Agreement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Offering Reorganization, the Company entered into the TRA with certain of its investors, which provides for the payment by the Company to these investors of </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the amount of the tax benefits, if any, that the Company is deemed to realize as a result of increases in our tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. See Note </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;"> above and &#8220;Part II - Item 8. Financial Statements and Supplementary Data - Note 12&#8221; in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K for discussion of our TRA.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> True Health Claims Reserves</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims reserves for the True Health segment reflect estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process), and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses actuarial principles and assumptions that are consistently applied each reporting period and recognizes the actuarial best estimate of the ultimate liability along with a margin for adverse deviation. This approach is consistent with actuarial standards of practice that the liabilities be adequate under moderately adverse conditions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This liability predominately consists of incurred but not reported amounts and reported claims in process including expected development on reported claims. The liability is primarily calculated using "completion factors" developed by comparing the claim incurred date to the date claims were paid. Completion factors are impacted by several key items including changes in: 1)&#160;electronic (auto-adjudication) versus manual claim processing, 2)&#160;provider claims submission rates, 3)&#160;membership and 4)&#160;the mix of products. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s policy is to use historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. The Company estimates the liability for claims incurred in each month by applying the current estimates of completion factors to the current paid claims data. This approach implicitly assumes that historical completion rates will be a useful indicator for the current period notwithstanding that we did not own NMHC&#8217;s commercial business prior to January 2, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For more recent months, the Company expects to rely more heavily on medical cost trend analysis that reflects expected claim payment patterns and other relevant operational considerations. Medical cost trend is primarily impacted by medical service utilization and unit costs that are affected by changes in the level and mix of medical benefits offered, including inpatient, outpatient and pharmacy, the impact of copays and deductibles, changes in provider practices and changes in consumer demographics and consumption behavior.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For each reporting period, the Company compares key assumptions used to establish the claims reserves to actual experience. When actual experience differs from these assumptions, claims reserves are adjusted through current period shareholders' net income. Additionally, the Company evaluates expected future developments and emerging trends that may impact key assumptions. The process used to determine this liability requires the Company to make critical accounting estimates that involve considerable judgment, reflecting the variability inherent in forecasting future claim payments. These estimates are highly sensitive to changes in the Company's key assumptions, specifically completion factors and medical cost trends.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity in claims reserves was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:519px;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:426px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incurred costs related to current period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,169</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Paid costs related to current period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,831</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change during the period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ending balance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,338</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-controlling Interests</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Immediately following the Offering Reorganization and IPO (as described in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K), the Company owned </font><font style="font-family:inherit;font-size:10pt;">70.3%</font><font style="font-family:inherit;font-size:10pt;"> of Evolent Health LLC. The Company&#8217;s ownership percentage changes with the issuance of Class A common stock and Class B Exchanges. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company completed the 2017 Secondary Offerings during 2017. The shares sold in the 2017 Secondary Offerings consisted of </font><font style="font-family:inherit;font-size:10pt;">20.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s Class A common stock, consisting of </font><font style="font-family:inherit;font-size:10pt;">7.4 million</font><font style="font-family:inherit;font-size:10pt;"> existing shares of the Company&#8217;s Class A common stock owned and held by certain Selling Stockholders, </font><font style="font-family:inherit;font-size:10pt;">12.6 million</font><font style="font-family:inherit;font-size:10pt;"> newly-issued shares of the Company&#8217;s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges and </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares issued upon the exercise of options by certain management selling stockholders. As a result of these Class B Exchanges and Evolent Health LLC&#8217;s cancellation of its Class B common units during the 2017 Secondary Offerings, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">77.4%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">96.1%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the June 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company issued </font><font style="font-family:inherit;font-size:10pt;">8.8 million</font><font style="font-family:inherit;font-size:10pt;"> shares of its Class A Common Stock during the August 2017 Primary for net proceeds of </font><font style="font-family:inherit;font-size:10pt;">$166.9 million</font><font style="font-family:inherit;font-size:10pt;">. For each share of Class A common stock issued by Evolent Health, Inc., the Company received a corresponding Class A common unit from Evolent Health LLC in exchange for contributing the issuance proceeds to Evolent Health LLC. As a result of the Class A common stock and Class A common units issued in conjunction with the August 2017 Primary, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">96.1%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">96.6%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the August 2017 Primary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company completed the March 2018 Private Sale during March&#160;2018. The shares sold in the March 2018 Private Sale consisted of </font><font style="font-family:inherit;font-size:10pt;">1.2 million</font><font style="font-family:inherit;font-size:10pt;"> existing shares of the Company&#8217;s Class A common stock owned and held by The Advisory Board and </font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;"> newly-issued shares of the Company&#8217;s Class A common stock received by The Advisory Board pursuant to a Class B Exchange.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of this Class B Exchange and Evolent Health LLC&#8217;s cancellation of the Class B units during the March 2018 Private Sale, the Company&#8217;s economic interest in Evolent Health LLC increased from </font><font style="font-family:inherit;font-size:10pt;">96.6%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">98.9%</font><font style="font-family:inherit;font-size:10pt;"> immediately following the March 2018 Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders&#8217; equity attributable to Evolent Health, Inc.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we owned </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">99.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">96.6%</font><font style="font-family:inherit;font-size:10pt;"> of the economic interests in Evolent Health LLC, respectively. See Note </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">4</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">for further discussion of the March 2018 Private Sale, August 2017 Primary and 2017 Secondary Offerings.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in non-controlling interests (in thousands) for the periods presented were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:703px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-controlling interests as of beginning-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,427</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">209,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative-effect adjustment from adoption of new accounting principle</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">594</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in non-controlling interests as a result of Class B Exchanges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(168,883</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification of non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,793</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(541</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(680</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,471</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-controlling interests as of end-of-period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adoption of New Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2018-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;">. The update expands the scope of ASC Topic 718, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation </font><font style="font-family:inherit;font-size:10pt;">(&#8220;ASC 718&#8221;), to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU specifies that ASC 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards. The amendments in the update also clarify that ASC 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606. The update is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity&#8217;s adoption date of ASC 606. We adopted the requirements of this standard effective July 1, 2018, and there was no impact to our financial condition and results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Going forward, we do not expect the adoption to have a material impact on our financial condition or results of operations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, in order to clarify the principles of recognizing revenue. This standard establishes the core principle of recognizing revenue to depict the transfer of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB defines a five-step process that systematically identifies the various components of the revenue recognition process, culminating with the recognition of revenue upon satisfaction of an entity&#8217;s performance obligations. By completing all five steps of the process, the core principles of revenue recognition will be achieved. The new revenue standard (including updates) is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. The guidance permits two methods of adoption: i) the full retrospective method applying the standard to each prior reporting period presented, or ii) the modified retrospective method with a cumulative effect of initially applying the guidance recognized at the date of initial application. The standard also allows entities to apply certain practical expedients at their discretion. The Company adopted the standard effective January 1, 2018, using the modified retrospective method for only contracts that were not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC Topic 605, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 605&#8221;). The adoption of this standard resulted in changes related to revenue recognition for contracts that contain certain features, such as variable consideration. These changes generally accelerate revenue recognition. In addition, certain customer setup costs, which have historically been expensed as incurred, will now be capitalized. Evolent recognized the cumulative effect of applying the new revenue standard as a </font><font style="font-family:inherit;font-size:10pt;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;"> adjustment to the opening balance of retained earnings, including non-controlling interests, in the first quarter of 2018, primarily as a result of capitalization of expenses related to contract acquisition and fulfillment costs and acceleration of revenue due to variable consideration estimation. See Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> for additional disclosures regarding Evolent's contracts with customers. See Note </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> for updated revenue recognition accounting policy and the impact of adopting the new revenue recognition standard on Evolent&#8217;s financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Future Adoption of New Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other-Internal Use Software: Customers Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Services Contract</font><font style="font-family:inherit;font-size:10pt;">. The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The amendments in this update should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We are currently evaluating the impact of adoption on our financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">. With respect to assets measured at amortized cost, such as held-to-maturity assets, the update requires presentation of the amortized cost net of a credit loss allowance. The update eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity&#8217;s current estimate of all future expected credit losses as opposed to the previous standard, when an entity only considered past events and current conditions. With respect to available for sale debt securities, the update requires that credit losses be presented as an allowance rather than as a write-down. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We intend to adopt the requirements of this standard effective January 1, 2020, and are currently evaluating the impact of the adoption on our financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight&#8209;line basis over the term of the lease, respectively. A lessee is also required to record a right&#8209;of&#8209;use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU 2016-02 (ASC Topic 842) supersedes the previous leases standard, ASC 840, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">. The ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has formulated an implementation team that is currently engaged in the evaluation process. We intend to adopt the requirements of this standard effective January 1, 2019, using a modified retrospective approach. We expect to take advantage of the package of practical expedients permitted within the new standard. In July 2018, the FASB issued ASU 2018-11, which is intended to make targeted improvements to ASU 2016-02. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The requirements of ASU 2018-11 are effective on the same date as the requirements of ASU 2016-02. Pursuant to ASU 2018-11, the Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements and recognize a cumulative-effect adjustment to the opening balance of retaining earnings. We anticipate that this standard will result in a material increase in the assets and liabilities on our consolidated balance sheets; however, we do not believe adoption will have a material impact on our results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adoption of New Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2018-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;">. The update expands the scope of ASC Topic 718, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation </font><font style="font-family:inherit;font-size:10pt;">(&#8220;ASC 718&#8221;), to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU specifies that ASC 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards. The amendments in the update also clarify that ASC 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606. The update is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity&#8217;s adoption date of ASC 606. We adopted the requirements of this standard effective July 1, 2018, and there was no impact to our financial condition and results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Going forward, we do not expect the adoption to have a material impact on our financial condition or results of operations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, in order to clarify the principles of recognizing revenue. This standard establishes the core principle of recognizing revenue to depict the transfer of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB defines a five-step process that systematically identifies the various components of the revenue recognition process, culminating with the recognition of revenue upon satisfaction of an entity&#8217;s performance obligations. By completing all five steps of the process, the core principles of revenue recognition will be achieved. The new revenue standard (including updates) is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. The guidance permits two methods of adoption: i) the full retrospective method applying the standard to each prior reporting period presented, or ii) the modified retrospective method with a cumulative effect of initially applying the guidance recognized at the date of initial application. The standard also allows entities to apply certain practical expedients at their discretion. The Company adopted the standard effective January 1, 2018, using the modified retrospective method for only contracts that were not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC Topic 605, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 605&#8221;). The adoption of this standard resulted in changes related to revenue recognition for contracts that contain certain features, such as variable consideration. These changes generally accelerate revenue recognition. In addition, certain customer setup costs, which have historically been expensed as incurred, will now be capitalized. Evolent recognized the cumulative effect of applying the new revenue standard as a </font><font style="font-family:inherit;font-size:10pt;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;"> adjustment to the opening balance of retained earnings, including non-controlling interests, in the first quarter of 2018, primarily as a result of capitalization of expenses related to contract acquisition and fulfillment costs and acceleration of revenue due to variable consideration estimation. See Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> for additional disclosures regarding Evolent's contracts with customers. See Note </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> for updated revenue recognition accounting policy and the impact of adopting the new revenue recognition standard on Evolent&#8217;s financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Future Adoption of New Accounting Standards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other-Internal Use Software: Customers Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Services Contract</font><font style="font-family:inherit;font-size:10pt;">. The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The amendments in this update should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We are currently evaluating the impact of adoption on our financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">. With respect to assets measured at amortized cost, such as held-to-maturity assets, the update requires presentation of the amortized cost net of a credit loss allowance. The update eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity&#8217;s current estimate of all future expected credit losses as opposed to the previous standard, when an entity only considered past events and current conditions. With respect to available for sale debt securities, the update requires that credit losses be presented as an allowance rather than as a write-down. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We intend to adopt the requirements of this standard effective January 1, 2020, and are currently evaluating the impact of the adoption on our financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight&#8209;line basis over the term of the lease, respectively. A lessee is also required to record a right&#8209;of&#8209;use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU 2016-02 (ASC Topic 842) supersedes the previous leases standard, ASC 840, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">. The ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has formulated an implementation team that is currently engaged in the evaluation process. We intend to adopt the requirements of this standard effective January 1, 2019, using a modified retrospective approach. We expect to take advantage of the package of practical expedients permitted within the new standard. In July 2018, the FASB issued ASU 2018-11, which is intended to make targeted improvements to ASU 2016-02. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The requirements of ASU 2018-11 are effective on the same date as the requirements of ASU 2016-02. Pursuant to ASU 2018-11, the Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements and recognize a cumulative-effect adjustment to the opening balance of retaining earnings. We anticipate that this standard will result in a material increase in the assets and liabilities on our consolidated balance sheets; however, we do not believe adoption will have a material impact on our results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evolent Health, Inc. was incorporated in December 2014 in the state of Delaware, and is a managed services firm that supports leading health systems and physician organizations in their migration toward value-based care and population health management. The Company operates through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> segments. The Company&#8217;s services segment (&#8220;Services&#8221;) provides our customers, who we refer to as partners, with a population management platform, integrated data and analytics capabilities, claims processing services, including pharmacy benefit management, and comprehensive health plan administration services. Together these services enable health systems to manage patient health in a more cost-effective manner. The Company&#8217;s contracts are structured as a combination of advisory fees, monthly member service fees, percentage of plan premiums and shared medical savings arrangements. The Company&#8217;s wholly-owned subsidiary, True Health New Mexico, Inc. (&#8220;True Health&#8221;) operates as a separate segment and is a commercial health plan we operate in New Mexico that focuses on small and large businesses. The Company&#8217;s headquarters is located in Arlington, Virginia.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our predecessor, Evolent Health Holdings, Inc. (&#8220;Evolent Health Holdings&#8221;), merged with and into Evolent Health, Inc. in connection with the offering reorganization which occurred on June 4, 2015 (the &#8220;Offering Reorganization&#8221;), as discussed in our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to our initial public offering (&#8220;IPO&#8221;) in June 2015 and the Offering Reorganization we undertook in connection therewith, Evolent Health Holdings did not control Evolent Health LLC, our operating subsidiary company due to certain participating rights granted to our investor, TPG Global, LLC and certain of its affiliates (&#8220;TPG&#8221;). However, Evolent Health Holdings was able to exert significant influence on Evolent Health LLC and, accordingly, accounted for its investment in Evolent Health LLC using the equity method of accounting through June 3, 2015. Subsequent to the Offering Reorganization, the financial results of Evolent Health LLC have been consolidated in the financial statements of Evolent Health, Inc. Following the Offering Reorganization, the IPO, various securities offerings and sales (as described in Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">) and acquisitions (as described in Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">), as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, Evolent Health, Inc. owned </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">99.0%</font><font style="font-family:inherit;font-size:10pt;"> of Evolent Health LLC, holds </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the voting rights, is the sole managing member and, therefore, controls its operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since its inception, the Company has incurred losses from operations. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had cash and cash equivalents of </font><font style="font-family:inherit;font-size:10pt;">$221.8 million</font><font style="font-family:inherit;font-size:10pt;">. The Company believes it has sufficient liquidity for the next 12 months as of the date the financial statements were available to be issued.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property and Equipment, Net</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes our property and equipment (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:504px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,448</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal-use software development costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,638</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,265</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,458</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,692</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,922</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalized </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$25.1 million</font><font style="font-family:inherit;font-size:10pt;"> of internal-use software development costs for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$8.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$20.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. The net book value of capitalized internal-use software development costs was </font><font style="font-family:inherit;font-size:10pt;">$58.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$42.1 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense related to property and equipment was </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$11.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, of which amortization expense related to capitalized internal-use software development costs was </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Depreciation expense related to property and equipment was </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, of which amortization expense related to capitalized internal-use software development costs was </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes our property and equipment (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:504px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,448</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal-use software development costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,638</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,265</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,458</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,692</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,922</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents our reconciliation of segments total Adjusted EBITDA to net income (loss) attributable to Evolent Health, Inc. (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:636px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Net Income (Loss) Attributable to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Evolent Health, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,429</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,588</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,971</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47,506</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Less:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">968</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,781</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">(Provision) benefit for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,009</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Depreciation and amortization expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,717</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29,882</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Income (loss) from equity method investees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,381</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(369</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,446</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Change in fair value of contingent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">consideration and indemnification asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(124</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Net (income) loss attributable to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">541</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">ASC 606 transition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Purchase accounting adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Stock-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,047</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,708</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,560</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,172</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Severance costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Amortization of contract cost assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(658</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,797</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Transaction costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(456</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,972</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,797</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,595</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present our segment information (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:673px;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intersegment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eliminations</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,845</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,308</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131,075</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,537</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127,538</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">True Health:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premiums</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,829</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(206</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,623</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131,075</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150,161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(214</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(214</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,861</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,743</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,947</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,157</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,157</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,065</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The True Health segment was created in January 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:673px;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intersegment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eliminations</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,697</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,949</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,748</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,949</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">370,353</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">True Health:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premiums</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,353</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(602</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,751</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,353</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439,104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC 606 transition adjustment </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(647</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">376,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,353</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,551</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433,959</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321,221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321,221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">921</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,595</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The True Health segment was created in January 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustment to Adjusted Transformation Services Revenue was approximately </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> and the adjustment to Adjusted Platform and Operations Services Revenue was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Related Parties</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The entities described below are considered related parties and the balances and/or transactions with them are reported in our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As discussed in Note&#160;</font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the Company has economic interests in several entities that are accounted for under the equity method of accounting. The Company has allocated its proportional share of the investees&#8217; earnings and losses each reporting period. In addition, Evolent has entered into services agreements with certain of the entities to provide certain management, operational and support services to help the entities manage elements of their service offerings.</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">Revenues related to these services agreements was </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$5.9 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also works closely with UPMC, one of its founding investors. The Company&#8217;s relationship with UPMC is a subcontractor relationship where UPMC has agreed to execute certain tasks (primarily TPA services) relating to certain customer commitments. We also conduct business with a company in which UPMC holds a significant equity interest.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, prior to the Offering Reorganization, we issued shares of our stock to certain of our partners while concurrently entering into revenue contracts with those partners. Those partners are considered related parties and the balances and/or transactions with them were reported on our consolidated financial statements for the periods in which they held a significant equity interest in Evolent Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents revenues and expenses attributable to our related parties (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:696px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:393px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,072</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue (exclusive of depreciation and amortization expenses)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,390</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">514</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. See &#8220;Changes in Accounting Principles&#8221; below for our updated revenue recognition policy as a result of our adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our True Health segment derives revenue from premiums that are earned over the terms of the related insurance policies. The portion of premiums that will be earned in the future or are received prior to the effectiveness of the policy are deferred and reported as premiums received in advance. These amounts are generally classified as short-term deferred revenue on our Consolidated Balance Sheets.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. Revenue is recognized when control of the services is transferred to our customers. We use the following 5-Step model, outlined in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 606&#8221;), to determine revenue recognition on our contracts with customers:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Identify the contract(s) with a customer</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Identify the performance obligations in the contract</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Determine the transaction price</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Allocate the transaction price to performance obligations</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Recognize revenue when (or as) the entity satisfies a performance obligation</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Transformation Services Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services consist of strategic assessments, or Blueprint contracts, and implementation services whereby we assist the customer in launching its population health or health plan strategy. In certain cases, transformation services can also include revenue associated with our support of certain one-time wind-down activities for clients who are exiting a line of business or population. The transformation services are usually completed within 12 months. We generally receive a fixed fee for transformation services and recognize revenue over time using an input method based on hours incurred compared to the total estimated hours required to satisfy our performance obligation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Platform and Operations Services Revenue</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services generally include multi-year arrangements with customers to provide various population health, health plan operations and claims processing services on an ongoing basis, as well as transition or run-out services to customers receiving primarily third-party administration (&#8220;TPA&#8221;) services. Our performance obligation in these arrangements is to provide an integrated suite of services, including access to our platform that is customized to meet the specialized needs of our customers. Generally we will apply the series guidance to the performance obligation as we have determined that each time increment is distinct. We primarily utilize a variable fee structure for these services that typically include a monthly payment that is calculated based on a specified per member per month rate, multiplied by the number of members that our partners are managing under a value-based care arrangement or a percentage of plan premiums. Our arrangements may also include other variable fees related to service level agreements, shared medical savings arrangements and other performance measures. Variable consideration is estimated using the most likely amount based on our historical experience and best judgment at the time. Due to the nature of our arrangements certain estimates may be constrained if it is probable that a significant reversal of revenue will occur when the uncertainty is resolved. We recognize revenue for platform and operations services over time using the time elapsed output method. Fixed consideration is recognized ratably over the contract term. In accordance with the series guidance, we allocate variable consideration to the period to which the fees relate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts with Multiple Performance Obligations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our contracts with customers may contain multiple performance obligations, primarily when the customer has requested both transformation services and platform and operations services as these services are distinct from one another. When a contract has multiple performance obligations, we allocate the transaction price to each performance obligation based on the relative standalone selling price using the expected cost margin approach. This approach requires estimates regarding both the level of effort it will take to satisfy the performance obligation as well as fees that will be received under the variable pricing model. We also take into consideration customer demographics, current market conditions, the scope of services and our overall pricing strategy and objectives when determining the standalone selling price.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principal vs Agent</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We occasionally use third parties to assist in satisfying our performance obligations. In order to determine whether we are the principal or agent in the arrangement, we review each third-party relationship on a contract by contract basis. We are an agent when our role is to arrange for another entity to provide the services to the customer. In these instances, we do not control the service before it is provided and recognize revenue on a net basis. We are the principal when we control the good or service prior to transferring control to the customer. We recognize revenue on a gross basis when we are the principal in the arrangement.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">, we adopted ASU 2014-09, effective January 1, 2018, which introduces ASC 606. See Note </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> for the updated revenue recognition policy and the impact of adopting the new revenue recognition standard on the Company&#8217;s financial statements. The following are other relevant disclosures as required by the adoption of ASU 2014-09. Provisions within ASC 606 are only applicable to revenues derived from our Services segment.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Disaggregation of Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents Evolent&#8217;s Services segment revenue disaggregated by revenue type for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> (in thousands), excluding revenues from our True Health segment and from our downside risk sharing arrangements through our insurance subsidiary, which are accounted for under ASC 944, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Services-Insurance</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,950</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335,509</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Transaction Price Allocated to the Remaining Performance Obligations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For contracts with a term that is greater than one year, we have allocated approximately </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$125.0 million</font><font style="font-family:inherit;font-size:10pt;"> of transaction price to performance obligations that are unsatisfied or partially unsatisfied as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. We do not include variable consideration that is allocated entirely to a wholly unsatisfied performance obligation accounted for under the series guidance in the calculation. As a result, the balance represents the value of the fixed consideration in our long-term contracts that will be recognized as revenue in a future period and excludes the majority of our platform and operations revenue, which is primarily derived based on variable consideration as discussed in Note </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">. We expect to recognize revenue on approximately </font><font style="font-family:inherit;font-size:10pt;">60%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">84%</font><font style="font-family:inherit;font-size:10pt;"> of these remaining performance obligations by December 31, 2019, and December 31, 2020, respectively, with the remaining balance to be recognized thereafter. However, because our existing contracts may be canceled or renegotiated including for reasons outside our control, the amount of this revenue that we actually receive may be less than this estimate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract balances consist of accounts receivable, contract assets and deferred revenue. Contract assets are recorded when the right to consideration for services is conditional on something other than the passage of time. Contract assets relating to unbilled receivables are transferred to accounts receivable when the right to consideration becomes unconditional. We classify contract assets as current or noncurrent based on the timing of our rights to the unconditional payments. Our contract assets are generally classified as current and recorded within &#8220;Contract assets&#8221; on our consolidated balance sheets. Our current accounts receivable are classified within &#8220;Accounts receivable, net&#8221; on our consolidated balance sheets and our noncurrent accounts receivable are classified within &#8220;Prepaid expenses and other noncurrent assets&#8221; on our consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue includes advance customer payments and billings in excess of revenue recognized. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue. Our current deferred revenue is recorded within &#8220;Deferred revenue&#8221; on our consolidated balance sheets, and noncurrent deferred revenue is recorded within &#8220;Other long-term liabilities&#8221; on our consolidated balance sheets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">January 1,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term receivables </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,131</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term receivables </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term contract assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,710</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term contract assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term deferred revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">493</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Excludes pharmacy claims receivable and premiums receivable</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, our contract asset balance decreased by </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, primarily as the right to the consideration became unconditional and the associated balance is reclassified to accounts receivable. During the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, our deferred revenue decreased by </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">, primarily as a result of the recognition of variable consideration estimate.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amount of revenue recognized during the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, from amounts included in deferred revenue at the beginning of the period was </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$17.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The amount of revenue recognized during the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> from performance obligations satisfied (or partially satisfied) in previous periods, due primarily to net gain share as well as other estimates, was </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$9.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$11.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract Costs</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain bonuses and commissions earned by our sales team are considered incremental costs of obtaining a contract with a customer that we expect to be recoverable. The capitalized contract acquisition costs are classified as noncurrent assets and recorded within &#8220;Contract cost assets&#8221; on our consolidated balance sheets. Amortization expense is recorded within &#8220;Selling, general and administrative expenses&#8221; on the accompanying consolidated statements of operations. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> of contract acquisition cost assets, net of accumulated amortization, and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">amortiza</font><font style="font-family:inherit;font-size:10pt;">tion expense of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our platforms and operations arrangements, we incur certain costs related to the implementation of our platform before we begin to satisfy our performance obligation to the customer. The costs, which we expect to recover, are considered costs to fulfill a contract. Our contract fulfillment costs primarily include our employee labor costs and third-party vendor costs. The capitalized contract fulfillment costs are classified as noncurrent and recorded within &#8220;Contract cost assets&#8221; on our consolidated balance sheets. Amortization expense is recorded within &#8220;Cost of revenue&#8221; on the accompanying consolidated statements of operations. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$12.3 million</font><font style="font-family:inherit;font-size:10pt;"> of contract fulfillment cost assets, net of accumulated amortization, and amortization expense of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the contract cost balance was recorded as part of the transition adjustment that was recorded upon implementation of ASC 606. These costs are deferred and then amortized on a straight-line basis over a period of benefit that we have determined to be </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years. The period of benefit was based on our technology, the nature of our customer arrangements and other factors.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchangeable Class B common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,251</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,846</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units ("RSUs")</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">577</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">923</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">557</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options and performance-based stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,698</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,976</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible senior notes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,862</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,408</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,861</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,635</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following represents supplemental disclosure of non-cash investing and financing information (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:572px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:426px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued property and equipment purchases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase to goodwill from measurement period adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">related to business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in accrued financing costs related to 2021 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consideration for asset acquisitions or business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of escrow related to asset acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,519</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of indemnification asset</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,004</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefit related to Accordion intangible technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,042</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Effects of Class B Exchanges</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in non-controlling interests as a result of Class B Exchanges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,883</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in deferred tax liability as a result of securities offerings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">908</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based awards were granted as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">857</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">461</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:650px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:346px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(55,977</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(541</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) available for common shareholders </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1) (2)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,429</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,588</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,971</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average common shares outstanding </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(2) (3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,328</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (Loss) per Common Share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.18</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.47</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.78</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For periods of net loss, net income (loss) available for common shareholders is the same for both basic and diluted purposes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For periods of net loss, shares used in the earnings (loss) per common share calculation represent basic shares as using diluted shares would be anti-dilutive.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes the estimated useful lives by asset classification:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:466px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15-25 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Details of our intangible assets (in thousands) are presented below:</font></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:551px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Life</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,834</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,719</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,169</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below market lease, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,179</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,955</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,049</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,243</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,806</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> The increase in the gross carrying amount of the customer relationships intangible is attributable to </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;"> of acquired customer relationships from the NMHC transaction and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> related the Vestica Healthcare LLC (&#8220;Vestica&#8221;) transaction. The Company acquired certain assets from Vestica in March 2016. The transaction included additional consideration of up to </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, which was being held in escrow and was recorded within &#8220;Prepaid expenses and other noncurrent assets&#8221; on our Consolidated Balance Sheets. In February 2018, the Company and Vestica reached an agreement to settle </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> in escrow. Based on the terms of the settlement agreement, the Company reclassified the unamortized portion of the additional consideration from &#8220;Prepaid expenses and other noncurrent assets&#8221; into &#8220;Customer relationships&#8221; as of the settlement date. See Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> for further information about the NMHC transaction and see &#8220;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Part II - Item 8. Financial Statements and Supplementary Data - Note 4</font><font style="font-family:inherit;font-size:10pt;">&#8221; of our </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K for further information about the Vestica transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:551px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Life</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate trade name</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,312</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185,188</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,810</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below market lease, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,662</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,499</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,238</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the changes in the carrying amount of goodwill, by reportable segment, for the periods presented (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:540px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of beginning-of-period </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill Acquired </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,826</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,060</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Measurement period adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of end-of-period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">629,262</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,826</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">635,088</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Net of cumulative inception to date impairment of </font><font style="font-family:inherit;font-size:10pt;">$160.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Goodwill acquired, measurement period adjustments and foreign currency translation are all related to transactions completed during the first quarter of 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:340px;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of beginning-of-period </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">626,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Measurement period adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,617</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of end-of-period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> All of the goodwill was allocated to the Services segment as of December 31, 2017, as the True Health segment was not established until the first quarter of 2018.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Net of cumulative inception to date impairment of </font><font style="font-family:inherit;font-size:10pt;">$160.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents measurement period adjustments related to Valence Health and Aldera. See </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#8220;Part II - Item 8. Financial Statements and Supplementary Data - Note 4&#8221; in our</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Form 10-K for further information regarding the Valence Health and Aldera transactions.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity in claims reserves was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:519px;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:426px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incurred costs related to current period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,169</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Paid costs related to current period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,831</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change during the period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ending balance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,338</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the requirements under ASU 2014-09, the impact of adoption to our consolidated financial statements was as follows. See Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> for additional disclosures regarding Evolent's contracts with customers.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:716px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:12px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:14px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statements of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(unaudited, in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts without</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption of</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Higher/(Lower)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(326</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,094</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue (exclusive of depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">presented separately below)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,442</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,566</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,676</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(110</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes and non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,378</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts without</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption of</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Higher/(Lower)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,950</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,322</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339,485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,773</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue (exclusive of depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">presented separately below)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214,945</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218,786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,841</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172,495</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,644</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,149</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes and non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,622</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42,063</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:715px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(unaudited, in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances without</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption of</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASC 606</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Higher/(Lower)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,054</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,848</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets (current)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract assets (noncurrent)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract cost assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and Shareholders' Equity (Deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,360</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,740</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,885</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,746</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shareholders' Equity (Deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings (accumulated deficit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,696</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,580</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,361</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the impact of the change in accounting principle to the Company&#8217;s Consolidated Statements of Cash Flows for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:586px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:293px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:72px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine Months Ended September 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flows from Investing Activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases and maturities of restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,200</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,200</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in restricted cash and restricted investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash and restricted cash provided by</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(used in) investing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Flows from Financing Activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in restricted cash held on behalf of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">partners for claims processing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash and restricted cash provided by</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(used in) financing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,570</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net increase (decrease) in cash and cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,580</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,684</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents and</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restricted cash as of beginning-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,563</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,466</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170,029</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents and</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restricted cash as of end-of-period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,782</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295,925</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of </font><font style="font-family:inherit;font-size:10pt;">January&#160;2, 2018</font><font style="font-family:inherit;font-size:10pt;">, as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:479px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:400px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid to NMHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid to escrow agent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Identifiable intangible assets acquired and liabilities assumed</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider network contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Above market lease</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and employee benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(474</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,826</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents revenues and expenses attributable to our related parties (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:696px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:393px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transformation services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform and operations services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,072</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue (exclusive of depreciation and amortization expenses)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,390</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">514</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:</font></div><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:424px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collateral for letters of credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">for facility leases </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,812</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collateral with financial institutions </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Claims processing services </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,942</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,286</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collateral for reinsurance agreement </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,042</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">862</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,722</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,685</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,328</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and restricted investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,328</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,398</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent restricted investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">605</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent restricted cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total noncurrent restricted cash</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and restricted investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,394</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,287</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of our lease commitments.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Represents collateral held with financial institutions for risk-sharing arrangements. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$22.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$16.6 million</font><font style="font-family:inherit;font-size:10pt;"> of the collateral amount was in a trust account and invested in a money market fund. The amounts invested in money market funds are considered restricted cash and are carried at fair value, which approximates cost. See Note </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> for further discussion of our fair value measurement. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$8.2 million</font><font style="font-family:inherit;font-size:10pt;"> of the collateral amount was invested in restricted certificates of deposit with remaining maturities of less than 12 months. The restricted investments are classified as held-to-maturity and stated at amortized cost. Fair value of the certificates of deposit is determined using Level 2 inputs and approximates amortized cost as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">See Note</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">9</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">for further discussion of our risk-sharing arrangements.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents cash held by Evolent on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.</font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents restricted cash required as part of our capital only reinsurance agreement to provide balance sheet support to NMHC. There is no transfer of underwriting risk to Evolent and we are not at risk for any cash payments on behalf of NMHC as part of the agreement. The reinsurance agreement is further discussed in Note </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the full </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> amount was invested in a money market fund. The amount invested in the money market fund is considered restricted cash and is carried at fair value, which approximates cost. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the full </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> amount was held in a FDIC participating bank account.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statements of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:675px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:66px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287,143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,722</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,932</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,416</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted investments included in</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restricted cash and restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(712</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,150</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,755</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,950</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash and cash equivalents and restricted cash</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">shown in the consolidated statements of cash flows</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295,925</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295,363</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170,029</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes those partners who represented at least </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> of our revenue for the periods presented:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:474px;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">* Represents less than 10.0% of the respective balance</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes those partners who represented at least </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> of our trade accounts receivable for the periods presented:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:7pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:346px;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:160px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:55px;" rowspan="1" colspan="1"></td><td style="width:11px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer B</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer C</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer D</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">* Represents less than 10.0% of the respective balance</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Reporting</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We define our reportable segments based on the way the chief operating decision maker (&#8220;CODM&#8221;), currently the Chief Executive Officer, manages the operations for purposes of allocating resources and assessing performance. We classify our operations into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services, which consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">True Health, which consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ordinary course of business, our reportable segments enter into transactions with one another. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues and expenses recognized by the segment that is the counterparty to the transaction are eliminated in consolidation and do not affect consolidated results.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The CODM uses Adjusted Revenue and Adjusted EBITDA as the relevant segment performance measures to evaluate the performance of the segments and allocate resources. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue and Adjusted EBITDA are segment performance financial measures that offer a useful view of the overall operation of our businesses and may be different than similarly-titled segment performance financial measures used by other companies. Adjusted Revenue is defined as the sum of Adjusted Services Revenue and True Health premiums revenue less intersegment eliminations. Adjusted Services Revenue is defined as Services revenue adjusted to exclude the impact of purchase accounting adjustments. Adjusted Services Revenue consists of Adjusted Transformation Services Revenue and Adjusted Platform and Operations Services Revenue, which are defined as transformation services revenue and platform and operations services revenue, respectively, before the effect of intersegment eliminations and adjusted to exclude the impact of purchase accounting adjustments. The company&#8217;s Adjusted Services Revenue for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, includes a </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> adjustment related to revenue that was contracted for prior to 2018 and that was properly excluded from revenue in our 2017 results under the revenue recognition rules then in effect under ASC 605.&#160;On January 1, 2018, we adopted the new revenue recognition rules under ASC 606 using the modified retrospective method, which required us to include this </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> as part of the cumulative transition adjustment to beginning retained earnings as of January 1, 2018. Under ASC 605, and based on proportionate performance revenue recognition, we would have recognized an additional </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> in revenue during 2018, primarily within our Adjusted Transformation Services Revenue. The Company has therefore included this revenue, and related profit, in its adjusted results for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, as they had not been previously reported prior to 2018 and the contracts are expected to be completed within 2018.&#160;This is a one-time adjustment and it will not reoccur in future periods.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA is the sum of Services Adjusted EBITDA and True Health Adjusted EBITDA and is defined as EBITDA (net income (loss) attributable to Evolent Health, Inc. before interest income, interest expense, (provision) benefit for income taxes, depreciation and amortization expenses), adjusted to exclude changes in fair value of contingent consideration and indemnification assets, income (loss) from equity method investees, other income (expense), net, net (income) loss attributable to non-controlling interests, purchase accounting adjustments, stock-based compensation expenses, severance costs, amortization of contract cost assets recorded as a result of a one-time ASC 606 transition adjustment, transaction costs related to acquisitions and business combinations and other one-time adjustments (which for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, includes the ASC 606 transition adjustment described above). When Adjusted EBITDA is discussed in this report, the most directly comparable GAAP financial measure is net income (loss) attributable to Evolent Health, Inc. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management considers Adjusted Revenue and Adjusted EBITDA to be the appropriate metrics to evaluate and compare the ongoing operating performance of our segments on a consistent basis across reporting periods as they eliminate the effect of items which are not indicative of each segment's core operating performance. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present our segment information (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:673px;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intersegment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eliminations</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,845</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,308</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131,075</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,537</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127,538</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">True Health:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premiums</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,829</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(206</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,623</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131,075</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150,161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(214</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(214</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,861</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,743</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,947</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,157</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,157</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,361</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,065</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The True Health segment was created in January 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:673px;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intersegment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eliminations</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,697</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,949</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,748</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381,302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,949</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">370,353</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">True Health:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premiums</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,353</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(602</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,751</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,353</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439,104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC 606 transition adjustment </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(647</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">376,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,353</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,551</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433,959</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Transformation Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Platform and Operations Services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Services Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322,445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321,221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321,221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">True Health </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">921</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,595</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The True Health segment was created in January 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustment to Adjusted Transformation Services Revenue was approximately </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> and the adjustment to Adjusted Platform and Operations Services Revenue was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents our reconciliation of segments total Adjusted EBITDA to net income (loss) attributable to Evolent Health, Inc. (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:636px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:320px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:13px;" rowspan="1" colspan="1"></td><td style="width:9px;" rowspan="1" colspan="1"></td><td style="width:52px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Net Income (Loss) Attributable to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Evolent Health, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,429</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,588</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,971</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47,506</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Less:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">968</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,781</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">(Provision) benefit for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,009</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Depreciation and amortization expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,717</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29,882</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Income (loss) from equity method investees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,381</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(369</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,446</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Change in fair value of contingent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">consideration and indemnification asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(124</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Net (income) loss attributable to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">non-controlling interests</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">541</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">ASC 606 transition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Purchase accounting adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(449</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Stock-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,047</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,708</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,560</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,172</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Severance costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Amortization of contract cost assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(658</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,797</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Transaction costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(456</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,972</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,797</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,595</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset information by segment is not a key measure of performance used by the CODM. Accordingly, we have not disclosed asset information by segment.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Segments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating segments are defined as components of a business that earn revenue and incur expenses for which discrete financial information is available that is evaluated, on a regular basis, by the chief operating decision maker (&#8220;CODM&#8221;) to decide how to allocate resources and assess performance. The Company operates through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> segments: (1) Services, and (2) True Health. Our Services segment consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services. Our True Health segment consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses. See Note </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;"> for a discussion of our operating results by segment.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisition of New Century Health</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">October&#160;1, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company completed its previously announced acquisition of New Century Health. The closing merger consideration, net of cash on hand and certain closing adjustments, was </font><font style="font-family:inherit;font-size:10pt;">$221.6 million</font><font style="font-family:inherit;font-size:10pt;">, based on the closing price of Evolent&#8217;s Class A common stock on the New York Stock Exchange on </font><font style="font-family:inherit;font-size:10pt;">October&#160;1, 2018</font><font style="font-family:inherit;font-size:10pt;">, and consisted of </font><font style="font-family:inherit;font-size:10pt;">3.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of Evolent Class B common stock, an equal number of Evolent Health LLC Class B units and </font><font style="font-family:inherit;font-size:10pt;">$117.2 million</font><font style="font-family:inherit;font-size:10pt;"> in cash. The shares issued at closing represent </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">3.8%</font><font style="font-family:inherit;font-size:10pt;"> of the Company&#8217;s issued and outstanding Class A common stock and Class B common stock after the transaction. The purchase price of </font><font style="font-family:inherit;font-size:10pt;">$221.6 million</font><font style="font-family:inherit;font-size:10pt;"> includes an earn-out potential of up to </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">, payable in cash and Evolent Class B common stock, subject to the satisfaction of certain conditions related to the operating results of New Century Health in 2019. Shares to be issued in relation to the earn-out are limited to </font><font style="font-family:inherit;font-size:10pt;">1.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of Evolent&#8217;s Class B common stock, with full payment expected to be made during the first quarter of 2020. The shares at closing were, and the shares for the earn-out, if any, will be issued in transactions exempt from registration under the Securities Act of 1933, as amended. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible debt issuance</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2018, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$172.5 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due 2025 (the &#8220;2025 Notes&#8221;) in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2025 Notes were issued at par for net proceeds, excluding expenses, of </font><font style="font-family:inherit;font-size:10pt;">$167.3 million</font><font style="font-family:inherit;font-size:10pt;">. We incurred </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;"> of debt issuance costs in connection with the 2025 Notes, which will be amortized to non-cash interest expense over the contractual term of the 2025 Notes. The closing of the private placement of </font><font style="font-family:inherit;font-size:10pt;">$150.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of the 2025 Notes occurred on </font><font style="font-family:inherit;font-size:10pt;">October&#160;22, 2018</font><font style="font-family:inherit;font-size:10pt;">, and the initial purchasers completed the exercise in full of their option to purchase an additional </font><font style="font-family:inherit;font-size:10pt;">$22.5 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of the 2025 Notes on </font><font style="font-family:inherit;font-size:10pt;">October&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">. The Company loaned the net proceeds to Evolent Health LLC, which intends to use the net proceeds for working capital and other general corporate purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the 2025 Notes are entitled to cash interest payments, which are payable semiannually in arrears on&#160;April 15&#160;and&#160;October 15&#160;of each year, beginning on&#160;</font><font style="font-family:inherit;font-size:10pt;">April&#160;15, 2019</font><font style="font-family:inherit;font-size:10pt;">, at a rate equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;">&#160;per annum. The 2025 Notes will mature on&#160;</font><font style="font-family:inherit;font-size:10pt;">October&#160;15, 2025</font><font style="font-family:inherit;font-size:10pt;">, unless earlier repurchased, redeemed or converted in accordance with their terms prior to such date. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the close of business on the business day immediately preceding </font><font style="font-family:inherit;font-size:10pt;">April&#160;15, 2025</font><font style="font-family:inherit;font-size:10pt;">, the 2025 Notes will be convertible at the option of the holders only upon the satisfaction of certain conditions, as described in the indenture, dated as of </font><font style="font-family:inherit;font-size:10pt;">October&#160;22, 2018</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Indenture&#8221;), between the Company and U.S. Bank National Association, as trustee. On or after </font><font style="font-family:inherit;font-size:10pt;">April&#160;15, 2025</font><font style="font-family:inherit;font-size:10pt;">, until the close of business on the business day immediately preceding the maturity date, holders may convert, at their option, all or any portion of their notes at the conversion rate at any time irrespective of any conditions.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2025 Notes will be convertible at an initial conversion rate of </font><font style="font-family:inherit;font-size:10pt;">29.9135</font><font style="font-family:inherit;font-size:10pt;"> shares of Class A common stock per </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to an initial conversion price of approximately </font><font style="font-family:inherit;font-size:10pt;">$33.43</font><font style="font-family:inherit;font-size:10pt;"> per share of the Company&#8217;s Class A common stock. In the aggregate, the 2025 Notes are initially convertible into </font><font style="font-family:inherit;font-size:10pt;">5.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s Class A common stock (excluding any shares issuable by the Company upon a conversion in connection with a make-whole fundamental change or a notice of redemption as described in the Indenture). The conversion rate may be adjusted under certain circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#8217;s Class A common stock or a combination of cash and shares of the Company&#8217;s Class A common stock, at the Company&#8217;s election.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the 2025 Notes may require the Company to repurchase all or part of their notes upon the occurrence of a fundamental change at a price equal to </font><font style="font-family:inherit;font-size:10pt;">100.0%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the notes being repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Company may not redeem the 2025 Notes prior to </font><font style="font-family:inherit;font-size:10pt;">October&#160;20, 2022</font><font style="font-family:inherit;font-size:10pt;">. The Company may redeem for cash all or any portion of the 2025 Notes, at its option, on or after </font><font style="font-family:inherit;font-size:10pt;">October&#160;20, 2022</font><font style="font-family:inherit;font-size:10pt;">, if the last reported sale price of the Company&#8217;s Class A common stock has been at least </font><font style="font-family:inherit;font-size:10pt;">130.0%</font><font style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to </font><font style="font-family:inherit;font-size:10pt;">100.0%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Estimates and Assumptions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including variable consideration, discounts and credits, estimated selling prices for performance obligations in contracts with multiple performance obligations, claims reserves, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> See Note 16 for amounts related to affiliates included in these line items. EX-101.SCH 7 evh-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles link:presentationLink link:calculationLink link:definitionLink 2402408 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Change in Accounting Principle (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Foreign Currency (Details) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Intangible Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Notes Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Policies) link:presentationLink link:calculationLink link:definitionLink 2402409 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Statement of Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 2302302 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Tables) link:presentationLink link:calculationLink link:definitionLink 2131100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2431402 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2431404 - Disclosure - Commitments and Contingencies - Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2331301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2134100 - Disclosure - Earnings (Loss) Per Common Share link:presentationLink link:calculationLink link:definitionLink 2434403 - Disclosure - Earnings (Loss) Per Common Share - Antidilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2434402 - Disclosure - Earnings (Loss) Per Common Share - Computation of Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2434402 - Disclosure - Earnings (Loss) Per Common Share - Computation of Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2334301 - Disclosure - Earnings (Loss) Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2154100 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 2454402 - Disclosure - Fair Value Measurement - Assets and Liabilities on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 2454403 - Disclosure - Fair Value Measurement - Changes in Contingent Consideration (Details) link:presentationLink link:calculationLink link:definitionLink 2354301 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 2454404 - Disclosure - Fair Value Measurement - Valuation Techniques and Significant Unobservable Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Goodwill and Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2425403 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2140100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2440401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2152100 - Disclosure - Investments In and Advances to Equity Method Investees link:presentationLink link:calculationLink link:definitionLink 2452401 - Disclosure - Investments In and Advances to Equity Method Investees (Details) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - Long-term Debt link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - Long-term Debt - Convertible Senior Notes Carrying Value (Details) link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - Long-term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2153100 - Disclosure - Non-controlling Interests link:presentationLink link:calculationLink link:definitionLink 2453402 - Disclosure - Non-controlling Interests (Details) link:presentationLink link:calculationLink link:definitionLink 2353301 - Disclosure - Non-controlling Interests (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Recently Issued Accounting Standards (Details) link:presentationLink link:calculationLink link:definitionLink 2155100 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 2455402 - Disclosure - Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 2455403 - Disclosure - Related Parties Related Parties - Revenues and Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2355301 - Disclosure - Related Parties (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Revenue Recognition - Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Revenue Recognition - Contract Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Revenue Recognition - Transaction Price Allocated to the Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2156100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2456402 - Disclosure - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 2456403 - Disclosure - Segment Reporting - Reconciliation of Adjusted EBITDA (Details) link:presentationLink link:calculationLink link:definitionLink 2356301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2137100 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 2437403 - Disclosure - Stock-based Compensation - Awards Granted (Details) link:presentationLink link:calculationLink link:definitionLink 2437402 - Disclosure - Stock-based Compensation - Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2337301 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2160100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2460401 - Disclosure - Subsequent Events - Acquisition of New Century Health (Details) link:presentationLink link:calculationLink link:definitionLink 2460402 - Disclosure - Subsequent Events - Convertible Debt Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 2158100 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 2458402 - Disclosure - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2358301 - Disclosure - Supplemental Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Transactions link:presentationLink link:calculationLink link:definitionLink 2407408 - Disclosure - Transactions - Accordion Health, Inc. (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Transactions - New Mexico Health Connections (Details) link:presentationLink link:calculationLink link:definitionLink 2407406 - Disclosure - Transactions - Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 2407407 - Disclosure - Transactions - Secondary Offerings and Sales (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 2157100 - Disclosure - True Health Claims Reserves link:presentationLink link:calculationLink link:definitionLink 2457402 - Disclosure - True Health Claims Reserves (Details) link:presentationLink link:calculationLink link:definitionLink 2357301 - Disclosure - True Health Claims Reserves (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 evh-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 evh-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 evh-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Insurance [Abstract] Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) [Abstract] Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) [Abstract] Beginning balance Liability for Claims and Claims Adjustment Expense Incurred costs related to current period Current Year Claims and Claims Adjustment Expense Paid costs related to current period Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Change during the period Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) Ending balance Segment Reporting [Abstract] Segment Reporting Segment Reporting Disclosure [Text Block] Related Party Transactions [Abstract] Revenues and expenses related to affiliates Schedule of Related Party Transactions [Table Text Block] Supplemental Cash Flow Elements [Abstract] Supplemental cash flow information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Stock options Employee Stock Option [Member] RSUs Restricted Stock Units (RSUs) [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock-based awards granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Noncontrolling Interest [Abstract] Noncontrolling Interest [Table] Noncontrolling Interest [Table] Ownership [Axis] Ownership [Axis] Ownership [Domain] Ownership [Domain] Evolent Health LLC Evolent Health LLC [Member] Evolent Health LLC [Member] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Class A Common Class A [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Evolent Health, Selling Stockholders Evolent Health, Selling Stockholders [Member] Evolent Health, Selling Stockholders [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Investor Stockholders Investor Stockholders [Member] Investor Stockholders [Member] Management Selling Stockholders Management Selling Stockholders [Member] Management Selling Stockholders [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Non-controlling Interests Noncontrolling Interest [Member] Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Parent's ownership percentage Noncontrolling Interest, Ownership Percentage by Parent Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Proceeds from issuance of common stock, net of payments of stock issuance costs Proceeds From Issuance Of Common Stock, Net Of Payments Of Stock Issuance Costs Proceeds From Issuance Of Common Stock, Net Of Payments Of Stock Issuance Costs Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Non-controlling interests as of beginning-of-period Stockholders' Equity Attributable to Noncontrolling Interest Cumulative-effect adjustment from adoption of new accounting principle Adjustments to Additional Paid in Capital, Adjustment from Adoption of New Accounting Principle Adjustments to Additional Paid in Capital, Adjustment from Adoption of New Accounting Principle Decrease in non-controlling interests as a result of Class B Exchanges Noncontrolling Interest, Decrease from Conversion of Shares Noncontrolling Interest, Decrease from Conversion of Shares Reclassification of non-controlling interests Noncontrolling Interest, Increase from Subsidiary Equity Issuance Net income (loss) attributable to non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Non-controlling interests as of end-of-period Number of reportable segments Number of Reportable Segments Reconciliation of Revenue from Segments to Consolidated [Table] Reconciliation of Revenue from Segments to Consolidated [Table] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Balances without adoption of ASC 606 Calculated under Revenue Guidance in Effect before Topic 606 [Member] Adjustments Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Transformation services Transformation Services [Member] Transformation Services [Member] Platform and operations services Platforms And Operations Services [Member] Platforms And Operations Services [Member] Premiums Premiums Revenue [Member] Premiums Revenue [Member] Services Revenue Service [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating segments Operating Segments [Member] Intersegment eliminations Intersegment Eliminations [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Services Services Segment [Member] Services Segment [Member] True Health True Health Segment [Member] True Health Segment [Member] Segment Reporting, Revenue Reconciling Item [Line Items] Segment Reporting, Revenue Reconciling Item [Line Items] Adjusted Revenue Revenue From Contract With Customer, Excluding Assessed Tax, Adjusted To Exclude Purchase Accounting Adjustments Revenue From Contract With Customer, Excluding Assessed Tax, Adjusted To Exclude Purchase Accounting Adjustments Revenues Revenue from Contract with Customer, Excluding Assessed Tax Adjusted EBITDA Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization Debt Disclosure [Abstract] Schedule of convertible debt Convertible Debt [Table Text Block] Stock-based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Equity Method Investments and Joint Ventures [Abstract] Investments In and Advances to Equity Method Investees Equity Method Investments and Joint Ventures Disclosure [Text Block] Schedule of changes in non-controlling interests Schedule of Changes in Noncontrolling Interest [Table Text Block] Schedule of Changes in Noncontrolling Interest [Table Text Block] Organizational Transactions [Abstract] Organizational Transactions [Abstract] Revenue Business Acquisition, Pro Forma Revenue Net income (loss) Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income (loss) attributable to non-controlling interests Business Acquisition, Pro Forma Net Income (Loss) Attributable to Noncontrolling Interest Business Acquisition, Pro Forma Net Income (Loss) Attributable to Noncontrolling Interest Net income (loss) attributable to Evolent Health, Inc. Business Acquisition, Pro Forma Net Income (Loss) Net income (loss) available to common shareholders, Basic (in dollars per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Net income (loss) available to common shareholders, Diluted (in dollars per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Underwriters Underwriters [Member] Underwriters [Member] Sale of Stock [Axis] Sale of Stock [Axis] Sale of Stock [Domain] Sale of Stock [Domain] Over-Allotment Option Over-Allotment Option [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Common stock, outstanding (in shares) Common Stock, Shares, Outstanding Share price (in usd per share) Share Price Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Payments of stock issuance costs Payments of Stock Issuance Costs Related Parties Related Party Transactions Disclosure [Text Block] Accordion Accordion Health, Inc. [Member] Accordion Health, Inc. [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Technology Assets Technology Assets [Member] Technology Assets [Member] Accordion purchase agreement, amount Accordion Purchase Agreement, Amount Accordion Purchase Agreement, Amount Accordion purchase agreement, contingent earn-out Accordion Purchase Agreement, Contingent Earn-Out Accordion Purchase Agreement, Contingent Earn-Out Accordion purchase agreement, intangible assets acquired Accordion Purchase Agreement, Intangible Assets Acquired Accordion Purchase Agreement, Intangible Assets Acquired Accordion purchase agreement, capitalized transaction costs Accordion Purchase Agreement, Capitalized Transaction Costs Accordion Purchase Agreement, Capitalized Transaction Costs Intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Accordion purchase agreement, deferred tax liabilities Accordion Purchase Agreement, Deferred Tax Liabilities Accordion Purchase Agreement, Deferred Tax Liabilities Accordion purchase agreement, increase in intangible asset Asset Purchase Agreement, Increase In Intangible Asset Asset Purchase Agreement, Increase In Intangible Asset Accounting Policies [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Cumulative effect on retained earnings Cumulative Effect on Retained Earnings, Net of Tax Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Accounting Estimates and Assumptions Use of Estimates, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Operating Segments Segment Reporting, Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Restricted Cash and Restricted Investments Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Intangible Assets, Net Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Adoption of New Accounting Standards and Future Adoption of New Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Fair Value Measurements and Other Fair Value Disclosures Fair Value Measurement, Policy [Policy Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Pre-Organization Members Pre-Organization Members [Member] Pre-Organization Members [Member] Organization [Line Items] Variable Interest Entity [Line Items] Evolent Health LLC ownership interest Limited Liability Company (LLC) or Limited Partnership (LP), Members or Limited Partners, Voting Interest Limited Liability Company (LLC) or Limited Partnership (LP), Members or Limited Partners, Voting Interest Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Revenue from Contract with Customer [Abstract] Disaggregation of revenue Disaggregation of Revenue [Table Text Block] Contract with customer, asset and liability Contract with Customer, Asset and Liability [Table Text Block] Business Combinations [Abstract] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] New Mexico Health Connections New Mexico Health Connections [Member] New Mexico Health Connections [Member] Customer relationships Customer Relationships [Member] Provider network contracts Contract-Based Intangible Assets [Member] Above market lease Above Market Leases [Member] Transaction costs Business Acquisition, Transaction Costs Purchase consideration: Business Combination, Consideration Transferred [Abstract] Cash paid to NMHC Payments to Acquire Businesses, Gross Cash paid to escrow agent Business Combination, Contingent Consideration, Liability Total consideration Business Combination, Consideration Transferred Identifiable intangible assets acquired and liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] Identifiable intangible assets acquired and liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Accrued compensation and employee benefits Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Compensation And Employee Benefits Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Compensation And Employee Benefits Goodwill Goodwill Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Useful life Reconciliation of revenue from segments to consolidated Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Reconciliation of Adjusted EBITDA to net income (loss) Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Fair Value Disclosures [Abstract] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Recurring Fair Value, Measurements, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Assets Assets, Fair Value Disclosure [Abstract] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Restricted cash and restricted investments Restricted Cash And Cash Equivalents, Fair Value Disclosure Restricted Cash And Cash Equivalents, Fair Value Disclosure Total Assets, Fair Value Disclosure Liabilities Liabilities, Fair Value Disclosure [Abstract] Contingent consideration Contingent consideration, fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Realized and unrealized (gains) losses, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Risk-adjusted recurring revenue compound annual growth rate, period Risk-Adjusted Recurring Revenue Compound Annual Growth Rate, Period Risk-Adjusted Recurring Revenue Compound Annual Growth Rate, Period Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Performance-based stock options Performance Shares [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of revenue Cost of Sales [Member] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based compensation expense Allocated Share-based Compensation Expense Share-based compensation expense capitalized as software development costs Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount Activity in claims reserves Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Stock-based compensation expense Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Stock-based awards granted Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Equity Method Investee Equity Method Investee [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Services Agreements Services Agreements [Member] Services Agreements [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Revenue related to long-term services agreement (less than $0.1 million - 3 months ended September 30, 2017) Income (Loss) from Equity Method Investments, Services Agreement Income (Loss) from Equity Method Investments, Services Agreement Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Real options approach Real Options Approach Valuation Technique [Member] Real Options Approach Valuation Technique [Member] Real options approach 2017-2021 Real Options Approach Valuation Technique 2017-2021 [Member] Real Options Approach Valuation Technique 2017-2021 [Member] Real options approach 2019-2021 Real Options Approach Valuation Technique 2019-2021 [Member] Real Options Approach Valuation Technique 2019-2021 [Member] Measurement Input Type [Axis] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input Type [Domain] Risk-adjusted recurring revenue CAGR Measurement Input, Long-term Revenue Growth Rate [Member] Discount rate/time value Measurement Input, Discount Rate [Member] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Contingent consideration Contingent Consideration Liability [Member] Contingent Consideration Liability [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Contingent consideration, Fair Value Assumption or Input Ranges Business Combination, Contingent Consideration, Liability, Measurement Input Theoretical recurring revenue Business Combination, Contingent Consideration, Liability, Measurement Input, Theoretical Recurring Revenue Business Combination, Contingent Consideration, Liability, Measurement Input, Theoretical Recurring Revenue Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Convertible Notes due 2025 Senior Convertible Notes Due 2025 [Member] Senior Convertible Notes Due 2025 [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes Senior Notes [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Face amount Debt Instrument, Face Amount Interest rate Debt Instrument, Interest Rate, Stated Percentage Proceeds from issuance of debt Proceeds from Issuance of Debt Debt issuance costs Debt Issuance Costs, Net Initial conversion rate per $1000 principal amount Debt Instrument, Convertible, Conversion Ratio Debt conversion denominator shares per principal amount Debt Conversion Denominator Shares Per Principal Amount Debt Conversion Denominator Shares Per Principal Amount Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Initial conversion amount (in shares) Debt Instrument, Convertible, Number of Equity Instruments Repurchase covenant, repurchase price due to fundamental change as percentage of principal amount Debt Instrument, Repurchase Price Due To Fundamental Change As Percentage Of Principal Amount Debt Instrument, Repurchase Price Due To Fundamental Change As Percentage Of Principal Amount Repurchase covenant, sale price as a percentage of conversion price Debt Instrument, Repurchase Covenant, Sale Price As A Percentage Of Conversion Price Debt Instrument, Repurchase Covenant, Sale Price As A Percentage Of Conversion Price Repurchase covenant, trading days (at least) Debt Instrument, Repurchase Covenant, Trading Days, Minimum Debt Instrument, Repurchase Covenant, Trading Days, Minimum Repurchase covenant, consecutive trading days Debt Instrument, Repurchase Covenant, Consecutive Trading Days, Minimum Debt Instrument, Repurchase Covenant, Consecutive Trading Days, Minimum Repurchase covenant, price due to change in sale price as percentage of conversion price Debt Instrument, Repurchase Price Due To Change In Sale Price As Percentage Of Conversion Price Debt Instrument, Repurchase Price Due To Change In Sale Price As Percentage Of Conversion Price Long-term Debt Debt Disclosure [Text Block] Net Income (Loss) Attributable to Evolent Health, Inc. Net Income (Loss) Available to Common Stockholders, Basic Interest income Investment Income, Interest Interest expense Interest Expense (Provision) benefit for income taxes Income Tax Expense (Benefit) Depreciation and amortization expenses Depreciation, Depletion and Amortization, Nonproduction Income (loss) from equity method investees Income (Loss) from Equity Method Investments Change in fair value of contingent consideration and indemnification asset Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Other income (expense), net Other Nonoperating Income (Expense) Net income (loss) attributable to non-controlling interests ASC 606 transition adjustments Adjustments For Initial Application Period Cumulative Effect Transition Adjustments For Initial Application Period Cumulative Effect Transition Purchase accounting adjustments Purchase Accounting Adjustments Purchase Accounting Adjustments Stock-based compensation expense Share-based Compensation Severance costs Severance Costs Amortization of contract cost assets Capitalized Contract Cost, Amortization, Purchase Accounting Adjustments Capitalized Contract Cost, Amortization, Purchase Accounting Adjustments Transaction costs Transaction Costs Transaction Costs Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Loans Payable Loans Payable [Member] Implementation Fund Loan Implementation Fund Loan [Member] Implementation Fund Loan [Member] Current Customer Current Customer [Member] Current Customer [Member] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Number of equal principal and interest installments Debt Instrument, Periodic Payment, Number Of Equal Installments Debt Instrument, Periodic Payment, Number Of Equal Installments Amount of equal principal and interest installments Debt Instrument, Periodic Payment Notes receivable Notes, Loans and Financing Receivable, Net, Current Accrued interest Interest Receivable Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Fair Value Measurement Fair Value Disclosures [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Convertible Senior Notes due 2021 Convertible Senior Notes due 2021 [Member] Convertible Senior Notes due 2021 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Carrying value Convertible Debt Fair value Long-term Debt, Fair Value Unamortized discount Debt Instrument, Unamortized Discount Principal amount Remaining amortization period Debt Instrument, Convertible, Remaining Discount Amortization Period Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Income Tax Disclosure [Abstract] Income Tax Contingency [Table] Income Tax Contingency [Table] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Additional Paid-in Capital Additional Paid-in Capital [Member] Income Tax Expense Benefit Income Tax Expense (Benefit) [Member] Income Tax Expense (Benefit) [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Income tax expense (benefit) (less than $0.1 million for nine months ended September 30, 2018) Effective tax rate Effective Income Tax Rate Reconciliation, Percent Decrease in deferred tax liabilities Increase (Decrease) in Deferred Income Taxes Unrecognized tax benefits Unrecognized Tax Benefits Tax receivables agreement, percent of tax savings to be paid Tax Receivables Agreement, Percent of Tax Savings to be Paid Tax Receivables Agreement, Percent of Tax Savings to be Paid Earnings Per Share [Abstract] Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Less: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Net income (loss) available for common shareholders Weighted-average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Earnings (Loss) per Common Share Earnings Per Share, Basic and Diluted [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Class B Common Class B [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Convertible preferred stock, shares issued upon conversion (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Income Statement [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Revenue Revenues [Abstract] Expenses Operating Expenses [Abstract] Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) Cost of Goods and Services Sold, Excluding Depreciation and Amortization Cost of Goods and Services Sold, Excluding Depreciation and Amortization Claims expenses Selling, general and administrative expenses Selling, General and Administrative Expense Depreciation and amortization expenses Change in fair value of contingent consideration and indemnification asset Total operating expenses Operating Expenses Operating income (loss) Operating Income (Loss) Income (loss) before income taxes and non-controlling interests Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision (benefit) for income taxes Net income (loss) Net income (loss) attributable to Evolent Health, Inc. Net Income (Loss) Attributable to Parent Earnings (Loss) Available for Common Shareholders Earnings (Loss) Available to Common Shareholders [Abstract] Earnings (Loss) Available to Common Shareholders [Abstract] Basic Diluted Net Income (Loss) Available to Common Stockholders, Diluted Weighted-Average Common Shares Outstanding Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Basic (in shares) Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] Net income (loss) Other comprehensive income (loss), net of taxes, related to: Other Comprehensive Income (Loss), Net of Tax [Abstract] Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Total comprehensive income (loss) attributable to non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Total comprehensive income (loss) attributable to Evolent Health, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Commitments and Contingencies Disclosure [Abstract] Concentration Risk [Table] Concentration Risk [Table] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Customer B Customer B [Member] Customer B [Member] Customer C Customer C [Member] Customer C [Member] Customer D Customer D [Member] Customer D [Member] Customer A Customer A [Member] Customer A [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Accounts Receivable Accounts Receivable [Member] Revenue Sales Revenue, Net [Member] Receivable Type [Axis] Receivable Type [Axis] Receivable [Domain] Receivable [Domain] Customer Receivable Financing Receivable [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Percentage of cash and cash equivalents held with FDIC participating banks Cash, FDIC Insured Amount, Percentage Cash, FDIC Insured Amount, Percentage Cash and cash equivalents (including restricted cash) Cash, Cash Equivalents, and Short-term Investments Percentage of cash and cash equivalents held in money market funds Cash, Held In Money Market Funds, Percentage Cash, Held In Money Market Funds, Percentage Percentage of cash held in international banks (less than) Cash, Held In International Banks, Percentage Cash, Held In International Banks, Percentage Concentration risk Concentration Risk, Percentage Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Collateral for letters of credit for facility leases Restricted Cash for Letters of Credit for Facility Leases [Member] Restricted Cash for Letters of Credit for Facility Leases [Member] Collateral with financial institutions Collateral with Financial Institutions [Member] Collateral with Financial Institutions [Member] Claims processing services Restricted Cash for Benefit Management Services [Member] Restricted Cash for Benefit Management Services [Member] Collateral for reinsurance agreement Restricted Cash For Reinsurance Agreement [Member] Restricted Cash For Reinsurance Agreement [Member] Other Restricted Cash for Other Contractual Commitments [Member] Restricted Cash for Other Contractual Commitments [Member] Collateral with financial institutions, money market fund Collateral With Financial Institutions, Money Market Fund [Member] Collateral With Financial Institutions, Money Market Fund [Member] Money market funds Money Market Funds [Member] FDIC participating bank account Bank Time Deposits [Member] Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Total restricted cash and restricted investments Restricted Cash and Cash Equivalents Current restricted investments Restricted Investments, Current Current restricted cash Restricted Cash and Cash Equivalents, Current Total current restricted cash and restricted investments Restricted Cash and Investments, Current Noncurrent restricted investments Restricted Investments, Noncurrent Noncurrent restricted cash Restricted Cash and Cash Equivalents, Noncurrent Total non-current restricted cash and restricted investments Restricted Cash and Investments, Noncurrent Restricted investments included in restricted cash and restricted investments Restricted Investments Cash and cash equivalents and restricted cash as of end-of-period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Statement of Financial Position [Abstract] Accounts receivable, related parties Due from Related Parties, Current Prepaid expenses and other current assets, related parties Prepaid Expense And Other Assets, Current, Related Parties Prepaid Expense And Other Assets, Current, Related Parties Prepaid expenses and other noncurrent assets, related parties Prepaid Expense and Other Assets, Noncurrent, Related Parties Prepaid Expense and Other Assets, Noncurrent, Related Parties Accounts payable, related parties Accounts Payable, Related Parties Accrued liabilities, related parties Due to Related Parties, Current Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, authorized (in shares) Common Stock, Shares Authorized Common stock, issued (in shares) Common Stock, Shares, Issued Property, Plant and Equipment [Abstract] Summary of property and equipment Property, Plant and Equipment [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Balance as of beginning of period Balance as of end of period Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash and restricted cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] (Income) loss from equity method investees Change in fair value of contingent consideration and indemnification asset Depreciation and amortization expenses Depreciation, Depletion and Amortization Amortization of deferred financing costs Amortization of Debt Issuance Costs Stock-based compensation expense Deferred tax provision (benefit) Deferred Income Tax Expense (Benefit) Amortization of contract cost assets Capitalized Contract Cost, Amortization Other Other Noncash Income (Expense) Changes in assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accounts receivables, net Increase (Decrease) in Accounts Receivable Prepaid expenses and other current and noncurrent assets Increase (Decrease) in Prepaid Expense and Other Assets Contract assets Increase (Decrease) in Contract with Customer, Asset Contract cost assets Increase (Decrease) In Capitalized Contract Cost, Net Increase (Decrease) In Capitalized Contract Cost, Net Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Accrued compensation and employee benefits Increase (Decrease) in Employee Related Liabilities Deferred revenue Increase (Decrease) in Contract with Customer, Liability Claims reserves Increase (Decrease) in Insurance Liabilities Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Net cash and restricted cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash paid for asset acquisitions or business combinations Principal repayment for implementation funding loan Proceeds from Collection of Loans Receivable Amount received from escrow in asset acquisition Cash Acquired from Acquisition Maturities and sales of investments Proceeds from Sale, Maturity and Collection of Investments Investments in and advances to equity method investees Payments to Acquire Interest in Subsidiaries and Affiliates Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Purchases and maturities of restricted investments Increase (Decrease) of Restricted Investments Net cash and restricted cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Change in restricted cash held on behalf of partners for claims processing Proceeds from (Repayments of) Restricted Cash, Financing Activities Proceeds from issuance of common stock, net of stock issuance costs Proceeds from stock option exercises Proceeds from Stock Options Exercised Taxes withheld and paid for vesting of restricted stock units Payments Related to Tax Withholding for Share-based Compensation Net cash and restricted cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate on cash and cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Net increase (decrease) in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents and restricted cash as of beginning-of-period Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Summary of assets at fair value on recurring basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Summary of liabilities at fair value on recurring basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Changes in contingent consideration measured at fair value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Valuation techniques and significant unobservable inputs of Level 3 fair value measurements Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Computation of basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Accounting Standards Update 2016-18 Accounting Standards Update 2016-18 [Member] Restatement [Axis] Restatement [Axis] Restatement [Domain] Restatement [Domain] As Reported Previously Reported [Member] Adjustments Restatement Adjustment [Member] Purchases and maturities of restricted investments Change in restricted cash and restricted investments Increase (Decrease) in Restricted Cash Net cash and restricted cash provided by (used in) investing activities Net cash and restricted cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents and restricted cash Schedule of goodwill Schedule of Goodwill [Table Text Block] Schedule of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Subsequent Events Subsequent Events [Text Block] True Health Claims Reserves Insurance Disclosure [Text Block] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Restricted cash and restricted investments Accounts receivable, net (amounts related to affiliates: 2018 - $7,774; 2017 - $3,358) Accounts Receivable, Net, Current Prepaid expenses and other current assets (amounts related to affiliates: 2018 - $48; 2017 - $25) Prepaid Expense and Other Assets, Current Contract assets Contract with Customer, Asset, Net, Current Total current assets Assets, Current Restricted cash and restricted investments Investments in and advances to equity method investees Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Property and equipment, net Property, Plant and Equipment, Net Prepaid expenses and other noncurrent assets (amounts related to affiliates: 2018 - $2,500; 2017 - $0) Other Assets, Noncurrent Contract assets Contract with Customer, Asset, Net, Noncurrent Contract cost assets Capitalized Contract Cost, Net, Noncurrent Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Total assets Assets LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) Liabilities and Equity [Abstract] Liabilities Liabilities [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable (amounts related to affiliates: 2018 - $1,425; 2017 - $10,284) Accounts Payable, Current Accrued liabilities (amounts related to affiliates: 2018 - $4,812; 2017 - $719) Accrued Liabilities, Current Accrued compensation and employee benefits Employee-related Liabilities, Current Deferred revenue Contract with Customer, Liability, Current Claims reserves Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense Total current liabilities Liabilities, Current Long-term debt, net of discount Long-term Debt Other long-term liabilities Other Liabilities, Noncurrent Deferred tax liabilities, net Deferred Income Tax Liabilities, Net Total liabilities Liabilities Commitments and Contingencies (See Note 9) Commitments and Contingencies Shareholders' Equity (Deficit) Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Common stock Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Total shareholders' equity (deficit) attributable to Evolent Health, Inc. Stockholders' Equity Attributable to Parent Non-controlling interests Total shareholders' equity (deficit) Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholders' equity (deficit) Liabilities and Equity Supplemental Cash Flow Information Cash Flow, Supplemental Disclosures [Text Block] Interest expense Interest Expense, Debt Statement of Stockholders' Equity [Abstract] Accumulated Other Comprehensive Income (Loss) AOCI Including Portion Attributable to Noncontrolling Interest [Member] Retained Earnings (Accumulated Deficit) Retained Earnings [Member] Class A Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance (in shares) Shares, Issued Beginning balance, amount Cumulative-effect adjustment from adoption of ASC 606 New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification Stock-based compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Exercise of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Restricted stock units vested, net of shares withheld for taxes (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Restricted stock units vested, net of shares withheld for taxes Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Shares released from Valence Health escrow (in shares) Stock Repurchased and Retired During Period, Shares Shares released from Valence Health escrow Stock Repurchased and Retired During Period, Value Exchange of Class B common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Exchange of Class B common stock Stock Issued During Period, Value, Conversion of Convertible Securities Tax impact of share issuances Stock Issued During Period, New Issues Tax Impact Stock Issued During Period, New Issues Tax Impact Issuance of Class A common stock during August 2017 Primary (in shares) Issuance of Class A common stock during August 2017 Primary Stock Issued During Period, Value, New Issues Tax impact of Class B Exchanges Stock Issued During Period, Conversion of Convertible Securities, Tax Impact Stock Issued During Period, Conversion of Convertible Securities, Tax Impact Settlement of indemnification asset Adjustments To Additional Paid In Capital, Settlement Of Indemnification Asset Adjustments To Additional Paid In Capital, Settlement Of Indemnification Asset Foreign Currency Translation Adjustment Ending balance (in shares) Ending balance, amount Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Exchangeable Class B common stock Exchangeable Class B Common Stock [Member] Exchangeable Class B Common Stock [Member] Restricted stock units (RSUs) Stock options and performance-based stock options Equity Option [Member] Convertible senior notes Convertible Debt Securities [Member] Number of antidilutive securities excluded from the calculation of earning per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Income Taxes Income Tax Disclosure [Text Block] Transactions Business Combination Disclosure [Text Block] Short-term receivables Receivables, Net, Current Long-term receivables Accounts, Notes, Loans and Financing Receivable, Net, Noncurrent Short-term contract assets Long-term contract assets Short-term deferred revenue Long-term deferred revenue Contract with Customer, Liability, Noncurrent Contract asset, reclassified to receivable Contract with Customer, Asset, Reclassified to Receivable Deferred revenue increase Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress Deferred revenue, revenue recognized Contract with Customer, Liability, Revenue Recognized Deferred revenue, adjustment due to net gain share, service-level agreement true-ups and changes in estimates Contract with Customer, Performance Obligation Satisfied in Previous Period Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Economic interest percentage Equity Method Investment, Economic Interest Percentage Equity Method Investment, Economic Interest Percentage Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Loss from affiliates Revenue related to long-term services agreement (less than $0.1 million - 3 months ended September 30, 2017) Affiliates Affiliated Entity [Member] Revenue Expenses Cost of revenue (exclusive of depreciation and amortization expenses) Number of reporting units Number of Reporting Units Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balance as of beginning-of-period Goodwill Acquired Goodwill, Acquired During Period Measurement period adjustment, goodwill Goodwill, Purchase Accounting Adjustments Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Balance as of end-of-period Accumulated impairment Goodwill, Impaired, Accumulated Impairment Loss Non-controlling Interests Noncontrolling Interest Disclosure [Text Block] Impact of adoption Higher/(Lower) Income (loss) before income taxes and non-controlling interests Accounts receivable, net Contract assets (current) Contract assets (noncurrent) Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles Basis of Presentation and Significant Accounting Policies [Text Block] Revenue, remaining performance obligation Revenue, Remaining Performance Obligation, Amount Revenue, remaining performance obligation, percent to be recognized in current fiscal year Revenue, Remaining Performance Obligation To Be Recognized In Next Fiscal Year, Percentage Revenue, Remaining Performance Obligation To Be Recognized In Next Fiscal Year, Percentage Revenue, remaining performance obligation, percent to be recognized in next fiscal year Revenue, Remaining Performance Obligation To Be Recognized In Year Two, Percentage Revenue, Remaining Performance Obligation To Be Recognized In Year Two, Percentage Schedule of net assets acquired Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Business acquisition, pro forma information Business Acquisition, Pro Forma Information [Table Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Computer hardware Computer Equipment [Member] Furniture and equipment Furniture and Fixtures [Member] Internal-use software development costs Software and Software Development Costs [Member] Leasehold improvements Leasehold Improvements [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Total property and equipment Property, Plant and Equipment, Gross Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property and equipment, net Capitalized computer software additions Capitalized Computer Software, Additions Depreciation expense Depreciation Capitalized computer software, amortization Capitalized Computer Software, Amortization Capitalized Contract Cost [Table] Capitalized Contract Cost [Table] Capitalized Contract Cost [Axis] Capitalized Contract Cost [Axis] Capitalized Contract Cost [Domain] Capitalized Contract Cost [Domain] Bonuses and Commissions Bonuses And Commissions [Member] Bonuses And Commissions [Member] Contract Fulfillment Costs Contract Fulfillment Costs [Member] Contract Fulfillment Costs [Member] Capitalized Contract Cost [Line Items] Capitalized Contract Cost [Line Items] Contract cost assets Capitalized Contract Cost, Net Contract cost amortization Capitalized contract cost, amortization period Capitalized Contract Cost, Amortization Period Summary of major partners Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Corporate trade name Trade Names [Member] Technology Developed Technology Rights [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] New Century Health New Century Health [Member] New Century Health [Member] Common Class B Units Common Class B Units [Member] Common Class B Units [Member] Consideration transferred Consideration transferred, shares issued (in shares) Business Combination, Consideration Transferred, Equity Interests Issued And Issuable, Shares Issued Business Combination, Consideration Transferred, Equity Interests Issued And Issuable, Shares Issued Cash Consideration transferred, shares issued, percentage of total shares issued and outstanding Business Combination, Consideration Transferred, Equity Interests Issued And Issuable, Shares Issued, Percentage Of Total Shares Issued And Outstanding Business Combination, Consideration Transferred, Equity Interests Issued And Issuable, Shares Issued, Percentage Of Total Shares Issued And Outstanding Contingent liability, earn-out potential Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Consideration transferred, shares issuable, contingent liability, maximum (in shares) Business Combination, Consideration Transferred, Equity Interests Issued And Issuable, Shares Issuable, Contingent Liability, Maximum Business Combination, Consideration Transferred, Equity Interests Issued And Issuable, Shares Issuable, Contingent Liability, Maximum Recently Issued Accounting Standards New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Earnings (Loss) Per Common Share Earnings Per Share [Text Block] Below market lease, net Below Market Leases, Net [Member] Below Market Leases, Net [Member] Vestica Vestica [Member] Vestica [Member] Weighted-Average Remaining Useful Life Finite-Lived Intangible Assets, Remaining Amortization Period Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Net Carrying Value Finite-Lived Intangible Assets, Net Identifiable intangible assets Contingent consideration, asset, held in escrow Business Combination, Contingent Consideration, Asset Contingent consideration settled Other Payments to Acquire Businesses Amortization of intangible assets Amortization of Intangible Assets Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Letter of Credit Letter of Credit [Member] Line of Credit Line of Credit [Member] Letters of credit for facility leases Operating capital support commitment, maximum amount Equity Method Investment, Operating Capital Support Commitment, Maximum Amount Equity Method Investment, Operating Capital Support Commitment, Maximum Amount Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Line of credit, quarterly rental fee percentage Line Of Credit Facility, Quarterly Rental Fee Percentage Line Of Credit Facility, Quarterly Rental Fee Percentage Rent expense Operating Leases, Rent Expense, Net Letters of credit outstanding, minimum Letters of Credit Outstanding, Amount Restricted funds Reinsurance arrangement, term Reinsurance Arrangement, Term Reinsurance Arrangement, Term Reinsurance arrangement, capital amount Reinsurance Arrangement, Capital Amount Reinsurance Arrangement, Capital Amount Reinsurance arrangement, quarterly fee Reinsurance Arrangement, Quarterly Fee Reinsurance Arrangement, Quarterly Fee Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Revenue Recognition Revenue from Contract with Customer [Text Block] Accrued property and equipment purchases Capital Expenditures Incurred but Not yet Paid Increase to goodwill from measurement period adjustments related to business combinations Noncash Or Part Noncash Acquisition, Noncash Financial Or Equity Instrument Consideration, Measurement Period Adjustment Noncash Or Part Noncash Acquisition, Noncash Financial Or Equity Instrument Consideration, Measurement Period Adjustment Decrease in accrued financing costs related to 2021 Notes Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Consideration for asset acquisitions or business combinations Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) Settlement of escrow related to asset acquisition Escrow Deposit Disbursements Related to Property Acquisition Settlement of indemnification asset Settlement Of Indemnification Asset Settlement Of Indemnification Asset Tax benefit related to Accordion intangible technology Tax Benefit Related To Intangible Assets Tax Benefit Related To Intangible Assets Effects of Class B Exchanges Effects of the Secondary [Abstract] Effects of the Secondary [Abstract] Decrease in deferred tax liability as a result of securities offerings Conversion of Stock, Amount Converted Decrease in deferred tax liability as a result of securities offerings Stock Issued, Decrease In Deferred Tax Liability Stock Issued, Decrease In Deferred Tax Liability Schedule of restricted cash and cash equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Schedule of adoption of ASC 606 Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] EX-101.PRE 11 evh-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 05, 2018
Document and Entity Information [Abstract]    
Entity Registrant Name Evolent Health, Inc.  
Entity Central Index Key 0001628908  
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Class A    
Entity Common Stock, Shares Outstanding (in shares)   78,341,481
Class B    
Entity Common Stock, Shares Outstanding (in shares)   3,885,947
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 221,837 $ 238,433
Restricted cash and restricted investments 42,328 62,398
Accounts receivable, net (amounts related to affiliates: 2018 - $7,774; 2017 - $3,358) 60,054 48,947
Prepaid expenses and other current assets (amounts related to affiliates: 2018 - $48; 2017 - $25) 14,667 8,404
Notes receivable 6,000 20,000
Contract assets 3,705 0
Total current assets 348,591 378,182
Restricted cash and restricted investments 3,394 3,287
Investments in and advances to equity method investees 5,672 1,531
Property and equipment, net 68,692 50,922
Prepaid expenses and other noncurrent assets (amounts related to affiliates: 2018 - $2,500; 2017 - $0) 15,181 9,328
Contract assets 1,000 0
Contract cost assets 14,252 0
Intangible assets, net 230,806 241,261
Goodwill 635,088 628,186
Total assets 1,322,676 1,312,697
Current liabilities:    
Accounts payable (amounts related to affiliates: 2018 - $1,425; 2017 - $10,284) 30,535 42,930
Accrued liabilities (amounts related to affiliates: 2018 - $4,812; 2017 - $719) 47,189 29,572
Accrued compensation and employee benefits 28,989 35,390
Deferred revenue 22,360 24,807
Claims reserves 10,338 0
Total current liabilities 139,411 132,699
Long-term debt, net of discount 122,082 121,394
Other long-term liabilities 10,885 9,861
Deferred tax liabilities, net 1,725 2,437
Total liabilities 274,103 266,391
Commitments and Contingencies (See Note 9)
Shareholders' Equity (Deficit)    
Additional paid-in capital 971,341 924,153
Accumulated other comprehensive income (loss) (264) 0
Retained earnings (accumulated deficit) 66,696 85,952
Total shareholders' equity (deficit) attributable to Evolent Health, Inc. 1,038,565 1,010,879
Non-controlling interests 10,008 35,427
Total shareholders' equity (deficit) 1,048,573 1,046,306
Total liabilities and shareholders' equity (deficit) 1,322,676 1,312,697
Class A    
Shareholders' Equity (Deficit)    
Common stock 784 747
Class B    
Shareholders' Equity (Deficit)    
Common stock $ 8 $ 27
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Accounts receivable, related parties $ 7,774 $ 3,358
Prepaid expenses and other current assets, related parties 48 25
Prepaid expenses and other noncurrent assets, related parties 2,500 0
Accounts payable, related parties 1,425 10,284
Accrued liabilities, related parties $ 4,812 $ 719
Class A    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 750,000,000 750,000,000
Common stock, issued (in shares) 78,392,052 74,723,597
Common stock, outstanding (in shares) 78,392,052 74,723,597
Class B    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 100,000,000 100,000,000
Common stock, issued (in shares) 765,646 2,653,544
Common stock, outstanding (in shares) 765,646 2,653,544
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue        
Revenues $ 149,947 $ 107,912 $ 433,959 $ 321,221
Expenses        
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) [1] 73,967 68,281 214,945 203,804
Claims expenses 16,992 0 52,169 0
Selling, general and administrative expenses [1] 59,566 45,834 172,495 150,474
Depreciation and amortization expenses 10,352 7,717 29,882 21,236
Change in fair value of contingent consideration and indemnification asset 100 100 (1,404) 300
Total operating expenses 160,977 121,932 468,087 375,814
Operating income (loss) (11,030) (14,020) (34,128) (54,593)
Interest income 968 411 2,918 813
Interest expense (853) (880) (2,561) (2,781)
Income (loss) from equity method investees (1,381) (369) (2,787) (1,446)
Other income (expense), net (124) 15 (64) 21
Income (loss) before income taxes and non-controlling interests (12,420) (14,843) (36,622) (57,986)
Provision (benefit) for income taxes 135 (1,714) 29 (2,009)
Net income (loss) (12,555) (13,129) (36,651) (55,977)
Net income (loss) attributable to non-controlling interests (126) (541) (680) (8,471)
Net income (loss) attributable to Evolent Health, Inc. (12,429) (12,588) (35,971) (47,506)
Earnings (Loss) Available for Common Shareholders        
Basic (12,429) (12,588) (35,971) (47,506)
Diluted $ (12,429) $ (12,588) $ (35,971) $ (47,506)
Earnings (Loss) per Common Share        
Basic (in dollars per share) $ (0.16) $ (0.18) $ (0.47) $ (0.78)
Diluted (in dollars per share) $ (0.16) $ (0.18) $ (0.47) $ (0.78)
Weighted-Average Common Shares Outstanding        
Basic (in shares) 77,999 70,328 76,871 60,867
Diluted (in shares) 77,999 70,328 76,871 60,867
Comprehensive income (loss)        
Net income (loss) $ (12,555) $ (13,129) $ (36,651) $ (55,977)
Other comprehensive income (loss), net of taxes, related to:        
Foreign currency translation adjustment (116) 0 (264) 0
Total comprehensive income (loss) (12,671) (13,129) (36,915) (55,977)
Total comprehensive income (loss) attributable to non-controlling interests (126) (541) (680) (8,471)
Total comprehensive income (loss) attributable to Evolent Health, Inc. (12,545) (12,588) (36,235) (47,506)
Transformation services        
Revenue        
Revenues [1] 9,230 8,204 23,950 23,799
Platform and operations services        
Revenue        
Revenues [1] 118,094 99,708 341,258 297,422
Premiums        
Revenue        
Revenues $ 22,623 $ 0 $ 68,751 $ 0
[1] See Note 16 for amounts related to affiliates included in these line items.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Operating Activities    
Net income (loss) $ (36,651) $ (55,977)
Adjustments to reconcile net income (loss) to net cash and restricted cash provided by (used in) operating activities:    
(Income) loss from equity method investees 2,787 1,446
Change in fair value of contingent consideration and indemnification asset (1,404) 300
Depreciation and amortization expenses 29,882 21,236
Amortization of deferred financing costs 688 685
Stock-based compensation expense 12,560 16,172
Deferred tax provision (benefit) 34 (2,668)
Amortization of contract cost assets 1,900 0
Other (111) 88
Changes in assets and liabilities, net of acquisitions:    
Accounts receivables, net (11,241) (5,075)
Prepaid expenses and other current and noncurrent assets (15,393) (5,125)
Contract assets 240 0
Contract cost assets (4,568) 0
Accounts payable 6,451 10,591
Accrued liabilities 13,946 (11,075)
Accrued compensation and employee benefits (7,059) (7,707)
Deferred revenue 828 4,835
Claims reserves 10,338 0
Other long-term liabilities 1,090 (1,719)
Net cash and restricted cash provided by (used in) operating activities 4,317 (33,993)
Cash Flows from Investing Activities    
Cash paid for asset acquisitions or business combinations (11,552) (3,694)
Principal repayment for implementation funding loan 14,000 0
Amount received from escrow in asset acquisition 500 0
Maturities and sales of investments 0 44,210
Investments in and advances to equity method investees (6,807) 0
Purchases of property and equipment (29,117) (21,349)
Purchases and maturities of restricted investments 8,043 (3,200)
Net cash and restricted cash provided by (used in) investing activities (24,933) 15,967
Cash Flows from Financing Activities    
Change in restricted cash held on behalf of partners for claims processing (17,344) (25,648)
Proceeds from issuance of common stock, net of stock issuance costs 0 166,947
Proceeds from stock option exercises 10,588 3,802
Taxes withheld and paid for vesting of restricted stock units (1,179) (1,179)
Net cash and restricted cash provided by (used in) financing activities (7,935) 143,922
Effect of exchange rate on cash and cash equivalents and restricted cash 35 0
Net increase (decrease) in cash and cash equivalents and restricted cash (28,516) 125,896
Cash and cash equivalents and restricted cash as of beginning-of-period 295,363 170,029
Cash and cash equivalents and restricted cash as of end-of-period $ 266,847 $ 295,925
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Class A
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2016     52,587 15,347        
Beginning balance, amount at Dec. 31, 2016 $ 912,114   $ 506 $ 153 $ 555,250 $ 0 $ 146,617 $ 209,588
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 20,437       20,437      
Exercise of stock options (in shares)     788          
Exercise of stock options 4,082   $ 28   4,054      
Restricted stock units vested, net of shares withheld for taxes (in shares)     149          
Restricted stock units vested, net of shares withheld for taxes (1,272)   $ 2   (1,274)      
Shares released from Valence Health escrow (in shares)     (310)          
Shares released from Valence Health escrow 908   $ (3)   911      
Exchange of Class B common stock (in shares)     12,693 (12,693)        
Exchange of Class B common stock 0   $ 126 $ (126) 168,883     (168,883)
Tax impact of share issuances 12,857       12,857      
Issuance of Class A common stock during August 2017 Primary (in shares)   20,100 8,816          
Issuance of Class A common stock during August 2017 Primary 166,947   $ 88   166,859      
Reclassification of non-controlling interests 0       (3,824)     3,824
Net income (loss) (69,767)           (60,665) (9,102)
Ending balance (in shares) at Dec. 31, 2017     74,723 2,654        
Ending balance, amount at Dec. 31, 2017 1,046,306   $ 747 $ 27 924,153 0 85,952 35,427
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment from adoption of ASC 606 17,309           16,715 594
Stock-based compensation expense 12,560       12,560      
Exercise of stock options (in shares)     1,574          
Exercise of stock options 10,588   $ 16   10,572      
Restricted stock units vested, net of shares withheld for taxes (in shares)     207          
Restricted stock units vested, net of shares withheld for taxes (1,179)   $ 2   (1,181)      
Exchange of Class B common stock (in shares)     1,888 (1,888)        
Exchange of Class B common stock 0   $ 19 $ (19) 25,334     (25,334)
Tax impact of Class B Exchanges 908       908      
Settlement of indemnification asset (1,004)       (1,004)      
Foreign Currency Translation Adjustment (264)         (264)    
Reclassification of non-controlling interests 0       (1)     1
Net income (loss) (36,651)           (35,971) (680)
Ending balance (in shares) at Sep. 30, 2018     78,392 766        
Ending balance, amount at Sep. 30, 2018 $ 1,048,573   $ 784 $ 8 $ 971,341 $ (264) $ 66,696 $ 10,008
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Organization

Evolent Health, Inc. was incorporated in December 2014 in the state of Delaware, and is a managed services firm that supports leading health systems and physician organizations in their migration toward value-based care and population health management. The Company operates through two segments. The Company’s services segment (“Services”) provides our customers, who we refer to as partners, with a population management platform, integrated data and analytics capabilities, claims processing services, including pharmacy benefit management, and comprehensive health plan administration services. Together these services enable health systems to manage patient health in a more cost-effective manner. The Company’s contracts are structured as a combination of advisory fees, monthly member service fees, percentage of plan premiums and shared medical savings arrangements. The Company’s wholly-owned subsidiary, True Health New Mexico, Inc. (“True Health”) operates as a separate segment and is a commercial health plan we operate in New Mexico that focuses on small and large businesses. The Company’s headquarters is located in Arlington, Virginia.

Our predecessor, Evolent Health Holdings, Inc. (“Evolent Health Holdings”), merged with and into Evolent Health, Inc. in connection with the offering reorganization which occurred on June 4, 2015 (the “Offering Reorganization”), as discussed in our 2017 Form 10-K.

Prior to our initial public offering (“IPO”) in June 2015 and the Offering Reorganization we undertook in connection therewith, Evolent Health Holdings did not control Evolent Health LLC, our operating subsidiary company due to certain participating rights granted to our investor, TPG Global, LLC and certain of its affiliates (“TPG”). However, Evolent Health Holdings was able to exert significant influence on Evolent Health LLC and, accordingly, accounted for its investment in Evolent Health LLC using the equity method of accounting through June 3, 2015. Subsequent to the Offering Reorganization, the financial results of Evolent Health LLC have been consolidated in the financial statements of Evolent Health, Inc. Following the Offering Reorganization, the IPO, various securities offerings and sales (as described in Note 4) and acquisitions (as described in Note 4), as of September 30, 2018, Evolent Health, Inc. owned 99.0% of Evolent Health LLC, holds 100% of the voting rights, is the sole managing member and, therefore, controls its operations.

Since its inception, the Company has incurred losses from operations. As of September 30, 2018, the Company had cash and cash equivalents of $221.8 million. The Company believes it has sufficient liquidity for the next 12 months as of the date the financial statements were available to be issued.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles

Basis of Presentation

In our opinion, the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to fairly state our financial position, results of operations, and cash flows. The Consolidated Balance Sheet at December 31, 2017, has been derived from audited financial statements as of that date. The interim consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain footnote disclosures normally included in financial statements prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) have been omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (“SEC”). The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our 2017 Form 10-K.

Summary of Significant Accounting Policies
 
Certain GAAP policies that significantly affect the determination of our financial position, results of operations and cash flows, are summarized below. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2017 Form 10-K for a complete summary of our significant accounting policies.

Accounting Estimates and Assumptions

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including variable consideration, discounts and credits, estimated selling prices for performance obligations in contracts with multiple performance obligations, claims reserves, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.

Principles of Consolidation
 
The consolidated financial statements include the accounts of Evolent Health, Inc. and its subsidiaries. All inter-company accounts and transactions are eliminated in consolidation.

Operating Segments

Operating segments are defined as components of a business that earn revenue and incur expenses for which discrete financial information is available that is evaluated, on a regular basis, by the chief operating decision maker (“CODM”) to decide how to allocate resources and assess performance. The Company operates through two segments: (1) Services, and (2) True Health. Our Services segment consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services. Our True Health segment consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses. See Note 17 for a discussion of our operating results by segment.

Revenue Recognition

Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. See “Changes in Accounting Principles” below for our updated revenue recognition policy as a result of our adoption of Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers.

Our True Health segment derives revenue from premiums that are earned over the terms of the related insurance policies. The portion of premiums that will be earned in the future or are received prior to the effectiveness of the policy are deferred and reported as premiums received in advance. These amounts are generally classified as short-term deferred revenue on our Consolidated Balance Sheets.
Restricted Cash and Restricted Investments

Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:

 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Collateral for letters of credit
 
 
 
 
 
 
for facility leases (1)
 
$
3,710

 
 
$
3,812

 
Collateral with financial institutions (2)
 
22,028

 
 
24,725

 
Claims processing services (3)
 
8,942

 
 
26,286

 
Collateral for reinsurance agreement (4)
 
10,000

 
 
10,000

 
Other
 
1,042

 
 
862

 
Total restricted cash
 
 
 
 
 
 
and restricted investments
 
45,722

 
 
65,685

 
 
 
 
 
 
 
 
Current restricted investments
 

 
 
8,150

 
Current restricted cash
 
42,328

 
 
54,248

 
Total current restricted cash
 
 
 
 
 
 
and restricted investments
 
42,328

 
 
62,398

 
 
 
 
 
 
 
 
Noncurrent restricted investments
 
712

 
 
605

 
Noncurrent restricted cash
 
2,682

 
 
2,682

 
Total noncurrent restricted cash
 
 
 
 
 
 
and restricted investments
 
$
3,394

 
 
$
3,287

 

(1) Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note 9 for further discussion of our lease commitments.
(2) Represents collateral held with financial institutions for risk-sharing arrangements. As of September 30, 2018, and December 31, 2017, approximately $22.0 million and $16.6 million of the collateral amount was in a trust account and invested in a money market fund. The amounts invested in money market funds are considered restricted cash and are carried at fair value, which approximates cost. See Note 15 for further discussion of our fair value measurement. As of December 31, 2017, approximately $8.2 million of the collateral amount was invested in restricted certificates of deposit with remaining maturities of less than 12 months. The restricted investments are classified as held-to-maturity and stated at amortized cost. Fair value of the certificates of deposit is determined using Level 2 inputs and approximates amortized cost as of December 31, 2017. See Note 9 for further discussion of our risk-sharing arrangements.
(3) Represents cash held by Evolent on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.
(4) Represents restricted cash required as part of our capital only reinsurance agreement to provide balance sheet support to NMHC. There is no transfer of underwriting risk to Evolent and we are not at risk for any cash payments on behalf of NMHC as part of the agreement. The reinsurance agreement is further discussed in Note 9. As of September 30, 2018, the full $10.0 million amount was invested in a money market fund. The amount invested in the money market fund is considered restricted cash and is carried at fair value, which approximates cost. As of December 31, 2017, the full $10.0 million amount was held in a FDIC participating bank account.

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statements of cash flows.

 
As of September 30,
 
As of December 31,
 
2018
 
2017
 
2017
 
2016
Cash and cash equivalents
$
221,837

 
$
287,143

 
$
238,433

 
$
134,563

Restricted cash and restricted investments
45,722

 
16,932

 
65,685

 
40,416

Restricted investments included in
 
 
 
 
 
 
 
restricted cash and restricted investments
(712
)
 
(8,150
)
 
(8,755
)
 
(4,950
)
Total cash and cash equivalents and restricted cash
 
 
 
 
 
 
 
shown in the consolidated statements of cash flows
$
266,847

 
$
295,925

 
$
295,363

 
$
170,029



Notes Receivable

Notes receivable are carried at the face amount of each note plus respective accrued interest receivable, less received payments. The Company does not typically carry notes receivable in the course of its regular business, but contributed $20.0 million in the form of an implementation funding loan (the “Implementation Loan”) under an agreement with a current customer entered during the year ended December 31, 2017. The Implementation Loan is expected to support implementation services to assist the customer in expanding its Medicaid membership. The Implementation Loan carries a fixed interest rate of 2.5% per annum and the terms of the agreement governing the Implementation Loan require it to be repaid in ten equal monthly installments of $2.0 million, plus accrued interest, during 2018. As of September 30, 2018, the outstanding principal balance of the Implementation Loan was $6.0 million, excluding approximately $0.1 million of accrued interest. As of December 31, 2017, the outstanding principal balance of the Implementation Loan was $20.0 million, excluding approximately $0.1 million of accrued interest.

Intangible Assets, Net

Identified intangible assets are recorded at their estimated fair values at the date of acquisition and are amortized over their respective estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are used. The Company acquired additional intangible assets in conjunction with a strategic acquisition made during 2018. Information regarding the determination and allocation of the fair value of the acquired assets and liabilities is further described within Note 4.

The following summarizes the estimated useful lives by asset classification:

Corporate trade name
20 years
Customer relationships
15-25 years
Technology
5 years
Provider network contracts
5 years


Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the asset’s carrying value. The Company evaluates recoverability by determining whether the undiscounted cash flows expected to result from the use and eventual disposition of that asset or group exceed the carrying value at the evaluation date. If the undiscounted cash flows are not sufficient to cover the carrying value, the Company measures an impairment loss as the excess of the carrying amount of the long-lived asset or group over its fair value. See Note 7 for additional discussion regarding our intangible assets.

Goodwill

We recognize the excess of the purchase price, plus the fair value of any non-controlling interests in the acquiree, over the fair value of identifiable net assets acquired as goodwill. Goodwill is not amortized, but is reviewed at least annually for indications of impairment, with consideration given to financial performance and other relevant factors. We perform impairment tests of goodwill at a reporting unit level, which is consistent with the way management evaluates our business. Goodwill is assigned to the reporting unit that benefits from the synergies arising from each business combination.

Foreign Currency

The Company established an international subsidiary during the first quarter of 2018. The functional currency of our international subsidiary is the Indian Rupee. We translate the financial statements of this subsidiary to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenue, costs, and expenses. Translation gains and losses are recorded in accumulated other comprehensive income (loss) as a component of shareholders' equity. We recorded a foreign currency translation loss of $0.1 million and $0.3 million on our Consolidated Statements of Operations for the three and nine months ended September 30, 2018, which resulted in an “Accumulated other comprehensive loss” of $0.3 million on our Consolidated Balance Sheet as of September 30, 2018.

Changes in Accounting Principles

Adoption of ASU 2014-09, Revenue from Contracts with Customers

As discussed in Note 3, the Company adopted ASU 2014-09, Revenue from Contracts with Customers, effective January 1, 2018. The following is our updated accounting policy with respect to revenue recognition for our Services segment.

Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. Revenue is recognized when control of the services is transferred to our customers. We use the following 5-Step model, outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), to determine revenue recognition on our contracts with customers:

Identify the contract(s) with a customer
Identify the performance obligations in the contract
Determine the transaction price
Allocate the transaction price to performance obligations
Recognize revenue when (or as) the entity satisfies a performance obligation

Transformation Services Revenue

Transformation services consist of strategic assessments, or Blueprint contracts, and implementation services whereby we assist the customer in launching its population health or health plan strategy. In certain cases, transformation services can also include revenue associated with our support of certain one-time wind-down activities for clients who are exiting a line of business or population. The transformation services are usually completed within 12 months. We generally receive a fixed fee for transformation services and recognize revenue over time using an input method based on hours incurred compared to the total estimated hours required to satisfy our performance obligation.

Platform and Operations Services Revenue

Platform and operations services generally include multi-year arrangements with customers to provide various population health, health plan operations and claims processing services on an ongoing basis, as well as transition or run-out services to customers receiving primarily third-party administration (“TPA”) services. Our performance obligation in these arrangements is to provide an integrated suite of services, including access to our platform that is customized to meet the specialized needs of our customers. Generally we will apply the series guidance to the performance obligation as we have determined that each time increment is distinct. We primarily utilize a variable fee structure for these services that typically include a monthly payment that is calculated based on a specified per member per month rate, multiplied by the number of members that our partners are managing under a value-based care arrangement or a percentage of plan premiums. Our arrangements may also include other variable fees related to service level agreements, shared medical savings arrangements and other performance measures. Variable consideration is estimated using the most likely amount based on our historical experience and best judgment at the time. Due to the nature of our arrangements certain estimates may be constrained if it is probable that a significant reversal of revenue will occur when the uncertainty is resolved. We recognize revenue for platform and operations services over time using the time elapsed output method. Fixed consideration is recognized ratably over the contract term. In accordance with the series guidance, we allocate variable consideration to the period to which the fees relate.

Contracts with Multiple Performance Obligations

Our contracts with customers may contain multiple performance obligations, primarily when the customer has requested both transformation services and platform and operations services as these services are distinct from one another. When a contract has multiple performance obligations, we allocate the transaction price to each performance obligation based on the relative standalone selling price using the expected cost margin approach. This approach requires estimates regarding both the level of effort it will take to satisfy the performance obligation as well as fees that will be received under the variable pricing model. We also take into consideration customer demographics, current market conditions, the scope of services and our overall pricing strategy and objectives when determining the standalone selling price.

Principal vs Agent

We occasionally use third parties to assist in satisfying our performance obligations. In order to determine whether we are the principal or agent in the arrangement, we review each third-party relationship on a contract by contract basis. We are an agent when our role is to arrange for another entity to provide the services to the customer. In these instances, we do not control the service before it is provided and recognize revenue on a net basis. We are the principal when we control the good or service prior to transferring control to the customer. We recognize revenue on a gross basis when we are the principal in the arrangement.

In accordance with the requirements under ASU 2014-09, the impact of adoption to our consolidated financial statements was as follows. See Note 5 for additional disclosures regarding Evolent's contracts with customers.

Condensed Consolidated Statements of Operations
 
 
 
 
 
 
 
 
 
(unaudited, in thousands)
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended September 30, 2018
 
 
 
 
 
Amounts without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Revenue
 
 
 
 
 
 
 
 
 
Transformation services
 
$
9,230

 
 
$
9,556

 
 
$
(326
)
 
Platform and operations services
 
118,094

 
 
117,942

 
 
152

 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
 
 
presented separately below)
 
73,967

 
 
77,409

 
 
(3,442
)
 
Selling, general and administrative expenses
 
59,566

 
 
59,676

 
 
(110
)
 
Income (loss) before income taxes and non-controlling interests
 
(12,420
)
 
 
(15,798
)
 
 
3,378

 
 
 
 
 
 
 
 
 
 
 
 
For the Nine Months Ended September 30, 2018
 
 
 
 
 
Amounts without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Revenue
 
 
 
 
 
 
 
 
 
Transformation services
 
$
23,950

 
 
$
25,272

 
 
$
(1,322
)
 
Platform and operations services
 
341,258

 
 
339,485

 
 
1,773

 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
 
 
presented separately below)
 
214,945

 
 
218,786

 
 
(3,841
)
 
Selling, general and administrative expenses
 
172,495

 
 
173,644

 
 
(1,149
)
 
Income (loss) before income taxes and non-controlling interests
 
(36,622
)
 
 
(42,063
)
 
 
5,441

 

Condensed Consolidated Balance Sheets
 
 
 
 
 
 
 
 
 
(unaudited, in thousands)
 
 
 
 
 
 
 
 
 
 
As of September 30, 2018
 
 
 
 
 
Balances without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Assets
 
 
 
 
 
 
 
 
 
Accounts receivable, net
 
$
60,054

 
 
$
57,848

 
 
$
2,206

 
Contract assets (current)
 
3,705

 
 

 
 
3,705

 
Contract assets (noncurrent)
 
1,000

 
 

 
 
1,000

 
Contract cost assets
 
14,252

 
 

 
 
14,252

 
 
 
 
 
 
 
 
 
 
 
Liabilities and Shareholders' Equity (Deficit)
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
Deferred revenue
 
$
22,360

 
 
$
24,100

 
 
$
(1,740
)
 
Other long-term liabilities
 
10,885

 
 
10,746

 
 
139

 
 
 
 
 
 
 
 
 
 
 
Shareholders' Equity (Deficit)
 
 
 
 
 
 
 
 
 
Retained earnings (accumulated deficit)
 
66,696

 
 
44,580

 
 
22,116

 
Non-controlling interests
 
10,008

 
 
9,361

 
 
647

 



Adoption of ASU 2016-18, Statement of Cash Flows: Restricted Cash

The Company adopted ASU 2016-18, Statement of Cash Flows: Restricted Cash, effective December 31, 2017, using the retroactive transition method, which resulted in the recast of our statement of cash flows for each period presented. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 2” in our 2017 Form 10-K for further information about the adoption.

The amendments in the ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.

A significant portion of the Company’s restricted cash consists of cash held on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed. Under the previous standard, there was no net impact to the statement of cash flows related to these amounts as the changes in accounts payable and accounts receivable were offset by the change in restricted cash. Upon adoption of ASU 2016-18, the change in restricted cash held on behalf of partners for claims processing would no longer net to zero, thereby potentially having a significant impact on cash flows from operations period over period. Given the pass-through nature of these claim payments, the change in restricted cash held on behalf of partners for claims processing is presented within cash flows from financing activities on our statements of changes in cash flows.

The following table summarizes the impact of the change in accounting principle to the Company’s Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 (in thousands):

 
For the Nine Months Ended September 30, 2017
 
As Reported
Adjustments
As Adjusted
Cash Flows from Investing Activities
 
 
 
 
 
 
 
 
Purchases and maturities of restricted investments
 
$

 
 
$
(3,200
)
 
 
$
(3,200
)
Change in restricted cash and restricted investments
 
(2,164
)
 
 
2,164

 
 

Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) investing activities
 
17,003

 
 
(1,036
)
 
 
15,967

 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities
 
 
 
 
 
 
 
 
Change in restricted cash held on behalf of
 
 
 
 
 
 
 
 
partners for claims processing
 

 
 
(25,648
)
 
 
(25,648
)
Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) financing activities
 
169,570

 
 
(25,648
)
 
 
143,922

 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash
 
 
 
 
 
 
 
 
equivalents and restricted cash
 
152,580

 
 
(26,684
)
 
 
125,896

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of beginning-of-period
 
134,563

 
 
35,466

 
 
170,029

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of end-of-period
 
$
287,143

 
 
$
8,782

 
 
$
295,925

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recently Issued Accounting Standards
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Recently Issued Accounting Standards
Recently Issued Accounting Standards

Adoption of New Accounting Standards

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting. The update expands the scope of ASC Topic 718, Compensation - Stock Compensation (“ASC 718”), to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU specifies that ASC 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments in the update also clarify that ASC 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606. The update is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity’s adoption date of ASC 606. We adopted the requirements of this standard effective July 1, 2018, and there was no impact to our financial condition and results of operations for the three and nine months ended September 30, 2018. Going forward, we do not expect the adoption to have a material impact on our financial condition or results of operations.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, in order to clarify the principles of recognizing revenue. This standard establishes the core principle of recognizing revenue to depict the transfer of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB defines a five-step process that systematically identifies the various components of the revenue recognition process, culminating with the recognition of revenue upon satisfaction of an entity’s performance obligations. By completing all five steps of the process, the core principles of revenue recognition will be achieved. The new revenue standard (including updates) is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. The guidance permits two methods of adoption: i) the full retrospective method applying the standard to each prior reporting period presented, or ii) the modified retrospective method with a cumulative effect of initially applying the guidance recognized at the date of initial application. The standard also allows entities to apply certain practical expedients at their discretion. The Company adopted the standard effective January 1, 2018, using the modified retrospective method for only contracts that were not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC Topic 605, Revenue Recognition (“ASC 605”). The adoption of this standard resulted in changes related to revenue recognition for contracts that contain certain features, such as variable consideration. These changes generally accelerate revenue recognition. In addition, certain customer setup costs, which have historically been expensed as incurred, will now be capitalized. Evolent recognized the cumulative effect of applying the new revenue standard as a $17.3 million adjustment to the opening balance of retained earnings, including non-controlling interests, in the first quarter of 2018, primarily as a result of capitalization of expenses related to contract acquisition and fulfillment costs and acceleration of revenue due to variable consideration estimation. See Note 5 for additional disclosures regarding Evolent's contracts with customers. See Note 2 for updated revenue recognition accounting policy and the impact of adopting the new revenue recognition standard on Evolent’s financial statements.

Future Adoption of New Accounting Standards

In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal Use Software: Customers Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Services Contract. The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The amendments in this update should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We are currently evaluating the impact of adoption on our financial condition and results of operations.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. With respect to assets measured at amortized cost, such as held-to-maturity assets, the update requires presentation of the amortized cost net of a credit loss allowance. The update eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses as opposed to the previous standard, when an entity only considered past events and current conditions. With respect to available for sale debt securities, the update requires that credit losses be presented as an allowance rather than as a write-down. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We intend to adopt the requirements of this standard effective January 1, 2020, and are currently evaluating the impact of the adoption on our financial condition and results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight‑line basis over the term of the lease, respectively. A lessee is also required to record a right‑of‑use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU 2016-02 (ASC Topic 842) supersedes the previous leases standard, ASC 840, Leases. The ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available.

The Company has formulated an implementation team that is currently engaged in the evaluation process. We intend to adopt the requirements of this standard effective January 1, 2019, using a modified retrospective approach. We expect to take advantage of the package of practical expedients permitted within the new standard. In July 2018, the FASB issued ASU 2018-11, which is intended to make targeted improvements to ASU 2016-02. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The requirements of ASU 2018-11 are effective on the same date as the requirements of ASU 2016-02. Pursuant to ASU 2018-11, the Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements and recognize a cumulative-effect adjustment to the opening balance of retaining earnings. We anticipate that this standard will result in a material increase in the assets and liabilities on our consolidated balance sheets; however, we do not believe adoption will have a material impact on our results of operations.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Transactions
9 Months Ended
Sep. 30, 2018
Organizational Transactions [Abstract]  
Transactions
Transactions

Business Combinations

New Mexico Health Connections

On January 2, 2018, the Company, through its wholly-owned subsidiary, True Health, completed its previously announced acquisition of assets related to NMHC’s commercial, small and large group business. The assets include a health plan management services organization with a leadership team and employee base with experience working locally with providers to run NMHC’s suite of preventive, disease and care management programs. The consideration paid by the Company in connection with the acquisition consisted of $10.3 million in cash (subject to certain adjustments), of which $0.3 million was deposited in an escrow account. This acquisition is expected to allow the Company to leverage its platform to support a value-based, provider-centric model of care in New Mexico.

The Company commenced operations of the commercial health plan and began reporting the results of True Health as a new reportable segment during the first quarter of 2018. See Note 17 for further information about the Company’s segment reporting. At the time of the acquisition, the Company also entered into a managed services agreement (“MSA”) with NMHC to support its ongoing business. During the fourth quarter of 2017, the Company also entered into a reinsurance agreement with NMHC to provide balance sheet support. See Note 9 for further discussion of the reinsurance agreement. The MSA and reinsurance agreement were considered separate transactions and accounted for outside of the business combination. Therefore, there is no allocation of purchase price to these agreements at fair value.

The Company incurred approximately $1.2 million in transaction costs related to the NHMC transaction, materially all of which were recorded within “Selling, general and administrative expenses” on our Consolidated Statements of Operations for the year ended December 31, 2017. The transaction was accounted for as a business combination using purchase accounting.

The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of January 2, 2018, as follows (in thousands):

Purchase consideration
 
Cash paid to NMHC
$
10,000

Cash paid to escrow agent
252

Total consideration
$
10,252

 
 
Identifiable intangible assets acquired and liabilities assumed
 
Customer relationships
$
2,700

Provider network contracts
2,300

Above market lease
(100
)
Accrued compensation and employee benefits
(474
)
 
 
Goodwill
5,826

Net assets acquired
$
10,252



Identifiable intangible assets associated with customer relationships and provider network contracts will be amortized on a straight-line basis over their estimated useful lives of 15 and 5 years, respectively. The customer relationships represent existing contracts in place to provide health plan services to a number of large and small group customers throughout the state of New Mexico. The provider network contracts represent a network of hospitals and physicians to service the health plan customers. The fair value of the customer relationship intangible asset was primarily determined using the income approach. The income approach estimates fair value for an asset based on the present value of cash flows projected to be generated by the asset. Projected cash flows are discounted at a required rate of return that reflects the relative risk of achieving the cash flows and the time value of money. The fair value of the provider network intangible asset was primarily determined using the cost approach. The cost approach estimates the fair value for an asset based on the amount it would cost to replace the asset. Goodwill is calculated as the difference between the acquisition date fair value of the total consideration and the fair value of the net assets acquired, and represents the future economic benefits that we expect to achieve as a result of the acquisition. Goodwill associated with the acquisition of True Health is allocated entirely to the True Health segment. The goodwill is attributable primarily to the acquired workforce and expected cost synergies, none of which qualify for recognition as a separate intangible asset. Goodwill is considered an indefinite-lived asset. The transaction is an asset acquisition for tax purposes, and as such the tax-basis in the acquired assets is equal to the book-basis fair value calculated and is recorded at the True Health legal entity. Therefore, no opening balance sheet deferred tax liability was recorded.

The amounts above reflect management’s preliminary estimate of the fair value of the tangible and intangible assets acquired and liabilities assumed based on a valuation performed using currently available information. Any remaining adjustments are expected to be finalized within one year of the acquisition date.

True Health is a separate segment, and its results of operations are provided in Note 17 - Segment Reporting.

Pro Forma Financial Information (Unaudited)

The unaudited pro forma Consolidated Statements of Operations presented below gives effect to the NMHC transaction as if it took place on January 1, 2017. The following pro forma information includes adjustments to:

reclassify transaction costs related to the NMHC transaction to the period beginning January 1, 2017;
record revenue and expenses related to the MSA beginning January 1, 2017; and
record amortization expenses related to intangible assets beginning January 1, 2017, for intangible assets acquired as part of the NMHC transaction.

This pro forma data is presented for informational purposes only and does not purport to be indicative of the results of future operations or of the results that would have occurred had the transactions described above occurred in the specified prior periods. The pro forma adjustments are based on available information and assumptions that the Company believes are reasonable to reflect the impact of these transactions on the Company’s historical financial information on a pro forma basis (in thousands, except per share data).
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Revenue
$
149,947

 
$
129,820

 
$
433,959

 
$
378,801

Net income (loss)
(12,555
)
 
(11,320
)
 
(36,651
)
 
(65,113
)
Net income (loss) attributable to non-controlling interests
(126
)
 
(413
)
 
(680
)
 
(8,414
)
Net income (loss) attributable to Evolent Health, Inc.
(12,429
)
 
(10,907
)
 
(35,971
)
 
(56,699
)
 
 
 
 
 
 
 
 
Net income (loss) per Common Share available to common shareholders
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.16
)
 
$
(0.47
)
 
$
(0.93
)
Diluted
(0.16
)
 
(0.16
)
 
(0.47
)
 
(0.93
)

Securities Offerings and Sales

Under an exchange agreement we entered into at the time of our IPO, we granted TPG, The Advisory Board Company (“The Advisory Board”) and Ptolemy Capital, LLC (“Ptolemy Capital”) (together, the “Investor Stockholders”) an exchange right that allows receipt of newly-issued shares of the Company’s Class A common stock in exchange (a “Class B Exchange”) for an equal number of shares of the Company’s Class B common stock (which are subsequently canceled) and an equal number of Evolent Health LLC’s Class B common units (“Class B units”). Class B units received by the Company from relevant Investor Stockholders are simultaneously exchanged for an equivalent number of Class A units of Evolent Health LLC, and Evolent Health LLC cancels the Class B units it receives in the Class B Exchange. The cancellation of the Class B units results in an increase in the Company’s economic interest in Evolent Health LLC.

March and June 2018 Private Sales

In March 2018, The Advisory Board sold 3.0 million shares of the Company’s Class A common Stock in a private sale (the “March 2018 Private Sale”). The shares sold in the March 2018 Private Sale consisted of 1.2 million existing shares of the Company’s Class A common stock owned by The Advisory Board and 1.8 million newly-issued shares of the Company’s Class A common stock received by The Advisory Board pursuant to a Class B Exchange for all of its outstanding shares of the Company’s Class B common stock and Class B units. The Company did not receive any proceeds from the March 2018 Private Sale. Subsequent to this Class B Exchange, in June 2018, The Advisory Board sold all of their remaining shares of the Company’s Class A common stock and no longer owns any shares of our Class A common stock.

As a result of this Class B Exchange and Evolent Health LLC’s cancellation of the Class B units during the March 2018 Private Sale, the Company’s economic interest in Evolent Health LLC increased from 96.6% to 98.9% immediately following the March 2018 Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

August 2017 Primary Offering

In August 2017, the Company completed a primary offering of 8.8 million shares of its Class A common stock at a price to the public of $19.85 per share and a corresponding price to the underwriters of $19.01 per share (the “August 2017 Primary”). This offering resulted in net cash proceeds to the Company of approximately $166.9 million (gross proceeds of $175.0 million, net of $8.1 million in underwriting discounts and stock issuance costs). For each share of Class A common stock issued by Evolent Health, Inc., the Company received a corresponding Class A common unit from Evolent Health LLC in exchange for contributing the issuance proceeds to Evolent Health LLC. As a result of the Class A common stock and Class A common units issued during the August 2017 Primary, the Company’s economic interest in Evolent Health LLC increased from 96.1% to 96.6% immediately following the August 2017 Primary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

Secondary Offerings

The Investor Stockholders initiated several Class B Exchanges as part of various secondary offerings during 2017, thus increasing the Company’s economic interest in Evolent Health LLC, as discussed below. The Company did not receive any proceeds from the secondary offerings described below.

June 2017 Secondary Offering

In June 2017, the Company completed a secondary offering of 4.5 million shares of its Class A common stock at a price to the underwriters of $25.87 per share (the “June 2017 Secondary”).

The shares sold in the June 2017 Secondary consisted of 0.7 million existing shares of the Company’s Class A common stock owned and held by certain Investor Stockholders and 3.8 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.

As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the June 2017 Secondary, the Company’s economic interest in Evolent Health LLC increased from 90.5% to 96.1% immediately following the June 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

May 2017 Secondary Offering

In May 2017, the Company completed a secondary offering of 7.0 million shares of its Class A common stock at a price to the underwriters of $24.30 per share (the “May 2017 Secondary”). The shares were sold by the Investor Stockholders and certain management selling stockholders (together with the Investor Stockholders, the “Selling Stockholders”).

The shares sold in the May 2017 Secondary consisted of 3.1 million existing shares of the Company’s Class A common stock owned and held by the Selling Stockholders, 3.8 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges and 0.1 million shares issued upon the exercise of options by certain management selling stockholders.

As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the May 2017 Secondary, the Company’s economic interest in Evolent Health LLC increased from 84.9% to 90.5% immediately following the May 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

March 2017 Secondary Offering

In March 2017, the Company completed a secondary offering of 7.5 million shares of its Class A common stock at a price to the underwriters of $19.53 per share (the “March 2017 Secondary”).

The shares sold in the March 2017 Secondary consisted of 3.1 million existing shares of the Company’s Class A common stock owned and held by the Investor Stockholders and 4.4 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.

As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the March 2017 Secondary, the Company’s economic interest in Evolent Health LLC increased from 77.4% to 83.9% immediately following the March 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

In connection with the March 2017 Secondary, the underwriters exercised, in full, their option to purchase an additional 1.1 million shares of Class A common stock (the “March 2017 Option to Purchase Additional Shares”) from the Investor Stockholders at a price of $19.53 per share. The March 2017 Option to Purchase Additional Shares closed in May 2017.

The shares sold in the March 2017 Option to Purchase Additional Shares consisted of 0.5 million existing shares of the Company’s Class A common stock owned and held by certain Investor Stockholders. It also included 0.6 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges.

As a result of the Class B Exchanges and Evolent Health LLC’s cancellation of the Class B units during the March 2017 Option to Purchase Additional Shares, the Company’s economic interest in Evolent Health LLC increased from 83.9% to 84.9% immediately following the March 2017 Option to Purchase Additional Shares, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

The June 2017 Secondary, May 2017 Secondary, March 2017 Secondary and March 2017 Option to Purchase Additional Shares are collectively referred to as the “2017 Secondary Offerings.”

The Company’s economic interest in Evolent Health LLC will increase if further Class B Exchanges occur.

Asset Acquisitions

Accordion Health, Inc.

On June 8, 2017, the Company entered into an agreement to acquire Accordion Health, Inc. (“Accordion”) for $3.2 million (the “Accordion Purchase Agreement”). Accordion provides technology that the Company believes enhances its risk-adjustment factor services to its partners. In addition to technology assets, the software development team from Accordion joined Evolent as full-time employees. Under the terms of the Accordion Purchase Agreement, members of the software development team will be eligible for an additional $0.8 million earn-out, contingent upon the completion of specified software development targets.

We accounted for the transaction as an asset acquisition as substantially all of the fair value of the gross assets acquired was concentrated in a single identified asset, thus satisfying the requirements of the screen test introduced in ASU 2017-01. The assets acquired in the transaction were measured based on the amount of cash paid to Accordion, including transaction costs, as the fair value of the assets given was more readily determinable than the fair value of the assets received. We classified and designated the identifiable assets acquired as a $3.3 million technology intangible asset, inclusive of approximately $0.1 million of capitalized transaction costs. We also assessed and determined the useful life of the acquired intangible assets to be five years, subject to amortization. The Company will account for the contingent earn-out as a post-acquisition expense as the specified software development targets are achieved. The transaction was a taxable stock acquisition and the Company recognized deferred tax liability of $2.0 million related to the book-tax basis difference in the acquired asset, which resulted in a $2.0 million increase in the value of the intangible asset. The additional deferred tax liability represents a future source of taxable income that enables the Company to release some of its previously established valuation allowance, the reduction of which is accounted for outside of acquisition accounting, resulting in income tax benefit.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition
9 Months Ended
Sep. 30, 2018
Revenue from Contract with Customer [Abstract]  
Revenue Recognition
Revenue Recognition

As discussed in Note 3, we adopted ASU 2014-09, effective January 1, 2018, which introduces ASC 606. See Note 2 for the updated revenue recognition policy and the impact of adopting the new revenue recognition standard on the Company’s financial statements. The following are other relevant disclosures as required by the adoption of ASU 2014-09. Provisions within ASC 606 are only applicable to revenues derived from our Services segment.

Disaggregation of Revenue

The following table represents Evolent’s Services segment revenue disaggregated by revenue type for the three and nine months ended September 30, 2018 (in thousands), excluding revenues from our True Health segment and from our downside risk sharing arrangements through our insurance subsidiary, which are accounted for under ASC 944, Financial Services-Insurance.

  
For the Three
For the Nine
 
Months Ended
Months Ended
  
September 30,
September 30,
 
 
2018
 
 
2018
 
Services Revenue
 
 
 
 
 
 
Transformation services
 
$
9,230

 
 
$
23,950

 
Platform and operations services
 
116,226

 
 
335,509

 


Transaction Price Allocated to the Remaining Performance Obligations

For contracts with a term that is greater than one year, we have allocated approximately $125.0 million of transaction price to performance obligations that are unsatisfied or partially unsatisfied as of September 30, 2018. We do not include variable consideration that is allocated entirely to a wholly unsatisfied performance obligation accounted for under the series guidance in the calculation. As a result, the balance represents the value of the fixed consideration in our long-term contracts that will be recognized as revenue in a future period and excludes the majority of our platform and operations revenue, which is primarily derived based on variable consideration as discussed in Note 2. We expect to recognize revenue on approximately 60% and 84% of these remaining performance obligations by December 31, 2019, and December 31, 2020, respectively, with the remaining balance to be recognized thereafter. However, because our existing contracts may be canceled or renegotiated including for reasons outside our control, the amount of this revenue that we actually receive may be less than this estimate.

Contract Balances

Contract balances consist of accounts receivable, contract assets and deferred revenue. Contract assets are recorded when the right to consideration for services is conditional on something other than the passage of time. Contract assets relating to unbilled receivables are transferred to accounts receivable when the right to consideration becomes unconditional. We classify contract assets as current or noncurrent based on the timing of our rights to the unconditional payments. Our contract assets are generally classified as current and recorded within “Contract assets” on our consolidated balance sheets. Our current accounts receivable are classified within “Accounts receivable, net” on our consolidated balance sheets and our noncurrent accounts receivable are classified within “Prepaid expenses and other noncurrent assets” on our consolidated balance sheets.

Deferred revenue includes advance customer payments and billings in excess of revenue recognized. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue. Our current deferred revenue is recorded within “Deferred revenue” on our consolidated balance sheets, and noncurrent deferred revenue is recorded within “Other long-term liabilities” on our consolidated balance sheets.

The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):

 
 
As of
 
 
As of
 
 
September 30,
January 1,
 
 
2018
 
2018
Short-term receivables (1)
 
$
58,190

 
 
$
47,131

 
Long-term receivables (1)
 
6,550

 
 

 
Short-term contract assets
 
3,705

 
 
3,710

 
Long-term contract assets
 
1,000

 
 
1,791

 
Short-term deferred revenue
 
22,360

 
 
26,147

 
Long-term deferred revenue
 
1,000

 
 
493

 
(1) Excludes pharmacy claims receivable and premiums receivable

During the nine months ended September 30, 2018, our contract asset balance decreased by $0.8 million, primarily as the right to the consideration became unconditional and the associated balance is reclassified to accounts receivable. During the nine months ended September 30, 2018, our deferred revenue decreased by $3.3 million, primarily as a result of the recognition of variable consideration estimate.

The amount of revenue recognized during the three and nine months ended September 30, 2018, from amounts included in deferred revenue at the beginning of the period was $3.7 million and $17.0 million, respectively. The amount of revenue recognized during the three and nine months ended September 30, 2018 from performance obligations satisfied (or partially satisfied) in previous periods, due primarily to net gain share as well as other estimates, was $9.4 million and $11.5 million, respectively.

Contract Costs

Certain bonuses and commissions earned by our sales team are considered incremental costs of obtaining a contract with a customer that we expect to be recoverable. The capitalized contract acquisition costs are classified as noncurrent assets and recorded within “Contract cost assets” on our consolidated balance sheets. Amortization expense is recorded within “Selling, general and administrative expenses” on the accompanying consolidated statements of operations. As of September 30, 2018, the Company had $2.0 million of contract acquisition cost assets, net of accumulated amortization, and amortization expense of $0.1 million and $0.2 million for the three and nine months ended September 30, 2018, respectively.

In our platforms and operations arrangements, we incur certain costs related to the implementation of our platform before we begin to satisfy our performance obligation to the customer. The costs, which we expect to recover, are considered costs to fulfill a contract. Our contract fulfillment costs primarily include our employee labor costs and third-party vendor costs. The capitalized contract fulfillment costs are classified as noncurrent and recorded within “Contract cost assets” on our consolidated balance sheets. Amortization expense is recorded within “Cost of revenue” on the accompanying consolidated statements of operations. As of September 30, 2018, the Company had $12.3 million of contract fulfillment cost assets, net of accumulated amortization, and amortization expense of $0.6 million and $1.7 million for the three and nine months ended September 30, 2018, respectively.

The majority of the contract cost balance was recorded as part of the transition adjustment that was recorded upon implementation of ASC 606. These costs are deferred and then amortized on a straight-line basis over a period of benefit that we have determined to be five years. The period of benefit was based on our technology, the nature of our customer arrangements and other factors.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, Net
9 Months Ended
Sep. 30, 2018
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net
Property and Equipment, Net

The following summarizes our property and equipment (in thousands):
 
 
 
As of
 
 
As of
 
  
September 30,
December 31,
  
 
2018
 
 
2017
 
Computer hardware
 
$
8,602

 
 
$
5,667

 
Furniture and equipment
 
3,038

 
 
2,448

 
Internal-use software development costs
 
73,679

 
 
48,557

 
Leasehold improvements
 
9,638

 
 
8,708

 
Total property and equipment
 
94,957

 
 
65,380

 
Accumulated depreciation and amortization
 
(26,265
)
 
 
(14,458
)
 
Total property and equipment, net
 
$
68,692

 
 
$
50,922

 


The Company capitalized $7.0 million and $25.1 million of internal-use software development costs for the three and nine months ended September 30, 2018, respectively, and $8.4 million and $20.4 million for the three and nine months ended September 30, 2017, respectively. The net book value of capitalized internal-use software development costs was $58.7 million and $42.1 million as of September 30, 2018, and December 31, 2017, respectively.

Depreciation expense related to property and equipment was $4.3 million and $11.8 million for the three and nine months ended September 30, 2018, respectively, of which amortization expense related to capitalized internal-use software development costs was $3.1 million and $8.5 million, respectively. Depreciation expense related to property and equipment was $2.3 million and $6.0 million for the three and nine months ended September 30, 2017, respectively, of which amortization expense related to capitalized internal-use software development costs was $1.2 million and $2.8 million, respectively.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets, Net
9 Months Ended
Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets, Net

Goodwill

Goodwill has an estimated indefinite life and is not amortized; rather, it is reviewed for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.

The Company has two reporting units: Services and True Health. Our annual goodwill impairment review occurs during the fourth quarter of each fiscal year. In interim periods between annual goodwill reviews, we also evaluate qualitative factors that could cause us to believe the estimated fair value of each of our reporting units may be lower than the carrying value and trigger a quantitative assessment, including, but not limited to (i) macroeconomic conditions, (ii) industry and market considerations, (iii) our overall financial performance, including an analysis of our current and projected cash flows, revenues and earnings, (iv) a sustained decrease in share price and (v) other relevant entity-specific events including changes in strategy, partners, or litigation.

We did not identify any qualitative factors that would trigger a quantitative goodwill impairment test during the nine months ended September 30, 2018. We will perform our annual impairment test as of October 31, 2018.

The following tables summarize the changes in the carrying amount of goodwill, by reportable segment, for the periods presented (in thousands):

 
 
For the Nine Months Ended September 30, 2018
 
 
 
Services
 
 
True Health
 
Consolidated
Balance as of beginning-of-period (1)
 
$
628,186

 
 
$

 
 
$
628,186

 
Goodwill Acquired (2)
 
1,234

 
 
5,826

 
 
7,060

 
Measurement period adjustments (2)
 
4

 
 

 
 
4

 
Foreign currency translation (2)
 
(162
)
 
 

 
 
(162
)
 
Balance as of end-of-period
 
$
629,262

 
 
$
5,826

 
 
$
635,088

 

(1) Net of cumulative inception to date impairment of $160.6 million.
(2) Goodwill acquired, measurement period adjustments and foreign currency translation are all related to transactions completed during the first quarter of 2018.
 
 
For the Year
 
 
 
Ended
 
 
 
December 31,
 
 
2017 (1)
 
Balance as of beginning-of-period (2)
 
$
626,569

 
Measurement period adjustments (3)
 
1,617

 
Balance as of end-of-period
 
$
628,186

 

(1) All of the goodwill was allocated to the Services segment as of December 31, 2017, as the True Health segment was not established until the first quarter of 2018.
(2) Net of cumulative inception to date impairment of $160.6 million.
(3) Represents measurement period adjustments related to Valence Health and Aldera. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” in our 2017 Form 10-K for further information regarding the Valence Health and Aldera transactions.

Intangible Assets, Net

Details of our intangible assets (in thousands) are presented below:

 
 
As of September 30, 2018
 
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
  
Useful Life
Amount
Amortization
Value
Corporate trade name
 
16.7
 
$
19,000

 
$
3,166

 
$
15,834

Customer relationships (1)
 
19.5
 
208,719

 
25,550

 
183,169

Technology
 
2.4
 
55,933

 
27,264

 
28,669

Below market lease, net
 
4.3
 
4,097

 
2,918

 
1,179

Provider network contracts
 
4.3
 
2,300

 
345

 
1,955

Total
 
 
 
$
290,049

 
$
59,243

 
$
230,806


(1) The increase in the gross carrying amount of the customer relationships intangible is attributable to $2.7 million of acquired customer relationships from the NMHC transaction and $2.5 million related the Vestica Healthcare LLC (“Vestica”) transaction. The Company acquired certain assets from Vestica in March 2016. The transaction included additional consideration of up to $4.0 million, which was being held in escrow and was recorded within “Prepaid expenses and other noncurrent assets” on our Consolidated Balance Sheets. In February 2018, the Company and Vestica reached an agreement to settle $3.5 million of the $4.0 million in escrow. Based on the terms of the settlement agreement, the Company reclassified the unamortized portion of the additional consideration from “Prepaid expenses and other noncurrent assets” into “Customer relationships” as of the settlement date. See Note 4 for further information about the NMHC transaction and see “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” of our 2017 Form 10-K for further information about the Vestica transaction.

 
 
As of December 31, 2017
  
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
 
Useful Life
Amount
Amortization
Value
Corporate trade name
 
17.4
 
$
19,000

 
$
2,454

 
$
16,546

Customer relationships
 
20.5
 
203,500

 
18,312

 
185,188

Technology
 
3.1
 
55,802

 
17,810

 
37,992

Below market lease, net
 
4.8
 
4,197

 
2,662

 
1,535

Total
 
 
 
$
282,499

 
$
41,238

 
$
241,261



Amortization expense related to intangible assets was $6.1 million and $18.0 million for the three and nine months ended September 30, 2018, respectively, and $5.3 million and $15.0 million for the three and nine months ended September 30, 2017, respectively.

Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the assets’ carrying value. We did not identify any circumstances during nine months ended September 30, 2018, that would require an impairment test for our intangible assets.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term Debt
9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Long-term Debt
Long-term Debt

In December 2016, the Company issued $125.0 million aggregate principal amount of its 2.00% Convertible Senior Notes due 2021 (the “2021 Notes”) in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2021 Notes were issued at par for net proceeds of $120.4 million. We incurred $4.6 million of debt issuance costs in connection with the 2021 Notes, which we are amortizing to non-cash interest expense using the straight line method over the contractual term of the 2021 Notes, since this method was not materially different from the effective interest method. The closing of the private placement of the 2021 Notes occurred on December 5, 2016.

Holders of the 2021 Notes are entitled to cash interest payments, which are payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2017, at a rate equal to 2.00% per annum. The 2021 Notes will mature on December 1, 2021, unless earlier repurchased or converted in accordance with their terms prior to such date. In addition, holders of the 2021 Notes may require the Company to repurchase their 2021 Notes upon the occurrence of a fundamental change at a price equal to 100.00% of the principal amount of the 2021 Notes being repurchased, plus any accrued and unpaid interest. Upon maturity, and at the option of the holders of the 2021 Notes, the principal amount of the notes may be settled via shares of the Company’s Class A common stock. For the three and nine months ended September 30, 2018 and 2017, the Company recorded approximately $0.6 million and $1.9 million, respectively, in interest expense and $0.2 million and $0.7 million, respectively, in non-cash interest expense related to the amortization of deferred financing costs.

The 2021 Notes are convertible into shares of the Company’s Class A common stock, based on an initial conversion rate of 41.6082 shares of Class A common stock per $1,000 principal amount of the 2021 Notes, which is equivalent to an initial conversion price of approximately $24.03 per share of the Company’s Class A common stock. In the aggregate, the 2021 Notes are initially convertible into 5.2 million shares of the Company’s Class A common stock (excluding any shares issuable by the Company upon a conversion in connection with a make-whole provision upon a fundamental change under the indenture between Evolent Health, Inc. and U.S. Bank National Association, as trustee, related to the 2.00% convertible senior notes due 2021, dated as of December 5, 2016).

The 2021 Notes are convertible, in multiples of $1,000 principal amount, at the option of the holders at any time prior to the close of business on the business day immediately preceding the maturity date. Upon conversion, we will deliver for each $1,000 principal amount of notes converted a number of shares of our Class A common stock equal to the applicable conversion rate (together with a cash payment in lieu of delivering any fractional share) on the third business day following the relevant conversion date.

Convertible Senior Notes Carrying Value

While the 2021 Notes are recorded on our accompanying unaudited interim consolidated balance sheets at their net carrying value of $122.1 million as of September 30, 2018, the 2021 Notes are privately traded by qualified institutional buyers (within the meaning of Rule 144A under the Securities Act of 1933, as amended) and their fair value was $169.1 million, based on a traded price on September 28, 2018, a Level 2 input. The fair value as of December 31, 2017, was $120.4 million, based on a traded price on December 29, 2017, a Level 2 input. The 2021 Notes also have embedded conversion options and contingent interest provisions, which have not been recorded as separate financial instruments.

The following table summarizes the carrying value of the long-term debt (in thousands):

 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Carrying value
 
$
122,082

 
 
$
121,394

 
Unamortized discount
 
2,918

 
 
3,606

 
Principal amount
 
$
125,000

 
 
$
125,000

 
Remaining amortization period (years)
 
3.2

 
 
3.9

 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
9 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies

Contingencies

Tax Receivables Agreement

In connection with the Offering Reorganization, the Company entered into the Tax Receivables Agreement (the “TRA”) with certain of its investors, which provides for the payment by the Company to these investors of 85% of the amount of the tax benefits, if any, that the Company is deemed to realize as a result of increases in our tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. These payment obligations are obligations of the Company. For purposes of the TRA, the benefit deemed realized by the Company will be computed by comparing its actual income tax liability to the amount of such taxes that the Company would have been required to pay had there been no increase to the tax basis of the assets of the Company as a result of the exchanges or had the Company had no NOL carryforward balance. The actual amount and timing of any payments under the TRA will vary depending upon a number of factors, including:
 
the timing of the exchanges and the price of the Class A shares at the time of the transaction, triggering a tax basis increase in the Company’s asset and a corresponding benefit to be realized under the TRA; and
the amount and timing of our taxable income - the Company will be required to pay 85% of the tax savings as and when realized, if any. If the Company does not have taxable income, it will not be required to make payments under the TRA for that taxable year because no tax savings were actually realized.

Due to the items noted above, and the fact that the Company is in a full valuation allowance position such that the deferred tax assets related to the Company’s historical pre-IPO losses and tax basis increase benefit from exchanges have not been realized, the Company has not recorded a liability pursuant to the TRA.

Litigation Matters

We are engaged from time to time in certain legal disputes arising in the ordinary course of business, including employment claims. When the likelihood of a loss contingency becomes probable and the amount of the loss can be reasonably estimated, we accrue a liability for the loss contingency. We continue to review accruals and adjust them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained, and our views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in our accrued liabilities would be recorded in the period in which such determination is made. The Company is not aware of any legal proceedings or claims as of September 30, 2018, that the Company believes will have, individually or in the aggregate, a material adverse effect on the Company’s financial position or result of operations.

Commitments

Commitments to Equity-Method Investees

The Company has contractual arrangements with its equity-method investees that will require the Company to provide operating capital support in the form of equity financing of up to $2.6 million as of September 30, 2018, in accordance with the Company’s contribution agreements with its equity-method investees. These obligations are outside of Company’s control and payment could be requested during 2018. The Company did not have any contingent commitments to equity-method investees as of December 31, 2017.

Letter of Credit

During the first quarter of 2017, the Company entered into an agreement to provide a letter of credit, for up to $5.0 million, to assist a customer in demonstrating adequate reserves to the customer’s state regulatory authorities. The letter of credit is effective from September 30, 2017 through June 30, 2019, and carries a quarterly facility rental fee of 0.80% per annum on the amount of the outstanding balance. The letter of credit will terminate after June 30, 2019. The letter of credit is presented at the face amount plus accrued facility rental fee, less received payments. There was no outstanding balance related to this letter of credit as of September 30, 2018, or December 31, 2017.

Lease Commitments

The Company has entered into lease agreements for its primary office locations in Arlington, Virginia, Lisle, Illinois, Chicago, Illinois, Albuquerque, New Mexico and Pune, India. Certain leases acquired as part of the Valence Health transaction included existing sublease agreements for office locations in Chicago, Illinois. The Company also has several smaller leases in various locations within Texas and California. Total rental expense, net of sublease income, on operating leases was $3.3 million and $10.1 million for the three and nine months ended September 30, 2018, respectively, and $3.0 million and $8.0 million for the three and nine months ended September 30, 2017, respectively.

In connection with various lease agreements, the Company is required to maintain $3.7 million in letters of credit and, as such, held $3.7 million in restricted cash and restricted investments as collateral for the letters of credit as of September 30, 2018.

Indemnifications

The Company’s customer agreements generally include a provision by which the Company agrees to defend its partners against third-party claims (a) for death, bodily injury, or damage to personal property caused by Company negligence or willful misconduct, (b) by former or current Company employees arising from such managed service agreements, (c) for intellectual property infringement under specified conditions and (d) for Company violation of applicable laws, and to indemnify them against any damages and costs awarded in connection with such claims. To date, the Company has not incurred any material costs as a result of such indemnities and has not accrued any liabilities related to such obligations in the accompanying consolidated financial statements.

Registration Rights Agreement

We entered into a registration rights agreement with The Advisory Board, the University of Pittsburgh Medical Center (“UPMC”), TPG and another investor to register for sale under the Securities Act of 1933, as amended, shares of our Class A common stock, including those delivered in exchange for Class B common stock and Class B common units. Subject to certain conditions and limitations, this agreement provides these investors with certain demand, piggyback and shelf registration rights. The registration rights granted under the registration rights agreement will terminate upon the date the holders of shares that are a party thereto no longer hold any such shares that are entitled to registration rights. Pursuant to our contractual obligations under this agreement, we filed a registration statement on Form S-3 with the SEC on July 28, 2016, which was declared effective on August 12, 2016.

Pursuant to certain terms of the registration rights agreement, certain Investor Stockholders sold 19.7 million shares of the Company’s Class A common stock during the 2017 Secondary Offerings, as discussed in Note 4. The Company incurred $0.3 million and $1.5 million in expenses related to the 2017 Secondary Offerings for the three and nine months ended September 30, 2017, pursuant to the terms of the registration rights agreement. The expenses were recorded within “Selling, general and administrative expenses” on our Consolidated Statements of Operations. We did not incur any expenses related to secondary offerings or other sales of shares by our Investor Stockholders for the three and nine months ended September 30, 2018.

We will continue to pay all expenses relating to any demand, piggyback or shelf registration, other than underwriting discounts and commissions and any transfer taxes, subject to specified conditions and limitations. The registration rights agreement includes customary indemnification provisions, including indemnification of the participating holders of shares of Class A common stock and their directors, officers and employees by us for any losses, claims, damages or liabilities in respect thereof and expenses to which such holders may become subject under the Securities Act of 1933, as amended, state law or otherwise.
 
Guarantees
 
As part of our strategy to support certain of our partners in the Next Generation Accountable Care Program, we entered into upside and downside risk sharing arrangements. Our downside risk-sharing arrangements are limited to our fees and are executed through our wholly-owned captive insurance company. To satisfy the capital requirements of our insurance entity as well as state insurance regulators, Evolent entered into letters of credit of $22.0 million as of September 30, 2018, to secure potential losses related to insurance services. This amount is in excess of our actuarial assessment of loss.

Reinsurance Agreement
 
During the fourth quarter of 2017, the Company entered into a 15-month, $10.0 million capital-only reinsurance agreement with NMHC, expiring on December 31, 2018. The purpose of the capital-only reinsurance is to provide balance sheet support to NMHC. There is no uncertainty to the outcome of the agreement as there is no transfer of underwriting risk to Evolent or True Health, and neither Evolent nor True Health is at risk for any cash payments on behalf of NMHC. As a result, this agreement does not qualify for reinsurance accounting. The Company will record a quarterly fee of approximately $0.2 million as non-operating income on its consolidated statements of operations and will maintain $10.0 million in restricted cash and restricted investments on its consolidated balance sheets for the duration of the reinsurance agreement.

UPMC Reseller Agreement

The Company and UPMC are parties to a reseller, services and non-competition agreement, dated August 31, 2011, which was amended and restated by the parties on June 27, 2013 (as amended through the date hereof, the “UPMC Reseller Agreement”). Under the terms of the UPMC Reseller Agreement, UPMC has appointed the Company as a non-exclusive reseller of certain services, subject to certain conditions and limitations specified in the UPMC Reseller Agreement. In consideration for the Company’s obligations under the UPMC Reseller Agreement and subject to certain conditions described therein, UPMC has agreed not to sell certain products and services directly to a defined list of 20 of the Company’s customers.
 
Credit and Concentration Risk

The Company is subject to significant concentrations of credit risk related to cash and cash equivalents and accounts receivable. As of September 30, 2018, approximately 72.3% of our $266.8 million of cash and cash equivalents (including restricted cash) were held in bank deposits with FDIC participating banks, approximately 27.4% were held in money market funds and less than 1.0% were held in international banks. While the Company maintains its cash and cash equivalents with financial institutions with high credit ratings, it often maintains these deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any realized losses on cash and cash equivalents to date.

The Company is also subject to significant concentration of accounts receivable risk as a substantial portion of our trade accounts receivable is derived from a small number of our partners. The following table summarizes those partners who represented at least 10.0% of our trade accounts receivable for the periods presented:
 
 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Customer B
 
*

 
 
11.8
%
 
Customer C
 
16.2
%
 
 
32.1
%
 
Customer D
 
*

 
 
16.5
%
 
 
* Represents less than 10.0% of the respective balance

In addition, the Company is subject to significant concentration of revenue risk as a substantial portion of our revenue is derived from a small number of contractual relationships with our operating partners.
 
The following table summarizes those partners who represented at least 10.0% of our revenue for the periods presented:
 
 
 
For the Three
 
For the Nine
 
 
Months Ended
 
Months Ended
 
 
September 30,
 
September 30,
 
 
2018
 
2017
 
2018
 
2017
Customer A
 
18.8
%
 
19.0
%
 
18.9
%
 
18.5
%
Customer B
 
*

 
*

 
*

 
10.0
%
 
* Represents less than 10.0% of the respective balance
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings (Loss) Per Common Share
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Earnings (Loss) Per Common Share
Earnings (Loss) Per Common Share
 
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Net income (loss)
$
(12,555
)
 
$
(13,129
)
 
$
(36,651
)
 
$
(55,977
)
Less:
 
 
 
 
 
 
 
Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Net income (loss) available for common shareholders (1) (2)
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding (2) (3)
77,999

 
70,328

 
76,871

 
60,867

 
 
 
 
 
 
 
 
Earnings (Loss) per Common Share
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.18
)
 
$
(0.47
)
 
$
(0.78
)
Diluted
(0.16
)
 
(0.18
)
 
(0.47
)
 
(0.78
)

(1) 
For periods of net loss, net income (loss) available for common shareholders is the same for both basic and diluted purposes.
(2) 
Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for one share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.
(3) 
For periods of net loss, shares used in the earnings (loss) per common share calculation represent basic shares as using diluted shares would be anti-dilutive.

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Exchangeable Class B common stock
766

 
2,654

 
1,251

 
8,846

Restricted stock units ("RSUs")
1,197

 
577

 
923

 
557

Stock options and performance-based stock options
2,698

 
2,976

 
2,486

 
3,031

Convertible senior notes
5,201

 
5,201

 
5,201

 
5,201

Total
9,862

 
11,408

 
9,861

 
17,635

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-based Compensation
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based Compensation
Stock-based Compensation

Total compensation expense by award type and line item in our consolidated financial statements was as follows (in thousands):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
  
September 30,
 
September 30,
  
2018
 
2017
 
2018
 
2017
Award Type
 
 
 
 
 
 
 
Stock options
$
2,139

 
$
4,291

 
$
7,009

 
$
12,452

Performance-based stock options
113

 
113

 
334

 
335

RSUs
1,795

 
1,304

 
5,217

 
3,385

Total
$
4,047

 
$
5,708

 
$
12,560

 
$
16,172

 
 
 
 
 
 
 
 
Line Item
 
 
 
 
 
 
 
Cost of revenue
$
376

 
$
401

 
$
1,130

 
$
1,143

Selling, general and
 
 
 
 
 
 
 
administrative expenses
3,671

 
5,307

 
11,430

 
15,029

Total
$
4,047

 
$
5,708

 
$
12,560

 
$
16,172



No stock-based compensation in the totals above was capitalized as software development costs for the three and nine months ended September 30, 2018 and 2017, respectively.

Stock-based awards were granted as follows (in thousands):
 
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Stock options
3

 
84

 
1,054

 
961

RSUs
18

 
37

 
857

 
461

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
9 Months Ended
Sep. 30, 2018
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

For interim periods, we recognize an income tax provision (benefit) based on our estimated annual effective tax rate expected for the full year.

The Company recorded $0.1 million and less than $0.1 million in income tax expense for the three and nine months ended September 30, 2018, respectively, which resulted in effective tax rates of (0.9)% and (0.1)%, respectively. The Company recorded $1.7 million and $2.0 million in income tax benefit for the three and nine months ended September 30, 2017, respectively, which resulted in effective tax rates of 11.6% and 3.5%, respectively. The income tax benefit recorded during the three and nine months ended September 30, 2018, primarily relates to the change in indefinite-lived components and components expected to reverse outside of the net operating loss carryover period as part of the outside basis difference in our partnership interest in Evolent Health LLC. With the exception of these components, the Company continues to record a valuation allowance against the net deferred tax assets. As a result of the Tax Cuts and Jobs Act (the “Tax Act”) enacted on December 22, 2017, and subsequent state jurisdictions conforming to certain provisions of the Tax Act with respect to the indefinite carryforward period and 80% taxable income limitation on NOLs arising after December 31, 2017, these components of the deferred tax liabilities are comprised of the entire nonconforming state indefinite-lived components and those outside of the NOL carryforward period and a portion of our federal and conforming states components that could not be used as a source of income. As of December 31, 2017, the Company had recorded a provisional estimate of the financial statement impact of the Tax Act in accordance with SEC Staff Accounting Bulletin No. 118. During the three and nine months ended September 30, 2018, the change in the initial provisional estimates is immaterial. The Company will continue to evaluate any further adjustments necessary through 2018.

As a result of the increase in our ownership of Evolent Health LLC following the March 2018 Private Sale discussed in Note 4 above, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by approximately $0.9 million for the nine months ended September 30, 2018. The effect of this change in the deferred tax liability was recorded as additional paid-in capital.
As a result of the increase in our ownership of Evolent Health LLC following the August 2017 Primary and 2017 Secondary Offerings discussed in Note 4 above, the Company reduced the indefinite portion of the deferred tax liability related to the book basis compared to the tax basis in our partnership interest in Evolent Health LLC by $13.1 million for the nine months ended September 30, 2017. The effect of this change in the deferred tax liability was recorded as $12.8 million of additional paid-in capital and $0.3 million of income tax benefit.

As of December 31, 2017, the Company had unrecognized tax benefits of $0.8 million that, if recognized, would not affect the effective tax rate. As of September 30, 2018, the Company has released all unrecognized tax benefits due to the filing of a federal income tax automatic accounting method change application. The Company is not currently subject to income tax audits in any U.S., state, or foreign jurisdictions for any tax year.

Tax Receivables Agreement

In connection with the Offering Reorganization, the Company entered into the TRA with certain of its investors, which provides for the payment by the Company to these investors of 85% of the amount of the tax benefits, if any, that the Company is deemed to realize as a result of increases in our tax basis related to exchanges of Class B common units as well as tax benefits attributable to the future utilization of pre-IPO NOLs. See Note 9 above and “Part II - Item 8. Financial Statements and Supplementary Data - Note 12” in our 2017 Form 10-K for discussion of our TRA.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments In and Advances to Equity Method Investees
9 Months Ended
Sep. 30, 2018
Equity Method Investments and Joint Ventures [Abstract]  
Investments In and Advances to Equity Method Investees
Investments In and Advances to Equity Method Investees

The Company has entered into joint venture agreements with various entities. As of September 30, 2018, the Company’s economic and voting interests in these entities ranged between 4% and 40%. As of December 31, 2017, the Company’s economic interests in these entities ranged between 26% and 40% and voting interests ranged between 27% and 40%. The Company determined that it has significant influence over these entities but that it does not have control over any of the entities. Accordingly, the investments are accounted for under the equity method of accounting and the Company is allocated its proportional share of the entities’ earnings and losses for each reporting period. The Company’s proportional share of the losses from these investments was approximately $1.4 million and $2.8 million for the three and nine months ended September 30, 2018, respectively, and $0.4 million and $1.4 million for the three and nine months ended September 30, 2017, respectively.

The Company signed services agreements with certain of the aforementioned entities to provide certain management, operational and support services to help manage elements of their service offerings. Revenues related to these services agreements was $5.1 million and $5.9 million for the three and nine months ended September 30, 2018, respectively, and less than $0.1 million and $0.4 million for the three and nine months ended September 30, 2017, respectively.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Non-controlling Interests
9 Months Ended
Sep. 30, 2018
Noncontrolling Interest [Abstract]  
Non-controlling Interests
Non-controlling Interests

Immediately following the Offering Reorganization and IPO (as described in our 2017 Form 10-K), the Company owned 70.3% of Evolent Health LLC. The Company’s ownership percentage changes with the issuance of Class A common stock and Class B Exchanges.

The Company completed the 2017 Secondary Offerings during 2017. The shares sold in the 2017 Secondary Offerings consisted of 20.1 million shares of the Company’s Class A common stock, consisting of 7.4 million existing shares of the Company’s Class A common stock owned and held by certain Selling Stockholders, 12.6 million newly-issued shares of the Company’s Class A common stock received by certain Investor Stockholders pursuant to Class B Exchanges and 0.1 million shares issued upon the exercise of options by certain management selling stockholders. As a result of these Class B Exchanges and Evolent Health LLC’s cancellation of its Class B common units during the 2017 Secondary Offerings, the Company’s economic interest in Evolent Health LLC increased from 77.4% to 96.1% immediately following the June 2017 Secondary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

In addition, the Company issued 8.8 million shares of its Class A Common Stock during the August 2017 Primary for net proceeds of $166.9 million. For each share of Class A common stock issued by Evolent Health, Inc., the Company received a corresponding Class A common unit from Evolent Health LLC in exchange for contributing the issuance proceeds to Evolent Health LLC. As a result of the Class A common stock and Class A common units issued in conjunction with the August 2017 Primary, the Company’s economic interest in Evolent Health LLC increased from 96.1% to 96.6% immediately following the August 2017 Primary, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

The Company completed the March 2018 Private Sale during March 2018. The shares sold in the March 2018 Private Sale consisted of 1.2 million existing shares of the Company’s Class A common stock owned and held by The Advisory Board and 1.8 million newly-issued shares of the Company’s Class A common stock received by The Advisory Board pursuant to a Class B Exchange.

As a result of this Class B Exchange and Evolent Health LLC’s cancellation of the Class B units during the March 2018 Private Sale, the Company’s economic interest in Evolent Health LLC increased from 96.6% to 98.9% immediately following the March 2018 Private Sale, and, accordingly, we reclassified a portion of our non-controlling interests into shareholders’ equity attributable to Evolent Health, Inc.

As of September 30, 2018, and December 31, 2017, we owned 99.0% and 96.6% of the economic interests in Evolent Health LLC, respectively. See Note 4 for further discussion of the March 2018 Private Sale, August 2017 Primary and 2017 Secondary Offerings.

Changes in non-controlling interests (in thousands) for the periods presented were as follows:

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Non-controlling interests as of beginning-of-period
$
10,148

 
$
34,680

 
$
35,427

 
$
209,588

Cumulative-effect adjustment from adoption of new accounting principle

 

 
594

 

Decrease in non-controlling interests as a result of Class B Exchanges

 

 
(25,334
)
 
(168,883
)
Reclassification of non-controlling interests
(14
)
 
1,793

 
1

 
3,698

Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Non-controlling interests as of end-of-period
$
10,008

 
$
35,932

 
$
10,008

 
$
35,932

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurement
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurement
Fair Value Measurement
 
GAAP defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) assuming an orderly transaction in the most advantageous market at the measurement date. GAAP also establishes a hierarchical disclosure framework which prioritizes and ranks the level of observability of inputs used in measuring fair value. These tiers include:

Level 1 - inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date;
Level 2 - inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date and the fair value can be determined through the use of models or other valuation methodologies; and
Level 3 - inputs to the valuation methodology are unobservable inputs in situations where there is little or no market activity for the asset or liability.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the particular asset or liability being measured.

Recurring Fair Value Measurements
 
In accordance with GAAP, certain assets and liabilities are required to be recorded at fair value on a recurring basis. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands):

 
As of September 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
41,186

 
$

 
$

 
$
41,186

Restricted cash and restricted investments (1)
32,028

 

 

 
32,028

Total
$
73,214

 
$

 
$

 
$
73,214

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,300

 
8,300


 
As of December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
60,535

 
$

 
$

 
$
60,535

Restricted cash and restricted investments (1)
16,575

 

 

 
16,575

Total
$
77,110

 
$

 
$

 
$
77,110

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,700

 
8,700

(1) Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of September 30, 2018, and December 31, 2017, as presented in the tables above.
(2) Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (“Passport”) acquisition as described below.
The Company recognizes any transfers between levels within the hierarchy as of the beginning of the reporting period. There were no transfers between fair value levels for the three and nine month periods ended September 30, 2018 and 2017, respectively.
In the absence of observable market prices, the fair value is based on the best information available and involves a significant degree of judgment, taking into consideration a combination of internal and external factors, including the appropriate risk adjustments for non-performance and liquidity risks.

The strategic alliance with Passport includes a provision for additional equity consideration contingent upon the Company obtaining new third-party Medicaid business in future periods. The contingent consideration of $8.3 million and $8.7 million is a mark-to-market liability recorded within “Other long-term liabilities” on our Consolidated Balance Sheets as of September 30, 2018, and December 31, 2017. We recorded a re-measurement loss of approximately $0.1 million for the three months ended September 30, 2018, and a re-measurement gain of approximately $0.4 million for the nine months ended September 30, 2018, and re-measurement losses of approximately $0.1 million and $0.3 million for the three and nine months ended September 30, 2017, respectively, based on changes in the underlying assumptions of the fair value calculation. The fair value of the contingent equity consideration was estimated based on the real options approach, a form of the income approach, which estimated the probability of the Company achieving future revenues under the agreement. The significant unobservable inputs used in the fair value measurement of the Passport contingent consideration are the five-year risk-adjusted recurring revenue compound annual growth rate (“CAGR”) and the applicable discount rate. A significant increase in the assumed five-year risk-adjusted recurring revenue CAGR projection or decrease in discount rate in isolation would result in a significantly higher fair value of the contingent consideration.

The changes in our contingent consideration, measured at fair value, for which the Company uses Level 3 inputs to determine fair value are as follows (in thousands):
                                                                  
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Balance as of beginning-of-period
$
8,200

 
$
8,500

 
$
8,700

 
$
8,300

Realized and unrealized (gains) losses, net
100

 
100

 
(400
)
 
300

Balance as of end-of-period
$
8,300

 
$
8,600

 
$
8,300

 
$
8,600


The following table summarizes the fair value (in thousands), valuation techniques and significant unobservable inputs of our Level 3 fair value measurements as of the periods presented:

 
As of September 30, 2018
 
 
Fair
 
Valuation
 
Significant
 
Assumption or
 
 
Value
 
Technique
 
Unobservable Inputs
 
Input Ranges
 
Contingent consideration (1)
$
8,300

 
Real options approach
 
Risk-adjusted recurring revenue CAGR
 
112.7
%
(2) 
 
 
 
 
 
Discount rate/time value
 
3.8% - 4.5%

 
(1) Related to additional Passport earn-out consideration as described above.
(2) The risk-adjusted recurring revenue CAGR is calculated over the five-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of $1.0 million, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is 78.6%.

 
As of December 31, 2017
 
 
Fair
 
Valuation
 
Significant
 
Assumption or
 
 
Value
 
Technique
 
Unobservable Inputs
 
Input Ranges
 
Contingent consideration (1)
$
8,700

 
Real options approach
 
Risk-adjusted recurring revenue CAGR
 
92.5
%
(2) 
 
 
 
 
 
Discount rate/time value
 
2.7% - 4.0%

 

(1) Related to additional Passport earn-out consideration as described above.
(2) The risk-adjusted recurring revenue CAGR is calculated over the five-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of $1.0 million, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is 19.2%.

Nonrecurring Fair Value Measurements

In addition to the assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets and liabilities at fair value on a nonrecurring basis as required by GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. This includes goodwill, intangible assets, property, plant and equipment, held-to-maturity investments and equity method investments. While not carried at fair value on a recurring basis, these items are continually monitored for indicators of impairment that would indicate current carrying value is greater than fair value. In those situations, the assets are considered impaired and written down to current fair value. See Notes 4, 5, 6, 7 and 13 for further discussion of assets measured at fair value on a nonrecurring basis.

Other Fair Value Disclosures

The carrying amounts of cash and cash equivalents (those not held in a money market fund), restricted cash, receivables, prepaid expenses, accounts payable, accrued liabilities and accrued compensation approximate their fair values because of the relatively short-term maturities of these items and financial instruments.

See Note 8 for information regarding the fair value of the 2021 Notes.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Parties
9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
Related Parties
Related Parties

The entities described below are considered related parties and the balances and/or transactions with them are reported in our consolidated financial statements.

As discussed in Note 13, the Company has economic interests in several entities that are accounted for under the equity method of accounting. The Company has allocated its proportional share of the investees’ earnings and losses each reporting period. In addition, Evolent has entered into services agreements with certain of the entities to provide certain management, operational and support services to help the entities manage elements of their service offerings. Revenues related to these services agreements was $5.1 million and $5.9 million for the three and nine months ended September 30, 2018, respectively, and less than $0.1 million and $0.4 million for the three and nine months ended September 30, 2017, respectively.

The Company also works closely with UPMC, one of its founding investors. The Company’s relationship with UPMC is a subcontractor relationship where UPMC has agreed to execute certain tasks (primarily TPA services) relating to certain customer commitments. We also conduct business with a company in which UPMC holds a significant equity interest.

Additionally, prior to the Offering Reorganization, we issued shares of our stock to certain of our partners while concurrently entering into revenue contracts with those partners. Those partners are considered related parties and the balances and/or transactions with them were reported on our consolidated financial statements for the periods in which they held a significant equity interest in Evolent Health, Inc.

The following table presents revenues and expenses attributable to our related parties (in thousands):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Revenue
 
 
 
 
 
 
 
Transformation services
$
5,332

 
$
352

 
$
6,112

 
$
597

Platform and operations services
12,180

 
9,411

 
27,072

 
24,764

Expenses
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization expenses)
2,390

 
5,299

 
6,842

 
17,382

Selling, general and administrative expenses
241

 
514

 
620

 
1,038

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting

We define our reportable segments based on the way the chief operating decision maker (“CODM”), currently the Chief Executive Officer, manages the operations for purposes of allocating resources and assessing performance. We classify our operations into two reportable segments as follows:

Services, which consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services; and
True Health, which consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses.

In the ordinary course of business, our reportable segments enter into transactions with one another. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues and expenses recognized by the segment that is the counterparty to the transaction are eliminated in consolidation and do not affect consolidated results.

The CODM uses Adjusted Revenue and Adjusted EBITDA as the relevant segment performance measures to evaluate the performance of the segments and allocate resources.

Adjusted Revenue and Adjusted EBITDA are segment performance financial measures that offer a useful view of the overall operation of our businesses and may be different than similarly-titled segment performance financial measures used by other companies. Adjusted Revenue is defined as the sum of Adjusted Services Revenue and True Health premiums revenue less intersegment eliminations. Adjusted Services Revenue is defined as Services revenue adjusted to exclude the impact of purchase accounting adjustments. Adjusted Services Revenue consists of Adjusted Transformation Services Revenue and Adjusted Platform and Operations Services Revenue, which are defined as transformation services revenue and platform and operations services revenue, respectively, before the effect of intersegment eliminations and adjusted to exclude the impact of purchase accounting adjustments. The company’s Adjusted Services Revenue for the nine months ended September 30, 2018, includes a $4.5 million adjustment related to revenue that was contracted for prior to 2018 and that was properly excluded from revenue in our 2017 results under the revenue recognition rules then in effect under ASC 605. On January 1, 2018, we adopted the new revenue recognition rules under ASC 606 using the modified retrospective method, which required us to include this $4.5 million as part of the cumulative transition adjustment to beginning retained earnings as of January 1, 2018. Under ASC 605, and based on proportionate performance revenue recognition, we would have recognized an additional $4.5 million in revenue during 2018, primarily within our Adjusted Transformation Services Revenue. The Company has therefore included this revenue, and related profit, in its adjusted results for the nine months ended September 30, 2018, as they had not been previously reported prior to 2018 and the contracts are expected to be completed within 2018. This is a one-time adjustment and it will not reoccur in future periods.

Adjusted EBITDA is the sum of Services Adjusted EBITDA and True Health Adjusted EBITDA and is defined as EBITDA (net income (loss) attributable to Evolent Health, Inc. before interest income, interest expense, (provision) benefit for income taxes, depreciation and amortization expenses), adjusted to exclude changes in fair value of contingent consideration and indemnification assets, income (loss) from equity method investees, other income (expense), net, net (income) loss attributable to non-controlling interests, purchase accounting adjustments, stock-based compensation expenses, severance costs, amortization of contract cost assets recorded as a result of a one-time ASC 606 transition adjustment, transaction costs related to acquisitions and business combinations and other one-time adjustments (which for the nine months ended September 30, 2018, includes the ASC 606 transition adjustment described above). When Adjusted EBITDA is discussed in this report, the most directly comparable GAAP financial measure is net income (loss) attributable to Evolent Health, Inc.

Management considers Adjusted Revenue and Adjusted EBITDA to be the appropriate metrics to evaluate and compare the ongoing operating performance of our segments on a consistent basis across reporting periods as they eliminate the effect of items which are not indicative of each segment's core operating performance.

The following tables present our segment information (in thousands):

 
 
 
 
 
 
 
Intersegment
 
 
 
 
 
Services
 
True Health (1)
Eliminations
Consolidated
Adjusted Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
9,230

 
 
$

 
 
$

 
 
$
9,230

 
Adjusted Platform and Operations Services
 
121,845

 
 

 
 
(3,537
)
 
 
118,308

 
Adjusted Services Revenue
 
131,075

 
 

 
 
(3,537
)
 
 
127,538

 
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 

 
 
22,829

 
 
(206
)
 
 
22,623

 
Adjusted Revenue
 
131,075

 
 
22,829

 
 
(3,743
)
 
 
150,161

 
Purchase accounting adjustments (2)
 
(214
)
 
 

 
 

 
 
(214
)
 
Total revenue
 
$
130,861

 
 
$
22,829

 
 
$
(3,743
)
 
 
$
149,947

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
8,204

 
 
$

 
 
$

 
 
$
8,204

 
Adjusted Platform and Operations Services
 
100,157

 
 

 
 

 
 
100,157

 
Adjusted Services Revenue
 
108,361

 
 

 
 

 
 
108,361

 
Adjusted Revenue
 
108,361

 
 

 
 

 
 
108,361

 
Purchase accounting adjustments (2)
 
(449
)
 
 

 
 

 
 
(449
)
 
Total revenue
 
$
107,912

 
 
$

 
 
$

 
 
$
107,912

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segments
 
 
 
 
 
 
Services
 
True Health (1)
Total
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
4,065

 
 
$
732

 
 
$
4,797

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
2,648

 
 
$

 
 
$
2,648

 
 
 
 

(1) 
The True Health segment was created in January 2018.
(2) 
Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were no purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.

 
 
 
 
 
 
 
Intersegment
 
 
 
 
 
Services
 
True Health (1)
Eliminations
Consolidated
Adjusted Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
27,605

 
 
$

 
 
$

 
 
$
27,605

 
Adjusted Platform and Operations Services
 
353,697

 
 

 
 
(10,949
)
 
 
342,748

 
Adjusted Services Revenue
 
381,302

 
 

 
 
(10,949
)
 
 
370,353

 
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 

 
 
69,353

 
 
(602
)
 
 
68,751

 
Adjusted Revenue
 
381,302

 
 
69,353

 
 
(11,551
)
 
 
439,104

 
ASC 606 transition adjustment (2)
 
(4,498
)
 
 

 
 

 
 
(4,498
)
 
Purchase accounting adjustments (3)
 
(647
)
 
 

 
 

 
 
(647
)
 
Total revenue
 
$
376,157

 
 
$
69,353

 
 
$
(11,551
)
 
 
$
433,959

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
23,799

 
 
$

 
 
$

 
 
$
23,799

 
Adjusted Platform and Operations Services
 
298,646

 
 

 
 

 
 
298,646

 
Adjusted Services Revenue
 
322,445

 
 

 
 

 
 
322,445

 
Adjusted Revenue
 
322,445

 
 

 
 

 
 
322,445

 
Purchase accounting adjustments (3)
 
(1,224
)
 
 

 
 

 
 
(1,224
)
 
Total revenue
 
$
321,221

 
 
$

 
 
$

 
 
$
321,221

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segments
 
 
 
 
 
 
Services
 
True Health (1)
Total
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
16,674

 
 
$
921

 
 
$
17,595

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
(5,689
)
 
 
$

 
 
$
(5,689
)
 
 
 
 

(1) 
The True Health segment was created in January 2018.
(2) 
Adjustment to Adjusted Transformation Services Revenue was approximately $3.7 million and the adjustment to Adjusted Platform and Operations Services Revenue was approximately $0.8 million.
(3) 
Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were no purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.

The following table presents our reconciliation of segments total Adjusted EBITDA to net income (loss) attributable to Evolent Health, Inc. (in thousands):

 
 
For the Three
 
For the Nine
 
 
Months Ended
 
Months Ended
 
 
September 30,
 
September 30,
 
 
2018
 
2017
 
2018
 
2017
Net Income (Loss) Attributable to
 
 
 
 
 
 
 
 
Evolent Health, Inc.
 
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
Less:
 
 
 
 
 
 
 
 
Interest income
 
968

 
411

 
2,918

 
813

Interest expense
 
(853
)
 
(880
)
 
(2,561
)
 
(2,781
)
(Provision) benefit for income taxes
 
(135
)
 
1,714

 
(29
)
 
2,009

Depreciation and amortization expenses
 
(10,352
)
 
(7,717
)
 
(29,882
)
 
(21,236
)
Income (loss) from equity method investees
 
(1,381
)
 
(369
)
 
(2,787
)
 
(1,446
)
Change in fair value of contingent
 
 
 
 
 
 
 
 
consideration and indemnification asset
 
(100
)
 
(100
)
 
1,404

 
(300
)
Other income (expense), net
 
(124
)
 
15

 
(64
)
 
21

Net (income) loss attributable to
 
 
 
 
 
 
 
 
non-controlling interests
 
126

 
541

 
680

 
8,471

ASC 606 transition adjustments
 

 

 
(4,498
)
 

Purchase accounting adjustments
 
(214
)
 
(449
)
 
(647
)
 
(1,224
)
Stock-based compensation expense
 
(4,047
)
 
(5,708
)
 
(12,560
)
 
(16,172
)
Severance costs
 

 

 
(1,489
)
 

Amortization of contract cost assets
 
(658
)
 

 
(1,797
)
 

Transaction costs
 
(456
)
 
(2,694
)
 
(2,254
)
 
(9,972
)
Adjusted EBITDA
 
$
4,797

 
$
2,648

 
$
17,595

 
$
(5,689
)


Asset information by segment is not a key measure of performance used by the CODM. Accordingly, we have not disclosed asset information by segment.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
True Health Claims Reserves
9 Months Ended
Sep. 30, 2018
Insurance [Abstract]  
True Health Claims Reserves
True Health Claims Reserves

Claims reserves for the True Health segment reflect estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process), and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.

The Company uses actuarial principles and assumptions that are consistently applied each reporting period and recognizes the actuarial best estimate of the ultimate liability along with a margin for adverse deviation. This approach is consistent with actuarial standards of practice that the liabilities be adequate under moderately adverse conditions.

This liability predominately consists of incurred but not reported amounts and reported claims in process including expected development on reported claims. The liability is primarily calculated using "completion factors" developed by comparing the claim incurred date to the date claims were paid. Completion factors are impacted by several key items including changes in: 1) electronic (auto-adjudication) versus manual claim processing, 2) provider claims submission rates, 3) membership and 4) the mix of products.

The Company’s policy is to use historical completion factors combined with an analysis of current trends and operational factors to develop current estimates of completion factors. The Company estimates the liability for claims incurred in each month by applying the current estimates of completion factors to the current paid claims data. This approach implicitly assumes that historical completion rates will be a useful indicator for the current period notwithstanding that we did not own NMHC’s commercial business prior to January 2, 2018.

For more recent months, the Company expects to rely more heavily on medical cost trend analysis that reflects expected claim payment patterns and other relevant operational considerations. Medical cost trend is primarily impacted by medical service utilization and unit costs that are affected by changes in the level and mix of medical benefits offered, including inpatient, outpatient and pharmacy, the impact of copays and deductibles, changes in provider practices and changes in consumer demographics and consumption behavior.

For each reporting period, the Company compares key assumptions used to establish the claims reserves to actual experience. When actual experience differs from these assumptions, claims reserves are adjusted through current period shareholders' net income. Additionally, the Company evaluates expected future developments and emerging trends that may impact key assumptions. The process used to determine this liability requires the Company to make critical accounting estimates that involve considerable judgment, reflecting the variability inherent in forecasting future claim payments. These estimates are highly sensitive to changes in the Company's key assumptions, specifically completion factors and medical cost trends.

Activity in claims reserves was as follows (in thousands):

 
For the Nine
 
Months Ended
 
September 30,
 
 
2018
 
Incurred costs related to current period
 
$
52,169

 
Paid costs related to current period
 
41,831

 
Change during the period
 
10,338

 
Beginning balance
 

 
Ending balance
 
$
10,338

 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Cash Flow Information
9 Months Ended
Sep. 30, 2018
Supplemental Cash Flow Elements [Abstract]  
Supplemental Cash Flow Information
Supplemental Cash Flow Information

The following represents supplemental disclosure of non-cash investing and financing information (in thousands):

 
For the Nine
 
Months Ended
 
September 30,
 
2018
 
2017
Accrued property and equipment purchases
$
501

 
$
83

Increase to goodwill from measurement period adjustments
 
 
 
related to business combinations
4

 
1,766

Decrease in accrued financing costs related to 2021 Notes

 
196

Consideration for asset acquisitions or business combinations
500

 

Settlement of escrow related to asset acquisition
2,519

 

Settlement of indemnification asset
1,004

 

Tax benefit related to Accordion intangible technology

 
2,042

 
 
 
 
Effects of Class B Exchanges
 
 
 
Decrease in non-controlling interests as a result of Class B Exchanges
25,334

 
168,883

Decrease in deferred tax liability as a result of securities offerings
908

 
12,992

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
9 Months Ended
Sep. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events
Subsequent Events

Acquisition of New Century Health

On October 1, 2018, the Company completed its previously announced acquisition of New Century Health. The closing merger consideration, net of cash on hand and certain closing adjustments, was $221.6 million, based on the closing price of Evolent’s Class A common stock on the New York Stock Exchange on October 1, 2018, and consisted of 3.1 million shares of Evolent Class B common stock, an equal number of Evolent Health LLC Class B units and $117.2 million in cash. The shares issued at closing represent 3.8% of the Company’s issued and outstanding Class A common stock and Class B common stock after the transaction. The purchase price of $221.6 million includes an earn-out potential of up to $20.0 million, payable in cash and Evolent Class B common stock, subject to the satisfaction of certain conditions related to the operating results of New Century Health in 2019. Shares to be issued in relation to the earn-out are limited to 1.0 million shares of Evolent’s Class B common stock, with full payment expected to be made during the first quarter of 2020. The shares at closing were, and the shares for the earn-out, if any, will be issued in transactions exempt from registration under the Securities Act of 1933, as amended.

Convertible debt issuance

In October 2018, the Company issued $172.5 million aggregate principal amount of its 1.50% Convertible Senior Notes due 2025 (the “2025 Notes”) in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. The 2025 Notes were issued at par for net proceeds, excluding expenses, of $167.3 million. We incurred $5.2 million of debt issuance costs in connection with the 2025 Notes, which will be amortized to non-cash interest expense over the contractual term of the 2025 Notes. The closing of the private placement of $150.0 million aggregate principal amount of the 2025 Notes occurred on October 22, 2018, and the initial purchasers completed the exercise in full of their option to purchase an additional $22.5 million aggregate principal amount of the 2025 Notes on October 24, 2018. The Company loaned the net proceeds to Evolent Health LLC, which intends to use the net proceeds for working capital and other general corporate purposes.

Holders of the 2025 Notes are entitled to cash interest payments, which are payable semiannually in arrears on April 15 and October 15 of each year, beginning on April 15, 2019, at a rate equal to 1.50% per annum. The 2025 Notes will mature on October 15, 2025, unless earlier repurchased, redeemed or converted in accordance with their terms prior to such date.

Prior to the close of business on the business day immediately preceding April 15, 2025, the 2025 Notes will be convertible at the option of the holders only upon the satisfaction of certain conditions, as described in the indenture, dated as of October 22, 2018 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. On or after April 15, 2025, until the close of business on the business day immediately preceding the maturity date, holders may convert, at their option, all or any portion of their notes at the conversion rate at any time irrespective of any conditions.

The 2025 Notes will be convertible at an initial conversion rate of 29.9135 shares of Class A common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $33.43 per share of the Company’s Class A common stock. In the aggregate, the 2025 Notes are initially convertible into 5.2 million shares of the Company’s Class A common stock (excluding any shares issuable by the Company upon a conversion in connection with a make-whole fundamental change or a notice of redemption as described in the Indenture). The conversion rate may be adjusted under certain circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s Class A common stock or a combination of cash and shares of the Company’s Class A common stock, at the Company’s election.

Holders of the 2025 Notes may require the Company to repurchase all or part of their notes upon the occurrence of a fundamental change at a price equal to 100.0% of the principal amount of the notes being repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Company may not redeem the 2025 Notes prior to October 20, 2022. The Company may redeem for cash all or any portion of the 2025 Notes, at its option, on or after October 20, 2022, if the last reported sale price of the Company’s Class A common stock has been at least 130.0% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100.0% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Policies)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

In our opinion, the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to fairly state our financial position, results of operations, and cash flows. The Consolidated Balance Sheet at December 31, 2017, has been derived from audited financial statements as of that date. The interim consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain footnote disclosures normally included in financial statements prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) have been omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (“SEC”). The disclosures provided herein should be read in conjunction with the audited financial statements and notes thereto included in our 2017 Form 10-K.
Accounting Estimates and Assumptions
Accounting Estimates and Assumptions

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including variable consideration, discounts and credits, estimated selling prices for performance obligations in contracts with multiple performance obligations, claims reserves, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.

Principles of Consolidation
Principles of Consolidation
 
The consolidated financial statements include the accounts of Evolent Health, Inc. and its subsidiaries. All inter-company accounts and transactions are eliminated in consolidation.

Operating Segments
Operating Segments

Operating segments are defined as components of a business that earn revenue and incur expenses for which discrete financial information is available that is evaluated, on a regular basis, by the chief operating decision maker (“CODM”) to decide how to allocate resources and assess performance. The Company operates through two segments: (1) Services, and (2) True Health. Our Services segment consists of our technology-enabled services platform that supports our various value-based operations, such as delivery network alignment, population health performance, integrated cost and revenue management solutions and financial and administrative management services. Our True Health segment consists of a commercial health plan we operate in New Mexico that focuses on small and large businesses. See Note 17 for a discussion of our operating results by segment.
Revenue Recognition
Revenue Recognition

Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. See “Changes in Accounting Principles” below for our updated revenue recognition policy as a result of our adoption of Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers.

Our True Health segment derives revenue from premiums that are earned over the terms of the related insurance policies. The portion of premiums that will be earned in the future or are received prior to the effectiveness of the policy are deferred and reported as premiums received in advance. These amounts are generally classified as short-term deferred revenue on our Consolidated Balance Sheets.
Our Services segment derives revenue from two sources: (1) transformation services and (2) platform and operations services. Revenue is recognized when control of the services is transferred to our customers. We use the following 5-Step model, outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), to determine revenue recognition on our contracts with customers:

Identify the contract(s) with a customer
Identify the performance obligations in the contract
Determine the transaction price
Allocate the transaction price to performance obligations
Recognize revenue when (or as) the entity satisfies a performance obligation

Transformation Services Revenue

Transformation services consist of strategic assessments, or Blueprint contracts, and implementation services whereby we assist the customer in launching its population health or health plan strategy. In certain cases, transformation services can also include revenue associated with our support of certain one-time wind-down activities for clients who are exiting a line of business or population. The transformation services are usually completed within 12 months. We generally receive a fixed fee for transformation services and recognize revenue over time using an input method based on hours incurred compared to the total estimated hours required to satisfy our performance obligation.

Platform and Operations Services Revenue

Platform and operations services generally include multi-year arrangements with customers to provide various population health, health plan operations and claims processing services on an ongoing basis, as well as transition or run-out services to customers receiving primarily third-party administration (“TPA”) services. Our performance obligation in these arrangements is to provide an integrated suite of services, including access to our platform that is customized to meet the specialized needs of our customers. Generally we will apply the series guidance to the performance obligation as we have determined that each time increment is distinct. We primarily utilize a variable fee structure for these services that typically include a monthly payment that is calculated based on a specified per member per month rate, multiplied by the number of members that our partners are managing under a value-based care arrangement or a percentage of plan premiums. Our arrangements may also include other variable fees related to service level agreements, shared medical savings arrangements and other performance measures. Variable consideration is estimated using the most likely amount based on our historical experience and best judgment at the time. Due to the nature of our arrangements certain estimates may be constrained if it is probable that a significant reversal of revenue will occur when the uncertainty is resolved. We recognize revenue for platform and operations services over time using the time elapsed output method. Fixed consideration is recognized ratably over the contract term. In accordance with the series guidance, we allocate variable consideration to the period to which the fees relate.

Contracts with Multiple Performance Obligations

Our contracts with customers may contain multiple performance obligations, primarily when the customer has requested both transformation services and platform and operations services as these services are distinct from one another. When a contract has multiple performance obligations, we allocate the transaction price to each performance obligation based on the relative standalone selling price using the expected cost margin approach. This approach requires estimates regarding both the level of effort it will take to satisfy the performance obligation as well as fees that will be received under the variable pricing model. We also take into consideration customer demographics, current market conditions, the scope of services and our overall pricing strategy and objectives when determining the standalone selling price.

Principal vs Agent

We occasionally use third parties to assist in satisfying our performance obligations. In order to determine whether we are the principal or agent in the arrangement, we review each third-party relationship on a contract by contract basis. We are an agent when our role is to arrange for another entity to provide the services to the customer. In these instances, we do not control the service before it is provided and recognize revenue on a net basis. We are the principal when we control the good or service prior to transferring control to the customer. We recognize revenue on a gross basis when we are the principal in the arrangement.
Restricted Cash and Restricted Investments
Restricted Cash and Restricted Investments

Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations
Intangible Assets, Net
Intangible Assets, Net

Identified intangible assets are recorded at their estimated fair values at the date of acquisition and are amortized over their respective estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are used. The Company acquired additional intangible assets in conjunction with a strategic acquisition made during 2018. Information regarding the determination and allocation of the fair value of the acquired assets and liabilities is further described within Note 4.

The following summarizes the estimated useful lives by asset classification:

Corporate trade name
20 years
Customer relationships
15-25 years
Technology
5 years
Provider network contracts
5 years


Intangible assets are reviewed for impairment if circumstances indicate the Company may not be able to recover the asset’s carrying value. The Company evaluates recoverability by determining whether the undiscounted cash flows expected to result from the use and eventual disposition of that asset or group exceed the carrying value at the evaluation date. If the undiscounted cash flows are not sufficient to cover the carrying value, the Company measures an impairment loss as the excess of the carrying amount of the long-lived asset or group over its fair value. See Note 7 for additional discussion regarding our intangible assets.
Goodwill
Goodwill

We recognize the excess of the purchase price, plus the fair value of any non-controlling interests in the acquiree, over the fair value of identifiable net assets acquired as goodwill. Goodwill is not amortized, but is reviewed at least annually for indications of impairment, with consideration given to financial performance and other relevant factors. We perform impairment tests of goodwill at a reporting unit level, which is consistent with the way management evaluates our business. Goodwill is assigned to the reporting unit that benefits from the synergies arising from each business combination.
Foreign Currency
Foreign Currency

The Company established an international subsidiary during the first quarter of 2018. The functional currency of our international subsidiary is the Indian Rupee. We translate the financial statements of this subsidiary to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenue, costs, and expenses. Translation gains and losses are recorded in accumulated other comprehensive income (loss) as a component of shareholders' equity.
Adoption of New Accounting Standards and Future Adoption of New Accounting Standards
Adoption of New Accounting Standards

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting. The update expands the scope of ASC Topic 718, Compensation - Stock Compensation (“ASC 718”), to include share-based payment transactions for acquiring goods and services from nonemployees. The ASU specifies that ASC 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments in the update also clarify that ASC 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606. The update is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity’s adoption date of ASC 606. We adopted the requirements of this standard effective July 1, 2018, and there was no impact to our financial condition and results of operations for the three and nine months ended September 30, 2018. Going forward, we do not expect the adoption to have a material impact on our financial condition or results of operations.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, in order to clarify the principles of recognizing revenue. This standard establishes the core principle of recognizing revenue to depict the transfer of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB defines a five-step process that systematically identifies the various components of the revenue recognition process, culminating with the recognition of revenue upon satisfaction of an entity’s performance obligations. By completing all five steps of the process, the core principles of revenue recognition will be achieved. The new revenue standard (including updates) is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. The guidance permits two methods of adoption: i) the full retrospective method applying the standard to each prior reporting period presented, or ii) the modified retrospective method with a cumulative effect of initially applying the guidance recognized at the date of initial application. The standard also allows entities to apply certain practical expedients at their discretion. The Company adopted the standard effective January 1, 2018, using the modified retrospective method for only contracts that were not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC Topic 605, Revenue Recognition (“ASC 605”). The adoption of this standard resulted in changes related to revenue recognition for contracts that contain certain features, such as variable consideration. These changes generally accelerate revenue recognition. In addition, certain customer setup costs, which have historically been expensed as incurred, will now be capitalized. Evolent recognized the cumulative effect of applying the new revenue standard as a $17.3 million adjustment to the opening balance of retained earnings, including non-controlling interests, in the first quarter of 2018, primarily as a result of capitalization of expenses related to contract acquisition and fulfillment costs and acceleration of revenue due to variable consideration estimation. See Note 5 for additional disclosures regarding Evolent's contracts with customers. See Note 2 for updated revenue recognition accounting policy and the impact of adopting the new revenue recognition standard on Evolent’s financial statements.

Future Adoption of New Accounting Standards

In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal Use Software: Customers Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Services Contract. The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The amendments in this update should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We are currently evaluating the impact of adoption on our financial condition and results of operations.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. With respect to assets measured at amortized cost, such as held-to-maturity assets, the update requires presentation of the amortized cost net of a credit loss allowance. The update eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses as opposed to the previous standard, when an entity only considered past events and current conditions. With respect to available for sale debt securities, the update requires that credit losses be presented as an allowance rather than as a write-down. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We intend to adopt the requirements of this standard effective January 1, 2020, and are currently evaluating the impact of the adoption on our financial condition and results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight‑line basis over the term of the lease, respectively. A lessee is also required to record a right‑of‑use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU 2016-02 (ASC Topic 842) supersedes the previous leases standard, ASC 840, Leases. The ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available.

The Company has formulated an implementation team that is currently engaged in the evaluation process. We intend to adopt the requirements of this standard effective January 1, 2019, using a modified retrospective approach. We expect to take advantage of the package of practical expedients permitted within the new standard. In July 2018, the FASB issued ASU 2018-11, which is intended to make targeted improvements to ASU 2016-02. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The requirements of ASU 2018-11 are effective on the same date as the requirements of ASU 2016-02. Pursuant to ASU 2018-11, the Company will apply the new standard at its adoption date rather than at the earliest comparative period presented in the financial statements and recognize a cumulative-effect adjustment to the opening balance of retaining earnings. We anticipate that this standard will result in a material increase in the assets and liabilities on our consolidated balance sheets; however, we do not believe adoption will have a material impact on our results of operations.
Fair Value Measurements and Other Fair Value Disclosures
Nonrecurring Fair Value Measurements

In addition to the assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets and liabilities at fair value on a nonrecurring basis as required by GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. This includes goodwill, intangible assets, property, plant and equipment, held-to-maturity investments and equity method investments. While not carried at fair value on a recurring basis, these items are continually monitored for indicators of impairment that would indicate current carrying value is greater than fair value. In those situations, the assets are considered impaired and written down to current fair value. See Notes 4, 5, 6, 7 and 13 for further discussion of assets measured at fair value on a nonrecurring basis.

Other Fair Value Disclosures

The carrying amounts of cash and cash equivalents (those not held in a money market fund), restricted cash, receivables, prepaid expenses, accounts payable, accrued liabilities and accrued compensation approximate their fair values because of the relatively short-term maturities of these items and financial instruments.

See Note 8 for information regarding the fair value of the 2021 Notes.

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of restricted cash and cash equivalents
Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:

 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Collateral for letters of credit
 
 
 
 
 
 
for facility leases (1)
 
$
3,710

 
 
$
3,812

 
Collateral with financial institutions (2)
 
22,028

 
 
24,725

 
Claims processing services (3)
 
8,942

 
 
26,286

 
Collateral for reinsurance agreement (4)
 
10,000

 
 
10,000

 
Other
 
1,042

 
 
862

 
Total restricted cash
 
 
 
 
 
 
and restricted investments
 
45,722

 
 
65,685

 
 
 
 
 
 
 
 
Current restricted investments
 

 
 
8,150

 
Current restricted cash
 
42,328

 
 
54,248

 
Total current restricted cash
 
 
 
 
 
 
and restricted investments
 
42,328

 
 
62,398

 
 
 
 
 
 
 
 
Noncurrent restricted investments
 
712

 
 
605

 
Noncurrent restricted cash
 
2,682

 
 
2,682

 
Total noncurrent restricted cash
 
 
 
 
 
 
and restricted investments
 
$
3,394

 
 
$
3,287

 

(1) Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note 9 for further discussion of our lease commitments.
(2) Represents collateral held with financial institutions for risk-sharing arrangements. As of September 30, 2018, and December 31, 2017, approximately $22.0 million and $16.6 million of the collateral amount was in a trust account and invested in a money market fund. The amounts invested in money market funds are considered restricted cash and are carried at fair value, which approximates cost. See Note 15 for further discussion of our fair value measurement. As of December 31, 2017, approximately $8.2 million of the collateral amount was invested in restricted certificates of deposit with remaining maturities of less than 12 months. The restricted investments are classified as held-to-maturity and stated at amortized cost. Fair value of the certificates of deposit is determined using Level 2 inputs and approximates amortized cost as of December 31, 2017. See Note 9 for further discussion of our risk-sharing arrangements.
(3) Represents cash held by Evolent on behalf of partners for claims processing services. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.
(4) Represents restricted cash required as part of our capital only reinsurance agreement to provide balance sheet support to NMHC. There is no transfer of underwriting risk to Evolent and we are not at risk for any cash payments on behalf of NMHC as part of the agreement. The reinsurance agreement is further discussed in Note 9. As of September 30, 2018, the full $10.0 million amount was invested in a money market fund. The amount invested in the money market fund is considered restricted cash and is carried at fair value, which approximates cost. As of December 31, 2017, the full $10.0 million amount was held in a FDIC participating bank account.

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statements of cash flows.

 
As of September 30,
 
As of December 31,
 
2018
 
2017
 
2017
 
2016
Cash and cash equivalents
$
221,837

 
$
287,143

 
$
238,433

 
$
134,563

Restricted cash and restricted investments
45,722

 
16,932

 
65,685

 
40,416

Restricted investments included in
 
 
 
 
 
 
 
restricted cash and restricted investments
(712
)
 
(8,150
)
 
(8,755
)
 
(4,950
)
Total cash and cash equivalents and restricted cash
 
 
 
 
 
 
 
shown in the consolidated statements of cash flows
$
266,847

 
$
295,925

 
$
295,363

 
$
170,029

Schedule of intangible assets
The following summarizes the estimated useful lives by asset classification:

Corporate trade name
20 years
Customer relationships
15-25 years
Technology
5 years
Provider network contracts
5 years
Details of our intangible assets (in thousands) are presented below:

 
 
As of September 30, 2018
 
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
  
Useful Life
Amount
Amortization
Value
Corporate trade name
 
16.7
 
$
19,000

 
$
3,166

 
$
15,834

Customer relationships (1)
 
19.5
 
208,719

 
25,550

 
183,169

Technology
 
2.4
 
55,933

 
27,264

 
28,669

Below market lease, net
 
4.3
 
4,097

 
2,918

 
1,179

Provider network contracts
 
4.3
 
2,300

 
345

 
1,955

Total
 
 
 
$
290,049

 
$
59,243

 
$
230,806


(1) The increase in the gross carrying amount of the customer relationships intangible is attributable to $2.7 million of acquired customer relationships from the NMHC transaction and $2.5 million related the Vestica Healthcare LLC (“Vestica”) transaction. The Company acquired certain assets from Vestica in March 2016. The transaction included additional consideration of up to $4.0 million, which was being held in escrow and was recorded within “Prepaid expenses and other noncurrent assets” on our Consolidated Balance Sheets. In February 2018, the Company and Vestica reached an agreement to settle $3.5 million of the $4.0 million in escrow. Based on the terms of the settlement agreement, the Company reclassified the unamortized portion of the additional consideration from “Prepaid expenses and other noncurrent assets” into “Customer relationships” as of the settlement date. See Note 4 for further information about the NMHC transaction and see “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” of our 2017 Form 10-K for further information about the Vestica transaction.

 
 
As of December 31, 2017
  
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
 
Useful Life
Amount
Amortization
Value
Corporate trade name
 
17.4
 
$
19,000

 
$
2,454

 
$
16,546

Customer relationships
 
20.5
 
203,500

 
18,312

 
185,188

Technology
 
3.1
 
55,802

 
17,810

 
37,992

Below market lease, net
 
4.8
 
4,197

 
2,662

 
1,535

Total
 
 
 
$
282,499

 
$
41,238

 
$
241,261

Schedule of adoption of ASC 606
In accordance with the requirements under ASU 2014-09, the impact of adoption to our consolidated financial statements was as follows. See Note 5 for additional disclosures regarding Evolent's contracts with customers.

Condensed Consolidated Statements of Operations
 
 
 
 
 
 
 
 
 
(unaudited, in thousands)
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended September 30, 2018
 
 
 
 
 
Amounts without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Revenue
 
 
 
 
 
 
 
 
 
Transformation services
 
$
9,230

 
 
$
9,556

 
 
$
(326
)
 
Platform and operations services
 
118,094

 
 
117,942

 
 
152

 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
 
 
presented separately below)
 
73,967

 
 
77,409

 
 
(3,442
)
 
Selling, general and administrative expenses
 
59,566

 
 
59,676

 
 
(110
)
 
Income (loss) before income taxes and non-controlling interests
 
(12,420
)
 
 
(15,798
)
 
 
3,378

 
 
 
 
 
 
 
 
 
 
 
 
For the Nine Months Ended September 30, 2018
 
 
 
 
 
Amounts without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Revenue
 
 
 
 
 
 
 
 
 
Transformation services
 
$
23,950

 
 
$
25,272

 
 
$
(1,322
)
 
Platform and operations services
 
341,258

 
 
339,485

 
 
1,773

 
 
 
 
 
 
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization
 
 
 
 
 
 
 
 
 
presented separately below)
 
214,945

 
 
218,786

 
 
(3,841
)
 
Selling, general and administrative expenses
 
172,495

 
 
173,644

 
 
(1,149
)
 
Income (loss) before income taxes and non-controlling interests
 
(36,622
)
 
 
(42,063
)
 
 
5,441

 

Condensed Consolidated Balance Sheets
 
 
 
 
 
 
 
 
 
(unaudited, in thousands)
 
 
 
 
 
 
 
 
 
 
As of September 30, 2018
 
 
 
 
 
Balances without
Impact of
 
 
 
 
adoption of
adoption
 
As Reported
 
ASC 606
 
Higher/(Lower)
Assets
 
 
 
 
 
 
 
 
 
Accounts receivable, net
 
$
60,054

 
 
$
57,848

 
 
$
2,206

 
Contract assets (current)
 
3,705

 
 

 
 
3,705

 
Contract assets (noncurrent)
 
1,000

 
 

 
 
1,000

 
Contract cost assets
 
14,252

 
 

 
 
14,252

 
 
 
 
 
 
 
 
 
 
 
Liabilities and Shareholders' Equity (Deficit)
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
Deferred revenue
 
$
22,360

 
 
$
24,100

 
 
$
(1,740
)
 
Other long-term liabilities
 
10,885

 
 
10,746

 
 
139

 
 
 
 
 
 
 
 
 
 
 
Shareholders' Equity (Deficit)
 
 
 
 
 
 
 
 
 
Retained earnings (accumulated deficit)
 
66,696

 
 
44,580

 
 
22,116

 
Non-controlling interests
 
10,008

 
 
9,361

 
 
647

 
The following table summarizes the impact of the change in accounting principle to the Company’s Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 (in thousands):

 
For the Nine Months Ended September 30, 2017
 
As Reported
Adjustments
As Adjusted
Cash Flows from Investing Activities
 
 
 
 
 
 
 
 
Purchases and maturities of restricted investments
 
$

 
 
$
(3,200
)
 
 
$
(3,200
)
Change in restricted cash and restricted investments
 
(2,164
)
 
 
2,164

 
 

Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) investing activities
 
17,003

 
 
(1,036
)
 
 
15,967

 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities
 
 
 
 
 
 
 
 
Change in restricted cash held on behalf of
 
 
 
 
 
 
 
 
partners for claims processing
 

 
 
(25,648
)
 
 
(25,648
)
Net cash and restricted cash provided by
 
 
 
 
 
 
 
 
(used in) financing activities
 
169,570

 
 
(25,648
)
 
 
143,922

 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash
 
 
 
 
 
 
 
 
equivalents and restricted cash
 
152,580

 
 
(26,684
)
 
 
125,896

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of beginning-of-period
 
134,563

 
 
35,466

 
 
170,029

Cash and cash equivalents and
 
 
 
 
 
 
 
 
restricted cash as of end-of-period
 
$
287,143

 
 
$
8,782

 
 
$
295,925

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Transactions (Tables)
9 Months Ended
Sep. 30, 2018
Organizational Transactions [Abstract]  
Schedule of net assets acquired
The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of January 2, 2018, as follows (in thousands):

Purchase consideration
 
Cash paid to NMHC
$
10,000

Cash paid to escrow agent
252

Total consideration
$
10,252

 
 
Identifiable intangible assets acquired and liabilities assumed
 
Customer relationships
$
2,700

Provider network contracts
2,300

Above market lease
(100
)
Accrued compensation and employee benefits
(474
)
 
 
Goodwill
5,826

Net assets acquired
$
10,252

Business acquisition, pro forma information
The pro forma adjustments are based on available information and assumptions that the Company believes are reasonable to reflect the impact of these transactions on the Company’s historical financial information on a pro forma basis (in thousands, except per share data).
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Revenue
$
149,947

 
$
129,820

 
$
433,959

 
$
378,801

Net income (loss)
(12,555
)
 
(11,320
)
 
(36,651
)
 
(65,113
)
Net income (loss) attributable to non-controlling interests
(126
)
 
(413
)
 
(680
)
 
(8,414
)
Net income (loss) attributable to Evolent Health, Inc.
(12,429
)
 
(10,907
)
 
(35,971
)
 
(56,699
)
 
 
 
 
 
 
 
 
Net income (loss) per Common Share available to common shareholders
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.16
)
 
$
(0.47
)
 
$
(0.93
)
Diluted
(0.16
)
 
(0.16
)
 
(0.47
)
 
(0.93
)

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2018
Revenue from Contract with Customer [Abstract]  
Disaggregation of revenue
The following table represents Evolent’s Services segment revenue disaggregated by revenue type for the three and nine months ended September 30, 2018 (in thousands), excluding revenues from our True Health segment and from our downside risk sharing arrangements through our insurance subsidiary, which are accounted for under ASC 944, Financial Services-Insurance.

  
For the Three
For the Nine
 
Months Ended
Months Ended
  
September 30,
September 30,
 
 
2018
 
 
2018
 
Services Revenue
 
 
 
 
 
 
Transformation services
 
$
9,230

 
 
$
23,950

 
Platform and operations services
 
116,226

 
 
335,509

 
Contract with customer, asset and liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):

 
 
As of
 
 
As of
 
 
September 30,
January 1,
 
 
2018
 
2018
Short-term receivables (1)
 
$
58,190

 
 
$
47,131

 
Long-term receivables (1)
 
6,550

 
 

 
Short-term contract assets
 
3,705

 
 
3,710

 
Long-term contract assets
 
1,000

 
 
1,791

 
Short-term deferred revenue
 
22,360

 
 
26,147

 
Long-term deferred revenue
 
1,000

 
 
493

 
(1) Excludes pharmacy claims receivable and premiums receivable
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, Net (Tables)
9 Months Ended
Sep. 30, 2018
Property, Plant and Equipment [Abstract]  
Summary of property and equipment
The following summarizes our property and equipment (in thousands):
 
 
 
As of
 
 
As of
 
  
September 30,
December 31,
  
 
2018
 
 
2017
 
Computer hardware
 
$
8,602

 
 
$
5,667

 
Furniture and equipment
 
3,038

 
 
2,448

 
Internal-use software development costs
 
73,679

 
 
48,557

 
Leasehold improvements
 
9,638

 
 
8,708

 
Total property and equipment
 
94,957

 
 
65,380

 
Accumulated depreciation and amortization
 
(26,265
)
 
 
(14,458
)
 
Total property and equipment, net
 
$
68,692

 
 
$
50,922

 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets, Net (Tables)
9 Months Ended
Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
The following tables summarize the changes in the carrying amount of goodwill, by reportable segment, for the periods presented (in thousands):

 
 
For the Nine Months Ended September 30, 2018
 
 
 
Services
 
 
True Health
 
Consolidated
Balance as of beginning-of-period (1)
 
$
628,186

 
 
$

 
 
$
628,186

 
Goodwill Acquired (2)
 
1,234

 
 
5,826

 
 
7,060

 
Measurement period adjustments (2)
 
4

 
 

 
 
4

 
Foreign currency translation (2)
 
(162
)
 
 

 
 
(162
)
 
Balance as of end-of-period
 
$
629,262

 
 
$
5,826

 
 
$
635,088

 

(1) Net of cumulative inception to date impairment of $160.6 million.
(2) Goodwill acquired, measurement period adjustments and foreign currency translation are all related to transactions completed during the first quarter of 2018.
 
 
For the Year
 
 
 
Ended
 
 
 
December 31,
 
 
2017 (1)
 
Balance as of beginning-of-period (2)
 
$
626,569

 
Measurement period adjustments (3)
 
1,617

 
Balance as of end-of-period
 
$
628,186

 

(1) All of the goodwill was allocated to the Services segment as of December 31, 2017, as the True Health segment was not established until the first quarter of 2018.
(2) Net of cumulative inception to date impairment of $160.6 million.
(3) Represents measurement period adjustments related to Valence Health and Aldera. See “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” in our 2017 Form 10-K for further information regarding the Valence Health and Aldera transactions.
Schedule of intangible assets
The following summarizes the estimated useful lives by asset classification:

Corporate trade name
20 years
Customer relationships
15-25 years
Technology
5 years
Provider network contracts
5 years
Details of our intangible assets (in thousands) are presented below:

 
 
As of September 30, 2018
 
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
  
Useful Life
Amount
Amortization
Value
Corporate trade name
 
16.7
 
$
19,000

 
$
3,166

 
$
15,834

Customer relationships (1)
 
19.5
 
208,719

 
25,550

 
183,169

Technology
 
2.4
 
55,933

 
27,264

 
28,669

Below market lease, net
 
4.3
 
4,097

 
2,918

 
1,179

Provider network contracts
 
4.3
 
2,300

 
345

 
1,955

Total
 
 
 
$
290,049

 
$
59,243

 
$
230,806


(1) The increase in the gross carrying amount of the customer relationships intangible is attributable to $2.7 million of acquired customer relationships from the NMHC transaction and $2.5 million related the Vestica Healthcare LLC (“Vestica”) transaction. The Company acquired certain assets from Vestica in March 2016. The transaction included additional consideration of up to $4.0 million, which was being held in escrow and was recorded within “Prepaid expenses and other noncurrent assets” on our Consolidated Balance Sheets. In February 2018, the Company and Vestica reached an agreement to settle $3.5 million of the $4.0 million in escrow. Based on the terms of the settlement agreement, the Company reclassified the unamortized portion of the additional consideration from “Prepaid expenses and other noncurrent assets” into “Customer relationships” as of the settlement date. See Note 4 for further information about the NMHC transaction and see “Part II - Item 8. Financial Statements and Supplementary Data - Note 4” of our 2017 Form 10-K for further information about the Vestica transaction.

 
 
As of December 31, 2017
  
 
Weighted-
 
 
 
 
Average
 
Gross
 
 
 
Net
 
Remaining
Carrying
Accumulated
Carrying
 
Useful Life
Amount
Amortization
Value
Corporate trade name
 
17.4
 
$
19,000

 
$
2,454

 
$
16,546

Customer relationships
 
20.5
 
203,500

 
18,312

 
185,188

Technology
 
3.1
 
55,802

 
17,810

 
37,992

Below market lease, net
 
4.8
 
4,197

 
2,662

 
1,535

Total
 
 
 
$
282,499

 
$
41,238

 
$
241,261

XML 44 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term Debt (Tables)
9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Schedule of convertible debt
The following table summarizes the carrying value of the long-term debt (in thousands):

 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Carrying value
 
$
122,082

 
 
$
121,394

 
Unamortized discount
 
2,918

 
 
3,606

 
Principal amount
 
$
125,000

 
 
$
125,000

 
Remaining amortization period (years)
 
3.2

 
 
3.9

 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Summary of major partners
The following table summarizes those partners who represented at least 10.0% of our revenue for the periods presented:
 
 
 
For the Three
 
For the Nine
 
 
Months Ended
 
Months Ended
 
 
September 30,
 
September 30,
 
 
2018
 
2017
 
2018
 
2017
Customer A
 
18.8
%
 
19.0
%
 
18.9
%
 
18.5
%
Customer B
 
*

 
*

 
*

 
10.0
%
 
* Represents less than 10.0% of the respective balance
The following table summarizes those partners who represented at least 10.0% of our trade accounts receivable for the periods presented:
 
 
 
As of
 
 
As of
 
 
September 30,
December 31,
 
 
2018
 
 
2017
 
Customer B
 
*

 
 
11.8
%
 
Customer C
 
16.2
%
 
 
32.1
%
 
Customer D
 
*

 
 
16.5
%
 
 
* Represents less than 10.0% of the respective balance
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings (Loss) Per Common Share (Tables)
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Computation of basic and diluted earnings per share
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Net income (loss)
$
(12,555
)
 
$
(13,129
)
 
$
(36,651
)
 
$
(55,977
)
Less:
 
 
 
 
 
 
 
Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Net income (loss) available for common shareholders (1) (2)
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding (2) (3)
77,999

 
70,328

 
76,871

 
60,867

 
 
 
 
 
 
 
 
Earnings (Loss) per Common Share
 
 
 
 
 
 
 
Basic
$
(0.16
)
 
$
(0.18
)
 
$
(0.47
)
 
$
(0.78
)
Diluted
(0.16
)
 
(0.18
)
 
(0.47
)
 
(0.78
)

(1) 
For periods of net loss, net income (loss) available for common shareholders is the same for both basic and diluted purposes.
(2) 
Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for one share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.
(3) 
For periods of net loss, shares used in the earnings (loss) per common share calculation represent basic shares as using diluted shares would be anti-dilutive.

Schedule of antidilutive securities excluded from computation of earnings per share
Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Exchangeable Class B common stock
766

 
2,654

 
1,251

 
8,846

Restricted stock units ("RSUs")
1,197

 
577

 
923

 
557

Stock options and performance-based stock options
2,698

 
2,976

 
2,486

 
3,031

Convertible senior notes
5,201

 
5,201

 
5,201

 
5,201

Total
9,862

 
11,408

 
9,861

 
17,635

XML 47 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based compensation expense
Total compensation expense by award type and line item in our consolidated financial statements was as follows (in thousands):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
  
September 30,
 
September 30,
  
2018
 
2017
 
2018
 
2017
Award Type
 
 
 
 
 
 
 
Stock options
$
2,139

 
$
4,291

 
$
7,009

 
$
12,452

Performance-based stock options
113

 
113

 
334

 
335

RSUs
1,795

 
1,304

 
5,217

 
3,385

Total
$
4,047

 
$
5,708

 
$
12,560

 
$
16,172

 
 
 
 
 
 
 
 
Line Item
 
 
 
 
 
 
 
Cost of revenue
$
376

 
$
401

 
$
1,130

 
$
1,143

Selling, general and
 
 
 
 
 
 
 
administrative expenses
3,671

 
5,307

 
11,430

 
15,029

Total
$
4,047

 
$
5,708

 
$
12,560

 
$
16,172

Stock-based awards granted
Stock-based awards were granted as follows (in thousands):
 
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Stock options
3

 
84

 
1,054

 
961

RSUs
18

 
37

 
857

 
461



XML 48 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Non-controlling Interests (Tables)
9 Months Ended
Sep. 30, 2018
Noncontrolling Interest [Abstract]  
Schedule of changes in non-controlling interests
Changes in non-controlling interests (in thousands) for the periods presented were as follows:

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Non-controlling interests as of beginning-of-period
$
10,148

 
$
34,680

 
$
35,427

 
$
209,588

Cumulative-effect adjustment from adoption of new accounting principle

 

 
594

 

Decrease in non-controlling interests as a result of Class B Exchanges

 

 
(25,334
)
 
(168,883
)
Reclassification of non-controlling interests
(14
)
 
1,793

 
1

 
3,698

Net income (loss) attributable to non-controlling interests
(126
)
 
(541
)
 
(680
)
 
(8,471
)
Non-controlling interests as of end-of-period
$
10,008

 
$
35,932

 
$
10,008

 
$
35,932

XML 49 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurement (Tables)
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Summary of assets at fair value on recurring basis
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands):

 
As of September 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
41,186

 
$

 
$

 
$
41,186

Restricted cash and restricted investments (1)
32,028

 

 

 
32,028

Total
$
73,214

 
$

 
$

 
$
73,214

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,300

 
8,300


 
As of December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
60,535

 
$

 
$

 
$
60,535

Restricted cash and restricted investments (1)
16,575

 

 

 
16,575

Total
$
77,110

 
$

 
$

 
$
77,110

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,700

 
8,700

(1) Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of September 30, 2018, and December 31, 2017, as presented in the tables above.
(2) Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (“Passport”) acquisition as described below.
Summary of liabilities at fair value on recurring basis
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands):

 
As of September 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
41,186

 
$

 
$

 
$
41,186

Restricted cash and restricted investments (1)
32,028

 

 

 
32,028

Total
$
73,214

 
$

 
$

 
$
73,214

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,300

 
8,300


 
As of December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash and cash equivalents (1)
$
60,535

 
$

 
$

 
$
60,535

Restricted cash and restricted investments (1)
16,575

 

 

 
16,575

Total
$
77,110

 
$

 
$

 
$
77,110

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Contingent consideration (2)

 

 
8,700

 
8,700

(1) Represents the cash and cash equivalents and restricted cash and restricted investments that were held in money market funds as of September 30, 2018, and December 31, 2017, as presented in the tables above.
(2) Represents the contingent earn-out consideration related to the University Health Care, Inc. d/b/a Passport Health Plan (“Passport”) acquisition as described below.
Changes in contingent consideration measured at fair value
The changes in our contingent consideration, measured at fair value, for which the Company uses Level 3 inputs to determine fair value are as follows (in thousands):
                                                                  
 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Balance as of beginning-of-period
$
8,200

 
$
8,500

 
$
8,700

 
$
8,300

Realized and unrealized (gains) losses, net
100

 
100

 
(400
)
 
300

Balance as of end-of-period
$
8,300

 
$
8,600

 
$
8,300

 
$
8,600


Valuation techniques and significant unobservable inputs of Level 3 fair value measurements
The following table summarizes the fair value (in thousands), valuation techniques and significant unobservable inputs of our Level 3 fair value measurements as of the periods presented:

 
As of September 30, 2018
 
 
Fair
 
Valuation
 
Significant
 
Assumption or
 
 
Value
 
Technique
 
Unobservable Inputs
 
Input Ranges
 
Contingent consideration (1)
$
8,300

 
Real options approach
 
Risk-adjusted recurring revenue CAGR
 
112.7
%
(2) 
 
 
 
 
 
Discount rate/time value
 
3.8% - 4.5%

 
(1) Related to additional Passport earn-out consideration as described above.
(2) The risk-adjusted recurring revenue CAGR is calculated over the five-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of $1.0 million, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is 78.6%.

 
As of December 31, 2017
 
 
Fair
 
Valuation
 
Significant
 
Assumption or
 
 
Value
 
Technique
 
Unobservable Inputs
 
Input Ranges
 
Contingent consideration (1)
$
8,700

 
Real options approach
 
Risk-adjusted recurring revenue CAGR
 
92.5
%
(2) 
 
 
 
 
 
Discount rate/time value
 
2.7% - 4.0%

 

(1) Related to additional Passport earn-out consideration as described above.
(2) The risk-adjusted recurring revenue CAGR is calculated over the five-year period 2017-2021. Given that there was no recurring revenue in 2016 and 2017, the calculation of the 2017 and 2018 growth rate is based on a theoretical 2016 and 2017 recurring revenue of $1.0 million, resulting in a higher growth rate. The risk-adjusted recurring revenue CAGR over the period 2019-2021 is 19.2%.
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Parties (Tables)
9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
Revenues and expenses related to affiliates
The following table presents revenues and expenses attributable to our related parties (in thousands):

 
For the Three
 
For the Nine
 
Months Ended
 
Months Ended
 
September 30,
 
September 30,
 
2018
 
2017
 
2018
 
2017
Revenue
 
 
 
 
 
 
 
Transformation services
$
5,332

 
$
352

 
$
6,112

 
$
597

Platform and operations services
12,180

 
9,411

 
27,072

 
24,764

Expenses
 
 
 
 
 
 
 
Cost of revenue (exclusive of depreciation and amortization expenses)
2,390

 
5,299

 
6,842

 
17,382

Selling, general and administrative expenses
241

 
514

 
620

 
1,038

XML 51 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Reconciliation of revenue from segments to consolidated
The following tables present our segment information (in thousands):

 
 
 
 
 
 
 
Intersegment
 
 
 
 
 
Services
 
True Health (1)
Eliminations
Consolidated
Adjusted Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
9,230

 
 
$

 
 
$

 
 
$
9,230

 
Adjusted Platform and Operations Services
 
121,845

 
 

 
 
(3,537
)
 
 
118,308

 
Adjusted Services Revenue
 
131,075

 
 

 
 
(3,537
)
 
 
127,538

 
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 

 
 
22,829

 
 
(206
)
 
 
22,623

 
Adjusted Revenue
 
131,075

 
 
22,829

 
 
(3,743
)
 
 
150,161

 
Purchase accounting adjustments (2)
 
(214
)
 
 

 
 

 
 
(214
)
 
Total revenue
 
$
130,861

 
 
$
22,829

 
 
$
(3,743
)
 
 
$
149,947

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
8,204

 
 
$

 
 
$

 
 
$
8,204

 
Adjusted Platform and Operations Services
 
100,157

 
 

 
 

 
 
100,157

 
Adjusted Services Revenue
 
108,361

 
 

 
 

 
 
108,361

 
Adjusted Revenue
 
108,361

 
 

 
 

 
 
108,361

 
Purchase accounting adjustments (2)
 
(449
)
 
 

 
 

 
 
(449
)
 
Total revenue
 
$
107,912

 
 
$

 
 
$

 
 
$
107,912

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segments
 
 
 
 
 
 
Services
 
True Health (1)
Total
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
4,065

 
 
$
732

 
 
$
4,797

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
2,648

 
 
$

 
 
$
2,648

 
 
 
 

(1) 
The True Health segment was created in January 2018.
(2) 
Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were no purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.

 
 
 
 
 
 
 
Intersegment
 
 
 
 
 
Services
 
True Health (1)
Eliminations
Consolidated
Adjusted Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
27,605

 
 
$

 
 
$

 
 
$
27,605

 
Adjusted Platform and Operations Services
 
353,697

 
 

 
 
(10,949
)
 
 
342,748

 
Adjusted Services Revenue
 
381,302

 
 

 
 
(10,949
)
 
 
370,353

 
True Health:
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 

 
 
69,353

 
 
(602
)
 
 
68,751

 
Adjusted Revenue
 
381,302

 
 
69,353

 
 
(11,551
)
 
 
439,104

 
ASC 606 transition adjustment (2)
 
(4,498
)
 
 

 
 

 
 
(4,498
)
 
Purchase accounting adjustments (3)
 
(647
)
 
 

 
 

 
 
(647
)
 
Total revenue
 
$
376,157

 
 
$
69,353

 
 
$
(11,551
)
 
 
$
433,959

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Services:
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Transformation Services
 
$
23,799

 
 
$

 
 
$

 
 
$
23,799

 
Adjusted Platform and Operations Services
 
298,646

 
 

 
 

 
 
298,646

 
Adjusted Services Revenue
 
322,445

 
 

 
 

 
 
322,445

 
Adjusted Revenue
 
322,445

 
 

 
 

 
 
322,445

 
Purchase accounting adjustments (3)
 
(1,224
)
 
 

 
 

 
 
(1,224
)
 
Total revenue
 
$
321,221

 
 
$

 
 
$

 
 
$
321,221

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segments
 
 
 
 
 
 
Services
 
True Health (1)
Total
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
16,674

 
 
$
921

 
 
$
17,595

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
(5,689
)
 
 
$

 
 
$
(5,689
)
 
 
 
 

(1) 
The True Health segment was created in January 2018.
(2) 
Adjustment to Adjusted Transformation Services Revenue was approximately $3.7 million and the adjustment to Adjusted Platform and Operations Services Revenue was approximately $0.8 million.
(3) 
Purchase accounting adjustments pertain to Adjusted Platform and Operations Services Revenue. There were no purchase accounting adjustments in relation to Adjusted Transformation Services Revenue or True Health premiums revenue.

Reconciliation of Adjusted EBITDA to net income (loss)
The following table presents our reconciliation of segments total Adjusted EBITDA to net income (loss) attributable to Evolent Health, Inc. (in thousands):

 
 
For the Three
 
For the Nine
 
 
Months Ended
 
Months Ended
 
 
September 30,
 
September 30,
 
 
2018
 
2017
 
2018
 
2017
Net Income (Loss) Attributable to
 
 
 
 
 
 
 
 
Evolent Health, Inc.
 
$
(12,429
)
 
$
(12,588
)
 
$
(35,971
)
 
$
(47,506
)
Less:
 
 
 
 
 
 
 
 
Interest income
 
968

 
411

 
2,918

 
813

Interest expense
 
(853
)
 
(880
)
 
(2,561
)
 
(2,781
)
(Provision) benefit for income taxes
 
(135
)
 
1,714

 
(29
)
 
2,009

Depreciation and amortization expenses
 
(10,352
)
 
(7,717
)
 
(29,882
)
 
(21,236
)
Income (loss) from equity method investees
 
(1,381
)
 
(369
)
 
(2,787
)
 
(1,446
)
Change in fair value of contingent
 
 
 
 
 
 
 
 
consideration and indemnification asset
 
(100
)
 
(100
)
 
1,404

 
(300
)
Other income (expense), net
 
(124
)
 
15

 
(64
)
 
21

Net (income) loss attributable to
 
 
 
 
 
 
 
 
non-controlling interests
 
126

 
541

 
680

 
8,471

ASC 606 transition adjustments
 

 

 
(4,498
)
 

Purchase accounting adjustments
 
(214
)
 
(449
)
 
(647
)
 
(1,224
)
Stock-based compensation expense
 
(4,047
)
 
(5,708
)
 
(12,560
)
 
(16,172
)
Severance costs
 

 

 
(1,489
)
 

Amortization of contract cost assets
 
(658
)
 

 
(1,797
)
 

Transaction costs
 
(456
)
 
(2,694
)
 
(2,254
)
 
(9,972
)
Adjusted EBITDA
 
$
4,797

 
$
2,648

 
$
17,595

 
$
(5,689
)
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
True Health Claims Reserves (Tables)
9 Months Ended
Sep. 30, 2018
Insurance [Abstract]  
Activity in claims reserves
Activity in claims reserves was as follows (in thousands):

 
For the Nine
 
Months Ended
 
September 30,
 
 
2018
 
Incurred costs related to current period
 
$
52,169

 
Paid costs related to current period
 
41,831

 
Change during the period
 
10,338

 
Beginning balance
 

 
Ending balance
 
$
10,338

 
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Cash Flow Information (Tables)
9 Months Ended
Sep. 30, 2018
Supplemental Cash Flow Elements [Abstract]  
Supplemental cash flow information
The following represents supplemental disclosure of non-cash investing and financing information (in thousands):

 
For the Nine
 
Months Ended
 
September 30,
 
2018
 
2017
Accrued property and equipment purchases
$
501

 
$
83

Increase to goodwill from measurement period adjustments
 
 
 
related to business combinations
4

 
1,766

Decrease in accrued financing costs related to 2021 Notes

 
196

Consideration for asset acquisitions or business combinations
500

 

Settlement of escrow related to asset acquisition
2,519

 

Settlement of indemnification asset
1,004

 

Tax benefit related to Accordion intangible technology

 
2,042

 
 
 
 
Effects of Class B Exchanges
 
 
 
Decrease in non-controlling interests as a result of Class B Exchanges
25,334

 
168,883

Decrease in deferred tax liability as a result of securities offerings
908

 
12,992

XML 54 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2018
USD ($)
segment
Mar. 31, 2018
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Aug. 31, 2017
Jul. 31, 2017
Jun. 30, 2017
May 31, 2017
Apr. 30, 2017
Mar. 31, 2017
Feb. 28, 2017
Dec. 31, 2016
USD ($)
Jun. 05, 2015
Organization [Line Items]                          
Number of reportable segments | segment 2                        
Cash and cash equivalents | $ $ 221,837   $ 238,433 $ 287,143               $ 134,563  
Evolent Health LLC                          
Organization [Line Items]                          
Parent's ownership percentage 99.00% 98.90% 96.60%   96.60% 96.10% 96.10% 90.50% 84.90% 83.90% 77.40%   70.30%
Evolent Health LLC | Pre-Organization Members                          
Organization [Line Items]                          
Evolent Health LLC ownership interest 100.00%                        
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2018
USD ($)
segment
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
Accounting Policies [Abstract]        
Number of reportable segments | segment 2      
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments $ 45,722 $ 65,685 $ 16,932 $ 40,416
Current restricted investments 0 8,150    
Current restricted cash 42,328 54,248    
Total current restricted cash and restricted investments 42,328 62,398    
Noncurrent restricted investments 712 605    
Noncurrent restricted cash 2,682 2,682    
Total non-current restricted cash and restricted investments 3,394 3,287    
Cash and cash equivalents 221,837 238,433 287,143 134,563
Restricted investments included in restricted cash and restricted investments (712) (8,755) $ (8,150) $ (4,950)
Cash and cash equivalents and restricted cash as of end-of-period 266,847      
Collateral for letters of credit for facility leases        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments 3,710 3,812    
Collateral with financial institutions        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments 22,028 24,725    
Claims processing services        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments 8,942 26,286    
Collateral for reinsurance agreement        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments 10,000 10,000    
Other        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments 1,042 862    
Collateral with financial institutions, money market fund        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments   16,600    
Money market funds        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments $ 10,000      
FDIC participating bank account        
Restricted Cash and Cash Equivalents Items [Line Items]        
Total restricted cash and restricted investments   $ 10,000    
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Notes Receivable (Details)
12 Months Ended
Dec. 31, 2017
USD ($)
installment
Sep. 30, 2018
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Notes receivable $ 20,000,000 $ 6,000,000
Loans Payable | Implementation Fund Loan | Current Customer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Face amount $ 20,000,000.0  
Interest rate 2.50%  
Number of equal principal and interest installments | installment 10  
Amount of equal principal and interest installments $ 2,000,000.0  
Notes receivable 20,000,000 6,000,000
Accrued interest $ 100,000 $ 100,000
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Intangible Assets, Net (Details)
9 Months Ended
Sep. 30, 2018
Corporate trade name  
Finite-Lived Intangible Assets [Line Items]  
Useful life 20 years
Customer relationships | Minimum  
Finite-Lived Intangible Assets [Line Items]  
Useful life 15 years
Customer relationships | Maximum  
Finite-Lived Intangible Assets [Line Items]  
Useful life 25 years
Technology  
Finite-Lived Intangible Assets [Line Items]  
Useful life 5 years
Provider network contracts  
Finite-Lived Intangible Assets [Line Items]  
Useful life 5 years
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Foreign Currency (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Accounting Policies [Abstract]          
Foreign currency translation adjustment $ (116) $ 0 $ (264) $ 0  
Accumulated other comprehensive income (loss) $ (264)   $ (264)   $ 0
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Change in Accounting Principle (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Jan. 01, 2018
Dec. 31, 2017
Revenue            
Revenues $ 149,947 $ 107,912 $ 433,959 $ 321,221    
Expenses            
Cost of revenue (exclusive of depreciation and amortization expenses) [1] 73,967 68,281 214,945 203,804    
Selling, general and administrative expenses [1] 59,566 45,834 172,495 150,474    
Income (loss) before income taxes and non-controlling interests (12,420) (14,843) (36,622) (57,986)    
ASSETS            
Accounts receivable, net 60,054   60,054     $ 48,947
Contract assets (current) 3,705   3,705   $ 3,710 0
Contract assets (noncurrent) 1,000   1,000   1,791 0
Contract cost assets 14,252   14,252     0
Liabilities            
Deferred revenue 22,360   22,360   $ 26,147 24,807
Other long-term liabilities 10,885   10,885     9,861
Shareholders' Equity (Deficit)            
Retained earnings (accumulated deficit) 66,696   66,696     85,952
Non-controlling interests 10,008   10,008     $ 35,427
Balances without adoption of ASC 606            
Expenses            
Cost of revenue (exclusive of depreciation and amortization expenses) 77,409   218,786      
Selling, general and administrative expenses 59,676   173,644      
Income (loss) before income taxes and non-controlling interests (15,798)   (42,063)      
ASSETS            
Accounts receivable, net 57,848   57,848      
Contract assets (current) 0   0      
Contract assets (noncurrent) 0   0      
Contract cost assets 0   0      
Liabilities            
Deferred revenue 24,100   24,100      
Other long-term liabilities 10,746   10,746      
Shareholders' Equity (Deficit)            
Retained earnings (accumulated deficit) 44,580   44,580      
Non-controlling interests 9,361   9,361      
Impact of adoption Higher/(Lower)            
Revenue            
Revenues (214) (449) (647) (1,224)    
Impact of adoption Higher/(Lower) | Accounting Standards Update 2014-09            
Revenue            
Revenues     (4,498)      
Expenses            
Cost of revenue (exclusive of depreciation and amortization expenses) (3,442)   (3,841)      
Selling, general and administrative expenses (110)   (1,149)      
Income (loss) before income taxes and non-controlling interests 3,378   5,441      
ASSETS            
Accounts receivable, net 2,206   2,206      
Contract assets (current) 3,705   3,705      
Contract assets (noncurrent) 1,000   1,000      
Contract cost assets 14,252   14,252      
Liabilities            
Deferred revenue (1,740)   (1,740)      
Other long-term liabilities 139   139      
Shareholders' Equity (Deficit)            
Retained earnings (accumulated deficit) 22,116   22,116      
Non-controlling interests 647   647      
Transformation services            
Revenue            
Revenues [1] 9,230 8,204 23,950 23,799    
Transformation services | Balances without adoption of ASC 606            
Revenue            
Revenues 9,556   25,272      
Transformation services | Impact of adoption Higher/(Lower) | Accounting Standards Update 2014-09            
Revenue            
Revenues (326)   (1,322)      
Platform and operations services            
Revenue            
Revenues [1] 118,094 $ 99,708 341,258 $ 297,422    
Platform and operations services | Balances without adoption of ASC 606            
Revenue            
Revenues 117,942   339,485      
Platform and operations services | Impact of adoption Higher/(Lower) | Accounting Standards Update 2014-09            
Revenue            
Revenues $ 152   $ 1,773      
[1] See Note 16 for amounts related to affiliates included in these line items.
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Investing Activities    
Purchases and maturities of restricted investments $ (8,043) $ 3,200
Net cash and restricted cash provided by (used in) investing activities (24,933) 15,967
Cash Flows from Financing Activities    
Change in restricted cash held on behalf of partners for claims processing (17,344) (25,648)
Net cash and restricted cash provided by (used in) financing activities (7,935) 143,922
Net increase (decrease) in cash and cash equivalents and restricted cash (28,516) 125,896
Cash and cash equivalents and restricted cash as of beginning-of-period 295,363 170,029
Cash and cash equivalents and restricted cash as of end-of-period $ 266,847 295,925
Accounting Standards Update 2016-18    
Cash Flows from Investing Activities    
Purchases and maturities of restricted investments   (3,200)
Change in restricted cash and restricted investments   0
Net cash and restricted cash provided by (used in) investing activities   15,967
Cash Flows from Financing Activities    
Change in restricted cash held on behalf of partners for claims processing   (25,648)
Net cash and restricted cash provided by (used in) financing activities   143,922
Net increase (decrease) in cash and cash equivalents and restricted cash   125,896
Cash and cash equivalents and restricted cash as of beginning-of-period   170,029
Cash and cash equivalents and restricted cash as of end-of-period   295,925
Accounting Standards Update 2016-18 | As Reported    
Cash Flows from Investing Activities    
Purchases and maturities of restricted investments   0
Change in restricted cash and restricted investments   (2,164)
Net cash and restricted cash provided by (used in) investing activities   17,003
Cash Flows from Financing Activities    
Change in restricted cash held on behalf of partners for claims processing   0
Net cash and restricted cash provided by (used in) financing activities   169,570
Net increase (decrease) in cash and cash equivalents and restricted cash   152,580
Cash and cash equivalents and restricted cash as of beginning-of-period   134,563
Cash and cash equivalents and restricted cash as of end-of-period   287,143
Accounting Standards Update 2016-18 | Adjustments    
Cash Flows from Investing Activities    
Purchases and maturities of restricted investments   (3,200)
Change in restricted cash and restricted investments   2,164
Net cash and restricted cash provided by (used in) investing activities   (1,036)
Cash Flows from Financing Activities    
Change in restricted cash held on behalf of partners for claims processing   (25,648)
Net cash and restricted cash provided by (used in) financing activities   (25,648)
Net increase (decrease) in cash and cash equivalents and restricted cash   (26,684)
Cash and cash equivalents and restricted cash as of beginning-of-period   35,466
Cash and cash equivalents and restricted cash as of end-of-period   $ 8,782
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recently Issued Accounting Standards (Details)
$ in Millions
3 Months Ended
Mar. 31, 2018
USD ($)
Accounting Standards Update 2014-09  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Cumulative effect on retained earnings $ 17.3
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Transactions - New Mexico Health Connections (Details) - USD ($)
$ in Thousands
9 Months Ended
Jan. 02, 2018
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Purchase consideration:          
Cash paid to NMHC   $ 11,552 $ 3,694    
Identifiable intangible assets acquired and liabilities assumed          
Goodwill   $ 635,088   $ 628,186 $ 626,569
Provider network contracts          
Identifiable intangible assets acquired and liabilities assumed          
Useful life   5 years      
New Mexico Health Connections          
Business Acquisition [Line Items]          
Transaction costs       $ 1,200  
Purchase consideration:          
Cash paid to NMHC $ 10,000        
Cash paid to escrow agent 252        
Total consideration 10,252        
Identifiable intangible assets acquired and liabilities assumed          
Accrued compensation and employee benefits (474)        
Goodwill 5,826        
Net assets acquired 10,252        
New Mexico Health Connections | Customer relationships          
Identifiable intangible assets acquired and liabilities assumed          
Identifiable intangible assets acquired and liabilities assumed $ 2,700        
Useful life 15 years        
New Mexico Health Connections | Provider network contracts          
Identifiable intangible assets acquired and liabilities assumed          
Identifiable intangible assets acquired and liabilities assumed $ 2,300        
Useful life 5 years        
New Mexico Health Connections | Above market lease          
Identifiable intangible assets acquired and liabilities assumed          
Identifiable intangible assets acquired and liabilities assumed $ (100)        
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Transactions - Pro Forma Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Organizational Transactions [Abstract]        
Revenue $ 149,947 $ 129,820 $ 433,959 $ 378,801
Net income (loss) (12,555) (11,320) (36,651) (65,113)
Net income (loss) attributable to non-controlling interests (126) (413) (680) (8,414)
Net income (loss) attributable to Evolent Health, Inc. $ (12,429) $ (10,907) $ (35,971) $ (56,699)
Net income (loss) available to common shareholders, Basic (in dollars per share) $ (0.16) $ (0.16) $ (0.47) $ (0.93)
Net income (loss) available to common shareholders, Diluted (in dollars per share) $ (0.16) $ (0.16) $ (0.47) $ (0.93)
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Transactions - Secondary Offerings and Sales (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2018
Aug. 31, 2017
Jun. 30, 2017
May 31, 2017
Mar. 31, 2017
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Jun. 30, 2018
Jul. 31, 2017
Apr. 30, 2017
Feb. 28, 2017
Jun. 05, 2015
Business Acquisition [Line Items]                              
Proceeds from issuance of common stock               $ 0 $ 166,947            
Payments of stock issuance costs           $ 300     $ 1,500            
Evolent Health LLC                              
Business Acquisition [Line Items]                              
Parent's ownership percentage 98.90% 96.60% 96.10% 90.50% 83.90%   96.60% 99.00%   96.60%   96.10% 84.90% 77.40% 70.30%
Evolent Health LLC | Over-Allotment Option                              
Business Acquisition [Line Items]                              
Parent's ownership percentage         84.90%                 83.90%  
Class A                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)                   20,100,000          
Common stock, outstanding (in shares)               78,392,052   74,723,597          
Proceeds from issuance of common stock, net of payments of stock issuance costs   $ 166,900                          
Proceeds from issuance of common stock   $ 175,000                          
Class A | Investor Stockholders                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)                   12,600,000          
Class A | Management Selling Stockholders                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)                   100,000          
Class A | Evolent Health, Selling Stockholders                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)                   7,400,000          
Class A | Common Stock                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares) 3,000,000 8,800,000 4,500,000 7,000,000 7,500,000   19,700,000     8,816,000          
Share price (in usd per share)   $ 19.85 $ 25.87 $ 24.30 $ 19.53   $ 19.85                
Payments of stock issuance costs   $ 8,100                          
Class A | Common Stock | Over-Allotment Option                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)         1,100,000                    
Share price (in usd per share)         $ 19.53                    
Class A | Common Stock | Investor Stockholders                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares) 1,800,000   3,800,000 3,800,000 4,400,000                    
Common stock, outstanding (in shares)                     0        
Class A | Common Stock | Investor Stockholders | Over-Allotment Option                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)         600,000                    
Class A | Common Stock | Underwriters                              
Business Acquisition [Line Items]                              
Share price (in usd per share)   $ 19.01         $ 19.01                
Class A | Common Stock | Management Selling Stockholders                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)       100,000                      
Class A | Common Stock | Evolent Health, Selling Stockholders                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares) 1,200,000   700,000 3,100,000 3,100,000                    
Class A | Common Stock | Evolent Health, Selling Stockholders | Over-Allotment Option                              
Business Acquisition [Line Items]                              
Issuance of common stock (in shares)         500,000                    
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Transactions - Accordion Health, Inc. (Details) - Accordion
$ in Millions
Jun. 08, 2017
USD ($)
Business Acquisition [Line Items]  
Accordion purchase agreement, amount $ 3.2
Accordion purchase agreement, contingent earn-out 0.8
Accordion purchase agreement, deferred tax liabilities 2.0
Technology Assets  
Business Acquisition [Line Items]  
Accordion purchase agreement, intangible assets acquired 3.3
Accordion purchase agreement, capitalized transaction costs $ 0.1
Intangible asset, useful life 5 years
Accordion purchase agreement, increase in intangible asset $ 2.0
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Disaggregation of Revenue [Line Items]        
Revenues $ 149,947 $ 107,912 $ 433,959 $ 321,221
Transformation services        
Disaggregation of Revenue [Line Items]        
Revenues [1] 9,230 8,204 23,950 23,799
Platform and operations services        
Disaggregation of Revenue [Line Items]        
Revenues [1] 118,094 $ 99,708 341,258 $ 297,422
Services | Transformation services        
Disaggregation of Revenue [Line Items]        
Revenues 9,230   23,950  
Services | Platform and operations services        
Disaggregation of Revenue [Line Items]        
Revenues $ 116,226   $ 335,509  
[1] See Note 16 for amounts related to affiliates included in these line items.
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Transaction Price Allocated to the Remaining Performance Obligations (Details)
$ in Millions
Sep. 30, 2018
USD ($)
Revenue from Contract with Customer [Abstract]  
Revenue, remaining performance obligation $ 125.0
Revenue, remaining performance obligation, percent to be recognized in current fiscal year 60.00%
Revenue, remaining performance obligation, percent to be recognized in next fiscal year 84.00%
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Contract Balances (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2018
Jan. 01, 2018
Dec. 31, 2017
Revenue from Contract with Customer [Abstract]        
Short-term receivables $ 58,190 $ 58,190 $ 47,131  
Long-term receivables 6,550 6,550 0  
Short-term contract assets 3,705 3,705 3,710 $ 0
Long-term contract assets 1,000 1,000 1,791 0
Short-term deferred revenue 22,360 22,360 26,147 $ 24,807
Long-term deferred revenue 1,000 1,000 $ 493  
Contract asset, reclassified to receivable   (800)    
Deferred revenue increase   (3,300)    
Deferred revenue, revenue recognized 3,700 17,000    
Deferred revenue, adjustment due to net gain share, service-level agreement true-ups and changes in estimates $ 9,400 $ 11,500    
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition - Contract Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Capitalized Contract Cost [Line Items]      
Contract cost amortization   $ 1,900 $ 0
Capitalized contract cost, amortization period 5 years 5 years  
Bonuses and Commissions      
Capitalized Contract Cost [Line Items]      
Contract cost assets $ 2,000 $ 2,000  
Contract cost amortization 100 200  
Contract Fulfillment Costs      
Capitalized Contract Cost [Line Items]      
Contract cost assets 12,300 12,300  
Contract cost amortization $ 600 $ 1,700  
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, Net (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Property, Plant and Equipment [Line Items]          
Total property and equipment $ 94,957   $ 94,957   $ 65,380
Accumulated depreciation and amortization (26,265)   (26,265)   (14,458)
Total property and equipment, net 68,692   68,692   50,922
Depreciation expense 4,300 $ 2,300 11,800 $ 6,000  
Capitalized computer software, amortization 3,100 1,200 8,500 2,800  
Computer hardware          
Property, Plant and Equipment [Line Items]          
Total property and equipment 8,602   8,602   5,667
Furniture and equipment          
Property, Plant and Equipment [Line Items]          
Total property and equipment 3,038   3,038   2,448
Internal-use software development costs          
Property, Plant and Equipment [Line Items]          
Total property and equipment 73,679   73,679   48,557
Total property and equipment, net 58,700   58,700   42,100
Capitalized computer software additions 7,000 $ 8,400 25,100 $ 20,400  
Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Total property and equipment $ 9,638   $ 9,638   $ 8,708
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets, Net - Goodwill (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2018
USD ($)
reporting_unit
Dec. 31, 2017
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]    
Number of reporting units | reporting_unit 2  
Goodwill [Roll Forward]    
Balance as of beginning-of-period $ 628,186 $ 626,569
Goodwill Acquired 7,060  
Measurement period adjustment, goodwill 4 1,617
Foreign currency translation (162)  
Balance as of end-of-period 635,088 628,186
Accumulated impairment 160,600 160,600
Services    
Goodwill [Roll Forward]    
Balance as of beginning-of-period 628,186  
Goodwill Acquired 1,234  
Measurement period adjustment, goodwill 4  
Foreign currency translation (162)  
Balance as of end-of-period 629,262 628,186
True Health    
Goodwill [Roll Forward]    
Balance as of beginning-of-period 0  
Goodwill Acquired 5,826  
Measurement period adjustment, goodwill 0  
Foreign currency translation 0  
Balance as of end-of-period $ 5,826 $ 0
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets, Net - Intangible Assets, Net (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Feb. 28, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Jan. 02, 2018
Finite-Lived Intangible Assets [Line Items]              
Gross Carrying Amount   $ 290,049   $ 290,049   $ 282,499  
Accumulated Amortization   59,243   59,243   41,238  
Net Carrying Value   230,806   230,806   $ 241,261  
Amortization of intangible assets   6,100 $ 5,300 $ 18,000 $ 15,000    
Vestica              
Finite-Lived Intangible Assets [Line Items]              
Contingent consideration settled $ 3,500            
Corporate trade name              
Finite-Lived Intangible Assets [Line Items]              
Weighted-Average Remaining Useful Life       16 years 8 months 15 days   17 years 4 months 26 days  
Gross Carrying Amount   19,000   $ 19,000   $ 19,000  
Accumulated Amortization   3,166   3,166   2,454  
Net Carrying Value   15,834   $ 15,834   $ 16,546  
Customer relationships              
Finite-Lived Intangible Assets [Line Items]              
Weighted-Average Remaining Useful Life       19 years 6 months   20 years 6 months  
Gross Carrying Amount   208,719   $ 208,719   $ 203,500  
Accumulated Amortization   25,550   25,550   18,312  
Net Carrying Value   183,169   $ 183,169   $ 185,188  
Customer relationships | New Mexico Health Connections              
Finite-Lived Intangible Assets [Line Items]              
Identifiable intangible assets             $ 2,700
Customer relationships | Vestica              
Finite-Lived Intangible Assets [Line Items]              
Identifiable intangible assets             2,500
Contingent consideration, asset, held in escrow             4,000
Technology              
Finite-Lived Intangible Assets [Line Items]              
Weighted-Average Remaining Useful Life       2 years 5 months 5 days   3 years 1 month 12 days  
Gross Carrying Amount   55,933   $ 55,933   $ 55,802  
Accumulated Amortization   27,264   27,264   17,810  
Net Carrying Value   28,669   $ 28,669   $ 37,992  
Below market lease, net              
Finite-Lived Intangible Assets [Line Items]              
Weighted-Average Remaining Useful Life       4 years 4 months   4 years 9 months 25 days  
Gross Carrying Amount   4,097   $ 4,097   $ 4,197  
Accumulated Amortization   2,918   2,918   2,662  
Net Carrying Value   1,179   $ 1,179   $ 1,535  
Provider network contracts              
Finite-Lived Intangible Assets [Line Items]              
Weighted-Average Remaining Useful Life       4 years 4 months      
Gross Carrying Amount   2,300   $ 2,300      
Accumulated Amortization   345   345      
Net Carrying Value   $ 1,955   $ 1,955      
Provider network contracts | New Mexico Health Connections              
Finite-Lived Intangible Assets [Line Items]              
Identifiable intangible assets             $ 2,300
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term Debt (Details)
$ / shares in Units, shares in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2016
USD ($)
shares
$ / shares
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
Debt Instrument [Line Items]            
Amortization of deferred financing costs       $ 688,000 $ 685,000  
Senior Notes | Convertible Senior Notes due 2021            
Debt Instrument [Line Items]            
Face amount $ 125,000,000.0 $ 125,000,000   $ 125,000,000   $ 125,000,000
Interest rate 2.00%          
Proceeds from issuance of debt $ 120,400,000          
Debt issuance costs $ 4,600,000          
Repurchase covenant, repurchase price due to fundamental change as percentage of principal amount 100.00%          
Interest expense   600,000 $ 1,900,000      
Amortization of deferred financing costs   $ 200,000 $ 700,000      
Debt conversion denominator shares per principal amount $ 1,000          
Senior Notes | Convertible Senior Notes due 2021 | Class A | Common Stock            
Debt Instrument [Line Items]            
Initial conversion rate per $1000 principal amount 0.0416082          
Conversion price (in dollars per share) | $ / shares $ 24.03          
Initial conversion amount (in shares) | shares 5.2          
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term Debt - Convertible Senior Notes Carrying Value (Details) - Senior Notes - Convertible Senior Notes due 2021 - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Jun. 27, 2018
Dec. 31, 2016
Debt Instrument [Line Items]        
Carrying value $ 122,082,000 $ 121,394,000    
Unamortized discount 2,918,000 3,606,000    
Principal amount $ 125,000,000 $ 125,000,000   $ 125,000,000.0
Remaining amortization period 3 years 2 months 24 days 3 years 10 months 25 days    
Level 2        
Debt Instrument [Line Items]        
Fair value   $ 120,400,000 $ 169,100,000  
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - Additional Information (Details) - USD ($)
shares in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2018
Aug. 31, 2017
Jun. 30, 2017
May 31, 2017
Mar. 31, 2017
Sep. 30, 2018
Dec. 31, 2017
Sep. 30, 2017
Mar. 31, 2017
Aug. 31, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Restricted Cash and Cash Equivalents Items [Line Items]                            
Tax receivables agreement, percent of tax savings to be paid           85.00%         85.00%      
Operating capital support commitment, maximum amount           $ 2,600,000 $ 0       $ 2,600,000   $ 0  
Rent expense           3,300,000   $ 3,000,000     10,100,000 $ 8,000,000    
Restricted funds           45,722,000 $ 65,685,000 16,932,000     45,722,000 16,932,000 $ 65,685,000 $ 40,416,000
Payments of stock issuance costs               $ 300,000       $ 1,500,000    
New Mexico Health Connections                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Reinsurance arrangement, term             15 months              
Reinsurance arrangement, capital amount             $ 10,000,000              
Reinsurance arrangement, quarterly fee             200,000              
Class A                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Issuance of common stock (in shares)                         20,100  
Class A | Common Stock                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Issuance of common stock (in shares) 3,000 8,800 4,500 7,000 7,500         19,700     8,816  
Payments of stock issuance costs   $ 8,100,000                        
Letters of credit for facility leases                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Restricted funds           3,710,000 3,812,000       3,710,000   $ 3,812,000  
Collateral with financial institutions                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Restricted funds           22,028,000 24,725,000       22,028,000   24,725,000  
Collateral for reinsurance agreement                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Restricted funds           10,000,000 10,000,000       10,000,000   10,000,000  
Collateral for reinsurance agreement | New Mexico Health Connections                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Restricted funds             $ 10,000,000           $ 10,000,000  
Minimum                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Letters of credit outstanding, minimum           $ 3,700,000         $ 3,700,000      
Letter of Credit | Line of Credit                            
Restricted Cash and Cash Equivalents Items [Line Items]                            
Line of credit, maximum borrowing capacity         $ 5,000,000.0       $ 5,000,000.0          
Line of credit, quarterly rental fee percentage                 0.80%          
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - Concentration Risk (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Concentration Risk [Line Items]          
Percentage of cash and cash equivalents held with FDIC participating banks 72.30%   72.30%    
Cash and cash equivalents (including restricted cash) $ 266.8   $ 266.8    
Percentage of cash and cash equivalents held in money market funds 27.40%   27.40%    
Percentage of cash held in international banks (less than) 1.00%   1.00%    
Customer B | Customer Concentration Risk | Accounts Receivable | Customer Receivable          
Concentration Risk [Line Items]          
Concentration risk         11.80%
Customer B | Customer Concentration Risk | Revenue          
Concentration Risk [Line Items]          
Concentration risk       10.00%  
Customer C | Customer Concentration Risk | Accounts Receivable | Customer Receivable          
Concentration Risk [Line Items]          
Concentration risk     16.20%   32.10%
Customer D | Customer Concentration Risk | Accounts Receivable | Customer Receivable          
Concentration Risk [Line Items]          
Concentration risk         16.50%
Customer A | Customer Concentration Risk | Revenue          
Concentration Risk [Line Items]          
Concentration risk 18.80% 19.00% 18.90% 18.50%  
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings (Loss) Per Common Share - Computation of Earnings per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Earnings Per Share [Abstract]          
Net income (loss) $ (12,555) $ (13,129) $ (36,651) $ (55,977) $ (69,767)
Less:          
Net income (loss) attributable to non-controlling interests (126) (541) (680) (8,471)  
Net income (loss) available for common shareholders $ (12,429) $ (12,588) $ (35,971) $ (47,506)  
Weighted-average common shares outstanding (in shares) 77,999,000 70,328,000 76,871,000 60,867,000  
Earnings (Loss) per Common Share          
Basic (in dollars per share) $ (0.16) $ (0.18) $ (0.47) $ (0.78)  
Diluted (in dollars per share) $ (0.16) $ (0.18) $ (0.47) $ (0.78)  
Class B          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Convertible preferred stock, shares issued upon conversion (in shares) 1   1    
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings (Loss) Per Common Share - Antidilutive Securities (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of antidilutive securities excluded from the calculation of earning per share (in shares) 9,862 11,408 9,861 17,635
Exchangeable Class B common stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of antidilutive securities excluded from the calculation of earning per share (in shares) 766 2,654 1,251 8,846
Restricted stock units (RSUs)        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of antidilutive securities excluded from the calculation of earning per share (in shares) 1,197 577 923 557
Stock options and performance-based stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of antidilutive securities excluded from the calculation of earning per share (in shares) 2,698 2,976 2,486 3,031
Convertible senior notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of antidilutive securities excluded from the calculation of earning per share (in shares) 5,201 5,201 5,201 5,201
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-based Compensation - Compensation Expense (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation expense $ 4,047,000 $ 5,708,000 $ 12,560,000 $ 16,172,000
Share-based compensation expense capitalized as software development costs 0 0 0 0
Cost of revenue        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation expense 376,000 401,000 1,130,000 1,143,000
Selling, general and administrative expenses        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation expense 3,671,000 5,307,000 11,430,000 15,029,000
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation expense 2,139,000 4,291,000 7,009,000 12,452,000
Performance-based stock options        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation expense 113,000 113,000 334,000 335,000
RSUs        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation expense $ 1,795,000 $ 1,304,000 $ 5,217,000 $ 3,385,000
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-based Compensation - Awards Granted (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based awards granted (in shares) 3,444 84,249 1,053,660 961,313
RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based awards granted (in shares) 18,453 37,361 856,501 461,494
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Income Tax Contingency [Line Items]          
Income tax expense (benefit) (less than $0.1 million for nine months ended September 30, 2018) $ 135 $ (1,714) $ 29 $ (2,009)  
Effective tax rate (0.90%) 11.60% (0.10%) 3.50%  
Unrecognized tax benefits         $ 800
Tax receivables agreement, percent of tax savings to be paid 85.00%   85.00%    
Evolent Health LLC          
Income Tax Contingency [Line Items]          
Decrease in deferred tax liabilities       $ 13,100  
Evolent Health LLC | Income Tax Expense Benefit          
Income Tax Contingency [Line Items]          
Decrease in deferred tax liabilities       300  
Evolent Health LLC | Additional Paid-in Capital          
Income Tax Contingency [Line Items]          
Decrease in deferred tax liabilities     $ 900 $ 12,800  
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments In and Advances to Equity Method Investees (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Schedule of Equity Method Investments [Line Items]          
Loss from affiliates $ 1,381 $ 369 $ 2,787 $ 1,446  
Equity Method Investee | Services Agreements          
Schedule of Equity Method Investments [Line Items]          
Revenue related to long-term services agreement (less than $0.1 million - 3 months ended September 30, 2017) $ 5,100 $ 100 $ 5,900 $ 400  
Minimum          
Schedule of Equity Method Investments [Line Items]          
Economic interest percentage 4.00%   4.00%   26.00%
Equity method investment, ownership percentage         27.00%
Maximum          
Schedule of Equity Method Investments [Line Items]          
Economic interest percentage 40.00%   40.00%   40.00%
Equity method investment, ownership percentage         40.00%
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.10.0.1
Non-controlling Interests (Details) - USD ($)
shares in Thousands, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2018
Aug. 31, 2017
Jun. 30, 2017
May 31, 2017
Mar. 31, 2017
Sep. 30, 2018
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Jul. 31, 2017
Apr. 30, 2017
Feb. 28, 2017
Jun. 05, 2015
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]                              
Non-controlling interests as of beginning-of-period                 $ 35,427            
Reclassification of non-controlling interests                 0   $ 0        
Net income (loss) attributable to non-controlling interests           $ (126) $ (541)   (680) $ (8,471)          
Non-controlling interests as of end-of-period           10,008     10,008   35,427        
Non-controlling Interests                              
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]                              
Non-controlling interests as of beginning-of-period           10,148 34,680   35,427 209,588 209,588        
Cumulative-effect adjustment from adoption of new accounting principle           0 0   594 0          
Decrease in non-controlling interests as a result of Class B Exchanges           0 0   (25,334) (168,883)          
Reclassification of non-controlling interests           (14) 1,793   1 3,698 3,824        
Net income (loss) attributable to non-controlling interests             (541)   (680) (8,471)          
Non-controlling interests as of end-of-period     $ 34,680     $ 10,008 $ 35,932   $ 10,008 $ 35,932 $ 35,427        
Class A                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares)                     20,100        
Proceeds from issuance of common stock, net of payments of stock issuance costs   $ 166,900                          
Class A | Common Stock                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares) 3,000 8,800 4,500 7,000 7,500     19,700     8,816        
Class A | Investor Stockholders                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares)                     12,600        
Class A | Investor Stockholders | Common Stock                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares) 1,800   3,800 3,800 4,400                    
Class A | Management Selling Stockholders                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares)                     100        
Class A | Management Selling Stockholders | Common Stock                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares)       100                      
Class A | Evolent Health, Selling Stockholders                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares)                     7,400        
Class A | Evolent Health, Selling Stockholders | Common Stock                              
Noncontrolling Interest [Line Items]                              
Issuance of common stock (in shares) 1,200   700 3,100 3,100                    
Evolent Health LLC                              
Noncontrolling Interest [Line Items]                              
Parent's ownership percentage 98.90% 96.60% 96.10% 90.50% 83.90% 99.00%   96.60% 99.00%   96.60% 96.10% 84.90% 77.40% 70.30%
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurement - Assets and Liabilities on Recurring Basis (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Jun. 30, 2018
Dec. 31, 2017
Jun. 30, 2017
Dec. 31, 2016
Liabilities                
Contingent consideration, fair value $ 8,300 $ 8,600 $ 8,300 $ 8,600 $ 8,200 $ 8,700 $ 8,500 $ 8,300
Realized and unrealized (gains) losses, net 100 $ 100 (400) $ 300        
Recurring                
Assets                
Cash and cash equivalents 41,186   41,186     60,535    
Restricted cash and restricted investments 32,028   32,028     16,575    
Total 73,214   73,214     77,110    
Liabilities                
Contingent consideration 8,300   8,300     8,700    
Recurring | Level 1                
Assets                
Cash and cash equivalents 41,186   41,186     60,535    
Restricted cash and restricted investments 32,028   32,028     16,575    
Total 73,214   73,214     77,110    
Liabilities                
Contingent consideration 0   0     0    
Recurring | Level 2                
Assets                
Cash and cash equivalents 0   0     0    
Restricted cash and restricted investments 0   0     0    
Total 0   0     0    
Liabilities                
Contingent consideration 0   0     0    
Recurring | Level 3                
Assets                
Cash and cash equivalents 0   0     0    
Restricted cash and restricted investments 0   0     0    
Total 0   0     0    
Liabilities                
Contingent consideration $ 8,300   $ 8,300     $ 8,700    
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurement - Changes in Contingent Consideration (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Balance as of beginning of period $ 8,200 $ 8,500 $ 8,700 $ 8,300
Realized and unrealized (gains) losses, net 100 100 (400) 300
Balance as of end of period $ 8,300 $ 8,600 $ 8,300 $ 8,600
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurement - Valuation Techniques and Significant Unobservable Inputs (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jun. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Contingent consideration, Fair Value $ 8,300 $ 8,700 $ 8,200 $ 8,600 $ 8,500 $ 8,300
Level 3 | Real options approach | Contingent consideration            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Contingent consideration, Fair Value $ 8,300 $ 8,700        
Level 3 | Real options approach | Risk-adjusted recurring revenue CAGR | Contingent consideration            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Assumption or Input Ranges 1.127 0.925        
Level 3 | Real options approach | Discount rate/time value | Contingent consideration | Minimum            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Assumption or Input Ranges 0.038 0.027        
Level 3 | Real options approach | Discount rate/time value | Contingent consideration | Maximum            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Assumption or Input Ranges 0.045 0.040        
Level 3 | Real options approach 2017-2021 | Contingent consideration            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Risk-adjusted recurring revenue compound annual growth rate, period 5 years 5 years        
Level 3 | Real options approach 2017-2021 | Risk-adjusted recurring revenue CAGR | Contingent consideration            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Theoretical recurring revenue $ 1,000 $ 1,000        
Level 3 | Real options approach 2019-2021 | Risk-adjusted recurring revenue CAGR | Contingent consideration            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Assumption or Input Ranges 0.786          
Level 3 | Real options approach 2019-2021 | Risk-adjusted recurring revenue CAGR | Contingent consideration | Minimum            
Fair Value Measurement Inputs and Valuation Techniques [Line Items]            
Assumption or Input Ranges   0.192        
XML 87 R76.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Parties (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Equity Method Investee | Services Agreements        
Related Party Transaction [Line Items]        
Revenue related to long-term services agreement (less than $0.1 million - 3 months ended September 30, 2017) $ 5.1 $ 0.1 $ 5.9 $ 0.4
XML 88 R77.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Parties Related Parties - Revenues and Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue        
Revenues $ 149,947 $ 107,912 $ 433,959 $ 321,221
Expenses        
Cost of revenue (exclusive of depreciation and amortization expenses) [1] 73,967 68,281 214,945 203,804
Selling, general and administrative expenses [1] 59,566 45,834 172,495 150,474
Affiliates        
Expenses        
Cost of revenue (exclusive of depreciation and amortization expenses) 2,390 5,299 6,842 17,382
Selling, general and administrative expenses 241 514 620 1,038
Transformation services        
Revenue        
Revenues [1] 9,230 8,204 23,950 23,799
Transformation services | Affiliates        
Revenue        
Revenues 5,332 352 6,112 597
Platform and operations services        
Revenue        
Revenues [1] 118,094 99,708 341,258 297,422
Platform and operations services | Affiliates        
Revenue        
Revenues $ 12,180 $ 9,411 $ 27,072 $ 24,764
[1] See Note 16 for amounts related to affiliates included in these line items.
XML 89 R78.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
segment
Sep. 30, 2017
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment     2  
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues $ 149,947,000 $ 107,912,000 $ 433,959,000 $ 321,221,000
Adjusted EBITDA 4,797,000 2,648,000 17,595,000 (5,689,000)
Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 130,861,000 107,912,000 376,157,000 321,221,000
Adjusted EBITDA 4,065,000 2,648,000 16,674,000 (5,689,000)
Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 22,829,000 0 69,353,000 0
Adjusted EBITDA 732,000 0 921,000 0
Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues (3,743,000) 0 (11,551,000) 0
Adjusted EBITDA 4,797,000 2,648,000 17,595,000 (5,689,000)
Transformation services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 9,230,000 8,204,000 27,605,000 23,799,000
Revenues [1] 9,230,000 8,204,000 23,950,000 23,799,000
Transformation services | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 9,230,000   23,950,000  
Transformation services | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 9,230,000 8,204,000 27,605,000 23,799,000
Transformation services | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 0 0 0 0
Transformation services | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 0 0 0 0
Platform and operations services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 118,308,000 100,157,000 342,748,000 298,646,000
Revenues [1] 118,094,000 99,708,000 341,258,000 297,422,000
Platform and operations services | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 116,226,000   335,509,000  
Platform and operations services | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 121,845,000 100,157,000 353,697,000 298,646,000
Platform and operations services | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 0 0 0 0
Platform and operations services | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue (3,537,000) 0 (10,949,000) 0
Premiums        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 22,623,000 0 68,751,000 0
Services Revenue        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 127,538,000 108,361,000 370,353,000 322,445,000
Services Revenue | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 131,075,000 108,361,000 381,302,000 322,445,000
Services Revenue | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 0 0 0 0
Services Revenue | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue (3,537,000) 0 (10,949,000) 0
Balances without adoption of ASC 606        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 150,161,000 108,361,000 439,104,000 322,445,000
Balances without adoption of ASC 606 | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 131,075,000 108,361,000 381,302,000 322,445,000
Balances without adoption of ASC 606 | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 22,829,000 0 69,353,000 0
Balances without adoption of ASC 606 | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue (3,743,000) 0 (11,551,000) 0
Balances without adoption of ASC 606 | Transformation services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 9,556,000   25,272,000  
Balances without adoption of ASC 606 | Platform and operations services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 117,942,000   339,485,000  
Balances without adoption of ASC 606 | Premiums        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 22,623,000   68,751,000  
Balances without adoption of ASC 606 | Premiums | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 0   0  
Balances without adoption of ASC 606 | Premiums | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue 22,829,000   69,353,000  
Balances without adoption of ASC 606 | Premiums | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Adjusted Revenue (206,000)   (602,000)  
Adjustments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues (214,000) (449,000) (647,000) (1,224,000)
Adjustments | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues (214,000) (449,000) (647,000) (1,224,000)
Adjustments | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 0 0 0 0
Adjustments | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 0 0 0 0
Adjustments | Transformation services | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 0 0   0
Adjustments | Premiums | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 0 $ 0 0 $ 0
Adjustments | Accounting Standards Update 2014-09        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues     (4,498,000)  
Adjustments | Accounting Standards Update 2014-09 | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues     (4,498,000)  
Adjustments | Accounting Standards Update 2014-09 | Operating segments | True Health        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues     0  
Adjustments | Accounting Standards Update 2014-09 | Intersegment eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues     0  
Adjustments | Accounting Standards Update 2014-09 | Transformation services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues (326,000)   (1,322,000)  
Adjustments | Accounting Standards Update 2014-09 | Transformation services | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues     3,700,000  
Adjustments | Accounting Standards Update 2014-09 | Platform and operations services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues $ 152,000   1,773,000  
Adjustments | Accounting Standards Update 2014-09 | Platform and operations services | Operating segments | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues     $ 800,000  
[1] See Note 16 for amounts related to affiliates included in these line items.
XML 90 R79.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Segment Reporting [Abstract]        
Net Income (Loss) Attributable to Evolent Health, Inc. $ (12,429) $ (12,588) $ (35,971) $ (47,506)
Interest income 968 411 2,918 813
Interest expense (853) (880) (2,561) (2,781)
(Provision) benefit for income taxes (135) 1,714 (29) 2,009
Depreciation and amortization expenses (10,352) (7,717) (29,882) (21,236)
Income (loss) from equity method investees (1,381) (369) (2,787) (1,446)
Change in fair value of contingent consideration and indemnification asset (100) (100) 1,404 (300)
Other income (expense), net (124) 15 (64) 21
Net income (loss) attributable to non-controlling interests 126 541 680 8,471
ASC 606 transition adjustments 0 0 (4,498) 0
Purchase accounting adjustments (214) (449) (647) (1,224)
Stock-based compensation expense (4,047) (5,708) (12,560) (16,172)
Severance costs 0 0 (1,489) 0
Amortization of contract cost assets (658) 0 (1,797) 0
Transaction costs (456) (2,694) (2,254) (9,972)
Adjusted EBITDA $ 4,797 $ 2,648 $ 17,595 $ (5,689)
XML 91 R80.htm IDEA: XBRL DOCUMENT v3.10.0.1
True Health Claims Reserves (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) [Abstract]        
Beginning balance     $ 0  
Incurred costs related to current period $ 16,992 $ 0 52,169 $ 0
Paid costs related to current period     41,831  
Change during the period     10,338  
Ending balance $ 10,338   $ 10,338  
XML 92 R81.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Supplemental Cash Flow Elements [Abstract]    
Accrued property and equipment purchases $ 501 $ 83
Increase to goodwill from measurement period adjustments related to business combinations 4 1,766
Decrease in accrued financing costs related to 2021 Notes 0 196
Consideration for asset acquisitions or business combinations 500 0
Settlement of escrow related to asset acquisition 2,519 0
Settlement of indemnification asset 1,004 0
Tax benefit related to Accordion intangible technology 0 2,042
Effects of Class B Exchanges    
Decrease in deferred tax liability as a result of securities offerings 25,334 168,883
Decrease in deferred tax liability as a result of securities offerings $ 908 $ 12,992
XML 93 R82.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events - Acquisition of New Century Health (Details) - USD ($)
9 Months Ended
Oct. 01, 2018
Sep. 30, 2018
Sep. 30, 2017
Subsequent Event [Line Items]      
Cash   $ 11,552,000 $ 3,694,000
New Century Health | Subsequent Event      
Subsequent Event [Line Items]      
Consideration transferred $ 221,600,000    
Cash $ 117,200,000    
Consideration transferred, shares issued, percentage of total shares issued and outstanding 3.80%    
Contingent liability, earn-out potential $ 20,000,000.0    
Consideration transferred, shares issuable, contingent liability, maximum (in shares) 1,000,000.0    
New Century Health | Subsequent Event | Class B      
Subsequent Event [Line Items]      
Consideration transferred, shares issued (in shares) 3,100,000    
New Century Health | Subsequent Event | Common Class B Units      
Subsequent Event [Line Items]      
Consideration transferred, shares issued (in shares) 3,100,000    
XML 94 R83.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events - Convertible Debt Issuance (Details) - Senior Convertible Notes due 2025 - Senior Notes - Subsequent Event
$ / shares in Units, shares in Millions
1 Months Ended
Oct. 31, 2018
USD ($)
shares
$ / shares
Oct. 24, 2018
USD ($)
Oct. 22, 2018
USD ($)
Subsequent Event [Line Items]      
Face amount $ 172,500,000.0 $ 22,500,000.0 $ 150,000,000.0
Interest rate 1.50%    
Proceeds from issuance of debt $ 167,300,000    
Debt issuance costs 5,200,000    
Debt conversion denominator shares per principal amount $ 1,000    
Conversion price (in dollars per share) | $ / shares $ 33.43    
Initial conversion amount (in shares) | shares 5.2    
Repurchase covenant, repurchase price due to fundamental change as percentage of principal amount 100.00%    
Repurchase covenant, sale price as a percentage of conversion price 130.00%    
Repurchase covenant, trading days (at least) 20 days    
Repurchase covenant, consecutive trading days 30 days    
Repurchase covenant, price due to change in sale price as percentage of conversion price 100.00%    
Common Stock | Class A      
Subsequent Event [Line Items]      
Initial conversion rate per $1000 principal amount 0.0299135    
EXCEL 95 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 96 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 97 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 99 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 428 331 1 true 98 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.evolenthealth.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://www.evolenthealth.com/role/ConsolidatedBalanceSheetsUnaudited CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 1001001 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://www.evolenthealth.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) Sheet http://www.evolenthealth.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) Statements 4 false false R5.htm 1003000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.evolenthealth.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 5 false false R6.htm 1004000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY (DEFICIT) (Unaudited) Sheet http://www.evolenthealth.com/role/ConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY (DEFICIT) (Unaudited) Statements 6 false false R7.htm 2101100 - Disclosure - Organization Sheet http://www.evolenthealth.com/role/Organization Organization Notes 7 false false R8.htm 2102100 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciples Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles Notes 8 false false R9.htm 2104100 - Disclosure - Recently Issued Accounting Standards Sheet http://www.evolenthealth.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 9 false false R10.htm 2107100 - Disclosure - Transactions Sheet http://www.evolenthealth.com/role/Transactions Transactions Notes 10 false false R11.htm 2110100 - Disclosure - Revenue Recognition Sheet http://www.evolenthealth.com/role/RevenueRecognition Revenue Recognition Notes 11 false false R12.htm 2122100 - Disclosure - Property and Equipment, Net Sheet http://www.evolenthealth.com/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 12 false false R13.htm 2125100 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.evolenthealth.com/role/GoodwillAndIntangibleAssetsNet Goodwill and Intangible Assets, Net Notes 13 false false R14.htm 2128100 - Disclosure - Long-term Debt Sheet http://www.evolenthealth.com/role/LongTermDebt Long-term Debt Notes 14 false false R15.htm 2131100 - Disclosure - Commitments and Contingencies Sheet http://www.evolenthealth.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 2134100 - Disclosure - Earnings (Loss) Per Common Share Sheet http://www.evolenthealth.com/role/EarningsLossPerCommonShare Earnings (Loss) Per Common Share Notes 16 false false R17.htm 2137100 - Disclosure - Stock-based Compensation Sheet http://www.evolenthealth.com/role/StockBasedCompensation Stock-based Compensation Notes 17 false false R18.htm 2140100 - Disclosure - Income Taxes Sheet http://www.evolenthealth.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2152100 - Disclosure - Investments In and Advances to Equity Method Investees Sheet http://www.evolenthealth.com/role/InvestmentsInAndAdvancesToEquityMethodInvestees Investments In and Advances to Equity Method Investees Notes 19 false false R20.htm 2153100 - Disclosure - Non-controlling Interests Sheet http://www.evolenthealth.com/role/NonControllingInterests Non-controlling Interests Notes 20 false false R21.htm 2154100 - Disclosure - Fair Value Measurement Sheet http://www.evolenthealth.com/role/FairValueMeasurement Fair Value Measurement Notes 21 false false R22.htm 2155100 - Disclosure - Related Parties Sheet http://www.evolenthealth.com/role/RelatedParties Related Parties Notes 22 false false R23.htm 2156100 - Disclosure - Segment Reporting Sheet http://www.evolenthealth.com/role/SegmentReporting Segment Reporting Notes 23 false false R24.htm 2157100 - Disclosure - True Health Claims Reserves Sheet http://www.evolenthealth.com/role/TrueHealthClaimsReserves True Health Claims Reserves Notes 24 false false R25.htm 2158100 - Disclosure - Supplemental Cash Flow Information Sheet http://www.evolenthealth.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 25 false false R26.htm 2160100 - Disclosure - Subsequent Events Sheet http://www.evolenthealth.com/role/SubsequentEvents Subsequent Events Notes 26 false false R27.htm 2202201 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Policies) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesPolicies Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Policies) Policies http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciples 27 false false R28.htm 2302302 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Tables) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesTables Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Tables) Tables http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciples 28 false false R29.htm 2307301 - Disclosure - Transactions (Tables) Sheet http://www.evolenthealth.com/role/TransactionsTables Transactions (Tables) Tables http://www.evolenthealth.com/role/Transactions 29 false false R30.htm 2310301 - Disclosure - Revenue Recognition (Tables) Sheet http://www.evolenthealth.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.evolenthealth.com/role/RevenueRecognition 30 false false R31.htm 2322301 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.evolenthealth.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.evolenthealth.com/role/PropertyAndEquipmentNet 31 false false R32.htm 2325301 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.evolenthealth.com/role/GoodwillAndIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.evolenthealth.com/role/GoodwillAndIntangibleAssetsNet 32 false false R33.htm 2328301 - Disclosure - Long-term Debt (Tables) Sheet http://www.evolenthealth.com/role/LongTermDebtTables Long-term Debt (Tables) Tables http://www.evolenthealth.com/role/LongTermDebt 33 false false R34.htm 2331301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.evolenthealth.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.evolenthealth.com/role/CommitmentsAndContingencies 34 false false R35.htm 2334301 - Disclosure - Earnings (Loss) Per Common Share (Tables) Sheet http://www.evolenthealth.com/role/EarningsLossPerCommonShareTables Earnings (Loss) Per Common Share (Tables) Tables http://www.evolenthealth.com/role/EarningsLossPerCommonShare 35 false false R36.htm 2337301 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.evolenthealth.com/role/StockBasedCompensationTables Stock-based Compensation (Tables) Tables http://www.evolenthealth.com/role/StockBasedCompensation 36 false false R37.htm 2353301 - Disclosure - Non-controlling Interests (Tables) Sheet http://www.evolenthealth.com/role/NonControllingInterestsTables Non-controlling Interests (Tables) Tables http://www.evolenthealth.com/role/NonControllingInterests 37 false false R38.htm 2354301 - Disclosure - Fair Value Measurement (Tables) Sheet http://www.evolenthealth.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://www.evolenthealth.com/role/FairValueMeasurement 38 false false R39.htm 2355301 - Disclosure - Related Parties (Tables) Sheet http://www.evolenthealth.com/role/RelatedPartiesTables Related Parties (Tables) Tables http://www.evolenthealth.com/role/RelatedParties 39 false false R40.htm 2356301 - Disclosure - Segment Reporting (Tables) Sheet http://www.evolenthealth.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.evolenthealth.com/role/SegmentReporting 40 false false R41.htm 2357301 - Disclosure - True Health Claims Reserves (Tables) Sheet http://www.evolenthealth.com/role/TrueHealthClaimsReservesTables True Health Claims Reserves (Tables) Tables http://www.evolenthealth.com/role/TrueHealthClaimsReserves 41 false false R42.htm 2358301 - Disclosure - Supplemental Cash Flow Information (Tables) Sheet http://www.evolenthealth.com/role/SupplementalCashFlowInformationTables Supplemental Cash Flow Information (Tables) Tables http://www.evolenthealth.com/role/SupplementalCashFlowInformation 42 false false R43.htm 2401401 - Disclosure - Organization (Details) Sheet http://www.evolenthealth.com/role/OrganizationDetails Organization (Details) Details http://www.evolenthealth.com/role/Organization 43 false false R44.htm 2402403 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Details) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesDetails Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles (Details) Details http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesTables 44 false false R45.htm 2402404 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Notes Receivable (Details) Notes http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesNotesReceivableDetails Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Notes Receivable (Details) Details http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesTables 45 false false R46.htm 2402406 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Intangible Assets, Net (Details) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesIntangibleAssetsNetDetails Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Intangible Assets, Net (Details) Details http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesTables 46 false false R47.htm 2402407 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Foreign Currency (Details) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesForeignCurrencyDetails Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Foreign Currency (Details) Details http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesTables 47 false false R48.htm 2402408 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Change in Accounting Principle (Details) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesChangeInAccountingPrincipleDetails Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Change in Accounting Principle (Details) Details 48 false false R49.htm 2402409 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Statement of Cash Flows (Details) Sheet http://www.evolenthealth.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndChangesInAccountingPrinciplesStatementOfCashFlowsDetails Basis of Presentation, Summary of Significant Accounting Policies and Changes in Accounting Principles - Statement of Cash Flows (Details) Details 49 false false R50.htm 2404401 - Disclosure - Recently Issued Accounting Standards (Details) Sheet http://www.evolenthealth.com/role/RecentlyIssuedAccountingStandardsDetails Recently Issued Accounting Standards (Details) Details http://www.evolenthealth.com/role/RecentlyIssuedAccountingStandards 50 false false R51.htm 2407402 - Disclosure - Transactions - New Mexico Health Connections (Details) Sheet http://www.evolenthealth.com/role/TransactionsNewMexicoHealthConnectionsDetails Transactions - New Mexico Health Connections (Details) Details 51 false false R52.htm 2407406 - Disclosure - Transactions - Pro Forma Information (Details) Sheet http://www.evolenthealth.com/role/TransactionsProFormaInformationDetails Transactions - Pro Forma Information (Details) Details 52 false false R53.htm 2407407 - Disclosure - Transactions - Secondary Offerings and Sales (Details) Sheet http://www.evolenthealth.com/role/TransactionsSecondaryOfferingsAndSalesDetails Transactions - Secondary Offerings and Sales (Details) Details 53 false false R54.htm 2407408 - Disclosure - Transactions - Accordion Health, Inc. (Details) Sheet http://www.evolenthealth.com/role/TransactionsAccordionHealthIncDetails Transactions - Accordion Health, Inc. (Details) Details 54 false false R55.htm 2410402 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details) Sheet http://www.evolenthealth.com/role/RevenueRecognitionDisaggregationOfRevenueDetails Revenue Recognition - Disaggregation of Revenue (Details) Details 55 false false R56.htm 2410403 - Disclosure - Revenue Recognition - Transaction Price Allocated to the Remaining Performance Obligations (Details) Sheet http://www.evolenthealth.com/role/RevenueRecognitionTransactionPriceAllocatedToRemainingPerformanceObligationsDetails Revenue Recognition - Transaction Price Allocated to the Remaining Performance Obligations (Details) Details 56 false false R57.htm 2410404 - Disclosure - Revenue Recognition - Contract Balances (Details) Sheet http://www.evolenthealth.com/role/RevenueRecognitionContractBalancesDetails Revenue Recognition - Contract Balances (Details) Details 57 false false R58.htm 2410405 - Disclosure - Revenue Recognition - Contract Costs (Details) Sheet http://www.evolenthealth.com/role/RevenueRecognitionContractCostsDetails Revenue Recognition - Contract Costs (Details) Details 58 false false R59.htm 2422402 - Disclosure - Property and Equipment, Net (Details) Sheet http://www.evolenthealth.com/role/PropertyAndEquipmentNetDetails Property and Equipment, Net (Details) Details http://www.evolenthealth.com/role/PropertyAndEquipmentNetTables 59 false false R60.htm 2425402 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill (Details) Sheet http://www.evolenthealth.com/role/GoodwillAndIntangibleAssetsNetGoodwillDetails Goodwill and Intangible Assets, Net - Goodwill (Details) Details 60 false false R61.htm 2425403 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets, Net (Details) Sheet http://www.evolenthealth.com/role/GoodwillAndIntangibleAssetsNetIntangibleAssetsNetDetails Goodwill and Intangible Assets, Net - Intangible Assets, Net (Details) Details 61 false false R62.htm 2428402 - Disclosure - Long-term Debt (Details) Sheet http://www.evolenthealth.com/role/LongTermDebtDetails Long-term Debt (Details) Details http://www.evolenthealth.com/role/LongTermDebtTables 62 false false R63.htm 2428403 - Disclosure - Long-term Debt - Convertible Senior Notes Carrying Value (Details) Notes http://www.evolenthealth.com/role/LongTermDebtConvertibleSeniorNotesCarryingValueDetails Long-term Debt - Convertible Senior Notes Carrying Value (Details) Details 63 false false R64.htm 2431402 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.evolenthealth.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 64 false false R65.htm 2431404 - Disclosure - Commitments and Contingencies - Concentration Risk (Details) Sheet http://www.evolenthealth.com/role/CommitmentsAndContingenciesConcentrationRiskDetails Commitments and Contingencies - Concentration Risk (Details) Details 65 false false R66.htm 2434402 - Disclosure - Earnings (Loss) Per Common Share - Computation of Earnings per Share (Details) Sheet http://www.evolenthealth.com/role/EarningsLossPerCommonShareComputationOfEarningsPerShareDetails Earnings (Loss) Per Common Share - Computation of Earnings per Share (Details) Details http://www.evolenthealth.com/role/EarningsLossPerCommonShareTables 66 false false R67.htm 2434403 - Disclosure - Earnings (Loss) Per Common Share - Antidilutive Securities (Details) Sheet http://www.evolenthealth.com/role/EarningsLossPerCommonShareAntidilutiveSecuritiesDetails Earnings (Loss) Per Common Share - Antidilutive Securities (Details) Details http://www.evolenthealth.com/role/EarningsLossPerCommonShareTables 67 false false R68.htm 2437402 - Disclosure - Stock-based Compensation - Compensation Expense (Details) Sheet http://www.evolenthealth.com/role/StockBasedCompensationCompensationExpenseDetails Stock-based Compensation - Compensation Expense (Details) Details 68 false false R69.htm 2437403 - Disclosure - Stock-based Compensation - Awards Granted (Details) Sheet http://www.evolenthealth.com/role/StockBasedCompensationAwardsGrantedDetails Stock-based Compensation - Awards Granted (Details) Details 69 false false R70.htm 2440401 - Disclosure - Income Taxes (Details) Sheet http://www.evolenthealth.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.evolenthealth.com/role/IncomeTaxes 70 false false R71.htm 2452401 - Disclosure - Investments In and Advances to Equity Method Investees (Details) Sheet http://www.evolenthealth.com/role/InvestmentsInAndAdvancesToEquityMethodInvesteesDetails Investments In and Advances to Equity Method Investees (Details) Details http://www.evolenthealth.com/role/InvestmentsInAndAdvancesToEquityMethodInvestees 71 false false R72.htm 2453402 - Disclosure - Non-controlling Interests (Details) Sheet http://www.evolenthealth.com/role/NonControllingInterestsDetails Non-controlling Interests (Details) Details http://www.evolenthealth.com/role/NonControllingInterestsTables 72 false false R73.htm 2454402 - Disclosure - Fair Value Measurement - Assets and Liabilities on Recurring Basis (Details) Sheet http://www.evolenthealth.com/role/FairValueMeasurementAssetsAndLiabilitiesOnRecurringBasisDetails Fair Value Measurement - Assets and Liabilities on Recurring Basis (Details) Details 73 false false R74.htm 2454403 - Disclosure - Fair Value Measurement - Changes in Contingent Consideration (Details) Sheet http://www.evolenthealth.com/role/FairValueMeasurementChangesInContingentConsiderationDetails Fair Value Measurement - Changes in Contingent Consideration (Details) Details 74 false false R75.htm 2454404 - Disclosure - Fair Value Measurement - Valuation Techniques and Significant Unobservable Inputs (Details) Sheet http://www.evolenthealth.com/role/FairValueMeasurementValuationTechniquesAndSignificantUnobservableInputsDetails Fair Value Measurement - Valuation Techniques and Significant Unobservable Inputs (Details) Details 75 false false R76.htm 2455402 - Disclosure - Related Parties (Details) Sheet http://www.evolenthealth.com/role/RelatedPartiesDetails Related Parties (Details) Details http://www.evolenthealth.com/role/RelatedPartiesTables 76 false false R77.htm 2455403 - Disclosure - Related Parties Related Parties - Revenues and Expenses (Details) Sheet http://www.evolenthealth.com/role/RelatedPartiesRelatedPartiesRevenuesAndExpensesDetails Related Parties Related Parties - Revenues and Expenses (Details) Details 77 false false R78.htm 2456402 - Disclosure - Segment Reporting (Details) Sheet http://www.evolenthealth.com/role/SegmentReportingDetails Segment Reporting (Details) Details http://www.evolenthealth.com/role/SegmentReportingTables 78 false false R79.htm 2456403 - Disclosure - Segment Reporting - Reconciliation of Adjusted EBITDA (Details) Sheet http://www.evolenthealth.com/role/SegmentReportingReconciliationOfAdjustedEbitdaDetails Segment Reporting - Reconciliation of Adjusted EBITDA (Details) Details 79 false false R80.htm 2457402 - Disclosure - True Health Claims Reserves (Details) Sheet http://www.evolenthealth.com/role/TrueHealthClaimsReservesDetails True Health Claims Reserves (Details) Details http://www.evolenthealth.com/role/TrueHealthClaimsReservesTables 80 false false R81.htm 2458402 - Disclosure - Supplemental Cash Flow Information (Details) Sheet http://www.evolenthealth.com/role/SupplementalCashFlowInformationDetails Supplemental Cash Flow Information (Details) Details http://www.evolenthealth.com/role/SupplementalCashFlowInformationTables 81 false false R82.htm 2460401 - Disclosure - Subsequent Events - Acquisition of New Century Health (Details) Sheet http://www.evolenthealth.com/role/SubsequentEventsAcquisitionOfNewCenturyHealthDetails Subsequent Events - Acquisition of New Century Health (Details) Details 82 false false R83.htm 2460402 - Disclosure - Subsequent Events - Convertible Debt Issuance (Details) Sheet http://www.evolenthealth.com/role/SubsequentEventsConvertibleDebtIssuanceDetails Subsequent Events - Convertible Debt Issuance (Details) Details 83 false false All Reports Book All Reports evh-20180930.xml evh-20180930.xsd evh-20180930_cal.xml evh-20180930_def.xml evh-20180930_lab.xml evh-20180930_pre.xml http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 101 0001628908-18-000083-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628908-18-000083-xbrl.zip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end

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